Guidance law simulation studies for complex approaches using the Microwave Landing System (MLS)

NASA Technical Reports Server (NTRS)

Feather, J. B.

1986-01-01

This report documents results for MLS guidance algorithm development conducted by DAC for NASA under the Advance Transport Operating Systems (ATOPS) Technology Studies program (NAS1-18028). The study consisted of evaluating guidance laws for vertical and lateral path control, as well as speed control, by simulating an MLS approach for the Washington National Airport. This work is an extension and generalization of a previous ATOPS contract (NAS1-16202) completed by DAC in 1985. The Washington river approach was simulated by six waypoints and one glideslope change and consisted of an eleven nautical mile approach path. Tracking performance was generated for 10 cases representing several different conditions, which included MLS noise, steady wind, turbulence, and windshear. Results of this simulation phase are suitable for use in future fixed-base simulator evaluations employing actual hardware (autopilot and a performance management system), as well as crew procedures and information requirements for MLS.

Orion Crew Module Structural Test Article Arrival

NASA Image and Video Library

2016-11-15

NASA’s Super Guppy aircraft, carrying the Orion crew module structural test article (STA), arrives at the Shuttle Landing Facility operated by Space Florida at NASA’s Kennedy Space Center in Florida. The STA will be offloaded and transported to the Neil Armstrong Operations and Checkout Building high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Subaru Telescope, Hawaii

NASA Astrophysics Data System (ADS)

Murdin, P.

2000-11-01

The Subaru Telescope, Hawaii is an 8.2 m aperture optical infrared telescope being operated by the NATIONAL ASTRONOMICAL OBSERVATORY, JAPAN (NAOJ) atop Mauna Kea, Hawaii. It is one of the new-generation telescopes with an actively controlled large monolithic mirror, and has been producing testing-phase observational results on solar system, star formation, active galactic nuclei and quasars, grou...

KSC-2014-3781

NASA Image and Video Library

2014-09-10

CAPE CANAVERAL, Fla. – Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, members of the Brevard Police and Fire Pipes and Drums lead NASA and Lockheed Martin workers toward the Orion crew module, stacked atop its service module. A ceremony will begin to officially turn over the Orion spacecraft for Exploration Flight Test-1 to Lockheed Martin Ground Operations from Orion Assembly, Integration and Production. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch atop a United Launch Alliance Delta IV Heavy rocket from Cape Canaveral Air Force Station in Florida in December to an altitude of 3,600 miles above the Earth's surface. The two-orbit, four-hour flight test will help engineers evaluate the systems critical to crew safety including the heat shield, parachute system and launch abort system. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Daniel Casper

KSC-2014-3782

NASA Image and Video Library

2014-09-10

CAPE CANAVERAL, Fla. – Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, members of the Brevard Police and Fire Pipes and Drums lead NASA and Lockheed Martin workers toward the Orion crew module, stacked atop its service module. A ceremony will begin to officially turn over the Orion spacecraft for Exploration Flight Test-1 to Lockheed Martin Ground Operations from Orion Assembly, Integration and Production. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch atop a United Launch Alliance Delta IV Heavy rocket from Cape Canaveral Air Force Station in Florida in December to an altitude of 3,600 miles above the Earth's surface. The two-orbit, four-hour flight test will help engineers evaluate the systems critical to crew safety including the heat shield, parachute system and launch abort system. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Daniel Casper

Persistent activation of interlinked type 2 airway epithelial gene networks in sputum-derived cells from aeroallergen-sensitized symptomatic asthmatics.

PubMed

Jones, Anya C; Troy, Niamh M; White, Elisha; Hollams, Elysia M; Gout, Alexander M; Ling, Kak-Ming; Kicic, Anthony; Stick, Stephen M; Sly, Peter D; Holt, Patrick G; Hall, Graham L; Bosco, Anthony

2018-01-24

Atopic asthma is a persistent disease characterized by intermittent wheeze and progressive loss of lung function. The disease is thought to be driven primarily by chronic aeroallergen-induced type 2-associated inflammation. However, the vast majority of atopics do not develop asthma despite ongoing aeroallergen exposure, suggesting additional mechanisms operate in conjunction with type 2 immunity to drive asthma pathogenesis. We employed RNA-Seq profiling of sputum-derived cells to identify gene networks operative at baseline in house dust mite-sensitized (HDM S ) subjects with/without wheezing history that are characteristic of the ongoing asthmatic state. The expression of type 2 effectors (IL-5, IL-13) was equivalent in both cohorts of subjects. However, in HDM S -wheezers they were associated with upregulation of two coexpression modules comprising multiple type 2- and epithelial-associated genes. The first module was interlinked by the hubs EGFR, ERBB2, CDH1 and IL-13. The second module was associated with CDHR3 and mucociliary clearance genes. Our findings provide new insight into the molecular mechanisms operative at baseline in the airway mucosa in atopic asthmatics undergoing natural aeroallergen exposure, and suggest that susceptibility to asthma amongst these subjects involves complex interactions between type 2- and epithelial-associated gene networks, which are not operative in equivalently sensitized/exposed atopic non-asthmatics.

Enhanced Preliminary Assessment Report: Clementon Army Housing Units, Clementon, New Jersey

DTIC Science & Technology

1989-11-01

confining layers. In the vicinity of the Clementon housing area, the Potomac-Raritan- Magothy 14 aquifer system lies unconformably atop the pre-Cretaceous...groundwater withdrawals are taken from the Potomac-Raritan- Magothy system, although this situation may reflect very large withdrawals by the cities of...Cohansey aquifers because of the increasingly high salinity of the Potomac-Raritan- Magothy water. 15 3 ENVIRONMENTALLY SIGNIFICANT OPERATIONS 3.1

Mixing and CP violation in the B$$0\\atop{s}$$ meson system at CDF; Mélange et violation de CP dans le système des mésons B$$0\\atop{s}$$ à CDF (in French)

DOE Office of Scientific and Technical Information (OSTI.GOV)

Di Giovanni, Gian Piero

2008-01-01

The two analyses presented in the thesis, the Bmore » $$0\\atop{s}$$ mixing analysis and the B$$0\\atop{s}$$ → J/ψφ angular analysis, share most of the technical implementations and features. Thus, my choice was to pursue in parallel the common aspects of the analyses, avoiding, whenever possible, repetitions. Each Chapter is split in two parts, the first one dedicated to the B$$0\\atop{s}$$ mixing analysis and the second one describing the angular analysis on the B$$0\\atop{s}$$ → J/ψφ decay mode. They are organized as follows. In Chapter 1 we present the theoretical framework of the B$$0\\atop{s}$$ neutral mesons system. After a general introduction on the Standard Model, we focus on the quantities which are relevant to the Δms measurement and the CP violation phenomena, underlying the details concerning the study of pseudo-scalar to vector vector decays, P → VV, which allow to carry out an angular analysis. A discussion on the implication of the measurements performed in the search of physics beyond the Standard Model is presented. The accelerator facilities and the CDF-II detector are reported in Chapter 2. While describing the detector, more emphasis is given to the components fundamental to perform B physics analyses at CDF. The Chapter 3 is focused on the reconstruction and selection of the data samples. The Chapter starts with a description of the on-line trigger requirements, according to the B$$0\\atop{s}$$ sample considered, followed by the offline selection criteria implemented to reconstruct B$$0\\atop{s}$$ semileptonic and hadronic decays, fully and partially reconstructed, for the B$$0\\atop{s}$$ mixing analysis, as well as the B$$0\\atop{s}$$ → J/ψφ decay mode for the angular analysis. The subsequent Chapter 4 is dedicated to the revision of the technical ingredients needed in the final analyses. The B$$0\\atop{s}$$ mixing elements are firstly described. The methodology historically used in the oscillation searches, the 'amplitude scan', is here introduced together with the calibration of the proper-decay-time resolution and the flavor tagging algorithms, in particular a closer examination of the same-side tagger performances is given. The B$$0\\atop{s}$$ → J/ψφ angular analysis elements description then follows, focusing on the performances and the eventual differences with respect to the B$$0\\atop{s}$$ oscillation search. The final results of the analyses are obtained with the use of an un-binned likelihood fitting framework: Chapter 5 presents the general principles behind this methodology and a description of both the maximum likelihood fitters employed. Chapter 6 contains the conclusive results on the B$$0\\atop{s}$$ analyses. They are presented in an historical fashion: the measurement of the B$$0\\atop{s}$$ oscillation frequency is followed by the first flavor tagged ΔΓs and βs measurements. The impact and the constraints on the parameters of the flavor model is part of the discussion in the Chapter. As cross-check of the B$$0\\atop{s}$$ angular analysis, the B$$0\\atop{s}$$ → J/ψK*0 decay mode has been additionally studied. Its angular analysis shows a competitive sensitivity with the B factories in measuring the parameters which define the decay. Not only this contributes to enforce the reliability of the entire framework, but it constitutes an excellent result by itself. Thus, we devote the entire Chapter 7 to the sole discussion of the angular analysis of the B$$0\\atop{s}$$ → J/ψK*0 decay mode.« less

Orion Crew Module Adapter-Structural Test Article and European S

NASA Image and Video Library

2017-05-09

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, operations are underway to lower the Orion crew module adapter structural test article onto the European Space Agency's service module structural test article. After the hardware is attached, the structure will be packed and shipped to Lockheed Martin's Denver facility to undergo testing. The Orion spacecraft will launch atop the agency's Space Launch System rocket on Exploration Mission-1 in 2019.

Orion Crew Module Structural Test Article Lift & Uncrating

NASA Image and Video Library

2016-11-15

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, the cover has been removed from the container holding the Orion crew module structural test article (STA). The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article was moved inside the facility's high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Offload

NASA Image and Video Library

2016-11-15

After arriving at the Shuttle Landing Facility operated by Space Florida at NASA's Kennedy Space Center in Florida, the agency's Super Guppy aircraft has been opened and the container holding the Orion crew module structural test article (STA) is being offloaded. The test article will be transported to the Neil Armstrong Operations and Checkout Building high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Offload

NASA Image and Video Library

2016-11-15

NASA’s Super Guppy aircraft, carrying the Orion crew module structural test article, arrived at the Shuttle Landing Facility operated by Space Florida at NASA’s Kennedy Space Center in Florida. The unique aircraft has been opened to reveal the container holding the STA. The test article will be transported to the Neil Armstrong Operations and Checkout Building high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Unbagging

NASA Image and Video Library

2016-11-15

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, Lockheed Martin technicians remove the protective covering from the Orion crew module structural test article (STA). The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article was moved inside the facility's high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Unbagging

NASA Image and Video Library

2016-11-15

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, the cover has been removed from the container holding the Orion crew module structural test article (STA). The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article was moved inside the facility's high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Offload

NASA Image and Video Library

2016-11-15

After arriving at the Shuttle Landing Facility operated by Space Florida at NASA's Kennedy Space Center in Florida, the agency's Super Guppy aircraft has been opened and the container holding the Orion crew module structural test article (STA) is being offloaded. The test article will be transported to the Neil Armstrong Operations and Checkout Building high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018. Photo credit: NASA/Ben Smegelsky

Orion EM-1 Crew Module Structural Test Article Move to Birdcage

NASA Image and Video Library

2016-11-16

Inside the Neil Armstrong Operations and Checkout Building at NASA’s Kennedy Space Center in Florida, the Orion crew module structural test article (STA) is secured on a test tool called the birdcage. The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article will undergo further testing in the high bay. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Offload

NASA Image and Video Library

2016-11-15

NASA’s Super Guppy aircraft, carrying the Orion crew module structural test article (STA), arrived at the Shuttle Landing Facility operated by Space Florida at NASA’s Kennedy Space Center in Florida. The unique aircraft is being opened to offload the STA. The test article will be transported to the Neil Armstrong Operations and Checkout Building high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Offload

NASA Image and Video Library

2016-11-15

After arriving at the Shuttle Landing Facility operated by Space Florida at NASA's Kennedy Space Center in Florida, the agency's Super Guppy aircraft was opened and the container holding the Orion crew module structural test article (STA) was offloaded. The test article will be transported to the Neil Armstrong Operations and Checkout Building high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Offload

NASA Image and Video Library

2016-11-15

NASA’s Super Guppy aircraft, carrying the Orion crew module structural test article, arrived at the Shuttle Landing Facility operated by Space Florida at NASA’s Kennedy Space Center in Florida. The unique aircraft has been opened and the container holding the STA is being offloaded. The test article will be transported to the Neil Armstrong Operations and Checkout Building high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Offload

NASA Image and Video Library

2016-11-15

NASA’s Super Guppy aircraft, carrying the Orion crew module structural test article (STA), arrived at the Shuttle Landing Facility operated by Space Florida at NASA’s Kennedy Space Center in Florida. The front of the unique aircraft is being opened to offload the STA. The test article will be transported to the Neil Armstrong Operations and Checkout Building high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

The Inherent Limitations of Spacepower: Fact or Fiction?

DTIC Science & Technology

1995-01-01

advantageously to affect near-earth space, as well as the Earth, itself. These are termed the libration points . Collins writes: The five so-called libration ... Libration points allow for little or no energy expense for station keeping, while operating from atop the "gravity well" allows for high potential energy...navigation, communica- tions, earth resources, lift orbit transfer , and tracking and control systems. Integrating many aspects of these systems to serve both

The Development of a Practical and Reliable Assessment Measure for Atopic Dermatitis (ADAM).

ERIC Educational Resources Information Center

Charman, Denise; Varigos, George; Horne, David J. de L.; Oberklaid, Frank

1999-01-01

A study was conducted in Australia to develop a reliable, valid, and practical measure of atopic dermatitis. The test development process and validity evaluation with two doctors and 51 patients are discussed. Results suggest that operational definitions of the scales need to be defined more clearly. The measure satisfies assumptions for a partial…

KSC-2013-4428

NASA Image and Video Library

2013-12-13

CAPE CANAVERAL, Fla. – At Cape Canaveral Air Force Station's Launch Complex 41, a Centaur second stage is positioned atop a United Launch Alliance Atlas V rocket that will be used to boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft to orbit. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Charisse Nahser

KSC-2013-4429

NASA Image and Video Library

2013-12-13

CAPE CANAVERAL, Fla. – At Cape Canaveral Air Force Station's Launch Complex 41, a Centaur second stage is positioned atop a United Launch Alliance Atlas V rocket that will be used to boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft to orbit. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Charisse Nahser

Evidence that Singlet Oxygen-induced Human T Helper Cell Apoptosis Is the Basic Mechanism of Ultraviolet-A Radiation Phototherapy

PubMed Central

Morita, Akimichi; Werfel, Thomas; Stege, Helger; Ahrens, Constanze; Karmann, Karin; Grewe, Markus; Grether-Beck, Susanne; Ruzicka, Thomas; Kapp, Alexander; Klotz, Lars-Oliver; Sies, Helmut; Krutmann, Jean

1997-01-01

Ultraviolet A (UVA) irradiation is effectively used to treat patients with atopic dermatitis and other T cell mediated, inflammatory skin diseases. In the present study, successful phototherapy of atopic dermatitis was found to result from UVA radiation-induced apoptosis in skin-infiltrating T helper cells, leading to T cell depletion from eczematous skin. In vitro, UVA radiation-induced human T helper cell apoptosis was mediated through the FAS/FAS-ligand system, which was activated in irradiated T cells as a consequence of singlet oxygen generation. These studies demonstrate that singlet oxygen is a potent trigger for the induction of human T cell apoptosis. They also identify singlet oxygen generation as a fundamental mechanism of action operative in phototherapy. PMID:9362536

Orion Crew Module Move

NASA Image and Video Library

2017-11-17

A crane is being prepared for use during move operations of the Orion crew module for Exploration Mission-1 to the thermal chamber in the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida. The crew module will undergo a thermal cycle test to assess the workmanship of critical hardware and structural locations. The test also demonstrates crew module subsystem operations in a thermally stressing environment to confirm no damage or anomalous hardware conditions as a result of the test. The Orion spacecraft will launch atop NASA's Space Launch System rocket on its first uncrewed integrated flight.

Orion Crew Module Move

NASA Image and Video Library

2017-11-17

Technicians check a crane that will be used during move operations of the Orion crew module for Exploration Mission-1 to the thermal chamber in the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida. The crew module will undergo a thermal cycle test to assess the workmanship of critical hardware and structural locations. The test also demonstrates crew module subsystem operations in a thermally stressing environment to confirm no damage or anomalous hardware conditions as a result of the test. The Orion spacecraft will launch atop NASA's Space Launch System rocket on its first uncrewed integrated flight.

Orion Crew Module Move

NASA Image and Video Library

2017-11-17

Technicians prepare a crane for use during move operations of the Orion crew module for Exploration Mission-1 to the thermal chamber in the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida. The crew module will undergo a thermal cycle test to assess the workmanship of critical hardware and structural locations. The test also demonstrates crew module subsystem operations in a thermally stressing environment to confirm no damage or anomalous hardware conditions as a result of the test. The Orion spacecraft will launch atop NASA's Space Launch System rocket on its first uncrewed integrated flight.

Orion Splashdown Recovery

NASA Image and Video Library

2014-12-05

NASA's Orion spacecraft splashed down in the Pacific Ocean after its first flight test atop a Delta IV Heavy rocket from Space Launch Complex 37 at Cape Canaveral Air Force Station in Florida. U.S. Navy divers in Zodiac boats prepare to recover Orion and tow her in to the well deck of the USS Anchorage. NASA's Orion spacecraft completed a two-orbit, four-and-a-half hour mission to test systems critical to crew safety, including the launch abort system, the heat shield and the parachute system. The Ground Systems Development and Operations Program is leading the recovery efforts.

Management of Patients with Atopic Dermatitis: The Role of Emollient Therapy

PubMed Central

Catherine Mack Correa, M.; Nebus, Judith

2012-01-01

Atopic dermatitis is a common inflammatory skin disorder that afflicts a growing number of young children. Genetic, immune, and environmental factors interact in a complex fashion to contribute to disease expression. The compromised stratum corneum found in atopic dermatitis leads to skin barrier dysfunction, which results in aggravation of symptoms by aeroallergens, microbes, and other insults. Infants—whose immune system and epidermal barrier are still developing—display a higher frequency of atopic dermatitis. Management of patients with atopic dermatitis includes maintaining optimal skin care, avoiding allergic triggers, and routinely using emollients to maintain a hydrated stratum corneum and to improve barrier function. Flares of atopic dermatitis are often managed with courses of topical corticosteroids or calcineurin inhibitors. This paper discusses the role of emollients in the management of atopic dermatitis, with particular emphasis on infants and young children. PMID:23008699

SRB Processing Facilities Media Event

NASA Image and Video Library

2016-03-01

Inside the Booster Fabrication Facility (BFF) at NASA’s Kennedy Space Center in Florida, members of the news media photograph a frustrum that will be stacked atop a forward skirt for one of NASA’s Space Launch System (SLS) solid rocket boosters. Orbital ATK is a contractor for NASA’s Marshall Space Flight Center in Alabama, and operates the BFF to prepare aft booster segments and hardware for the SLS solid rocket boosters. The SLS rocket and Orion spacecraft will launch on Exploration Mission-1 in 2018. The Ground Systems Development and Operations Program is preparing the infrastructure to process and launch spacecraft on deep-space missions and the journey to Mars.

Effect of Benralizumab in Atopic Dermatitis

ClinicalTrials.gov

2018-06-22

Dermatitis, Atopic; Dermatitis; Eczema; Skin Diseases; Skin Diseases, Genetic; Genetic Diseases, Inborn; Skin Diseases, Eczematous; Hypersensitivity; Hypersensitivity, Immediate; Immune System Diseases

Cryo Tank Fill at Pad 39B

NASA Image and Video Library

2017-09-26

NASA Launch Director Charlie Blackwell-Thompson, at left, arrives at Launch Pad 39B at NASA's Kennedy Space Center in Florida, to observe the first major tanking operation of liquid oxygen, or LO2, into the giant storage sphere at the northwest corner of the pad to prepare for the launch of the agency's Orion spacecraft atop the Space Launch System (SLS) rocket. During the operation, several Praxair trucks will slowly offload LO2 to gradually chill down the sphere from normal temperature to about negative 298 degrees Fahrenheit. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to pad B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1, deep space missions and NASA’s journey to Mars.

Orion Crew Module Structural Test Article Offload

NASA Image and Video Library

2016-11-15

After arriving at the Shuttle Landing Facility operated by Space Florida at NASA's Kennedy Space Center in Florida, the agency's Super Guppy aircraft was opened and the container holding the Orion crew module structural test article (STA) was offloaded. A crane has lifted the container for placement on a transporter. The test article will be moved to the Neil Armstrong Operations and Checkout Building high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Offload

NASA Image and Video Library

2016-11-15

After arriving at the Shuttle Landing Facility operated by Space Florida at NASA's Kennedy Space Center in Florida, the agency's Super Guppy aircraft was opened and the container holding the Orion crew module structural test article (STA) was offloaded. A crane was used to lower the container onto a transporter. The test article will be moved to the Neil Armstrong Operations and Checkout Building high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Transport from SLF to

NASA Image and Video Library

2016-11-15

A transporter carrying the Orion crew module structural test article (STA) in its container arrives at the low bay entrance of the Neil Armstrong Operations and Checkout Building at NASA's Kennedy Space Center in Florida. The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article will be moved inside the facility's high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Unbagging

NASA Image and Video Library

2016-11-15

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, the protective covering was removed from the Orion crew module structural test article (STA). It remains secured on the bottom of its transport container. The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article was moved inside the facility's high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Offload

NASA Image and Video Library

2016-11-15

After arriving at the Shuttle Landing Facility operated by Space Florida at NASA's Kennedy Space Center in Florida, the agency's Super Guppy aircraft was opened and the container holding the Orion crew module structural test article (STA) was offloaded. A crane is used to lower the container for placement on a transporter. The test article will be moved to the Neil Armstrong Operations and Checkout Building high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Lift & Uncrating

NASA Image and Video Library

2016-11-15

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, technicians with Lockheed Martin assist as a crane lifts the cover away from the container holding the Orion crew module structural test article (STA). The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article was moved inside the facility's high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Transport from SLF to

NASA Image and Video Library

2016-11-15

A transporter carrying the Orion crew module structural test article (STA) in its container arrives inside the low bay of the Neil Armstrong Operations and Checkout Building at NASA's Kennedy Space Center in Florida. The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article will be moved inside the facility's high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Lift & Uncrating

NASA Image and Video Library

2016-11-15

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, a crane lifts the cover up from the container holding the Orion crew module structural test article (STA). The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article was moved inside the facility's high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Unbagging

NASA Image and Video Library

2016-11-15

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, technicians with Lockheed Martin look over the Orion crew module structural test article (STA) secured on the bottom of its transport container. The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article was moved inside the facility's high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Move

NASA Image and Video Library

2017-11-17

The Orion crew module for Exploration Mission-1 was moved into the thermal chamber in the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida. The crew module will undergo a thermal cycle test to assess the workmanship of critical hardware and structural locations. The test also demonstrates crew module subsystem operations in a thermally stressing environment to confirm no damage or anomalous hardware conditions as a result of the test. The Orion spacecraft will launch atop NASA's Space Launch System rocket on its first uncrewed integrated flight.

Orion Crew Module Move

NASA Image and Video Library

2017-11-17

Technicians assist as the Orion crew module for Exploration Mission-1 is moved toward the thermal chamber in the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida. The crew module will undergo a thermal cycle test to assess the workmanship of critical hardware and structural locations. The test also demonstrates crew module subsystem operations in a thermally stressing environment to confirm no damage or anomalous hardware conditions as a result of the test. The Orion spacecraft will launch atop NASA's Space Launch System rocket on its first uncrewed integrated flight.

Can atopic dermatitis be prevented?

PubMed

Gómez-de la Fuente, E

2015-05-01

Atopic dermatitis has become a health problem in our setting due to its rising prevalence, impact on quality of life, associated costs, and role in the progression to other atopic diseases. Furthermore, atopic dermatitis has no definitive cure and therefore preventive measures are important. In this article, we review the latest advances in both primary prevention (reduction of the incidence of atopic dermatitis) and secondary prevention (reduction of associated morbidity and reduction of the atopic march). We analyze the different preventive strategies available, including modification of the immune system through microbial exposure, induction of immune tolerance through antigen exposure, and restoration of skin barrier function to halt the atopic march. Dermatologists need to be familiar with these strategies in order to apply them where necessary and to accurately inform patients and their relatives to prevent misguided or inappropriate actions. Copyright © 2014 Elsevier España, S.L.U. and AEDV. All rights reserved.

Orion Heat Shield Move

NASA Image and Video Library

2017-10-23

Lockheed Martin engineers and technicians prepare the Orion heat shield for Exploration Mission-1 for its move to the thermal chamber in the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida. The heat shield will undergo a thermal cycle test to verify acceptable workmanship and material quality. The test serves to verify the heat shield's thermal protection systems have been manufactured and assembled correctly. The Orion spacecraft will launch atop NASA's Space Launch System rocket on its first uncrewed integrated flight.

Crawler Transporter 2 Trek

NASA Image and Video Library

2016-03-23

NASA’s upgraded crawler-transporter 2 (CT-2) begins its trek from the Vehicle Assembly Building (VAB) at the agency’s Kennedy Space Center in Florida to Launch Pad 39B to test recently completed upgrades and modifications for NASA’s journey to Mars. The Ground Systems Development and Operations Program at Kennedy oversaw upgrades to the crawler in the VAB. The crawler will carry the mobile launcher with Orion atop the Space Launch System rocket to Pad 39B for Exploration Mission-1, scheduled for 2018.

Crawler Transporter 2 Trek

NASA Image and Video Library

2016-03-23

NASA’s upgraded crawler-transporter 2 (CT-2) has exited the Vehicle Assembly Building (VAB) at the agency’s Kennedy Space Center in Florida for its trek along the crawlerway to Launch Pad 39B to test recently completed upgrades and modifications for NASA’s journey to Mars. The Ground Systems Development and Operations Program at Kennedy oversaw upgrades to the crawler in the VAB. The crawler will carry the mobile launcher with Orion atop the Space Launch System rocket to Pad 39B for Exploration Mission-1, scheduled for 2018.

Crawler Transporter 2 Trek

NASA Image and Video Library

2016-03-23

NASA’s upgraded crawler-transporter 2 (CT-2) travels along the crawlerway from the Vehicle Assembly Building (VAB) at the agency’s Kennedy Space Center in Florida on its trek to Launch Pad 39B to test recently completed upgrades and modifications for NASA’s journey to Mars. The Ground Systems Development and Operations Program at Kennedy oversaw upgrades to the crawler in the VAB. The crawler will carry the mobile launcher with Orion atop the Space Launch System rocket to Pad 39B for Exploration Mission-1, scheduled for 2018.

Crawler Transporter 2 Trek

NASA Image and Video Library

2016-03-23

NASA’s upgraded crawler-transporter 2 (CT-2) travels along the crawlerway during its trek to Launch Pad 39B at the agency’s Kennedy Space Center in Florida, to test recently completed upgrades and modifications for NASA’s journey to Mars. The Ground Systems Development and Operations Program at Kennedy oversaw upgrades to the crawler in the Vehicle Assembly Building. The crawler will carry the mobile launcher with Orion atop the Space Launch System rocket to Pad 39B for Exploration Mission-1, scheduled for 2018.

KSC-2013-4431

NASA Image and Video Library

2013-12-13

CAPE CANAVERAL, Fla. – At Cape Canaveral Air Force Station's Launch Complex 41, a United Launch Alliance Atlas V rocket, with its Centaur second stage atop, stands in the Vertical Integration Facility as preparations continue for lift off of the Tracking and Data Relay Satellite, or TDRS-L. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Charisse Nahser

KSC-2013-4427

NASA Image and Video Library

2013-12-13

CAPE CANAVERAL, Fla. – At Cape Canaveral Air Force Station's Launch Complex 41, a Centaur second stage is lifted for stacking atop a United Launch Alliance Atlas V rocket that will be used to boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft to orbit. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Charisse Nahser

KSC-2013-4423

NASA Image and Video Library

2013-12-13

CAPE CANAVERAL, Fla. – At Cape Canaveral Air Force Station's Launch Complex 41, engineers and technicians support lifting a Centaur second stage for stacking atop a United Launch Alliance Atlas V rocket that will be used to boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft to orbit. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Charisse Nahser

KSC-2013-4425

NASA Image and Video Library

2013-12-13

CAPE CANAVERAL, Fla. – At Cape Canaveral Air Force Station's Launch Complex 41, engineers and technicians support lifting a Centaur second stage for stacking atop a United Launch Alliance Atlas V rocket that will be used to boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft to orbit. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Charisse Nahser

KSC-2013-4430

NASA Image and Video Library

2013-12-13

CAPE CANAVERAL, Fla. – At Cape Canaveral Air Force Station's Launch Complex 41, engineers and technicians inspect a Centaur second stage that was just stacked atop a United Launch Alliance Atlas V rocket that will be used to boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft to orbit. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Charisse Nahser

KSC-2013-4424

NASA Image and Video Library

2013-12-13

CAPE CANAVERAL, Fla. – At Cape Canaveral Air Force Station's Launch Complex 41, engineers and technicians support lifting a Centaur second stage for stacking atop a United Launch Alliance Atlas V rocket that will be used to boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft to orbit. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Charisse Nahser

KSC-2013-4426

NASA Image and Video Library

2013-12-13

CAPE CANAVERAL, Fla. – At Cape Canaveral Air Force Station's Launch Complex 41, a Centaur second stage is lifted for stacking atop a United Launch Alliance Atlas V rocket that will be used to boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft to orbit. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Charisse Nahser

Launch and Landing Effects Ground Operations (LLEGO) Model

NASA Technical Reports Server (NTRS)

2008-01-01

LLEGO is a model for understanding recurring launch and landing operations costs at Kennedy Space Center for human space flight. Launch and landing operations are often referred to as ground processing, or ground operations. Currently, this function is specific to the ground operations for the Space Shuttle Space Transportation System within the Space Shuttle Program. The Constellation system to follow the Space Shuttle consists of the crewed Orion spacecraft atop an Ares I launch vehicle and the uncrewed Ares V cargo launch vehicle. The Constellation flight and ground systems build upon many elements of the existing Shuttle flight and ground hardware, as well as upon existing organizations and processes. In turn, the LLEGO model builds upon past ground operations research, modeling, data, and experience in estimating for future programs. Rather than to simply provide estimates, the LLEGO model s main purpose is to improve expenses by relating complex relationships among functions (ground operations contractor, subcontractors, civil service technical, center management, operations, etc.) to tangible drivers. Drivers include flight system complexity and reliability, as well as operations and supply chain management processes and technology. Together these factors define the operability and potential improvements for any future system, from the most direct to the least direct expenses.

Design of a steganographic virtual operating system

NASA Astrophysics Data System (ADS)

Ashendorf, Elan; Craver, Scott

2015-03-01

A steganographic file system is a secure file system whose very existence on a disk is concealed. Customarily, these systems hide an encrypted volume within unused disk blocks, slack space, or atop conventional encrypted volumes. These file systems are far from undetectable, however: aside from their ciphertext footprint, they require a software or driver installation whose presence can attract attention and then targeted surveillance. We describe a new steganographic operating environment that requires no visible software installation, launching instead from a concealed bootstrap program that can be extracted and invoked with a chain of common Unix commands. Our system conceals its payload within innocuous files that typically contain high-entropy data, producing a footprint that is far less conspicuous than existing methods. The system uses a local web server to provide a file system, user interface and applications through a web architecture.

The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma

PubMed Central

Bantz, Selene K.; Zhu, Zhou; Zheng, Tao

2014-01-01

The development of atopic dermatitis (AD) in infancy and subsequent allergic rhinitis and asthma in later childhood is known as the atopic march. This progressive atopy is dependent on various underlying factors such as the presence of filaggrin mutations as well as the time of onset and severity of AD. Clinical manifestations vary among individuals. Previously it was thought that atopic disorders may be unrelated with sequential development. Recent studies support the idea of a causal link between AD and later onset atopic disorders. These studies suggest that a dysfunctional skin barrier serves as a site for allergic sensitization to antigens and colonization of bacterial super antigens. This induces systemic Th2 immunity that predisposes patients to allergic nasal responses and promotes airway hyper reactivity. While AD often starts early in life and is a chronic condition, new research signifies that there may be an optimal window of time in which targeting the skin barrier with therapeutic interventions may prevent subsequent atopic disorders. In this review we highlight recent studies describing factors important in the development of atopic disorders and new insights in our understanding of the pathogenesis of the atopic march. PMID:25419479

Nickel allergy and relationship with Staphylococcus aureus in atopic dermatitis.

PubMed

Bogdali, Anna M; Anna, Bogdali M; Grazyna, Antoszczyk; Wojciech, Dyga; Aleksander, Obtulowicz; Anna, Bialecka; Andrzej, Kasprowicz; Zofia, Magnowska; Krystyna, Obtulowicz

2016-01-01

The increase of nickel air pollution is supposed to frequent side effects of nickel action related to virulence potential of Staphylococcus aureus in patients with nickel allergy in atopic dermatitis. The goal was to investigate the relationship between nickel allergy and infection by S. aureus in atopic dermatitis. Nickel allergy was confirmed in atopic patients and excluded in healthy volunteers using patch testing. Infection by S. aureus was tested in atopic patients and healthy volunteers by use of API Staph system. The specific IgE for staphylococcal enterotoxin A and B were measured. Secretion of IFN-g, IL-2, IL-13 by PBMC under nickel sulfate and the enterotoxins A and B stimulations were studied with ELISpot. We found the increased number of infections by S. aureus in atopic patients with nickel allergy in comparison to atopic patients and healthy volunteers without nickel allergy. The elevated secretion of IL-2 under nickel sulfate stimulation in vitro was exclusively found in atopic patients with nickel allergy infected by S. aureus. Our data suggest that nickel allergy and infection by S. aureus are linked in atopic dermatitis. Copyright © 2015 Elsevier GmbH. All rights reserved.

Lifetime of B c - Mesons Constrains Explanations for Anomalies in B → D ( * ) τ ν

DOE PAGES

Alonso, Rodrigo; Grinstein, Benjamín; Martin Camalich, Jorge

2017-02-22

Here, we investigate a new constraint on new-physics interpretations of the anomalies observed in B→D( *)τν decays making use of the lifetime of the Bmore » $$-\\atop{c}$$ meson. A constraint is obtained by demanding that the rate for B$$-\\atop{c}$$→τ -$$-\\atop{v}$$ does not exceed the fraction of the total width that is allowed by the calculation of the lifetime in the standard model. This leads to a very strong bound on new-physics scenarios involving scalar operators since they lift the slight, but not negligible, chiral suppression of the B$$-\\atop{c}$$→τ -$$-\\atop{v}$$ amplitude in the standard model. The new constraint renders a scalar interpretation of the enhancement measured in R D* implausible, including explanations implementing extra Higgs doublets or certain classes of leptoquarks. We also discuss the complementarity of R D(*) and a measurement of the longitudinal polarization of the τ in the B→D *τν decay in light of our findings.« less

Lifetime of B c - Mesons Constrains Explanations for Anomalies in B → D ( * ) τ ν

DOE Office of Scientific and Technical Information (OSTI.GOV)

Alonso, Rodrigo; Grinstein, Benjamín; Martin Camalich, Jorge

Here, we investigate a new constraint on new-physics interpretations of the anomalies observed in B→D( *)τν decays making use of the lifetime of the Bmore » $$-\\atop{c}$$ meson. A constraint is obtained by demanding that the rate for B$$-\\atop{c}$$→τ -$$-\\atop{v}$$ does not exceed the fraction of the total width that is allowed by the calculation of the lifetime in the standard model. This leads to a very strong bound on new-physics scenarios involving scalar operators since they lift the slight, but not negligible, chiral suppression of the B$$-\\atop{c}$$→τ -$$-\\atop{v}$$ amplitude in the standard model. The new constraint renders a scalar interpretation of the enhancement measured in R D* implausible, including explanations implementing extra Higgs doublets or certain classes of leptoquarks. We also discuss the complementarity of R D(*) and a measurement of the longitudinal polarization of the τ in the B→D *τν decay in light of our findings.« less

Global system data bus using the Digital Autonomous Terminal Access Communication protocol

NASA Technical Reports Server (NTRS)

Holmes, David C. E.

1986-01-01

Modern digital avionic systems with distributed processing require networking to connect the many elements. Digital Autonomous Terminal Access Communication (DATAC) is one of many such networks. DATAC has been implemented on the Transport Systems Research Vehicle (TSRV), a Boeing 737 aircraft operated by the National Aeronautics and Space Administration's Advanced Transport Operating Systems Program Office (ATOPS). This paper presents the TSRV implementation of the DATAC bus, a description of the DATAC system, a synchronization mechanism, details of data flow throughout the system, and a discussion of the modes available with DATAC. Numerous flight tests have been conducted using DATAC as the only means of communication between systems with outstanding results. DATAC is now an integral part of the TSRV and is expected to satisfy near term as well as future requirements for growth and flexibility.

Cryo Tank Fill at Pad 39B

NASA Image and Video Library

2017-09-26

Several Praxair trucks begin to depart Launch Pad 39B at NASA's Kennedy Space Center in Florida, after offloading their loads of liquid oxygen, or LO2, one at a time into the giant storage sphere located at the northwest corner of the pad. The sphere was gradually chilled down from normal temperature to about negative 298 degrees Fahrenheit, during the first major integrated operation to prepare for the launch of the agency's Orion spacecraft atop the Space Launch System (SLS) rocket. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to pad B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1, deep space missions and NASA’s journey to Mars.

Cryo Tank Fill at Pad 39B

NASA Image and Video Library

2017-09-26

Several Praxair trucks carrying their loads of liquid oxygen, or LO2, arrive at Launch Pad 39B at NASA's Kennedy Space Center in Florida. The trucks will offload LO2 slowly into a giant storage sphere located at the northwest corner of the pad to gradually chill it down from normal temperature to about negative 298 degrees Fahrenheit, during the first major integrated operation to prepare for the launch of the agency's Orion spacecraft atop the Space Launch System (SLS) rocket. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to pad B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1, deep space missions and NASA’s journey to Mars.

Cryo Tank Fill at Pad 39B

NASA Image and Video Library

2017-09-26

Mist or vapor is visible as a Praxair truck slowly transfers its load of liquid oxygen, or LO2, into a giant storage sphere at the northwest corner of Launch Pad 39B at NASA's Kennedy Space Center in Florida. The sphere will gradually be chilled down from normal temperature to about negative 298 degrees Fahrenheit, during the first major integrated operation to prepare for the launch of the agency's Orion spacecraft atop the Space Launch System (SLS) rocket. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to pad B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1, deep space missions and NASA’s journey to Mars.

Cryo Tank Fill at Pad 39B

NASA Image and Video Library

2017-09-26

NASA Launch Director Charlie Blackwell-Thompson, center, talks to engineers at Launch Pad 39B at the agency's Kennedy Space Center in Florida. Blackwell-Thompson will observe the first major tanking operation of liquid oxygen, or LO2, into the giant storage sphere at the northwest corner of the pad to prepare for the launch of the agency's Orion spacecraft atop the Space Launch System (SLS) rocket. During the operation, several Praxair trucks will slowly offload LO2 to gradually chill down the sphere from normal temperature to about negative 298 degrees Fahrenheit. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to pad B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1, deep space missions and NASA’s journey to Mars.

Cryo Tank Fill at Pad 39B

NASA Image and Video Library

2017-09-26

NASA Launch Director Charlie Blackwell-Thompson, at right, greets engineers and technicians at Launch Pad 39B at the agency's Kennedy Space Center in Florida. Blackwell-Thompson will observe the first major tanking operation of liquid oxygen, or LO2, into the giant storage sphere at the northwest corner of the pad to prepare for the launch of the agency's Orion spacecraft atop the Space Launch System (SLS) rocket. During the operation, several Praxair trucks will slowly offload LO2 to gradually chill down the sphere from normal temperature to about negative 298 degrees Fahrenheit. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to pad B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1, deep space missions and NASA’s journey to Mars.

Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march.

PubMed

Egawa, Gyohei; Kabashima, Kenji

2016-08-01

Atopic dermatitis (AD) is the most common inflammatory skin disease in the industrialized world and has multiple causes. Over the past decade, data from both experimental models and patients have highlighted the primary pathogenic role of skin barrier deficiency in patients with AD. Increased access of environmental agents into the skin results in chronic inflammation and contributes to the systemic "atopic (allergic) march." In addition, persistent skin inflammation further attenuates skin barrier function, resulting in a positive feedback loop between the skin epithelium and the immune system that drives pathology. Understanding the mechanisms of skin barrier maintenance is essential for improving management of AD and limiting downstream atopic manifestations. In this article we review the latest developments in our understanding of the pathomechanisms of skin barrier deficiency, with a particular focus on the formation of the stratum corneum, the outermost layer of the skin, which contributes significantly to skin barrier function. Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Management of Itch in Atopic Dermatitis

PubMed Central

Hong, Judith; Buddenkotte, Joerg; Berger, Timothy G.; Steinhoff, Martin

2013-01-01

Atopic dermatitis is a common, pruritic, inflammatory skin disorder. Chronic, localized, or even generalized pruritus is the diagnostic hallmark of atopic dermatitis, and its management remains a challenge for physicians. The threshold for itch and alloknesis is markedly reduced in these patients, and infections can promote exacerbation and thereby increase the itch. Modern management consists of anti-inflammatory, occasionally antiseptic, as well as antipruritic therapies to address the epidermal barrier as well as immunomodulation or infection. Mild forms of atopic dermatitis may be controlled with topical therapies, but moderate-to-severe forms often require a combination of systemic treatments consisting of antipruritic and immunosuppressive drugs, phototherapy, and topical compounds. In addition, patient education and a therapeutic regimen to help the patient cope with the itch and eczema are important adjuvant strategies for optimized long-term management. This review highlights various topical, systemic, and complementary and alternative therapies, as well as provide a therapeutic ladder for optimized long-term control of itch in atopic dermatitis. PMID:21767767

Can exhaled nitric oxide be a surrogate marker of bronchial hyperresponsiveness to adenosine 5'-monophosphate in steroid-naive asthmatic children?

PubMed

Arga, M; Bakirtas, A; Topal, E; Turktas, I

2015-04-01

The interrelation between airway inflammation, bronchial hyperresponsiveness (BHR) and atopy remains controversial. The aim of this study was to document whether exhaled nitric oxide (eNO) may be used as a surrogate marker that predicts BHR to adenosine 5'-monophosphate (AMP) in steroid-naive school children with asthma. This study was a retrospective analysis of steroid-naive school age children with atopic and non-atopic asthma. All patients whose eNO levels had been measured and who had been challenged with both methacholine (MCH) and AMP were included. Receiver operation characteristic analysis was performed, in both the atopic and the non-atopic groups, to evaluate the ability of eNO to detect the BHR to AMP. One hundred and sixteen patients, sixty-nine (59.5%) of whom had been atopic, were included in the analysis. In the atopic group, eNO values were significantly higher in patients with BHR to AMP compared to those without BHR to AMP (51.9 ± 16.9 p.p.b. vs. 33.7 ± 16.4 p.p.b.; P < 0.001), whereas in the non-atopic group, the differences were not statistically significant (29.7 ± 16.9 p.p.b. vs. 22.6 ± 8.1 p.p.b.; P = 0.152). In the atopic group, eNO levels (R(2) : 0.401; β: 0.092; 95% CI: 1.19-14.42; OR: 7.12; P = 0.008) were found to be the only independent factor for BHR to AMP, whereas none of the parameters predicted BHR to AMP in the non-atopic group. The best cut-off value of eNO that significantly predicts BHR to AMP was 33.3 p.p.b. in the atopic group (P < 0.001), whereas a significant cut-off value for eNO that predicts BHR to AMP was not determined in the non-atopic group (P = 0.142). An eNO ≤ 17.4 p.p.b. has 100% negative predictive values and 100% sensitivity and 60.47% PPV for prediction of BHR to AMP in the atopic group. Exhaled NO may be used to predict BHR to AMP in atopic but not in non-atopic steroid-naïve asthmatic children. © 2014 John Wiley & Sons Ltd.

TDRS-L spacecraft lift to mate on Atlas V

NASA Image and Video Library

2014-01-13

CAPE CANAVERAL, Fla. – At Cape Canaveral Air Force Station's Vertical Integration Facility at Launch Complex 41, NASA's Tracking and Data Relay Satellite, or TDRS-L, spacecraft is lifted for mounting atop a United Launch Alliance Atlas V rocket. The TDRS-L satellite will be a part of the second of three next-generation spacecraft designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop a United Launch Alliance Atlas V rocket on Jan. 23, 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay contact with orbiting spacecraft ranging from the International Space Station and Hubble Space Telescope to the array of scientific observatories. For more information, visit: http://www.nasa.gov/mission_pages/tdrs/home/index.html Photo credit: NASA/Dimitri Gerondidakis

TDRS-L spacecraft lift to mate on Atlas V

NASA Image and Video Library

2014-01-13

CAPE CANAVERAL, Fla. – At Cape Canaveral Air Force Station's Vertical Integration Facility at Launch Complex 41, NASA's Tracking and Data Relay Satellite, or TDRS-L, spacecraft is moved into position for mating atop a United Launch Alliance Atlas V rocket. The TDRS-L satellite will be a part of the second of three next-generation spacecraft designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop a United Launch Alliance Atlas V rocket on Jan. 23, 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay contact with orbiting spacecraft ranging from the International Space Station and Hubble Space Telescope to the array of scientific observatories. For more information, visit: http://www.nasa.gov/mission_pages/tdrs/home/index.html Photo credit: NASA/Dimitri Gerondidakis

KSC-2013-4420

NASA Image and Video Library

2013-12-13

CAPE CANAVERAL, Fla. – The United Launch Alliance Centaur second stage that will help boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit arrives at Cape Canaveral Air Force Station's Launch Complex 41. It will be lifted and mounted atop the Atlas V first stage already in position inside the Vertical Integration Facility. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Charisse Nahser

TDRS-L spacecraft lift to mate on Atlas V

NASA Image and Video Library

2014-01-13

CAPE CANAVERAL, Fla. – At Cape Canaveral Air Force Station's Vertical Integration Facility at Launch Complex 41, NASA's Tracking and Data Relay Satellite, or TDRS-L, spacecraft has been mated atop a United Launch Alliance Atlas V rocket. The TDRS-L satellite will be a part of the second of three next-generation spacecraft designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop a United Launch Alliance Atlas V rocket on Jan. 23, 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay contact with orbiting spacecraft ranging from the International Space Station and Hubble Space Telescope to the array of scientific observatories. For more information, visit: http://www.nasa.gov/mission_pages/tdrs/home/index.html Photo credit: NASA/Dimitri Gerondidakis

Diffractive J/Psi Production; Produção Difrativa de $J/psi$ no Experimento DØ (in Portuguese)

DOE Office of Scientific and Technical Information (OSTI.GOV)

dos Santos Assis Jesus, Ana Carolina

This work presents measurements of two diffractive production ratio for heavy flavour physics with the use of a reconstructed J/Ψ → μ +μ - sample in pmore » $$\\bar{p}$$ collisions at √s = 1.96 TeV using the D0 detector at Fermilab Tevatron. These events were selected using the Luminosity Monitor detectors, the calorimeter system and the muon system in a pseudo-rapidity region with range 2.7 ≤ |η| ≤ 4.4. The measured ratio were estimated to be N$$J/Ψ\\atop{diff}$$/N$$J/Ψ\\atop{total}$$ = (1.74 ± 0.16(stat) {+-} 0.13(syst))% e N$$b\\atop{diff}$$/N$$b\\atop{total}$$ = (0.79 ± 0.11(stat) ± 0.23(syst))%.« less

Orion EM-1 Crew Module Move from Clean Room to Work Station

NASA Image and Video Library

2017-05-11

The Orion crew module for NASA’s Exploration Mission 1 (EM-1) is secured in a work station in the Neil Armstrong Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida. Orion will undergo additional processing to prepare it for launch in 2019. The spacecraft is being prepared for its first integrated flight atop the Space Launch System rocket on Exploration Mission-1.

Orion EM-1 Crew Module Move from Clean Room to Work Station

NASA Image and Video Library

2017-05-11

The Orion crew module for NASA’s Exploration Mission 1 (EM-1) is being secured in a work station in the Neil Armstrong Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida. Orion will undergo additional processing to prepare it for launch in 2019. The spacecraft is being prepared for its first integrated flight atop the Space Launch System rocket on Exploration Mission-1.

Orion EM-1 Crew Module Structural Test Article Move to Birdcage

NASA Image and Video Library

2016-11-16

Inside the Neil Armstrong Operations and Checkout Building at NASA’s Kennedy Space Center in Florida, Lockheed Martin technicians attach lines from a crane to the Orion crew module structural test article (STA). The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article will be lifted out of its container and moved to a test tool called the birdcage for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion EM-1 Crew Module Structural Test Article Move to Birdcage

NASA Image and Video Library

2016-11-16

Inside the Neil Armstrong Operations and Checkout Building at NASA’s Kennedy Space Center in Florida, Lockheed Martin technicians prepare to attach lines from a crane to the Orion crew module structural test article (STA). The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article will be lifted out of its container and moved to a test tool called the birdcage for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion EM-1 Crew Module Structural Test Article Move to Birdcage

NASA Image and Video Library

2016-11-16

Inside the Neil Armstrong Operations and Checkout Building at NASA’s Kennedy Space Center in Florida, Lockheed Martin technicians monitor the progress as a crane begins to lift the Orion crew module structural test article (STA) up from the base of its transport container. The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article will be moved to a test tool called the birdcage for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion EM-1 Crew Module Structural Test Article Move to Birdcage

NASA Image and Video Library

2016-11-16

Inside the Neil Armstrong Operations and Checkout Building at NASA’s Kennedy Space Center in Florida, Lockheed Martin technicians monitor the progress as a crane moves the Orion crew module structural test article (STA) along the center aisle of the high bay. The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article will be moved to a test tool called the birdcage for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion EM-1 Crew Module Structural Test Article Move to Birdcage

NASA Image and Video Library

2016-11-16

Inside the Neil Armstrong Operations and Checkout Building at NASA’s Kennedy Space Center in Florida, Lockheed Martin technicians monitor the progress as a crane lowers the Orion crew module structural test article (STA) toward a test tool called the birdcage. The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article will be secured on the birdcage for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion EM-1 Crew Module Structural Test Article Move to Birdcage

NASA Image and Video Library

2016-11-16

Inside the Neil Armstrong Operations and Checkout Building at NASA’s Kennedy Space Center in Florida, Lockheed Martin technicians monitor the progress as a crane lowers the Orion crew module structural test article (STA) onto a test tool called the birdcage. The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article will be secured on the birdcage for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion Crew Module Structural Test Article Transport from SLF to

NASA Image and Video Library

2016-11-15

After arriving at the Shuttle Landing Facility operated by Space Florida at NASA's Kennedy Space Center in Florida, the agency's Super Guppy aircraft was opened and the container holding the Orion crew module structural test article (STA) was offloaded. A crane was used to lower the container for placement on a transporter. The Super Guppy has been closed. The test article will be moved to the Neil Armstrong Operations and Checkout Building high bay for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion EM-1 Crew Module Structural Test Article Move to Birdcage

NASA Image and Video Library

2016-11-16

Inside the Neil Armstrong Operations and Checkout Building at NASA’s Kennedy Space Center in Florida, Lockheed Martin technicians monitor the progress as a crane lifts the Orion crew module structural test article (STA) up from the base of its transport container. The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article will be moved to a test tool called the birdcage for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion EM-1 Crew Module Structural Test Article Move to Birdcage

NASA Image and Video Library

2016-11-16

Inside the Neil Armstrong Operations and Checkout Building at NASA’s Kennedy Space Center in Florida, Lockheed Martin technicians check the lines attached from a crane to the Orion crew module structural test article (STA). The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article will be lifted out of its container and moved to a test tool called the birdcage for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion EM-1 Crew Module Structural Test Article Move to Birdcage

NASA Image and Video Library

2016-11-16

Inside the Neil Armstrong Operations and Checkout Building at NASA’s Kennedy Space Center in Florida, Lockheed Martin technicians monitor the progress as a crane lifts the Orion crew module structural test article (STA) away from the base of its transport container. The STA arrived aboard NASA's Super Guppy aircraft at the Shuttle Landing Facility operated by Space Florida. The test article will be moved to a test tool called the birdcage for further testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Systemic Agents for Severe Atopic Dermatitis in Children.

PubMed

Notaro, Eliza R; Sidbury, Robert

2015-12-01

Atopic dermatitis (AD), or eczema, is a chronic inflammatory skin condition characterized by relapsing pruritic, scaly, erythematous papules and plaques frequently associated with superinfection. The lifelong prevalence of AD is over 20 % in affluent countries. When a child with severe AD is not responding to optimized topical therapy including phototherapy, and relevant triggers cannot be identified or avoided, systemic therapy should be considered. If studies show early aggressive intervention can prevent one from advancing along the atopic march, and relevant triggers such as food allergies cannot be either identified or avoided, systemic therapy may also play a prophylactic role. Though the majority of evidence exists in adult populations, four systemic non-specific immunosuppressive or immunomodulatory drugs have demonstrated efficacy in AD and are used in most patients requiring this level of intervention regardless of age: cyclosporine, mycophenolate mofetil, methotrexate, and azathioprine. This article reviews the use of these medications as well as several promising targeted therapies currently in development including dupilumab and apremilast. We briefly cover several other systemic interventions that have been studied in children with atopic dermatitis.

Orion Heat Shield Move

NASA Image and Video Library

2017-10-23

Technicians move the Orion heat shield for Exploration Mission-1 toward the thermal chamber in the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida. Protective pads are being attached to the heat shield surface. The heat shield will undergo a thermal cycle test to verify acceptable workmanship and material quality. The test also serves to verify the heat shield's thermal protection systems have been manufactured and assembled correctly. The Orion spacecraft will launch atop NASA's Space Launch System rocket on its first uncrewed integrated flight.

Crawler Transporter 2 Trek

NASA Image and Video Library

2016-03-23

An American flag flutters in the breeze as NASA’s upgraded crawler-transporter 2 (CT-2) travels along the crawlerway during its trek to Launch Pad 39B at the agency’s Kennedy Space Center in Florida, to test recently completed upgrades and modifications for NASA’s journey to Mars. The Ground Systems Development and Operations Program at Kennedy oversaw upgrades to the crawler in the Vehicle Assembly Building. The crawler will carry the mobile launcher with Orion atop the Space Launch System rocket to Pad 39B for Exploration Mission-1, scheduled for 2018.

Crawler Transporter 2 Trek

NASA Image and Video Library

2016-03-23

Technicians walk alongside NASA’s upgraded crawler-transporter 2 (CT-2) as it continues the trek on the crawlerway from the Vehicle Assembly Building (VAB) at the agency’s Kennedy Space Center in Florida to Launch Pad 39B to test recently completed upgrades and modifications for NASA’s journey to Mars. The Ground Systems Development and Operations Program at Kennedy oversaw upgrades to the crawler in the VAB. The crawler will carry the mobile launcher with Orion atop the Space Launch System rocket to Pad 39B for Exploration Mission-1, scheduled for 2018.

Crawler Transporter 2 Trek

NASA Image and Video Library

2016-03-23

Technicians walk alongside NASA’s upgraded crawler-transporter 2 (CT-2) as it continues the trek along the crawlerway from the Vehicle Assembly Building (VAB) at the agency’s Kennedy Space Center in Florida to Launch Pad 39B to test recently completed upgrades and modifications for NASA’s journey to Mars. The Ground Systems Development and Operations Program at Kennedy oversaw upgrades to the crawler in the VAB. The crawler will carry the mobile launcher with Orion atop the Space Launch System rocket to Pad 39B for Exploration Mission-1, scheduled for 2018.

Crawler Transporter 2 Trek

NASA Image and Video Library

2016-03-23

A truck sprays water in front of NASA’s upgraded crawler-transporter 2 (CT-2) to control dust as it begins the trek from the Vehicle Assembly Building (VAB) at the agency’s Kennedy Space Center in Florida to Launch Pad 39B to test recently completed upgrades and modifications for NASA’s journey to Mars. The Ground Systems Development and Operations Program at Kennedy oversaw upgrades to the crawler in the VAB. The crawler will carry the mobile launcher with Orion atop the Space Launch System rocket to Pad 39B for Exploration Mission-1, scheduled for 2018.

Orion EM-1 Crew Module Adapter Move to Clean Room

NASA Image and Video Library

2016-11-29

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, the Orion crew module adapter (CMA) for Exploration Mission 1 (EM-1) is being moved to a clean room. The CMA will undergo propellant and environmental control and life support system tube installation and welding. The adapter will connect the Orion crew module to the European Space Agency-provided service module. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion EM-1 Crew Module Adapter Move to Clean Room

NASA Image and Video Library

2016-11-29

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, Lockheed Martin technicians move the Orion crew module adapter (CMA) for Exploration Mission 1 (EM-1) into a clean room. The CMA will undergo propellant and environmental control and life support system tube installation and welding. The adapter will connect the Orion crew module to the European Space Agency-provided service module. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion EM-1 Crew Module Adapter Move to Clean Room

NASA Image and Video Library

2016-11-29

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, Lockheed Martin technicians move the Orion crew module adapter (CMA) for Exploration Mission 1 (EM-1) toward a clean room. The CMA will undergo propellant and environmental control and life support system tube installation and welding. The adapter will connect the Orion crew module to the European Space Agency-provided service module. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

KSC-2013-2918

NASA Image and Video Library

2013-06-27

CAPE CANAVERAL, Fla. – Inside the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, members of the media receive an on activities in NASA’s Ground Systems Development and Operations, or GSDO, Program, Space Launch System and Orion crew module for Exploration Test Flight 1. Speaking to the media is Scott Wilson, manager of Orion Production Operations at Kennedy. Orion is the exploration spacecraft designed to carry crews to space beyond low Earth orbit. It will provide emergency abort capability, sustain the crew during the space travel and provide safe re-entry from deep space return velocities. Orion’s first unpiloted test flight is scheduled to launch in 2014 atop a Delta IV rocket. A second uncrewed flight test is scheduled for 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Jim Grossmann

KSC-2013-2923

NASA Image and Video Library

2013-06-27

CAPE CANAVERAL, Fla. – Inside the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, members of the media receive an on activities in NASA’s Ground Systems Development and Operations, or GSDO, Program, Space Launch System and Orion crew module for Exploration Test Flight 1. Speaking to the media is Jeremy Parsons, chief of the GSDO Operations Integration Office at Kennedy. Orion is the exploration spacecraft designed to carry crews to space beyond low Earth orbit. It will provide emergency abort capability, sustain the crew during the space travel and provide safe re-entry from deep space return velocities. Orion’s first unpiloted test flight is scheduled to launch in 2014 atop a Delta IV rocket. A second uncrewed flight test is scheduled for 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Jim Grossmann

KSC-2013-2922

NASA Image and Video Library

2013-06-27

CAPE CANAVERAL, Fla. – Inside the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, members of the media receive an on activities in NASA’s Ground Systems Development and Operations, or GSDO, Program, Space Launch System and Orion crew module for Exploration Test Flight 1. Speaking to the media is Jeremy Parsons, chief of the GSDO Operations Integration Office at Kennedy. Orion is the exploration spacecraft designed to carry crews to space beyond low Earth orbit. It will provide emergency abort capability, sustain the crew during the space travel and provide safe re-entry from deep space return velocities. Orion’s first unpiloted test flight is scheduled to launch in 2014 atop a Delta IV rocket. A second uncrewed flight test is scheduled for 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Jim Grossmann

Is Patch Testing with Food Additives Useful in Children with Atopic Eczema?

PubMed

Catli, Gonul; Bostanci, Ilknur; Ozmen, Serap; Dibek Misirlioglu, Emine; Duman, Handan; Ertan, Ulker

2015-01-01

Atopy patch testing is a useful way to determine delayed-type hypersensitivity reactions to foods and aeroallergens. Although food additives have been accused of worsening atopic eczema symptoms, according to recent studies the role of food additives in atopic eczema remains unclear. The purpose of our study was to investigate food additive hypersensitivity in a group of children with atopic eczema by using standardized atopy patch testing and to determine the role of food additive hypersensitivity in atopic eczema. Thirty-four children with atopic eczema and 33 healthy children were enrolled in the study. Children who consumed foods containing additives and did not use either antihistamines or local or systemic corticosteroids for at least 7 days prior to admission were enrolled in the study. All children were subjected to atopy patch testing and after 48 and 72 hours their skin reactions were evaluated by using the guidelines. Positive atopy patch test results were significantly higher in the atopic eczema group. Forty-one percent of the atopic eczema group (n = 14) and 15.2% (n = 5) of the control group had positive atopy patch test results with food additives (p = 0.036) (estimated relative risk 1.68, case odds 0.7, control odds 0.17). Carmine hypersensitivity and the consumption of foods containing carmine, such as gumdrops, salami, and sausage, were significantly higher in the children with atopic eczema. This is the first study investigating hypersensitivity to food additives in children with atopic eczema. Our results indicate that carmine may play a role in atopic eczema. © 2015 Wiley Periodicals, Inc.

Determination of the proton spin structure functions for 0.05 < Q 2 < 5 GeV 2 using CLAS

DOE PAGES

Fersch, R. G.; Guler, N.; Bosted, P.; ...

2017-12-27

In this work, we present the results of our final analysis of the full data set of gmore » $$p\\atop{1}$$ (Q 2), the spin structure function of the proton, collected using CLAS at Jefferson Laboratory in 2000–2001. Polarized electrons with energies of 1.6, 2.5, 4.2, and 5.7 GeV were scattered from proton targets ( 15NH 3 dynamically polarized along the beam direction) and detected with CLAS. From the measured double spin asymmetries, we extracted virtual photon asymmetries A$$p\\atop{1}$$ and A$$p\\atop{2}$$ and spin structure functions g$$p\\atop{1}$$ and g$$p\\atop{2}$$ over a wide kinematic range (0.05 GeV 2 < Q 2 < 5 GeV 2 and 1.08 GeV < W < 3 GeV) and calculated moments of g$$p\\atop{1}$$. We compare our final results with various theoretical models and expectations, as well as with parametrizations of the world data. Lastly, our data, with their precision and dense kinematic coverage, are able to constrain fits of polarized parton distributions, test pQCD predictions for quark polarizations at large x, offer a better understanding of quark-hadron duality, and provide more precise values of higher twist matrix elements in the framework of the operator product expansion.« less

Dendritic Core-Multishell Nanocarriers in Murine Models of Healthy and Atopic Skin.

PubMed

Radbruch, Moritz; Pischon, Hannah; Ostrowski, Anja; Volz, Pierre; Brodwolf, Robert; Neumann, Falko; Unbehauen, Michael; Kleuser, Burkhard; Haag, Rainer; Ma, Nan; Alexiev, Ulrike; Mundhenk, Lars; Gruber, Achim D

2017-12-01

Dendritic hPG-amid-C18-mPEG core-multishell nanocarriers (CMS) represent a novel class of unimolecular micelles that hold great potential as drug transporters, e.g., to facilitate topical therapy in skin diseases. Atopic dermatitis is among the most common inflammatory skin disorders with complex barrier alterations which may affect the efficacy of topical treatment.Here, we tested the penetration behavior and identified target structures of unloaded CMS after topical administration in healthy mice and in mice with oxazolone-induced atopic dermatitis. We further examined whole body distribution and possible systemic side effects after simulating high dosage dermal penetration by subcutaneous injection.Following topical administration, CMS accumulated in the stratum corneum without penetration into deeper viable epidermal layers. The same was observed in atopic dermatitis mice, indicating that barrier alterations in atopic dermatitis had no influence on the penetration of CMS. Following subcutaneous injection, CMS were deposited in the regional lymph nodes as well as in liver, spleen, lung, and kidney. However, in vitro toxicity tests, clinical data, and morphometry-assisted histopathological analyses yielded no evidence of any toxic or otherwise adverse local or systemic effects of CMS, nor did they affect the severity or course of atopic dermatitis.Taken together, CMS accumulate in the stratum corneum in both healthy and inflammatory skin and appear to be highly biocompatible in the mouse even under conditions of atopic dermatitis and thus could potentially serve to create a depot for anti-inflammatory drugs in the skin.

The association between phthalate exposure and atopic dermatitis with a discussion of phthalate induced secretion of interleukin-1β and thymic stromal lymphopoietin.

PubMed

Overgaard, Line E K; Bonefeld, Charlotte M; Frederiksen, Hanne; Main, Katharina M; Thyssen, Jacob P

2016-06-01

Phthalate diesters are widely used as emollients in plastic and cosmetics as well as in food packaging and perfumes, potentially leading to prolonged and repeated dermal, oral and airborne exposure. We here review published articles that have evaluated the putative role of phthalate diesters in the pathogenesis of atopic dermatitis and discuss possible pathogenic pathways. A literature search resulted in 563 articles in Embase and 263 articles in Pubmed. After identification of relevant articles based on screening of titles, abstracts and reference lists, a total of 39 articles were selected and included. While no clear association has been shown between systemic phthalate levels and atopic dermatitis in human studies, animal data suggests that phthalates may worsen dermatitis and in vitro data suggests that interleukin-4 could be upregulated. Moreover, both loss-of-function mutations in the filaggrin gene and atopic dermatitis have been associated with elevated systemic phthalate levels. There is a need for prospective studies to clarify the possible pathogenic role of phthalate diesters in atopic dermatitis and the associated health risk, especially with the general trend towards barrier restoration with emollients in infants at risk of developing atopic dermatitis. In summary, we conclude that the results from published studies are controversial and inconclusive.

Orion EM-1 Crew Module Move from Clean Room to Work Station

NASA Image and Video Library

2017-05-11

The Orion crew module pressure vessel for NASA’s Exploration Mission 1 (EM-1) is moved from a clean room to a work station inside the Neil Armstrong Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida. Orion will undergo additional processing to prepare it for launch in 2019. The spacecraft is being prepared for its first integrated flight atop the Space Launch System rocket on Exploration Mission-1.

Orion EM-1 Crew Module Move from Clean Room to Work Station

NASA Image and Video Library

2017-05-11

The Orion crew module pressure vessel for NASA’s Exploration Mission 1 (EM-1) is being moved from a clean room to a work station inside the Neil Armstrong Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida. Orion will undergo additional processing to prepare it for launch in 2019. The spacecraft is being prepared for its first integrated flight atop the Space Launch System rocket on Exploration Mission-1.

Cryo Tank Fill at Pad 39B

NASA Image and Video Library

2017-09-26

Praxair trucks carrying their loads of liquid oxygen, or LO2, are on their way to Launch Pad 39B at NASA's Kennedy Space Center in Florida. The trucks will offload LO2 slowly into a giant storage sphere located at the northwest corner of the pad to gradually chill it down from normal temperature to about negative 298 degrees Fahrenheit, during the first major integrated operation to prepare for the launch of the agency's Orion spacecraft atop the Space Launch System (SLS) rocket. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to pad B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1, deep space missions and NASA’s journey to Mars.

Cryo Tank Fill at Pad 39B

NASA Image and Video Library

2017-09-26

A large plume of mist or vapor is visible as a Praxair truck slowly transfers its load of liquid oxygen, or LO2, into a giant storage sphere at the northwest corner of Launch Pad 39B at NASA's Kennedy Space Center in Florida. The sphere will gradually be chilled down from normal temperature to about negative 298 degrees Fahrenheit, during the first major integrated operation to prepare for the launch of the agency's Orion spacecraft atop the Space Launch System (SLS) rocket. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to pad B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1, deep space missions and NASA’s journey to Mars.

Cryo Tank Fill at Pad 39B

NASA Image and Video Library

2017-09-26

One of several Praxair trucks carrying its load of liquid oxygen, or LO2, is in route to Launch Pad 39B at NASA's Kennedy Space Center in Florida. The truck will offload LO2 slowly into a giant storage sphere located at the northwest corner of the pad to gradually chill it down from normal temperature to about negative 298 degrees Fahrenheit, during the first major integrated operation to prepare for the launch of the agency's Orion spacecraft atop the Space Launch System (SLS) rocket. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to pad B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1, deep space missions and NASA’s journey to Mars.

Cryo Tank Fill at Pad 39B

NASA Image and Video Library

2017-09-26

Several Praxair trucks carrying their loads of liquid oxygen, or LO2, have arrived at Launch Pad 39B at NASA's Kennedy Space Center in Florida. The trucks will offload LO2 slowly into a giant storage sphere located at the northwest corner of the pad to gradually chill it down from normal temperature to about negative 298 degrees Fahrenheit, during the first major integrated operation to prepare for the launch of the agency's Orion spacecraft atop the Space Launch System (SLS) rocket. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to pad B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1, deep space missions and NASA’s journey to Mars.

Resolving the Etiology of Atopic Disorders by Genetic Analysis of Racial Ancestry

PubMed Central

Gupta, Jayanta; Johansson, Elisabet; Bernstein, Jonathan A.; Chakraborty, Ranajit; Khurana Hershey, Gurjit K.; Rothenberg, Marc E.; Mersha, Tesfaye B.

2016-01-01

Atopic dermatitis (AD), food allergy (FA), allergic rhinitis (AR) and asthma are common atopic disorders of complex etiology. The frequently observed “atopic march” from early AD to asthma and/or AR later in life as well as the extensive comorbidity of atopic disorders, suggests common causal mechanisms in addition to distinct ones. Indeed, both disease-specific and shared genomic regions exist for atopic disorders. Their prevalence also varies among races; for example, AD and asthma have a higher prevalence in African-Americans when compared to European-Americans. Whether this disparity stems from true genetic or race-specific environmental risk factors or both is unknown. Thus far, the majority of the genetic studies on atopic diseases have utilized populations of European ancestry, limiting their generalizability. Large cohort initiatives and new analytic methods such as admixture mapping are currently being employed to address this knowledge gap. Here we discuss the unique and shared genetic risk factors for atopic disorders in the context of ancestry variations, and the promise of high-throughput “-omics” based systems biology approach in providing greater insight to deconstruct into their genetic and non-genetic etiologies. Future research will also focus on deep phenotyping and genotyping of diverse racial ancestry, gene-environment, and gene-gene interactions. PMID:27297995

Indoor risk factors for atopic eczema in school children from East Germany.

PubMed

Schäfer, T; Heinrich, J; Wjst, M; Krause, C; Adam, H; Ring, J; Wichmann, H E

1999-08-01

This study aimed to investigate the relation between environmental influences such as arsenic, cadmium, lead, and mercury, as well as environmental tobacco smoke, pet keeping, and heating systems on the prevalence of atopic eczema. Therefore, a multicenter cross-sectional study of school children aged 5-14 years, including a standardized questionnaire, blood and urine analyses, and a dermatological examination, was undertaken. A cases-control approach was chosen in order to identify relevant risk factors. A total of 2200 school children (response 79.1%) of two areas (Bitterfeld, Hettstedt) polluted by industrial activities and an agricultural control region (Zerbst) of the former German Democratic Republic were examined. Atopic eczema as identified by dermatological examination and history was the outcome variable of interest. Body burden of arsenic and heavy metals and questionnaire data on environmental tobacco smoke exposure, pet keeping, and heating system were investigated as potential risk factors. The overall prevalence of atopic eczema was 2.6%, with higher prevalences in the industrial areas (2.5 and 2.9%) compared to the control area (1.6%, not significant). Bivariate analyses did not reveal statistically significant associations between atopic eczema and tobacco smoke exposure or the body burden of arsenic and heavy metals. According to multiple logistic regression analysis, atopic eczema was significantly more frequent in predisposed families and those who reported keeping guinea pigs (OR=4.37, CI 2.15-8.91), but not other pets, like dogs, cats, and hamsters. In comparison to a distant heating system, a decreased risk was observed in households with central heating system (OR=0.30, CI 0.10-0.90), whereas the presence of a gas heater with an exhaust pipe connection to the wall was associated with a significantly elevated risk for eczema (OR=8.22, CI 2.44-27.66). The heating system and exposure to certain animal allergens are related to the manifestation of atopic eczema. Further studies are needed to clarify how far a causal relationship is reflected by these findings. Copyright 1999 Academic Press.

Sensitisation to Aspergillus fumigatus and Penicillium notatum in laboratory workers.

PubMed

Boscolo, P; Piccolomini, R; Benvenuti, F; Catamo, G; Di Gioacchino, M

1999-01-01

Four workers in medical research laboratories, located in a basement level of a University facility equipped with a humidified air conditioning system, complained of cough and/or asthma and/or rhinitis during their normal working activities. Since exposure to toxic compounds was very low (similar to that of the outdoor environment) only microbiological monitoring was performed. Aspergillus fumigatus and Penicillium notatum were found in some laboratories. Eight laboratory workers (including the 4 symptomatic subjects) out of 26 investigated were found to be atopic. Specific IgE sensitisation to Aspergillus fumigatus was found in the 8 atopic and in the 6 non-atopic workers, while Penicililum notatum was found in 7 atopic and 4 non-atopic subjects. History, physical examination and laboratory data excluded the presence of aspergillosis or allergic bronchial aspergillosis in the sensitised subjects. Our results suggest that evaluation of immune parameters, along with monitoring of the working environment, may reduce the risk of sensitisation and/or allergic symptoms in atopic laboratory workers.

View of the current distribution "bus" atop switching cabinets within ...

Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

View of the current distribution "bus" atop switching cabinets within the former transformer building. Looking northwest - Childs-Irving Hydroelectric Project, Childs System, Childs Powerhouse, Forest Service Road 708/502, Camp Verde, Yavapai County, AZ

Atopic eczema and the filaggrin story.

PubMed

Brown, Sara J; Irvine, Alan D

2008-06-01

The discovery that null mutations in the filaggrin gene (FLG) are associated with atopic eczema represents the single most significant breakthrough in understanding the genetic basis of this complex disorder. The association has been replicated in multiple independent studies during the past 2 years with the use of various methodologies, from populations in Europe, the United States, and Japan. Filaggrin plays a key role in epidermal barrier function, and its association with atopic eczema emphasizes the importance of barrier dysfunction in eczema pathogenesis. This review aims to summarize the current state of knowledge regarding the role of FLG mutations in ichthyosis vulgaris, atopic eczema, and other skin disorders, with an emphasis on potential clinical applications. Further research is needed to clarify the precise role of filaggrin in skin and systemic atopic disease, to pave the way for novel therapeutic interventions.

Diospyros lotus leaf and grapefruit stem extract synergistically ameliorate atopic dermatitis-like skin lesion in mice by suppressing infiltration of mast cells in skin lesions.

PubMed

Cho, Byoung Ok; Che, Denis Nchang; Yin, Hong Hua; Shin, Jae Young; Jang, Seon Il

2017-05-01

Atopic dermatitis, a chronic relapsing and pruritic inflammation of the skin also thought to be involved in, or caused by immune system destruction is an upsetting health problem due to its continuously increasing incidence especially in developed countries. Mast cell infiltration in atopic dermatitis skin lesions and its IgE-mediated activation releases various cytokines and chemokines that have been implicated in the pathogenesis of atopic dermatitis. This study was aimed at investigating synergistic anti-inflammatory, anti-pruritic and anti-atopic dermatitis effects of Diospyros lotus leaf extract (DLE) and Muscat bailey A grapefruit stem extract (GFSE) in atopic dermatitis-like induced skin lesions in mice. Combinations of DLE and GFSE inhibited TNF-α and IL-6 production more than DLE or GFSE in PMA plus calcium ionophore A23187-activated HMC-1 cells. DLE and GFSE synergistically inhibited compound 48/80-induced dermal infiltration of mast cells and reduced scratching behavior than DLE or GFSE. Furthermore, DLE and GFSE synergistically showed a stronger ameliorative effect in skin lesions by reducing clinical scores; dermal infiltration of mast cells; ear and dorsal skin thickness; serum IgE and IL-4 production in atopic dermatitis-like mice. Collectively, these results suggest that DLE and GFSE synergistically exhibit anti-atopic dermatitis effects in atopic dermatitis-like skin lesions in mice. Copyright © 2017. Published by Elsevier Masson SAS.

Electromagnetic Moments of Radioactive 136Te and the Emergence of Collectivity 2p ⊕ 2n outside of Double-Magic 132Sn

DOE Office of Scientific and Technical Information (OSTI.GOV)

Allmond, James M; Stuchberry, A. E.; Danchev, M.

Radioactive 136Te has two valence protons and two valence neutrons outside of the 132Sn double shell closure, providing a simple laboratory for exploring the emergence of collectivity and nucleon- nucleon interactions. Coulomb excitation of 136Te on a titanium target was utilized to determine an extensive set of electromagnetic moments for the three lowest-lying states, including B(E2;0more » $$+\\atop{1}$$→ 2$$+\\atop{1}$$ ), Q(2$$+\\atop{1}$$ ), and g(2$$+\\atop{1}$$ ). The results indicate that the first-excited state, 2$$+\\atop{1}$$ , composed of the simple 2p ⊕ 2n system, is prolate deformed, and its wave function is dominated by neutron degrees of freedom, but not to the extent previously suggested. It is demonstrated that extreme sensitivity of g(2$$+\\atop{1}$$) to the proton and neutron contributions to the wave function provides unique insight into the nature of emerging collectivity, and g(2$$+\\atop{1}$$ ) was used to differentiate among several state-of-the-art theoretical calculations. Finally, our results are best described by the most recent shell model calculations.« less

Electromagnetic Moments of Radioactive 136Te and the Emergence of Collectivity 2p ⊕ 2n outside of Double-Magic 132Sn

DOE PAGES

Allmond, James M; Stuchberry, A. E.; Danchev, M.; ...

2017-03-03

Radioactive 136Te has two valence protons and two valence neutrons outside of the 132Sn double shell closure, providing a simple laboratory for exploring the emergence of collectivity and nucleon- nucleon interactions. Coulomb excitation of 136Te on a titanium target was utilized to determine an extensive set of electromagnetic moments for the three lowest-lying states, including B(E2;0more » $$+\\atop{1}$$→ 2$$+\\atop{1}$$ ), Q(2$$+\\atop{1}$$ ), and g(2$$+\\atop{1}$$ ). The results indicate that the first-excited state, 2$$+\\atop{1}$$ , composed of the simple 2p ⊕ 2n system, is prolate deformed, and its wave function is dominated by neutron degrees of freedom, but not to the extent previously suggested. It is demonstrated that extreme sensitivity of g(2$$+\\atop{1}$$) to the proton and neutron contributions to the wave function provides unique insight into the nature of emerging collectivity, and g(2$$+\\atop{1}$$ ) was used to differentiate among several state-of-the-art theoretical calculations. Finally, our results are best described by the most recent shell model calculations.« less

[Role of IgE-dependent reactions in atopic dermatitis].

PubMed

Dynowski, Jarosław; Wasowska-Królikowska, Krystyna; Modzelewska-Hołyńska, Małgorzata; Tomaszewska, Monika; Funkowicz, Marzena

2007-01-01

Atopic dermatitis is a disease of multifactorial pathogenesis. of the study was to establish the most common allergens responsible for development of atopic symptoms in children with atopic dermatitis. the study complied 36 children aged 4 months - 3 years treated in the Department of Children Allergology, Gastroenterology and Nutrition because of atopic dermatitis. With each case the patient and family history of atopy was collected and basic laboratory tests were conducted (including total IgE and specific IgE using Polly Check system). eosinophilia was found in 11/36 children, elevated total IgE level in 16/36 and specific IgE were present in 14/36 patients. 6 patients proved to have sIgE for more then one allergen. The most commonly found allergens were animal hair, and food allergens. In 22 cases in spite of obvious clinical symptoms requiring therapy at hospital, all sIgE were negative for all tested allergens. although estimating sIgE is commonly used in diagnosing atopic dermatitis, it may not be sufficient to establish complete diagnosis. It seems that animal hair and food allergens are mainly responsible for development of atopic dermatitis.

36. SAR1 UNDER CONSTRUCTION, WITH WORKERS ATOP CRANE. EEC print ...

Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

36. SAR-1 UNDER CONSTRUCTION, WITH WORKERS ATOP CRANE. EEC print no. N-C-01-00031, no date. Photograph by Benjamin F. Pearson. - Santa Ana River Hydroelectric System, SAR-1 Powerhouse, Redlands, San Bernardino County, CA

2. PLANK WALKWAY ATOP PIPE, ALSO SHOWING OVERFLOW CONTROL BOX ...

Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

2. PLANK WALKWAY ATOP PIPE, ALSO SHOWING OVERFLOW CONTROL BOX AT JUNCTION OF PIPE WITH CONCRETE CHANNEL TO FISH SCREEN. VIEW TO NORTHEAST. - Santa Ana River Hydroelectric System, Pipeline to Fish Screen, Redlands, San Bernardino County, CA

7. Detail, machinery shed atop east portal of Tunnel 28, ...

Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

7. Detail, machinery shed atop east portal of Tunnel 28, showing shaft and pulley system, 210mm lens with electronic flash fill. - Central Pacific Transcontinental Railroad, Tunnel No. 28, Milepost 134.75, Applegate, Placer County, CA

FINDS: A fault inferring nonlinear detection system programmers manual, version 3.0

NASA Technical Reports Server (NTRS)

Lancraft, R. E.

1985-01-01

Detailed software documentation of the digital computer program FINDS (Fault Inferring Nonlinear Detection System) Version 3.0 is provided. FINDS is a highly modular and extensible computer program designed to monitor and detect sensor failures, while at the same time providing reliable state estimates. In this version of the program the FINDS methodology is used to detect, isolate, and compensate for failures in simulated avionics sensors used by the Advanced Transport Operating Systems (ATOPS) Transport System Research Vehicle (TSRV) in a Microwave Landing System (MLS) environment. It is intended that this report serve as a programmers guide to aid in the maintenance, modification, and revision of the FINDS software.

Bee and bee products allergy in Turkish beekeepers: determination of risk factors for systemic reactions.

PubMed

Celikel, S; Karakaya, G; Yurtsever, N; Sorkun, K; Kalyoncu, A F

2006-01-01

The prevalence of allergic reactions due to bee stings in beekeepers varies in different regions of the world. The aim of this study was to evaluate the characteristics of sting reactions and the risk factors for developing systemic reactions in Turkish beekeepers. A self-administered questionnaire was distributed to 1250 beekeepers to be completed in seven different cities of Turkey. A total of 494 (39.6 %) questionnaires were returned. There were 444 subjects (89.9 %) with a history of sting exposure in the previous 12 months. Systemic reactions were present in 29 subjects (6.5 %) and nine (2 %) reactions were anaphylactic. Fifty-five percent of beekeepers reported more than 100 bee stings in the previous year. When systemic reactions were controlled by age and duration of beekeeping in a logistic regression model, seasonal rhinitis (OR: 4.4, 95 % CI: 1.2-11.5), perennial rhinitis (OR: 4.6, 95 % CI: 1.2-18.2), food allergy (OR:7.0, 95 % CI: 2.0-25.0), physician-diagnosed asthma (OR: 8.0, 95 % CI: 2.5-25.6), having an atopic disease of any type (OR: 3.3, 95 % CI: 1.2-8.7) and having two or more atopic diseases (OR: 10.9, 95 % CI: 3.5-33.8) were significantly associated with systemic reactions due to bee sting in the previous 12 months. The incidence of systemic reactions in Turkish beekeepers is low, which might be due to the protective effect of a high frequency of bee stings. The risk of systemic reactions increases approximately three-fold when one atopic disease is present and eleven-fold when two or more concurrent atopic diseases are present with respect to no atopic disease.

KSC-2013-2917

NASA Image and Video Library

2013-06-27

CAPE CANAVERAL, Fla. – Inside the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, members of the media receive an on activities in NASA’s Ground Systems Development and Operations, or GSDO, Program, Space Launch System and Orion crew module for Exploration Test Flight 1. Speaking to the media, from left are Scott Wilson, manager of Orion Production Operations at Kennedy Larry Price, Lockheed Martin deputy program manager for Orion Tom Erdman, from Marshall Space Flight Center’s Kennedy resident office Jules Schneider, Lockheed Martin manager of Orion Production Operations and Jeremy Parsons, chief of the GSDO Operations Integration Office at Kennedy. Orion is the exploration spacecraft designed to carry crews to space beyond low Earth orbit. It will provide emergency abort capability, sustain the crew during the space travel and provide safe re-entry from deep space return velocities. Orion’s first unpiloted test flight is scheduled to launch in 2014 atop a Delta IV rocket. A second uncrewed flight test is scheduled for 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Jim Grossmann

Density functional theory + U analysis of the electronic structure and defect chemistry of LSCF (La 0.5 Sr 0.5 Co 0.25 Fe 0.75 O 3-δ )

DOE Office of Scientific and Technical Information (OSTI.GOV)

Ritzmann, Andrew M.; Dieterich, Johannes M.; Carter, Emily A.

2016-01-01

Reducing operating temperatures is a key step in making solid oxide fuel cell (SOFC) technology viable. A promising strategy for accomplishing this goal is employing mixed ion–electron conducting (MIEC) cathodes. La 1-xSr xCo 1-yFe yO 3-δ (LSCF) is the most widely employed MIEC cathode material; however, rational optimization of the composition of LSCF requires fundamental insight linking its electronic structure to its defect chemistry. To provide the necessary insight, density functional theory plus U (DFT+U) calculations are used to investigate the electronic structure of LSCF (xSr = 0.50, yCo = 0.25). The DFT+U calculations show that LSCF has a significantly different electronic structure than La 1-xSr xFeO 3 because of the addition of cobalt, but that minimal electronic structure differences exist between La 0.5Sr 0.5Co 0.25Fe 0.75O 3 and La 0.5Sr 0.5Co 0.5Fe 0.5O 3. The oxygen vacancy (Vmore » $$-\\atop{o}$$) formation energy (ΔEf,vac) is calculated for V$$-\\atop{o}$$ residing in different local environments within La 0.5Sr 0.5Co 0.25Fe 0.75O 3. These results show that Co-V$$-\\atop{o}$$-Co configurations have the highest ΔEf,vac, while Co-V$$-\\atop{o}$$-Fe have the lowest ΔEf,vac and may act as traps for V$$-\\atop{o}$$. We conclude that compositions with more Fe than Co are preferred because the additional Co-V$$-\\atop{o}$$-Co sites would lead to higher overall ΔEf,vac (and lower V$$-\\atop{o}$$ concentrations), while the trapping strength of the Image Co-V$$-\\atop{o}$$-Fe sites is relatively weak (~0.3 eV).« less

Orion EM-1 Crew Module Move from Clean Room to Work Station

NASA Image and Video Library

2017-05-11

Workers have moved the Orion crew module pressure vessel for NASA’s Exploration Mission 1 (EM-1) out of a clean room inside the Neil Armstrong Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida. The crew module will be moved to a work station where it will undergo additional processing to prepare it for launch in 2019. The spacecraft is being prepared for its first integrated flight atop the Space Launch System rocket on Exploration Mission-1.

MLP-1 on Crawler Transporter 2 (CT-2)

NASA Image and Video Library

2017-03-22

NASA's upgraded crawler-transporter 2 (CT-2), carrying mobile launcher platform 1, moves slowly along the crawlerway at the agency's Kennedy Space Center in Florida. The crawler's upgrades and modifications will be monitored and tested under loaded conditions during its travel to the crawlerway Pad A/B split and back to the crawler yard to confirm it is ready to support the load of the mobile launcher carrying the Space Launch System with Orion atop for the first test flight, Exploration Mission 1. The Ground Systems Development and Operations Program at Kennedy is managing upgrades to the crawler.

ICPS Turnover GSDO Employee Event

NASA Image and Video Library

2017-11-07

Kennedy Space Center Associate Director Kelvin Manning, right, speaks with a guest during a ceremony marking NASA's Spacecraft/Payload Integration and Evolution (SPIE) organization formally turning over processing of the Space Launch System (SLS) rocket's Interim Cryogenic Propulsion Stage (ICPS) to the center's Ground Systems Development and Operations (GSDO) Directorate. The ICPS is the first integrated piece of flight hardware to arrive in preparation for the uncrewed Exploration Mission-1. With the Orion attached, the ICPS sits atop the SLS rocket and will provide the spacecraft with the additional thrust needed to travel tens of thousands of miles beyond the Moon.

Interim Cryogenic Propulsion Stage (ICPS) Handover Signing

NASA Image and Video Library

2017-10-26

Meeting in the Launch Control Center of NASA's Kennedy Space Center in Florida, officials of the agency's Spacecraft/Payload Integration and Evolution (SPIE) organization formally turn over processing of the Space Launch System (SLS) rocket's Interim Cryogenic Propulsion Stage (ICPS) to the center's Ground Systems Development and Operations (GSDO) directorate. The ICPS is the first integrated piece of flight hardware to arrive in preparation for the uncrewed Exploration Mission-1. With the Orion attached, the ICPS sits atop the SLS rocket and will provide the spacecraft with the additional thrust needed to travel tens of thousands of miles beyond the Moon.

Vehicle Support Posts Installation at Mobile Launcher

NASA Image and Video Library

2017-05-11

Construction workers at the Mobile Launcher at NASA's Kennedy Space Center in Florida, prepare to install vehicle support posts. A total of eight support posts are being installed to support the load of the Space Launch System's (SLS) solid rocket boosters, with four posts for each of the boosters. The support posts are about five feet tall and each weigh about 10,000 pounds. The posts will structurally support the SLS rocket through T-0 and liftoff. The Ground Systems Development and Operations Program is overseeing installation of the support posts to prepare for the launch of the Orion spacecraft atop the SLS rocket.

Orion EM-1 Crew Module Adapter Move to Clean Room

NASA Image and Video Library

2016-11-29

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, Lockheed Martin technicians begin to move the Orion crew module adapter (CMA) for Exploration Mission 1 (EM-1) to a clean room. The CMA will undergo propellant and environmental control and life support system tube installation and welding. The adapter will connect the Orion crew module to the European Space Agency-provided service module. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion EM-1 Crew Module Adapter Move to Clean Room

NASA Image and Video Library

2016-11-29

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, Lockheed Martin technicians secure a protective cover around the Orion crew module adapter (CMA) for Exploration Mission 1 (EM-1) for its move to a clean room. The CMA will undergo propellant and environmental control and life support system tube installation and welding. The adapter will connect the Orion crew module to the European Space Agency-provided service module. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion EM-1 Crew Module Adapter Move to Clean Room

NASA Image and Video Library

2016-11-29

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, a Lockheed Martin technician secures a protective cover around the Orion crew module adapter (CMA) for Exploration Mission 1 (EM-1) for its move to a clean room The CMA will undergo propellant and environmental control and life support system tube installation and welding. The adapter will connect the Orion crew module to the European Space Agency-provided service module. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion EM-1 Crew Module Adapter Move to Clean Room

NASA Image and Video Library

2016-11-29

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, Lockheed Martin technicians secure a protective cover around the Orion crew module adapter (CMA) for Exploration Mission 1 (EM-1) for its move to a clean room. The CMA will undergo propellant and environmental control and life support system tube installation and welding. The adapter will connect the Orion crew module to the European Space Agency-provided service module. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion EM-1 Crew Module Adapter Move to Clean Room

NASA Image and Video Library

2016-11-29

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, a protective cover is installed around the Orion crew module adapter (CMA) for Exploration Mission 1 (EM-1) for its move to a clean room. The CMA will undergo propellant and environmental control and life support system tube installation and welding. The adapter will connect the Orion crew module to the European Space Agency-provided service module. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion EM-1 Crew Module Adapter Move to Clean Room

NASA Image and Video Library

2016-11-29

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, Lockheed Martin technicians are preparing the Orion crew module adapter (CMA) for Exploration Mission 1 (EM-1) for the move into a clean room. The CMA will undergo propellant and environmental control and life support system tube installation and welding. The adapter will connect the Orion crew module to the European Space Agency-provided service module. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion EM-1 Crew Module Adapter Move to Clean Room

NASA Image and Video Library

2016-11-29

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, Lockheed Martin technicians secure a protective cover around the Orion crew module adapter (CMA) for Exploration Mission 1 (EM-1) for its move to a clean. The CMA will undergo propellant and environmental control and life support system tube installation and welding. The adapter will connect the Orion crew module to the European Space Agency-provided service module. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Orion EM-1 Crew Module Adapter Move to Clean Room

NASA Image and Video Library

2016-11-29

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, the Orion crew module adapter (CMA) for Exploration Mission 1 (EM-1) is in a clean room with protective walls secured around it. The adapter will undergo propellant and environmental control and life support system tube installation and welding. The adapter will connect the Orion crew module to the European Space Agency-provided service module. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission, in late 2018.

Pathogenic mechanisms of allergic inflammation: atopic asthma as a paradigm.

PubMed

Holt, Patrick G; Strickland, Deborah H; Bosco, Anthony; Jahnsen, Frode L

2009-01-01

Prospective studies tracking birth cohorts over periods of years indicate that the seeds for atopic asthma in adulthood are sewn during early life. The key events involve programming of functional phenotypes within the immune and respiratory systems which determine long-term responsiveness to ubiquitous environmental stimuli, particularly respiratory viruses and aeroallergens. A crucial component of asthma pathogenesis is early sensitization to aeroallergens stemming from a failure of mucosal tolerance mechanisms during the preschool years, which is associated with delayed postnatal maturation of a range of adaptive and innate immune functions. These maturational defects also increase risk for severe respiratory infections, and the combination of sensitization and infections maximizes risk for early development of the persistent asthma phenotype. Interactions between immunoinflammatory pathways stimulated by these agents also sustain the disease in later life as major triggers of asthma exacerbations. Recent studies on the nature of these interactions suggest the operation of an infection-associated lung:bone marrow axis involving upregulation of FcERlalpha on myeloid precursor populations prior to their migration to the airways, thus amplifying local inflammation via IgE-mediated recruitment of bystander atopic effector mechanisms. The key participants in the disease process are airway mucosal dendritic cells and adjacent epithelial cells, and transiting CD4(+) effector and regulatory T-cell populations, and increasingly detailed characterization of their roles at different stages of pathogenesis is opening up novel possibilities for therapeutic control of asthma. Of particular interest is the application of genomics-based approaches to drug target identification in cell populations of interest, exemplified by recent findings discussed below relating to the gene network(s) triggered by activation of Th2-memory cells from atopics. 2009 Elsevier Inc. All rights reserved.

Vitamin D in atopic dermatitis, asthma and allergic diseases.

PubMed

Searing, Daniel A; Leung, Donald Y M

2010-08-01

This review examines the scientific evidence behind the hypothesis that vitamin D plays a role in the pathogenesis of allergic diseases, along with a focus on emerging data regarding vitamin D and atopic dermatitis. Elucidated molecular interactions of vitamin D with components of the immune system and clinical data regarding vitamin D deficiency and atopic diseases are discussed. The rationale behind the sunshine hypothesis, laboratory evidence supporting links between vitamin D deficiency and allergic diseases, the clinical evidence for and against vitamin D playing a role in allergic diseases, and the emerging evidence regarding the potential use of vitamin D to augment the innate immune response in atopic dermatitis are reviewed. Copyright 2010 Elsevier Inc. All rights reserved.

Prenatal animal contact and gene expression of innate immunity receptors at birth are associated with atopic dermatitis.

PubMed

Roduit, Caroline; Wohlgensinger, Johanna; Frei, Remo; Bitter, Sondhja; Bieli, Christian; Loeliger, Susanne; Büchele, Gisela; Riedler, Josef; Dalphin, Jean-Charles; Remes, Sami; Roponen, Marjut; Pekkanen, Juha; Kabesch, Michael; Schaub, Bianca; von Mutius, Erika; Braun-Fahrländer, Charlotte; Lauener, Roger

2011-01-01

Cross-sectional studies have suggested that prenatal farm exposures might protect against allergic disease and increase the expression of receptors of the innate immune system. However, epidemiologic evidence supporting the association with atopic dermatitis remains inconsistent. To study the association between prenatal farm-related exposures and atopic dermatitis in a prospective study. We further analyzed the association between the expression of innate immune genes at birth and atopic dermatitis. A total of 1063 children who participated in a birth cohort study, Protection against Allergy-Study in Rural Environments, were included in this study. Doctor diagnosis of atopic dermatitis was reported by the parents from 1 to 2 years of age by questionnaire. Gene expression of Toll-like receptors (TLRs) and CD14 was assessed in cord blood leukocytes by quantitative PCR. Maternal contact with farm animals and cats during pregnancy had a significantly protective effect on atopic dermatitis in the first 2 years of life. The risk of atopic dermatitis was reduced by more than half among children with mothers having contact with 3 or more farm animal species during pregnancy compared with children with mothers without contact (adjusted odds ratio, 0.43; 95% CI, 0.19-0.97). Elevated expression of TLR5 and TLR9 in cord blood was associated with decreased doctor diagnosis of atopic dermatitis. A significant interaction between polymorphism in TLR2 and prenatal cat exposure was observed in atopic dermatitis. Maternal contact with farm animals and cats during pregnancy has a protective effect on the development of atopic dermatitis in early life, which is associated with a lower expression of innate immune receptors at birth. Copyright © 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Search for the direct production of charginos and neutralinos in final states with tau leptons in $$\\sqrt{s}$$ =13 TeV pp collisions with the ATLAS detector

DOE PAGES

Aaboud, M.; Aad, G.; Abbott, B.; ...

2018-02-22

Here, a search for the direct production of charginos and neutralinos in final states with at least two hadronically decaying tau leptons is presented. The analysis uses a dataset of pp collisions corresponding to an integrated luminosity of 36.1fb -1, recorded with the ATLAS detector at the Large Hadron Collider at a centre-of-mass energy of 13 TeV. No significant deviation from the expected Standard Model background is observed. Limits are derived in scenarios ofmore » $$\\sim\\atop{\\chi}$$ $$+\\atop{1}$$ $$\\sim\\atop{\\chi}$$ $$\\bar{1}$$ pair production and of $$\\sim\\atop{\\chi}$$ $$±\\atop{1}$$ $$\\sim\\atop{\\chi}$$ $$0\\atop{2}$$ and $$\\sim\\atop{\\chi}$$ $$+\\atop{1}$$ $$\\sim\\atop{\\chi}$$ $$\\bar{1}$$ production in simplified models where the neutralinos and charginos decay solely via intermediate left-handed staus and tau sneutrinos, and the mass of the $$\\sim\\atop{\\tau}_L$$ state is set to be halfway between the masses of the $$\\sim\\atop{\\chi}$$ $$±\\atop{1}$$ and the $$\\sim\\atop{\\chi}$$ $$0\\atop{1}$$. Chargino masses up to 630 GeV are excluded at 95% confidence level in the scenario of direct production of $$\\sim\\atop{\\chi}$$ $$+\\atop{1}$$ $$\\sim\\atop{\\chi}$$ $$\\bar{1}$$ for a massless $$\\sim\\atop{\\chi}$$ $$0\\atop{1}$$. Common $$\\sim\\atop{\\chi}$$ $$±\\atop{1}$$ and $$\\sim\\atop{\\chi}$$ $$0\\atop{2}$$ masses up to 760 GeV are excluded in the case of production of $$\\sim\\atop{\\chi}$$ $$±\\atop{1}$$ $$\\sim\\atop{\\chi}$$ $$0\\atop{2}$$ and $$\\sim\\atop{\\chi}$$ $$+\\atop{1}$$ $$\\sim\\atop{\\chi}$$ $$-\\atop{1}$$ assuming a massless $$\\sim\\atop{\\chi}$$ $$0\\atop{1}$$. Exclusion limits for additional benchmark scenarios with large and small mass-splitting between the Open image in new window $$\\sim\\atop{\\chi}$$ $$±\\atop{1}$$ and the $$\\sim\\atop{\\chi}$$ $$0\\atop{1}$$ are also studied by varying the $$\\sim\\atop{\\tau}_L$$ mass between the masses of the $$\\sim\\atop{\\chi}$$ $$±\\atop{1}$$ and the $$\\sim\\atop{\\chi}$$ $$0\\atop{1}$$.« less

Search for the direct production of charginos and neutralinos in final states with tau leptons in $$\\sqrt{s}$$ =13 TeV pp collisions with the ATLAS detector

DOE Office of Scientific and Technical Information (OSTI.GOV)

Aaboud, M.; Aad, G.; Abbott, B.

Here, a search for the direct production of charginos and neutralinos in final states with at least two hadronically decaying tau leptons is presented. The analysis uses a dataset of pp collisions corresponding to an integrated luminosity of 36.1fb -1, recorded with the ATLAS detector at the Large Hadron Collider at a centre-of-mass energy of 13 TeV. No significant deviation from the expected Standard Model background is observed. Limits are derived in scenarios ofmore » $$\\sim\\atop{\\chi}$$ $$+\\atop{1}$$ $$\\sim\\atop{\\chi}$$ $$\\bar{1}$$ pair production and of $$\\sim\\atop{\\chi}$$ $$±\\atop{1}$$ $$\\sim\\atop{\\chi}$$ $$0\\atop{2}$$ and $$\\sim\\atop{\\chi}$$ $$+\\atop{1}$$ $$\\sim\\atop{\\chi}$$ $$\\bar{1}$$ production in simplified models where the neutralinos and charginos decay solely via intermediate left-handed staus and tau sneutrinos, and the mass of the $$\\sim\\atop{\\tau}_L$$ state is set to be halfway between the masses of the $$\\sim\\atop{\\chi}$$ $$±\\atop{1}$$ and the $$\\sim\\atop{\\chi}$$ $$0\\atop{1}$$. Chargino masses up to 630 GeV are excluded at 95% confidence level in the scenario of direct production of $$\\sim\\atop{\\chi}$$ $$+\\atop{1}$$ $$\\sim\\atop{\\chi}$$ $$\\bar{1}$$ for a massless $$\\sim\\atop{\\chi}$$ $$0\\atop{1}$$. Common $$\\sim\\atop{\\chi}$$ $$±\\atop{1}$$ and $$\\sim\\atop{\\chi}$$ $$0\\atop{2}$$ masses up to 760 GeV are excluded in the case of production of $$\\sim\\atop{\\chi}$$ $$±\\atop{1}$$ $$\\sim\\atop{\\chi}$$ $$0\\atop{2}$$ and $$\\sim\\atop{\\chi}$$ $$+\\atop{1}$$ $$\\sim\\atop{\\chi}$$ $$-\\atop{1}$$ assuming a massless $$\\sim\\atop{\\chi}$$ $$0\\atop{1}$$. Exclusion limits for additional benchmark scenarios with large and small mass-splitting between the Open image in new window $$\\sim\\atop{\\chi}$$ $$±\\atop{1}$$ and the $$\\sim\\atop{\\chi}$$ $$0\\atop{1}$$ are also studied by varying the $$\\sim\\atop{\\tau}_L$$ mass between the masses of the $$\\sim\\atop{\\chi}$$ $$±\\atop{1}$$ and the $$\\sim\\atop{\\chi}$$ $$0\\atop{1}$$.« less

KSC-2014-4766

NASA Image and Video Library

2014-12-05

SAN DIEGO, Calif. -- NASA's Orion spacecraft splashed down in the Pacific Ocean after its first flight test atop a Delta IV Heavy rocket from Space Launch Complex 37 at Cape Canaveral Air Force Station in Florida. U.S. Navy divers in Zodiac boats prepare to recover Orion and tow her in to the well deck of the USS Anchorage. NASA's Orion spacecraft completed a two-orbit, four-and-a-half hour mission to test systems critical to crew safety, including the launch abort system, the heat shield and the parachute system. The Ground Systems Development and Operations Program is leading the recovery efforts. For more information, visit www.nasa.gov/orion Photo credit: Courtesy of U.S. Navy

Orion Splashdown Recovery

NASA Image and Video Library

2014-12-06

The Orion crew module is recovered after splashdown in the Pacific Ocean about 600 miles off the coast of San Diego, California. NASA, the U.S. Navy and Lockheed Martin coordinated efforts to recover Orion and secure the spacecraft inside the well deck of the USS Anchorage. After lifting off at 7:05 a.m. EST atop a Delta IV Heavy rocket from Space Launch Complex 37 at Cape Canaveral Air Force Station in Florida, NASA's Orion spacecraft completed a two-orbit, four-and-a-half hour mission to test systems critical to crew safety, including the launch abort system, the heat shield and the parachute system. The Ground Systems Development and Operations Program is leading the recovery efforts.

Orion in the Well Deck After Splashdown and Recovery

NASA Image and Video Library

2014-12-05

NASA's Orion spacecraft is secured with tether lines inside the flooded well deck of the USS Anchorage in the Pacific Ocean about 600 miles off the coast of San Diego, California. After lifting off at 7:05 a.m. EST atop a Delta IV Heavy rocket from Space Launch Complex 37 at Cape Canaveral Air Force Station in Florida, Orion completed a two-orbit, four-and-a-half hour mission to test systems critical to crew safety, including the launch abort system, the heat shield and the parachute system. NASA, the U.S. Navy and Lockheed Martin coordinated efforts to recover Orion after splashdown. The Ground Systems Development and Operations Program is leading the recovery efforts.

Orion in the Well Deck After Splashdown and Recovery

NASA Image and Video Library

2014-12-05

NASA's Orion spacecraft has been recovered inside the flooded well deck of the USS Anchorage in the Pacific Ocean about 600 miles off the coast of San Diego, California. After lifting off at 7:05 a.m. EST atop a Delta IV Heavy rocket from Space Launch Complex 37 at Cape Canaveral Air Force Station in Florida, Orion completed a two-orbit, four-and-a-half hour mission to test systems critical to crew safety, including the launch abort system, the heat shield and the parachute system. NASA, the U.S. Navy and Lockheed Martin coordinated efforts to recover Orion after splashdown. The Ground Systems Development and Operations Program is leading the recovery efforts.

Cryo Tank Fill at Pad 39B

NASA Image and Video Library

2017-09-26

Several Praxair trucks carrying their loads of liquid oxygen, or LO2, have arrived at Launch Pad 39B at NASA's Kennedy Space Center in Florida. A mist is visible as LO2 is offloaded from one of the trucks into the giant storage sphere located at the northwest corner of the pad has begun. The sphere will gradually be chilled down from normal temperature to about negative 298 degrees Fahrenheit, during the first major integrated operation to prepare for the launch of the agency's Orion spacecraft atop the Space Launch System (SLS) rocket. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to pad B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1, deep space missions and NASA’s journey to Mars.

Cryo Tank Fill at Pad 39B

NASA Image and Video Library

2017-09-26

Several Praxair trucks carrying their loads of liquid oxygen, or LO2, have arrived at Launch Pad 39B at NASA's Kennedy Space Center in Florida. The trucks will begin to offload the LO2 one at a time into the giant storage sphere located at the northwest corner of the pad. The sphere will gradually be chilled down from normal temperature to about negative 298 degrees Fahrenheit, during the first major integrated operation to prepare for the launch of the agency's Orion spacecraft atop the Space Launch System (SLS) rocket. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to pad B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1, deep space missions and NASA’s journey to Mars.

Cryo Tank Fill at Pad 39B

NASA Image and Video Library

2017-09-26

Engineers watch as several Praxair trucks carrying their loads of liquid oxygen, or LO2, arrive at Launch Pad 39B at NASA's Kennedy Space Center in Florida. The trucks will offload the LO2 one at a time into the giant storage sphere located at the northwest corner of the pad. The sphere will gradually be chilled down from normal temperature to about negative 298 degrees Fahrenheit, during the first major integrated operation to prepare for the launch of the agency's Orion spacecraft atop the Space Launch System (SLS) rocket. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to pad B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1, deep space missions and NASA’s journey to Mars.

Infant feeding and the development of food allergies and atopic eczema: An update.

PubMed

Gamboni, Sarah E; Allen, Katrina J; Nixon, Rosemary L

2013-05-01

There is an increasing awareness of food allergies in the community. Dermatologists frequently see patients with atopic eczema, where parents are extremely concerned about the role of food allergy. Advice given to parents regarding the timing of introduction of solid foods has changed markedly over the past decade. Whereas previous advice advocated delaying the introduction of solid foods until the infant's gastrointestinal system had matured, recent studies suggest that the introduction of solids from around 4 to 6 months may actually prevent the development of allergies. Studies on maternal dietary restrictions during pregnancy and lactation have led researchers to believe that antigen avoidance does not play a significant role in the prevention of atopic disease. Breastfeeding exclusively for 4 to 6 months has multiple benefits for mother and child, however, it does not convincingly prevent food allergies or decrease atopic eczema. New evidence suggests that the use of hydrolysed formulas does not delay or prevent atopic eczema or food allergy. This article aims to highlight current evidence and provide an update for dermatologists on the role of food exposure in the development of atopic disease, namely atopic eczema. © 2012 The Authors. Australasian Journal of Dermatology © 2012 The Australasian College of Dermatologists.

Vitamin D in Atopic Dermatitis, Asthma and Allergic Diseases

PubMed Central

Searing, Daniel A; Leung, Donald YM

2010-01-01

Synopsis This review examines the scientific evidence behind the hypothesis that vitamin D plays a role in the pathogenesis of allergic diseases, with a particular focus on emerging data regarding vitamin D and atopic dermatitis. Both elucidated molecular interactions of vitamin D with components of the immune system, as well as clinical data regarding vitamin D deficiency and atopic diseases are discussed. The rationale behind the “sunshine hypothesis,” laboratory evidence supporting links between vitamin D deficiency and allergic diseases, the clinical evidence for/and against vitamin D playing a role in allergic diseases, and the emerging evidence regarding the potential use of vitamin D in augmentation of the innate immune response in atopic dermatitis are reviewed. PMID:20670821

GSE is Being Readied to Load onto the Ship for Orion Recovery

NASA Image and Video Library

2014-11-17

NASA Orion Recovery Director Jeremy Graeber, with the Ground Systems Development and Operations Program at Kennedy Space Center in Florida, reviews Orion recovery procedures with NASA, Lockheed Martin and U.S. Navy personnel aboard the USS Anchorage at Naval Base San Diego in California. Before the launch of Orion on its first flight test atop a Delta IV Heavy rocket from Cape Canaveral Air Force Station in Florida, NASA, Lockheed Martin and U.S. Navy personnel will head out to sea in the USS Anchorage and the USNS Salvor, a salvage ship, and wait for splashdown of the Orion crew module in the Pacific Ocean. The GSDO Program will lead the recovery efforts. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted flight test of Orion is scheduled to launch in December atop a United Launch Alliance Delta IV Heavy rocket and in 2018 on NASA’s Space Launch System rocket.

GSE is Being Readied to Load onto the Ship for Orion Recovery

NASA Image and Video Library

2014-11-17

NASA Orion Recovery Director Jeremy Graeber, with the Ground Systems Development and Operations Program at Kennedy Space Center in Florida, reviews Orion recovery procedures with NASA, Lockheed Martin and U.S. Navy personnel aboard the USS Anchorage at Naval Base San Diego in California. Before the launch of Orion on its first flight test atop a Delta IV Heavy rocket from Cape Canaveral Air Force Station in Florida, NASA, Lockheed Martin and the U.S. Navy personnel will head out to sea in the USS Anchorage and the USNS Salvor, a salvage ship, and wait for splashdown of the Orion crew module in the Pacific Ocean. The GSDO Program will lead the recovery efforts. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted flight test of Orion is scheduled to launch in December atop a United Launch Alliance Delta IV Heavy rocket and in 2018 on NASA’s Space Launch System rocket.

KSC-2014-3784

NASA Image and Video Library

2014-09-10

CAPE CANAVERAL, Fla. – During a ceremony inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, Jules Schneider, Lockheed Martin Orion Production Operations manager, holds the key to symbolically turn over the Orion spacecraft for Exploration Flight Test-1 to Ground Operations. Waiting to accept the key is Blake Hale, Lockheed Martin Ground Operations manager. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch atop a United Launch Alliance Delta IV Heavy rocket from Cape Canaveral Air Force Station in Florida in December to an altitude of 3,600 miles above the Earth's surface. The two-orbit, four-hour flight test will help engineers evaluate the systems critical to crew safety including the heat shield, parachute system and launch abort system. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Daniel Casper

KSC-2014-3785

NASA Image and Video Library

2014-09-10

CAPE CANAVERAL, Fla. – During a ceremony inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, Jules Schneider, at right, Lockheed Martin Orion Production Operations manager, presents the key to symbolically turn over the Orion spacecraft for Exploration Flight Test-1 to Ground Operations. Accepting the key is Blake Hale, Lockheed Martin Ground Operations manager. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch atop a United Launch Alliance Delta IV Heavy rocket from Cape Canaveral Air Force Station in Florida in December to an altitude of 3,600 miles above the Earth's surface. The two-orbit, four-hour flight test will help engineers evaluate the systems critical to crew safety including the heat shield, parachute system and launch abort system. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Daniel Casper

KSC-2014-3783

NASA Image and Video Library

2014-09-10

CAPE CANAVERAL, Fla. – Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, Jules Schneider, at right, Lockheed Martin Orion Production Operations manager, speaks to NASA and Lockheed Martin workers during a ceremony to turn over the Orion spacecraft for Exploration Flight Test-1 to Ground Operations. At left is Blake Hale, Lockheed Martin Ground Operations manager. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch atop a United Launch Alliance Delta IV Heavy rocket from Cape Canaveral Air Force Station in Florida in December to an altitude of 3,600 miles above the Earth's surface. The two-orbit, four-hour flight test will help engineers evaluate the systems critical to crew safety including the heat shield, parachute system and launch abort system. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Daniel Casper

KSC-2014-3786

NASA Image and Video Library

2014-09-10

CAPE CANAVERAL, Fla. – Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, Jules Schneider, at right, Lockheed Martin Orion Production Operations manager, shakes hands with Blake Hale, Lockheed Martin Ground Operations manager, during a ceremony to officially turn over the Orion spacecraft for Exploration Flight Test-1 to Lockheed Martin Ground Operations. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch atop a United Launch Alliance Delta IV Heavy rocket from Cape Canaveral Air Force Station in Florida in December to an altitude of 3,600 miles above the Earth's surface. The two-orbit, four-hour flight test will help engineers evaluate the systems critical to crew safety including the heat shield, parachute system and launch abort system. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Daniel Casper

Orion Crew Module Move

NASA Image and Video Library

2017-11-17

Technicians in clean-room suits attach a crane to the Orion crew module for Exploration Mission-1 for its move to the thermal chamber in the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida. Orion will be lifted out of a test stand and lowered onto another stand to for the move. The crew module will undergo a thermal cycle test to assess the workmanship of critical hardware and structural locations. The test also demonstrates crew module subsystem operations in a thermally stressing environment to confirm no damage or anomalous hardware conditions as a result of the test. The Orion spacecraft will launch atop NASA's Space Launch System rocket on its first uncrewed integrated flight.

KSC-2013-3938

NASA Image and Video Library

2013-11-07

CAPE CANAVERAL, Fla. – At NASA’s Kennedy Space Center in Florida, all four ogive panels have been installed on the Orion ground test vehicle in Vehicle Assembly Building high bay 4. The ogive panels enclose and protect the Orion spacecraft and attach to the Launch Abort System. The test vehicle is being used by the Ground Systems Development and Operations Program for path finding operations, including simulated manufacturing, assembly and stacking procedures. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion. Photo credit: Kim Shiflett

KSC-2013-3926

NASA Image and Video Library

2013-10-30

CAPE CANAVERAL, Fla. – At NASA’s Kennedy Space Center in Florida, the Orion ground test vehicle is being prepared for installation of the ogive panels in Vehicle Assembly Building high bay 4. The ogive panels enclose and protect the Orion spacecraft and attach to the Launch Abort System. The test vehicle is being used by the Ground Systems Development and Operations Program for path finding operations, including simulated manufacturing, assembly and stacking procedures. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion. Photo credit: Kim Shiflett

KSC-2013-3937

NASA Image and Video Library

2013-11-07

CAPE CANAVERAL, Fla. – At NASA’s Kennedy Space Center in Florida, technicians attach the fourth ogive panel on the Orion ground test vehicle in Vehicle Assembly Building high bay 4. The ogive panels enclose and protect the Orion spacecraft and attach to the Launch Abort System. The test vehicle is being used by the Ground Systems Development and Operations Program for path finding operations, including simulated manufacturing, assembly and stacking procedures. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion. Photo credit: Kim Shiflett

KSC-2012-4213

NASA Image and Video Library

2012-08-03

CAPE CANAVERAL, Fla. -- This is an artist's conception of Sierra Nevada Corp. SNC Space System's Dream Chaser spacecraft atop a United Launch Alliance ULA Atlas V rocket under development for NASA's Commercial Crew Program, or CCP. The integrated system was selected for CCP's Commercial Crew Integrated Capability, or CCiCap, initiative to propel America's next human space transportation system to low Earth orbit forward. Operating under a funded Space Act Agreement, or SAA, SNC will spend the next 21 months completing its design, conducting critical risk reduction testing on its spacecraft and launch vehicle, and showcasing how it would operate and manage missions from launch through orbit and landing, setting the stage for a future demonstration mission. To learn more about CCP, which is based at NASA's Kennedy Space Center in Florida and supported by NASA's Johnson Space Center in Houston, visit www.nasa.gov/commercialcrew. Image credit: SNC

Earth Science

NASA Image and Video Library

1994-04-12

The Atlas-1 (AC-77) that will loft the Geostationary Operational Environmental Satellite-J (GOES-J) next-generation advanced technology weather satellite into space sits poised for takeoff during final countdown operations at Cape Canaveral Air Station, Kennedy Space Center (KSC). GOES-J is atop the expendable launch vehicle inside the rocket's payload fairing.

Addressing the immunopathogenesis of atopic dermatitis: advances in topical and systemic treatment.

PubMed

Eichenfield, Lawrence F; Stein Gold, Linda F

2017-03-01

Several immunologic mediators-phosphodiesterase (PDE), interleukin (IL), small molecules, and Janus kinase-have been implicated in the pathogenesis of atopic dermatitis, and evidence has shown that blocking these mediators can help modify the disease process. Several new topical medications have been developed that target the enzyme PDE; crisaborole was recently approved by the US Food and Drug Administration (FDA) for the treatment of atopic dermatitis, and phase II studies have been completed on OPA-15406. The phase III clinical trial results of the systemic medication dupilumab, an inhibitor of the IL-4 receptor α subunit (which inhibits both IL-4 and IL-13 signaling), are currently being reviewed by the FDA. ©2017 Frontline Medical Communications.

Search for r-parity violating supersymmetry in multilepton final states with the D0 detector

DOE Office of Scientific and Technical Information (OSTI.GOV)

Kaefer, Daniela

Results obtained from a search for the trilepton signature μμℓ (with ℓ = e, or μ) are combined with two complementary searches for the trilepton signatures eeℓ and eer and interpreted in the framework of R-parity violating Supersymmetry. Pairwise, R-parity conserving production of the supersymmetric particles is assumed, followed by R-parity violating decays via an LLmore » $$\\bar{E}$$-operator with one dominant coupling λ 122. An LL$$\\bar{E}$$-operator couples two weak isospin doublet and one singlet (s)lepton fields and thus violates lepton number conservation. The data, collected with the D0 detector at the Fermilab proton-antiproton collider Tevatron, corresponds to an integrated luminosity of ∫ L dt = 360 ± 23 pb -1. No evident is observed, while 0.41 ± 0.11(stat) ± 0.07(sys) events are expected from Standard Model processes. The resulting 95% confidence level cross section limits on new physics producing a μμℓ signature in the detector are of the order of 0.020 to 0.136 pb. They are interpreted in two different supersymmetry scenarios: the mSUGRA and the MSSM model. The corresponding lower limits on the masses of the lightest neutralino ($$\\tilde{X}$$$0\\atop{1}$$) and the lightest chargino ($$\\tilde{X}$$$±\\atop{1}$$ in case of the mSUGRA model are found to be in the range of: mSUGRA, μ > 0: M($$\\tilde{X}$$$0\\atop{1}$$) ~> 115-128 GeV and M($$\\tilde{X}$$$±\\atop{1}$$) ~> 215-241 GeV; mSUGRA, μ < 0: ($$\\tilde{X}$$$0\\atop{1}$$) ~> 101-114 GeV and M($$\\tilde{X}$$$±\\atop{1}$$) ~> 194-230 GeV, depending on the actual values of the model parameters: m 0, m 1/2, A 0, tanβ, and μ. The first and second parameters provide the boundary conditions for the masses of the supersymmetric spin-0 and spin-1/2 particles, respectively, while A 0 gives the universal value for the trilinear couplings at the GUT scale. The parameter tan β denotes the ratio of the vacuum expectation values of the two Higgs fields and μ, finally, represents the Higgs mixing parameter. In the MSSM scenario the lower bound on the mass of the lightest chargino (for fixed neutralino mass) is found to be in the range of: M($$\\tilde{X}$$$±\\atop{1}$$) ~> 205 GeV, for M($$\\tilde{X}$$$0\\atop{1}$$) = 30 GeV; M($$\\tilde{X}$$$±\\atop{1}$$) ~> 232 GeV, for M($$\\tilde{X}$$$0\\atop{1}$$) = 200 GeV. The parameters of the considered MSSM model are: M 1, M 2, M 3, A 0, tan β, μ, and m A. The first three parameters define the common masses of the superpartners of the U(1) Y, SU(2) L, and SU(3) C bosons at the electroweak scale, respectively. The following three parameters are identical to those defined in the mSUGRA model above, while m A denotes the mass of the pseudoscalar Higgs boson, present in the supersymmetric extension of the Standard Model. In addition all sfermion masses are set to 1000 GeV.« less

Molecular basis of atopic dermatitis.

PubMed

Bonness, Sonja; Bieber, Thomas

2007-10-01

Atopic dermatitis is a common chronic inflammatory skin disease and there are numerous publications on this topic. This review will focus on developments in understanding the molecular basis of atopic dermatitis while considering the genetic background, skin barrier impairment, immune system deviation and microbial superinfections. Atopic dermatitis is a complex genetic disease in which gene-gene and gene-environment interactions play a key role. Surprisingly some genetic regions of interest were found to be overlapping with loci identified to play a role in another very common inflammatory skin disease, psoriasis, while no overlap has so far been observed with asthma. Impairment of the skin barrier followed by antigens trespassing seems to play an important role, favouring sensitization via transepidermal penetration which is the focus of current investigations. Superinfections by pathogens such as Staphylococcus aureus due to a weak innate defence seem to be significant in atopic dermatitis as they elicit a strong inflammatory response. Atopic dermatitis is a chronic inflammatory skin disease with a high incidence in school children and adults. Disease pathogenesis is complex and the background is multifactorial, making the underlying predispositions elusive. Understanding new pathogenic pathways may lead to the development of new drugs with enhanced benefit for the patient.

MLP-1 on Crawler Transporter 2 (CT-2)

NASA Image and Video Library

2017-03-22

Ground support technicians walk alongside NASA's upgraded crawler-transporter 2 (CT-2), carrying mobile launcher platform 1, as it slowly travels on the crawlerway at the agency's Kennedy Space Center in Florida. The crawler's upgrades and modifications will be monitored and tested under loaded conditions during its travel to the crawlerway Pad A/B split and back to the crawler yard to confirm it is ready to support the load of the mobile launcher carrying the Space Launch System with Orion atop for the first test flight, Exploration Mission 1. The Ground Systems Development and Operations Program at Kennedy is managing upgrades to the crawler.

MLP-1 on Crawler Transporter 2 (CT-2)

NASA Image and Video Library

2017-03-22

NASA's upgraded crawler-transporter 2 (CT-2), carrying mobile launcher platform 1, moves slowly along the crawlerway toward the Vehicle Assembly Building at the agency's Kennedy Space Center in Florida. The crawler's upgrades and modifications were monitored and tested during a loaded test to the crawlerway Pad A/B split. CT-2 will return to the crawler yard. The crawler is being tested to confirm it is ready to support the load of the mobile launcher carrying the Space Launch System with Orion atop for the first test flight, Exploration Mission 1. The Ground Systems Development and Operations Program at Kennedy is managing upgrades to the crawler.

ICPS Turnover GSDO Employee Event

NASA Image and Video Library

2017-11-07

In the Space Station Processing Facility at NASA's Kennedy Space Center in Florida, a ceremony is underway marking the agency's Spacecraft/Payload Integration and Evolution (SPIE) organization formally turning over processing of the Space Launch System (SLS) rocket's Interim Cryogenic Propulsion Stage (ICPS), to the center's Ground Systems Development and Operations (GSDO) Directorate. The ICPS is seen on the left in its shipping container and is the first integrated piece of flight hardware to arrive in preparation for the uncrewed Exploration Mission-1. With the Orion attached, the ICPS sits atop the SLS rocket and will provide the spacecraft with the additional thrust needed to travel tens of thousands of miles beyond the Moon.

Orion Flight Test Preview Briefing

NASA Image and Video Library

2014-11-06

In the Kennedy Space Center’s Press Site auditorium, members of the news media are briefed on the upcoming Orion flight test by Jeremy Graeber, Orion Recovery Director in Ground Systems Development and Operations at Kennedy. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted flight test of Orion is scheduled to launch Dec. 4, 2014 atop a United Launch Alliance Delta IV Heavy rocket, and in 2018 on NASA’s Space Launch System rocket.

Atopic March from Atopic Dermatitis to Asthma-Like Lesions in NC/Nga Mice Is Accelerated or Aggravated by Neutralization of Stratum Corneum but Partially Inhibited by Acidification.

PubMed

Lee, Hae-Jin; Lee, Noo Ri; Jung, Minyoung; Kim, Dong Hye; Choi, Eung Ho

2015-12-01

Prolonged and/or repeated damage to the skin barrier followed by atopic dermatitis (AD) is an initial step in atopic march that ultimately progresses to respiratory allergy. Maintaining normal stratum corneum (SC) acidity has been suggested as a therapeutic or preventive strategy for barrier impairment caused by skin inflammation. We determined whether a representative AD murine model, NC/Nga mice, develops airway inflammation after repeated epicutaneous application followed by inhalation of house dust mite (HDM), implying atopic march, and whether prolongation of non-proper SC acidity accelerates respiratory allergy. HDM was applied to the skin of NC/Nga mice, accompanied by the application of neutral cream (pH 7.4) or acidic cream (pH 2.8) for 6 weeks. Intranasal inhalation of HDM was administered daily during the last 3 days. Repeated epicutaneous applications followed by inhalation of HDM in NC/Nga mice induced an atopic march-like progression from AD lesions to respiratory allergy. Concurrent neutral cream treatment accelerated or aggravated the allergic inflammation in the skin and respiratory system, whereas an acidic cream partially alleviated these symptoms. Collectively, we developed an atopic march in NC/Nga mice by HDM application, and found that prevention of a neutral environment in the SC may be an interventional method to inhibit the march.

Measurement of the Ratio of Branching Fractions Br(B$$0\\atop{s}$$ → D$$-\\atop{s}$$ π +)/Br(B 0 → D - π +) at CDF-II

DOE Office of Scientific and Technical Information (OSTI.GOV)

Furic, Ivan Kresimir

The measurement of Bmore » $$0\\atop{s}$$ mixing is one of the flagship analyses for the Run II B physics program. The sensitivity of the measurement to the frequency of B$$0\\atop{s}$$ oscillations strongly depends on the number of reconstructed B$$0\\atop{s}$$ mesons. They present the measurement of the ratio of branching fractions Br(B$$0\\atop{s}$$ → D$$-\\atop{s}$$π +)/Br(B 0 → D -π +), which directly influences the number of B$$0\\atop{s}$$ events available for the measurement of B$$0\\atop{s}$$ mixing at CDF-II. They analyze 115 pb -1 of data collected with the CDF-II detector in p$$\\bar{p}$$ collisions at √s = 1.96 TeV using a novel displaced track trigger. They reconstruct 78 ± 11 B$$0\\atop{s}$$ → D$$-\\atop{s}$$π + decays at 1153 ± 45 B 0 → D -π + decays with good signal to background ratio. This is the world's largest sample of fully reconstructed B$$0\\atop{s}$$ → D$$-\\atop{s}$$π + decays. They find the ratio of production fractions multiplied by the ratio of branching fractions to be: f s/f d • Br(B$$0\\atop{s}$$ → D$$-\\atop{s}$$π +)/Br(B 0 → D -π +) = 0.325 ± 0.046(stat) ± 0.034(syst) ± 0.084 (BR). Using the world average value of f s/f d = 0.26 ± 0.03, we infer that the ratio of branching fractions is: Br(B$$0\\atop{s}$$ → D$$-\\atop{s}$$π +)/Br(B 0 → D -π +) = 1.25 ± 0.18(stat) ± 0.13(syst) ± 0.32(BR) ± 0.14(PR) where the last uncertainty is due to the uncertainty on the world average measurement of the ratio of B$$0\\atop{s}$$ to B 0 production rates, f s/f d.« less

Application of AI methods to aircraft guidance and control

NASA Technical Reports Server (NTRS)

Hueschen, Richard M.; Mcmanus, John W.

1988-01-01

A research program for integrating artificial intelligence (AI) techniques with tools and methods used for aircraft flight control system design, development, and implementation is discussed. The application of the AI methods for the development and implementation of the logic software which operates with the control mode panel (CMP) of an aircraft is presented. The CMP is the pilot control panel for the automatic flight control system of a commercial-type research aircraft of Langley Research Center's Advanced Transport Operating Systems (ATOPS) program. A mouse-driven color-display emulation of the CMP, which was developed with AI methods and used to test the AI software logic implementation, is discussed. The operation of the CMP was enhanced with the addition of a display which was quickly developed with AI methods. The display advises the pilot of conditions not satisfied when a mode does not arm or engage. The implementation of the CMP software logic has shown that the time required to develop, implement, and modify software systems can be significantly reduced with the use of the AI methods.

Orion EM-1 Crew Module Structural Test Article Prepped for Trans

NASA Image and Video Library

2017-04-24

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, technicians secure the transport container with the Orion Exploration Mission-1 (EM-1) structural test article onto a transport vehicle for the move to the Shuttle Landing Facility. The test article will be loaded in NASA's Super Guppy airplane and transported to Lockheed Martin's Denver facility for testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission.

European Service Module Structural Test Article Load onto Transport Truck

NASA Image and Video Library

2017-06-21

The Orion service module structural test article for Exploration Mission-1 (EM-1), built by the European Space Agency, is prepared for shipment to Lockheed Martin's Denver facility to undergo testing. Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, a crane lifts the module onto a transport truck, where it is secured to be moved to the Shuttle Landing Facility for shipment. The Orion spacecraft will launch atop the agency's Space Launch System rocket on EM-1 in 2019.

Orion EM-1 Crew Module Structural Test Article Prepped for Trans

NASA Image and Video Library

2017-04-24

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, the Orion Exploration Mission-1 (EM-1) structural test article inside its transport container, is secured onto a transport vehicle for the move to the Shuttle Landing Facility. The test article will be loaded in NASA's Super Guppy airplane and transported to Lockheed Martin's Denver facility for testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission.

Orion EM-1 Crew Module Structural Test Article Prepped for Trans

NASA Image and Video Library

2017-04-24

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, technicians secure the Orion Exploration Mission-1 (EM-1) structural test article in its transport container onto a transport vehicle for the move to the Shuttle Landing Facility. The test article will be loaded in NASA's Super Guppy airplane and transported to Lockheed Martin's Denver facility for testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission.

Orion EM-1 Crew Module Structural Test Article Prepped for Trans

NASA Image and Video Library

2017-04-24

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, the Orion Exploration Mission-1 (EM-1) structural test article, secured inside its transport container, is lowered onto a transport vehicle for the move to the Shuttle Landing Facility. The test article will be loaded in NASA's Super Guppy airplane and transported to Lockheed Martin's Denver facility for testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission.

European Service Module-Structural Test Article Load onto Transp

NASA Image and Video Library

2017-06-21

The Orion service module structural test article for Exploration Mission-1 (EM-1), built by the European Space Agency, is prepared for shipment to Lockheed Martin's Denver facility to undergo testing. Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, workers secure the protective covering around the module and a crane lifts the module, secured on stand, for the move to the transport truck. The Orion spacecraft will launch atop the agency's Space Launch System rocket on EM-1 in 2019.

Passive Autonomous Acoustic Monitoring of Marine Mammals: System Development Using Seaglider (Trademark)

DTIC Science & Technology

2015-01-30

plan was to run sg178 in offshore-onshore transects with one end at J. Hildebrand’s HARP mooring at approximately 47° 30’N, 125° 21’W. Seaglider sg179...was to survey along the Washington coast just offshore of the 1000m isobath, with significant time spent surveying atop the HARP mooring mentioned...operations. Figure 4. Surfacing positions of Seagliders S/N178 (green) and S/N179 (red) 11JUN-12JUL2012. HARP mooring locations (Wiggins, private

KSC-2013-2925

NASA Image and Video Library

2013-06-27

CAPE CANAVERAL, Fla. – Inside the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, members of the media receive an on activities in NASA’s Ground Systems Development and Operations, or GSDO, Program, Space Launch System and Orion crew module for Exploration Test Flight 1. Speaking to the media is Larry Price, Lockheed Martin deputy program manager for Orion. In the background, from left are Scott Wilson, manager of Orion Production Operations at Kennedy Jeremy Parsons, chief of the GSDO Operations Integration Office at Kennedy Tom Erdman, from Marshall Space Flight Center’s Kennedy resident office and Jules Schneider, Lockheed Martin manager of Orion Production Operations. Orion is the exploration spacecraft designed to carry crews to space beyond low Earth orbit. It will provide emergency abort capability, sustain the crew during the space travel and provide safe re-entry from deep space return velocities. Orion’s first unpiloted test flight is scheduled to launch in 2014 atop a Delta IV rocket. A second uncrewed flight test is scheduled for 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Jim Grossmann

Simulation of automatic precision departures and missed approaches using the microwave landing system

NASA Technical Reports Server (NTRS)

Feather, J. B.

1987-01-01

Results of simulated precision departures and missed approaches using MLS guidance concepts are presented. The study was conducted under the Terminal Configured Vehicle (TCV) Program, and is an extension of previous work by DAC under the Advanced Transport Operating System (ATOPS) Technology Studies Program. The study model included simulation of an MD-80 aircraft, an autopilot, and a MLS guidance computer that provided lateral and vertical steering commands. Precision departures were evaluated using a noise abatement procedure. Several curved path departures were simulated with MLS noise and under various environmental conditions. Missed approaches were considered for the same runway, where lateral MLS guidance maintained the aircraft along the extended runway centerline. In both the departures and the missed approach cases, pitch autopilot takeoff and go-around modes of operation were used in conjunction with MLS lateral guidance.

KSC-2012-4214

NASA Image and Video Library

2012-08-03

CAPE CANAVERAL, Fla. -- This is an artist's conception of Space Exploration Technologies', or SpaceX, crewed Dragon capsule atop the company's Falcon 9 rocket under development for NASA's Commercial Crew Program, or CCP. The integrated system was selected for CCP's Commercial Crew Integrated Capability, or CCiCap, initiative to propel America's next human space transportation system to low Earth orbit forward. Operating under a funded Space Act Agreement, or SAA, SpaceX will spend the next 21 months completing its design, conducting critical risk reduction testing on its spacecraft and launch vehicle, and showcasing how it would operate and manage missions from launch through orbit and landing, setting the stage for a future demonstration mission. To learn more about CCP, which is based at NASA's Kennedy Space Center in Florida and supported by NASA's Johnson Space Center in Houston, visit www.nasa.gov/commercialcrew. Image credit: SpaceX

KSC-2012-4212

NASA Image and Video Library

2012-08-03

CAPE CANAVERAL, Fla. -- This is an artist's conception of The Boeing Company's CST-100 spacecraft atop a United Launch Alliance ULA Atlas V rocket under development for NASA's Commercial Crew Program, or CCP. The integrated system was selected for CCP's Commercial Crew Integrated Capability, or CCiCap, initiative to propel America's next human space transportation system to low Earth orbit forward. Operating under a funded Space Act Agreement, or SAA, Boeing will spend the next 21 months completing its design, conducting critical risk reduction testing on its spacecraft and launch vehicle, and showcasing how it would operate and manage missions from launch through orbit and landing, setting the stage for a future demonstration mission. To learn more about CCP, which is based at NASA's Kennedy Space Center in Florida and supported by NASA's Johnson Space Center in Houston, visit www.nasa.gov/commercialcrew. Image credit: Boeing

Orion in the Well Deck After Splashdown and Recovery

NASA Image and Video Library

2014-12-05

After splashdown, NASA's Orion spacecraft has been recovered and is positioned on rubber "speed bumps" inside the flooded well deck of the USS Anchorage in the Pacific Ocean about 600 miles off the coast of San Diego, California. After lifting off at 7:05 a.m. EST atop a Delta IV Heavy rocket from Space Launch Complex 37 at Cape Canaveral Air Force Station in Florida, Orion completed a two-orbit, four-and-a-half hour mission to test systems critical to crew safety, including the launch abort system, the heat shield and the parachute system. NASA, the U.S. Navy and Lockheed Martin coordinated efforts to recover Orion after splashdown. The Ground Systems Development and Operations Program is leading the recovery efforts.

First measurement of the B$$0\\atop{2}$$ semileptonic branching ratio to an orbitally excited d$$**\\atop{s}$$ state, Br(B$$0\\atop{2}$$ → D$$-\\atop{s1}$$(2536)μ +vX)

DOE Office of Scientific and Technical Information (OSTI.GOV)

Rieger, Jason

2007-12-08

In a data sample of approximately 1.3 fb -1 collected with the D0 detector between 2002 and 2006, the orbitally excited charm state Dmore » $$±\\atop{s1}$$(2536)has been observed with a measured mass of 2535.7 ± 0.6(stat) ± 0.5(syst) MeV/c 2 via the decay mode B$$0\\atop{s}$$ → D$$-\\atop{s1}$$(2536)μ +vX followed by D$$±\\atop{s1}$$(2536) → D *±K$$0\\atop{S}$$. By normalizing to the known branching ratio Br($$\\bar{b}$$ → D* - μ +vX) and to the number of reconstructed D* mesons with an associated identified muon, a first-ever measurement is made of the product branching ratio ($$\\bar{b}$$ →} D$$-\\atop{s1}$$(2536)μ +vX) • Br(D$$-\\atop{s1}$$ → D* -K$$0\\atop{S}$$). Assuming that D$$-\\atop{s1}$$(2536) production in semileptonic decay is entirely from B$$0\\atop{s}$$, an extraction of the semileptonic branching ratio Br(B$$0\\atop{s}$$ → D$$-\\atop{s1}$$(2536)μ +vX) is made. Comparisons are made with theoretical expectations.« less

Cross sections for the reactions e + e - → K S 0 K L 0 π 0 , K S 0 K L 0 η , and K S 0 K L 0 π 0 π 0 from events with initial-state radiation

DOE PAGES

Lees, J. P.; Poireau, V.; Tisserand, V.; ...

2017-03-06

Here, we study the processes e + e - → Kmore » $$0\\atop{S}$$ K$$0\\atop{L}$$ π 0 γ , K $$0\\atop{S}$$ K$$0\\atop{L}$$ η γ , and K$$0\\atop{S}$$ K$$0\\atop{L}$$ π 0 π 0 γ , where the photon is radiated from the initial state, providing cross section measurements for the hadronic final states over a continuum of center-of-mass energies. The results are based on 469 fb -1 of data collected at or near the Υ ( 4 S ) resonance with the BABAR detector at SLAC. We present the first measurements of the e + e - → K$$0\\atop{S}$$ K$$0\\atop{L}$$ π 0 , K$$0\\atop{S}$$ K$$0\\atop{L}$$ η , and K$$0\\atop{S}$$ K$$0\\atop{L}$$ π 0π 0 cross sections up to a center-of-mass energy of 4 GeV and study their intermediate resonance structures. We observe J / ψ decays to all of these final states for the first time, present measurements of their J / ψ branching fractions, and search for ψ (2S) decays.« less

Cross sections for the reactions e + e - → K S 0 K L 0 π 0 , K S 0 K L 0 η , and K S 0 K L 0 π 0 π 0 from events with initial-state radiation

DOE Office of Scientific and Technical Information (OSTI.GOV)

Lees, J. P.; Poireau, V.; Tisserand, V.

Here, we study the processes e + e - → Kmore » $$0\\atop{S}$$ K$$0\\atop{L}$$ π 0 γ , K $$0\\atop{S}$$ K$$0\\atop{L}$$ η γ , and K$$0\\atop{S}$$ K$$0\\atop{L}$$ π 0 π 0 γ , where the photon is radiated from the initial state, providing cross section measurements for the hadronic final states over a continuum of center-of-mass energies. The results are based on 469 fb -1 of data collected at or near the Υ ( 4 S ) resonance with the BABAR detector at SLAC. We present the first measurements of the e + e - → K$$0\\atop{S}$$ K$$0\\atop{L}$$ π 0 , K$$0\\atop{S}$$ K$$0\\atop{L}$$ η , and K$$0\\atop{S}$$ K$$0\\atop{L}$$ π 0π 0 cross sections up to a center-of-mass energy of 4 GeV and study their intermediate resonance structures. We observe J / ψ decays to all of these final states for the first time, present measurements of their J / ψ branching fractions, and search for ψ (2S) decays.« less

Dalitz plot analyses of J / ψ → π + π - π 0 , J / ψ → K + K - π 0 , and J / ψ → K s 0 K ± π ∓ produced via e + e - annihilation with initial-state radiation

DOE Office of Scientific and Technical Information (OSTI.GOV)

Lees, J. P.; Poireau, V.; Tisserand, V.

Here, we study the processes e +e - → γ ISR J/ψ , where J/ψ → π +π -π 0, J/ψ → K +K -π 0 , and J / ψ → Kmore » $$0\\atop{S}$$ K ± π ∓ using a data sample of 519 fb -1 recorded with the BABAR detector operating at the SLAC PEP-II asymmetric-energy e +e - collider at center-of-mass energies at and near the Υ (nS) (n = 2 , 3 , 4) resonances. We measure the ratio of branching fractions R 1 = $$B(J/ψ →K^+K^- π^0)\\atop{B(J/ψ →π^+π^- π^0)}$$ and R 2= $$B(J/ψ →K^0_SK^±π^∓)\\atop{B(J/ψ →π^+π^- π^0)}$$. We perform Dalitz plot analyses of the three J/ψ decay modes and measure fractions for resonances contributing to the decays. We also analyze the J/ψ → $π^+π^- π^0$ decay using the Veneziano model. We observe structures compatible with the presence of ρ (1450) in all three J/ψ decay modes and measure the relative branching fraction: R (p(1450)) = $$Bp(1450)→K^+K^-)\\atop{B(p(1450)→π^+π^-)}$$ +0.307 ± 0.084 (stat) ± 0.082 (sys).« less

Dalitz plot analyses of J / ψ → π + π - π 0 , J / ψ → K + K - π 0 , and J / ψ → K s 0 K ± π ∓ produced via e + e - annihilation with initial-state radiation

DOE PAGES

Lees, J. P.; Poireau, V.; Tisserand, V.; ...

2017-04-10

Here, we study the processes e +e - → γ ISR J/ψ , where J/ψ → π +π -π 0, J/ψ → K +K -π 0 , and J / ψ → Kmore » $$0\\atop{S}$$ K ± π ∓ using a data sample of 519 fb -1 recorded with the BABAR detector operating at the SLAC PEP-II asymmetric-energy e +e - collider at center-of-mass energies at and near the Υ (nS) (n = 2 , 3 , 4) resonances. We measure the ratio of branching fractions R 1 = $$B(J/ψ →K^+K^- π^0)\\atop{B(J/ψ →π^+π^- π^0)}$$ and R 2= $$B(J/ψ →K^0_SK^±π^∓)\\atop{B(J/ψ →π^+π^- π^0)}$$. We perform Dalitz plot analyses of the three J/ψ decay modes and measure fractions for resonances contributing to the decays. We also analyze the J/ψ → $π^+π^- π^0$ decay using the Veneziano model. We observe structures compatible with the presence of ρ (1450) in all three J/ψ decay modes and measure the relative branching fraction: R (p(1450)) = $$Bp(1450)→K^+K^-)\\atop{B(p(1450)→π^+π^-)}$$ +0.307 ± 0.084 (stat) ± 0.082 (sys).« less

Presence of Headache and Migraine in Asthma Patients.

PubMed

Turan, Muzaffer Onur; Susuz, Çiğdem Çelik; Turan, Pakize Ayşe

2017-04-01

Migraine is a diseases characterized with severe headaches, with neurological and systemic findings. The purpose of this study is to investigate the prevalence of migraine and to examine whether there is a relationship between atopic disorders, parental history and migraine in asthma patients. A total of 288 asthma outpatients, who had the diagnosis by an early or late test of reversibility showing a reversible airway obstruction according to hospital database were included. The presence of headache, atopic symptoms and parental history about asthma, atopic disorders and migraine were asked. The patients with headache were consultated by neurology department and investigated about the presence of migraine. The diagnosis of migraine headache was made if patients fulfilled the International Headache Society (IHS) criteria. 60.4% of patients described a headache. There were 94 patients (32.6%) with headaches meeting the IHS criteria for migraine. Only 12 patients had migraine with aura. There were atopic symptoms in 86.8% of patients. According to parental history, there were asthma in 47.9%, atopic symptoms in 39.6% and migraine in 22.2% of parents. Patients with atopic symptoms were found to have significantly high rate of headaches (65.3%) "p=0.007". The prevalence of migraine was significantly high in patients with parental atopic symptoms (54%) "p=0.002". Multiple logistic regression analysis identified that gender, parental history of asthma, allergia and migraine, and smoking were independent risk factors for presence of migraine in asthmatics. There is a high prevalence of migraine headaches in patients with asthma. The coexistence of asthma and headaches may be related with a similar pathophysiological mechanism; parental history, common genetic compounds and smoking may play role in this mechanism. The headaches in asthma patients, atopic symptoms and family history should be questioned, and clinicians should be careful about the presence of migraine.

KSC-2013-2880

NASA Image and Video Library

2013-06-20

CAPE CANAVERAL, Fla. – Representatives from the European Space Agency, or ESA, toured the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida. From the left, are Nico Dettman, ESA Space Transportation Department director Bernardo Patti, ESA manager of International Space Station Operations Philippe Deloo, ESA European Service Module study manager and Mark Geyer, Orion Production Operations manager. Orion is the exploration spacecraft designed to carry crews to space beyond low Earth orbit. It will provide emergency abort capability, sustain the crew during the space travel and provide safe re-entry from deep space return velocities. Orion’s first unpiloted test flight is scheduled to launch in 2014 atop a Delta IV rocket. A second uncrewed flight test is scheduled for 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Jim Grossmann

Evolving Concepts in Atopic Dermatitis.

PubMed

Sidbury, Robert; Khorsand, Kate

2017-07-01

Tremendous advances have been made in the field of atopic dermatitis in the past 5 years. We will explore developments in burden of disease, co-morbidities, pathogenesis, prevention, and management. The tremendous burden moderate to severe atopic dermatitis (AD) places on families from a medical, psychosocial, and financial perspective has been characterized. Epidemiologic studies have identified intriguing new associations beyond the well-characterized "atopic march" of food allergies, asthma, and hay fever. Studies of primary prevention have gained traction including the remarkable impacts of early emollient therapy. Basic advances have simultaneously elucidated the nature of atopic inflammation, setting the stage for an explosion of new potential therapeutic targets. After a fallow period of nearly 15 years without a substantial therapeutic advance, this year has already seen two new FDA-approved treatments for AD. AD has a tremendous impact on quality of life with an underappreciated burden of disease; there are important newly described co-morbidities including ADHD and anemia; new insights into etio-pathogenesis have paved the way for novel topical therapies like crisaborole, and new systemic interventions like dupilumab.

Effects of examination stress on psychological responses, sleep and allergic symptoms in atopic and non-atopic students.

PubMed

Jernelöv, Susanna; Höglund, Caroline Olgart; Axelsson, John; Axén, Jennie; Grönneberg, Reidar; Grunewald, Johan; Stierna, Pontus; Lekander, Mats

2009-01-01

Recent findings indicate that atopics may be more vulnerable to stress than non-atopics. However, the roles of psychological well-being and sleep in this presumed increased sensitivity are not known. To investigate the effects of a brief naturalistic stressor on psychological responses, sleep, and allergic symptoms and to compare those responses between atopic and non-atopic individuals. We assessed atopic and non-atopic students during a period without and during a period with examinations. For both atopic and non-atopic students, tension, anxiety, and depression deteriorated in response to examination, as did sleep latency and sleep quality. Overall, atopics were more tense, had more anxiety, longer sleep latencies, and were less well rested than non-atopics. Non-atopic students rose from bed later during the examination period. In response to examination, atopic students reported increased frequency of stress behaviors (e.g., eating fast), while decreased stress behaviors were reported by non-atopic students. Allergic symptoms were not affected. Atopic students were worse off in aspects of psychological well-being and sleep, but displayed only partly stronger responses to a stressor compared to non-atopic students. In spite of a broad negative response to examination, allergic symptoms were not affected.

[The potential of the non-pharmacological methods for the rehabilitation and prophylaxis in the patients suffering from with atopic dermatitis].

PubMed

Kosheleva, I V; Bitkina, O A; Klivitskaya, N A; Shadyzheva, L I

This article was designed to discuss the therapeutic potential of various non-pharmacological and physiotherapeutic methods for the treatment and rehabilitation of the patients presenting with atopic dermatitis (AD) during the inter-recurrence period of the disease. The particular emphasis is placed on the physical agents most frequently used for the purpose with special reference to the combined therapy of atopic dermatitis in the adults and children and to their rehabilitation in the inter-exacerbation periods. In addition, the data on the prospects for the use of various medications intended for tissue- and organotherapy of the patients suffering from atopic dermatitis are presented. The main traditional approaches to the management of the patients with atopic dermatitis under conditions of the spa and health resort facilities are considered based on the original experience of the authors including the application of various modes of ozone therapy regarded as a physiotherapeutic procedure for the treatment of atopic dermatitis in the children and adult patients, their rehabilitation, and the prevention of exacerbations of the pathological process based on the external and/or systemic application of the ozone-oxygen gaseous mixture. The selected modalities of ozone therapy used to treat various clinical forms and stages of the atopic dermatitis differing in severity are described in detail. The data on the influence of ozone therapy on a variety of pathogenetic factors of atopic dermatitis are presented as obtained by the investigations into dynamics of the characteristics of immunity, microcirculation, and the levels of free radical metabolites. The results of the study give evidence of the high effectiveness of ozone therapy as a method of physiotherapeutic treatment both in the capacity of a component of combined therapy during the acute phase of atopic dermatitis and as the means of secondary (post-exposure) prophylaxis of the exacerbations and relapses of this condition based at the medical and preventive treatment facilities of various specialization.

Cytokine synthesis in occupational allergy to caddisflies in hydroelectric plant workers.

PubMed

Warrington, R J; Whitman, C; McPhillips Warrington, S

2003-10-01

Workers in hydroelectric plants appear to be readily sensitized to caddisfly allergens. This sensitization probably occurs de novo from occupational exposure. In some workers, sensitization occurs on a non-atopic background. Cytokine synthesis of IFN-gamma, IL-5 and IL-13 in atopic and non-atopic caddisfly-allergic workers was examined to determine if responses were similar or different. Peripheral blood mononuclear cells were isolated from atopic caddisfly-allergic workers, non-atopic caddisfly-allergic workers and non-atopic caddisfly-exposed but non-allergic workers. Stimulation with caddisfly antigens was carried out and synthesis of IFN-gamma, IL-5 and IL-13 was determined by sandwich ELISA. Both caddisfly-allergic and non-allergic subjects responded to stimulation with caddisfly extract. The response in non-atopic caddisfly-non-allergic subjects was TH1 predominant, while that in atopic caddisfly-allergic subjects was TH2 predominant. The response in non-atopic caddisfly-allergic subjects was between that of the atopic caddisfly-allergic workers and the non-atopic caddisfly-non-allergic workers and the trend was to a TH2 response. Work-related symptoms were similarly intermediate between the atopic caddisfly-allergic and non-atopic caddisfly-non-allergic group. Differences were significant for IFN-gamma/IL-5 ratios but not IFN-gamma/IL-13 ratios for atopic and non-atopic caddisfly-allergic individuals, compared to non-atopic caddisfly-non-allergic workers. However, a linear relationship existed between IFN-gamma synthesis and IL-5 and IL-13 synthesis in non-atopic caddisfly-allergic workers but not in atopic caddisfly-allergic subjects. Caddisfly allergy in hydroelectric workers may be a useful model for the development of allergy to a previously unencountered allergen, and points to some interesting differences between atopic and non-atopic subjects who become sensitized to environmental allergens. Copyright 2003 S. Karger AG, Basel

KSC-2014-3791

NASA Image and Video Library

2014-09-10

CAPE CANAVERAL, Fla. – During a ceremony inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, the Orion spacecraft for Exploration Flight Test-1 was officially turned over to Lockheed Martin Ground Operations from Orion Assembly, Integration and Production. Holding the key during the turn over, are Jules Schneider, at left, Lockheed Martin Orion Production Operations manager, and Blake Hale, Lockheed Martin Ground Operations manager. Behind them are members of the Brevard Police and Fire Pipes and Drums. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch atop a United Launch Alliance Delta IV Heavy rocket from Cape Canaveral Air Force Station in Florida in December to an altitude of 3,600 miles above the Earth's surface. The two-orbit, four-hour flight test will help engineers evaluate the systems critical to crew safety including the heat shield, parachute system and launch abort system. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Daniel Casper

KSC-2014-3790

NASA Image and Video Library

2014-09-10

CAPE CANAVERAL, Fla. – During a ceremony inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, the Orion spacecraft for Exploration Flight Test-1 was officially turned over to Lockheed Martin Ground Operations from Orion Assembly, Integration and Production. Shaking hands during the turn over, are Jules Schneider, at left, Lockheed Martin Orion Production Operations manager, and Blake Hale, Lockheed Martin Ground Operations manager. Behind them are members of the Brevard Police and Fire Pipes and Drums. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch atop a United Launch Alliance Delta IV Heavy rocket from Cape Canaveral Air Force Station in Florida in December to an altitude of 3,600 miles above the Earth's surface. The two-orbit, four-hour flight test will help engineers evaluate the systems critical to crew safety including the heat shield, parachute system and launch abort system. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Daniel Casper

Polyclonal and allergen-induced cytokine responses in children with elevated immunoglobulin E but no atopic disease.

PubMed

Smart, J M; Tang, M L K; Kemp, A S

2002-11-01

Reduced Th1 and elevated Th2 cytokine responses are considered to be a principal mechanism in the generation of the inflammation leading to the manifestations of atopic disease in the skin of atopic dermatitis and in the airways of asthma. If reduced Th1 and elevated Th2 responses are principal determinants of the manifestation of atopic disease it might be expected that subjects with established disease would exhibit differences in their cytokine profiles as compared with atopic patients without clinical disease. To determine whether asymptomatic atopic children exhibit a cytokine imbalance similar to that seen in patients with established atopic disease or if they behave like non-atopic controls. Cytokine responses in a group of children with elevated IgE but no clinical manifestations of disease, atopic children with established disease and non-atopic controls were compared. We examined allergen-induced (house dust mite, HDM, rye grass pollen and RYE) cytokine responses in parallel with polyclonal (staphylococcal enterotoxin B, SEB) cytokine responses in a group of children with elevated serum IgE levels without current or past evidence of atopic disease (median age 6.6 years) and compared these with a non-atopic control group (median age 6.5 years) and a group of children with atopic disease (median age 6.7 years). Symptomatic atopic children had reduced SEB-induced IFN-gamma and increased SEB-induced IL-4 and IL-5 as compared with non-atopic controls. In contrast, SEB-induced IFN-gamma, IL-4 and IL-5 production in asymptomatic atopics was not significantly different from the non-atopic control subjects. Allergen-induced Th1 (IFN-gamma) and Th2 (IL-5 and IL-13) cytokine production was increased in both symptomatic atopics and asymptomatic atopics when compared with non-atopic controls. The defect in polyclonally induced IFN-gamma production was associated with the clinical manifestation of atopic disease but not the atopic stateper se. This suggests that the global reduction in IFN-gamma is the key determinant of the development of overt atopic disease. In contrast, elevated allergen-induced Th2 cytokine responses in children related to the atopic state per se irrespective of the presence of clinical atopic disease.

KSC-2013-2882

NASA Image and Video Library

2013-06-20

CAPE CANAVERAL, Fla. – Representatives from the European Space Agency, or ESA, toured the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida. Pointing at thermal protection system tiles is Jules Schneider, Lockheed Martin senior manager. At right, in the blue suit, is Bernardo Patti, ESA manager of International Space Station Operations. Standing next to Patti is Nico Dettman, ESA Space Transportation Department director. Orion is the exploration spacecraft designed to carry crews to space beyond low Earth orbit. It will provide emergency abort capability, sustain the crew during the space travel and provide safe re-entry from deep space return velocities. Orion’s first unpiloted test flight is scheduled to launch in 2014 atop a Delta IV rocket. A second uncrewed flight test is scheduled for 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Jim Grossmann

Vehicle Support Posts Installation onto Mobile Launcher

NASA Image and Video Library

2017-05-11

Four vehicle support posts have been installed on the deck of the mobile launcher at NASA's Kennedy Space Center in Florida. A total of eight support posts will be installed to support the load of the Space Launch System's (SLS) solid rocket boosters, with four posts for each of the boosters. The support posts are about five feet tall and each weigh about 10,000 pounds. The posts will structurally support the SLS rocket through T-0 and liftoff, and will drop down before vehicle liftoff to avoid contact with the flight hardware. The Ground Systems Development and Operations Program is overseeing installation of the support posts to prepare for the launch of the Orion spacecraft atop the SLS rocket.

Final Flame Trench Brick Installation at Launch Pad 39B

NASA Image and Video Library

2017-05-09

The final brick was installed on the north side of the flame trench at Launch Complex 39B at NASA’s Kennedy Space Center in Florida. The walls of the flame trench are being upgraded to withstand the intense heat and fire at launch of NASA's Space Launch System rocket with Orion atop. About 96,000 heat-resistant bricks, in three different sizes, were secured to the walls using bonding mortar in combination with adhesive anchors. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to Pad 39B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1 and NASA’s journey to Mars.

Final Flame Trench Brick Installation at Launch Pad 39B

NASA Image and Video Library

2017-05-09

Construction workers sign the final bricks after they were installed on the north side of the flame trench at Launch Complex 39B at NASA’s Kennedy Space Center in Florida. The walls of the flame trench are being upgraded to withstand the intense heat and fire at launch of NASA's Space Launch System rocket with Orion atop. About 96,000 heat-resistant bricks, in three different sizes, were secured to the walls using bonding mortar in combination with adhesive anchors. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to Pad 39B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1 and NASA’s journey to Mars.

Final Flame Trench Brick Installation at Launch Pad 39B

NASA Image and Video Library

2017-05-09

A construction worker installs one of the final bricks on the north side of the flame trench at Launch Complex 39B at NASA's Kennedy Space Center in Florida. The walls of the flame trench are being upgraded to withstand the intense heat and fire at launch of NASA's Space Launch System rocket with Orion atop. About 96,000 heat-resistant bricks, in three different sizes, were secured to the walls using bonding mortar in combination with adhesive anchors. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to Pad 39B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1 and NASA’s journey to Mars.

Final Flame Trench Brick Installation at Launch Pad 39B

NASA Image and Video Library

2017-05-09

A view looking up from the north side of the flame trench beneath the pad at Launch Complex 39B at NASA's Kennedy Space Center in Florida. The walls of the flame trench are being upgraded to withstand the intense heat and fire at launch of NASA's Space Launch System rocket with Orion atop. About 96,000 heat-resistant bricks, in three different sizes, were secured to the walls using bonding mortar in combination with adhesive anchors. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to Pad 39B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1 and NASA’s journey to Mars.

Final Flame Trench Brick Installation at Launch Pad 39B

NASA Image and Video Library

2017-05-09

Preparations are underway to install the final brick on the north side of the flame trench at Launch Complex 39B at NASA's Kennedy Space Center in Florida. The walls of the flame trench are being upgraded to withstand the intense heat and fire at launch of NASA's Space Launch System rocket with Orion atop. About 96,000 heat-resistant bricks, in three different sizes, were secured to the walls using bonding mortar in combination with adhesive anchors. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to Pad 39B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1 and NASA’s journey to Mars.

Final Flame Trench Brick Installation at Launch Pad 39B

NASA Image and Video Library

2017-05-09

A construction worker installs the final brick on the north side of the flame trench at Launch Complex 39B at NASA's Kennedy Space Center in Florida. The walls of the flame trench are being upgraded to withstand the intense heat and fire at launch of NASA's Space Launch System rocket with Orion atop. About 96,000 heat-resistant bricks, in three different sizes, were secured to the walls using bonding mortar in combination with adhesive anchors. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to Pad 39B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1 and NASA’s journey to Mars.

GFAST Software Demonstration

NASA Image and Video Library

2017-03-17

NASA engineers and test directors gather in Firing Room 3 in the Launch Control Center at NASA's Kennedy Space Center in Florida, to watch a demonstration of the automated command and control software for the agency's Space Launch System (SLS) and Orion spacecraft. The software is called the Ground Launch Sequencer. It will be responsible for nearly all of the launch commit criteria during the final phases of launch countdowns. The Ground and Flight Application Software Team (GFAST) demonstrated the software. It was developed by the Command, Control and Communications team in the Ground Systems Development and Operations (GSDO) Program. GSDO is helping to prepare the center for the first test flight of Orion atop the SLS on Exploration Mission 1.

Crawler Transporter 2 (CT-2) Trek from Pad 39B to VAB

NASA Image and Video Library

2017-03-21

Crawler-transport 2 (CT-2) moves slowly along the crawlerway on its way back to the Vehicle Assembly Building at NASA's Kennedy Space Center in Florida. The crawler took a trip to the pad A/B split to test upgrades recently completed that will allow the giant vehicle to handle the load of the agency's Space Launch System rocket and Orion spacecraft atop the mobile launcher. The Ground Systems Development and Operations Program oversaw upgrades to the 50-year-old CT-2. New generators, gear assemblies, jacking, equalizing and leveling (JEL) hydraulic cylinders, roller bearings and brakes were installed, and other components were upgraded to prepare for Exploration Mission 1.

Crawler Transporter 2 (CT-2) Trek from Pad 39B to VAB

NASA Image and Video Library

2017-03-21

Crawler-transporter 2 (CT-2) moves slowly along the crawlerway on its way back to the Vehicle Assembly Building at NASA's Kennedy Space Center in Florida. The crawler took a trip to the Pad A/B split to test upgrades recently completed that will allow the giant vehicle to handle the load of the agency's Space Launch System rocket and Orion spacecraft atop the mobile launcher. The Ground Systems Development and Operations Program oversaw upgrades to the 50-year-old CT-2. New generators, gear assemblies, jacking, equalizing and leveling (JEL) hydraulic cylinders, roller bearings and brakes were installed, and other components were upgraded to prepare for Exploration Mission 1.

Crawler Transporter 2 (CT-2) Trek from Pad 39B to VAB

NASA Image and Video Library

2017-03-21

Crawler-transporter 2 (CT-2) moves slowly along the crawlerway toward the Vehicle Assembly Building (in the background) at NASA's Kennedy Space Center in Florida. The crawler took a trip to the Pad A/B split to test upgrades recently completed that will allow the giant vehicle to handle the load of the agency's Space Launch System rocket and Orion spacecraft atop the mobile launcher. The Ground Systems Development and Operations Program oversaw upgrades to the 50-year-old CT-2. New generators, gear assemblies, jacking, equalizing and leveling (JEL) hydraulic cylinders, roller bearings and brakes were installed, and other components were upgraded to prepare for Exploration Mission 1.

Final Flame Trench Brick Installation at Launch Pad 39B

NASA Image and Video Library

2017-05-09

Construction workers install the final bricks on the north side of the flame trench at Launch Complex 39B at NASA's Kennedy Space Center in Florida. The walls of the flame trench are being upgraded to withstand the intense heat and fire at launch of NASA's Space Launch System rocket with Orion atop. About 96,000 heat-resistant bricks, in three different sizes, were secured to the walls using bonding mortar in combination with adhesive anchors. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to Pad 39B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1 and NASA’s journey to Mars.

Atopic Dermatitis (Eczema): An Appraisal

PubMed Central

Hudson, Arthur L.

1962-01-01

Atopic (spontaneous) allergies and nonatopic (induced) allergies are often confused. The meaning of these terms is definite, but the occurrence of either (in a given individual) may depend upon his autonomic nervous system control. The evidence that allergens produce the cutaneous changes in atopic dermatitis is flimsy, and neurodermatitis would be a more appropriate term since the entity falls into that pattern of skin changes. Treatment carried out, from infancy sometimes to old age, consists of careful management of the patient in the physical and emotional spheres, avoidance of external irritation and the use of a multiplicity of anti-pruritic, anti-inflammatory and sedative agents. PMID:13955448

KSC-2014-4779

NASA Image and Video Library

2014-12-05

SAN DIEGO, Calif. -- After splashdown, NASA's Orion spacecraft has been recovered and is positioned on rubber "speed bumps" inside the flooded well deck of the USS Anchorage in the Pacific Ocean about 600 miles off the coast of San Diego, California. After lifting off at 7:05 a.m. EST atop a Delta IV Heavy rocket from Space Launch Complex 37 at Cape Canaveral Air Force Station in Florida, Orion completed a two-orbit, four-and-a-half hour mission to test systems critical to crew safety, including the launch abort system, the heat shield and the parachute system. NASA, the U.S. Navy and Lockheed Martin coordinated efforts to recover Orion after splashdown. The Ground Systems Development and Operations Program is leading the recovery efforts. For more information, visit www.nasa.gov/orion Photo credit: NASA/Cory Huston

Outstanding animal studies in allergy II. From atopic barrier and microbiome to allergen-specific immunotherapy.

PubMed

Jensen-Jarolim, Erika; Pali-Schöll, Isabella; Roth-Walter, Franziska

2017-06-01

Animal studies published within the past 18 months were assessed, focusing on innate and specific immunomodulation, providing knowledge of high translational relevance for human atopic and allergic diseases. Allergic companion animals represent alternative models, but most studies were done in mice. Atopic dermatitis mouse models were refined by the utilization of cytokines like IL-23 and relevant skin allergens or enzymes. A novel IL-6 reporter mouse allows biomonitoring of inflammation. Both skin pH and the (transferable) microflora have a pivotal role in modulating the skin barrier. The microflora of the gastrointestinal mucosa maintains tolerance to dietary compounds and can be disturbed by antiacid drugs. A key mouse study evidenced that dust from Amish households, but not from Hutterites protected mice against asthma. In studies on subcutaneous and sublingual allergen-specific immunotherapy, much focus was given on delivery and adjuvants, using poly-lacto-co-glycolic particles, CpGs, probiotics or Vitamin D3. The epicutaneous and intralymphatic routes showed promising results in mice and horses in terms of prophylactic and therapeutic allergy treatment. In atopic dermatitis, food allergies and asthma, environmental factors, together with the resident microflora and barrier status, decide on sensitization versus tolerance. Also allergen-specific immunotherapy operates with immunomodulatory principles.

Outstanding animal studies in allergy II. From atopic barrier and microbiome to allergen-specific immunotherapy

PubMed Central

Jensen-Jarolim, Erika; Pali-Schöll, Isabella; Roth-Walter, Franziska

2017-01-01

Purpose of review Animal studies published within the past 18 months were assessed, focusing on innate and specific immunomodulation, providing knowledge of high translational relevance for human atopic and allergic diseases. Recent findings Allergic companion animals represent alternative models, but most studies were done in mice. Atopic dermatitis mouse models were refined by the utilization of cytokines like IL-23 and relevant skin allergens or enzymes. A novel IL-6 reporter mouse allows biomonitoring of inflammation. Both skin pH and the (transferable) microflora have a pivotal role in modulating the skin barrier. The microflora of the gastrointestinal mucosa maintains tolerance to dietary compounds and can be disturbed by antiacid drugs. A key mouse study evidenced that dust from Amish households, but not from Hutterites protected mice against asthma. In studies on subcutaneous and sublingual allergen-specific immunotherapy, much focus was given on delivery and adjuvants, using poly-lacto-co-glycolic particles, CpGs, probiotics or Vitamin D3. The epicutaneous and intralymphatic routes showed promising results in mice and horses in terms of prophylactic and therapeutic allergy treatment. Summary In atopic dermatitis, food allergies and asthma, environmental factors, together with the resident microflora and barrier status, decide on sensitization versus tolerance. Also allergen-specific immunotherapy operates with immunomodulatory principles. PMID:28375932

Space X-3 Social Media Tour of KSC Facilities

NASA Image and Video Library

2014-03-14

CAPE CANAVERAL, Fla. – A group of news media and social media tweeters toured the Launch Abort System Facility and viewed the launch abort system for the Orion spacecraft at NASA's Kennedy Space Center in Florida. Speaking to the group is Scott Wilson, manager of Production Operations for the Orion Program. The group also toured the Launch Control Center and Vehicle Assembly Building, legacy facilities that are being upgraded by the Ground Systems Development and Operations Program at Kennedy to prepare for processing and launch of NASA's Space Launch System and Orion spacecraft. NASA is developing the Space Launch System and Orion spacecraft to provide an entirely new capability for human exploration beyond low-Earth orbit, with the flexibility to launch spacecraft for crew and cargo missions, including to an asteroid and Mars. Orion’s first unpiloted test flight is scheduled to launch later this year atop a Delta IV rocket. A second uncrewed flight test is scheduled for fiscal year 2018 on the Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Cory Huston

Measurements of the branching fractions for D + → K S 0 K S 0 K + , K S 0 K S 0 π + and D 0 → K S 0 K S 0 , K S 0 K S 0 K S 0

DOE PAGES

Ablikim, M.; Achasov, M. N.; Ahmed, S.; ...

2016-12-13

By analyzing 2.93 fb-1 of data taken at the ψ (3770) resonance peak with the BESIII detector, we measure the branching fractions for the hadronic decays D +→Kmore » $$0\\atop{S}$$K$$0\\atop{S}$$K +, D +→K$$0\\atop{S}$$K$$0\\atop{S}$$π +. D 0→K$$0\\atop{S}$$K$$0\\atop{S}$$ and D 0→K$$0\\atop{S}$$K$$0\\atop{S}$$K$$0\\atop{S}$$.« less

Measurements of the branching fractions for D + → K S 0 K S 0 K + , K S 0 K S 0 π + and D 0 → K S 0 K S 0 , K S 0 K S 0 K S 0

DOE Office of Scientific and Technical Information (OSTI.GOV)

Ablikim, M.; Achasov, M. N.; Ahmed, S.

By analyzing 2.93 fb-1 of data taken at the ψ (3770) resonance peak with the BESIII detector, we measure the branching fractions for the hadronic decays D +→Kmore » $$0\\atop{S}$$K$$0\\atop{S}$$K +, D +→K$$0\\atop{S}$$K$$0\\atop{S}$$π +. D 0→K$$0\\atop{S}$$K$$0\\atop{S}$$ and D 0→K$$0\\atop{S}$$K$$0\\atop{S}$$K$$0\\atop{S}$$.« less

Cutaneous nocardiosis in two dogs receiving ciclosporin therapy for the management of canine atopic dermatitis.

PubMed

Siak, Meng K; Burrows, Amanda K

2013-08-01

Ciclosporin is a calcineurin inhibitor that is currently registered for the treatment of canine atopic dermatitis. The most common adverse effects include mild, transient gastrointestinal disturbances. Single case reports of opportunistic infections due to Nocardia spp., Neospora spp. and papillomaviruses have also been reported. Clinicians should be aware of the potential risk of systemic immunosuppression and subsequent infection with Nocardia spp. in dogs receiving ciclosporin. Cutaneous nocardiosis in two dogs receiving ciclosporin therapy for management of canine atopic dermatitis. Histopathology, PCR for Nocardia spp. and computed tomography. One dog developed disseminated nocardiosis due to Nocardia brasiliensis and a second dog developed localized cutaneous nocardiosis due to a novel Nocardia species subsequent to ciclosporin administration at the recommended dose rate for the management of canine atopic dermatitis. The second case was receiving a combination of ciclosporin and ketoconazole, and serum trough ciclosporin levels were elevated. Clinicians should be aware of the potential risk of systemic immunosuppression and subsequent infection with Nocardia spp. in dogs receiving ciclosporin. Measurement of serum ciclosporin levels may be useful in identifying those individuals which are at risk of opportunistic infections. © 2013 ESVD and ACVD.

[The medical rehabilitation of the children presenting with atopic dermatitis (a literature review)].

PubMed

Kotenko, K V; Khan, M A; Lyan, N A; Vakhova, E L; Novikova, E V

Atopic dermatitis takes the predominant position in the structure of skin pathologies in the children of various age. Both the scientifically based forecasts and the data of numerous investigations give evidence not only of the significant increase in the number of patients presenting with this condition but also of the growing severity of this disease. Taken together, these facts account for the serious medico-social importance of the problems arising in connection with this pathology. The introduction of the eliminative actions, a hypoallergenic diet, local and systemic pharmacotherapeutic modalities do not always allow to prevent or arrest the inflammatory process and achieve the long-standing remission. The high frequency of undesirable reactions to the pharmacological products turns the attention of many clinicians to the application of the non-pharmacological factors and methods for the treatment of atopic dermatitis in the children. The main objectives of physical therapy in the case of atopic dermatitis include the normalization of the state of the central and vegetative nervous system, the achievement of hyposensitization, sedative, anti-toxic, and anti-inflammatory effects, as well as the application of the dissolving, trophic, and antipruritogenic agents, strengthening of the general health status of the children.

Cross allergic reactions in infants and toddlers with atopic dermatitis.

PubMed

Cudowska, B; Kaczmarski, M; Wasilewska, J

2013-01-01

Prevalence and clinical significance of cross sensitization in children up to 3 years old, diagnosed with atopic dermatitis. The retrospective study included 69 children up to 3 years old with atopic dermatitis. Allergological diagnostics was performed based on skin tests, determination of total IgE concentration and allergen-specific IgE. Cross sensitization was found in 26% of children. Other patients were qualified to the control group. The sensitization to trees pollen and fruits as well as grass pollen and vegetables were the most frequent types of cross allergy. The patient's family history was positive with regard to atopy in 72% of children from the study group vs. 31% of children from the control group. The statistically higher prevalence of allergic rhinitis and bronchial asthma as well as co-existence of sensitization to house dust mite and animal dander were revealed in the study group. The total concentration of IgE, eosinophilia and SCORAD values were statistically higher in the study group. Children with cross sensitization required systemic steroid therapy more frequently. In children up to 3 years with atopic dermatitis and sensitization to plant pollen, the role of a pollen-food allergy syndrome must be taken into account in the pathogenesis of the disease. In children with cross sensitization, the course of atopic dermatitis is more severe; the symptoms from the respiratory and digestive system co-exist. The positive family history is a factor, predisposing to the development of cross sensitization in infants and toddlers.

Deciphering the Complexities of Atopic Dermatitis: Shifting Paradigms in Treatment Approaches

PubMed Central

Leung, Donald Y. M.; Guttman-Yassky, Emma

2014-01-01

Atopic dermatitis (AD) is the most common chronic inflammatory skin disease. It often precedes the development of food allergy and asthma. Recent insights into AD reveal abnormalities in terminal differentiation of the epidermal epithelium leading to a defective stratum corneum, which allows enhanced allergen penetration and systemic IgE sensitization. Atopic skin is also predisposed to colonization or infection by pathogenic microbes, most notably Staphylococcus aureus and herpes simplex virus (HSV). Causes of this abnormal skin barrier are complex and driven by a combination of genetic, environmental and immunologic factors. These factors likely account for the heterogeneity of AD onset, severity and natural history of this skin disease. Recent studies suggest prevention of AD can be achieved by early interventions protecting the skin barrier. Onset of lesional AD requires effective control of local and systemic immune activation for optimal management. Early intervention may improve long term outcomes for AD and reduce the systemic allergen sensitization leading to associated allergic diseases in the gastrointestinal and respiratory tract. PMID:25282559

Fermented rice bran prevents atopic dermatitis in DNCB-treated NC/Nga mice

PubMed Central

Saba, Evelyn; Lee, Chun Hee; Jeong, Da Hye; Lee, Kija; Kim, Tae-Hwan; Roh, Seong-Soo; Kim, Seung-Hyung; Rhee, Man Hee

2016-01-01

Abstract The fermentation of natural plants has a favorable effect on the functional and biological activities of living systems. These include anti-oxidative, anti-inflammatory, and anti-platelet aggregation activities. This is attributed to the chemical conversion of the parent plants to functional constituents, which show more potent biological activity. In our study, rice bran along with oriental medicinal plants (Angelicae gigantis, Cnidium officinale, Artemisia princeps, and Camellia sinensis) was fermented by Lactobacillus rhamnosus and Pichia deserticola (FRBE). We evaluated the effects of oral administration of FRBE on atopic dermatitis in 1-chloro-2,4-dinitrobenzene (DNCB)-treated NC/Nga mice. FRBE significantly ameliorated the macroscopic and microscopic appearance of skin lesions in DNCB-induced atopic dermatitis and reduced levels of serum immunoglobulin E and the differential white blood cell count. In addition, it reduced skin thickness compared to that of atopic dermatitis-affected skin. FRBE treatment also reduced mast cell incorporation in skin lesions of atopic dermatitis. The total cell number in dorsal skin tissue and the axillary lymph node increased following DNCB application, and this was normalized by FRBE treatment. Moreover, it decreased the levels of CD8+ helper T cells and Gr-1+/CD11b+ B cells in peripheral blood mononuclear cells and skin lesions in DNCB-induced atopic dermatitis. Using real-time polymerase chain reaction analysis, we demonstrated that FRBE significantly inhibited mRNA expression of cytokines (e.g., interleukin-5 and interleukin-13) and cyclooxygenase-2 in AD skin lesions. These results suggest that FRBE could be a valuable herbal remedy for the treatment of atopic dermatitis. PMID:27323667

The efficacy of commercially available veterinary diets recommended for dogs with atopic dermatitis.

PubMed

Glos, Katharina; Linek, Monika; Loewenstein, Christine; Mayer, Ursula; Mueller, Ralf S

2008-10-01

The classical treatments for dogs with atopic dermatitis have traditionally been oral antipruritic drugs, allergen-specific immunotherapy and topical therapy. Fifty dogs with atopic dermatitis were included in this multicentred, double-blinded, randomized study to compare clinical response to an 8-week period of feeding one of three commercial veterinary foods marketed for dogs with atopic dermatitis (diets A-C) or a widely distributed supermarket food (diet D). Atopic dermatitis was diagnosed using Willemse's criteria and through the exclusion of differential diagnoses. Fourteen dogs were assigned to diet A and 12 dogs each to diet B, C or D. Flea and tick control using a monthly fipronil spot-on product was administered for a minimum of 4 weeks prior to inclusion in the study and during the study period. Evaluations were made monthly. These included lesion scores, using an established scoring system (canine atopic dermatitis extent and severity index, CADESI-03) and owner evaluation of pruritus level using a visual analogue scale. After 8 weeks on the new diets, there was a significant improvement in CADESI and pruritus scores with diet B (Wilcoxon test, P = 0.043 and paired t-test, P = 0.012, respectively), in pruritus scores with diet A (paired t-test, P = 0.019) and in CADESI scores with diet D (Wilcoxon test, P = 0.037). No significant changes were detected with diet C. Based on the results of this study, in addition to the conventional therapies, changing the diet of dogs with atopic dermatitis may be a useful adjunctive therapeutic measure.

Impairment of T-regulatory cells in cord blood of atopic mothers.

PubMed

Schaub, Bianca; Liu, Jing; Höppler, Sabine; Haug, Severine; Sattler, Christine; Lluis, Anna; Illi, Sabina; von Mutius, Erika

2008-06-01

Maternal atopy is a strong predictor for the development of childhood allergic diseases. The underlying mechanisms are ill defined, yet regulatory T (Treg) and T(H)17 cells may play a key role potentially shaping the early immune system toward a proallergic or antiallergic immune regulation. We examined T(H)1/T(H)2, Treg, and T(H)17 cell responses to innate (lipid A/peptidoglycan) and mitogen/adaptive (phytohemagglutinin/Dermatophagoides pteronyssinus 1) immune stimulation in cord blood from offspring of atopic/nonatopic mothers. Cord blood mononuclear cells from 161 healthy neonates (59% nonatopic, 41% atopic mothers) were investigated regarding Treg and T(H)17 cells (mRNA/surface markers), suppressive function, and proliferation/cytokine secretion. Cord blood from offspring of atopic mothers showed fewer innate-induced Treg cells (CD4(+)CD25(+)high), lower mRNA expression of associated markers (glucocorticoid-induced tumor necrosis factor receptor-related protein/lymphocyte activation gene 3; P < .05), and a trend toward lower Forkhead box transcription factor 3 (Foxp3) expression. Treg cell function was impaired in mitogen-induced suppression of T effector cells in cord blood of offspring from atopic mothers (P = .03). Furthermore, IL-10 and IFN-gamma secretion were decreased in innate-stimulated cord blood of offspring from atopic mothers (P = .04/.05). Innate-induced IL-17 was independent of maternal atopy and highly correlated with IL-13 secretion. In offspring of atopic mothers, Treg cell numbers, expression, and function were impaired at birth. T(H)17 cells were correlated with T(H)2 cells, independently of maternal atopy.

Oral administration of Lactococcus chungangensis inhibits 2,4-dinitrochlorobenzene-induced atopic-like dermatitis in NC/Nga mice.

PubMed

Choi, Woo Jin; Konkit, Maytiya; Kim, Yena; Kim, Mi-Kyung; Kim, Wonyong

2016-09-01

Interest is increasing in the potentially beneficial role of probiotics in the prevention and treatment of atopic diseases. In this study, we investigated the protective effects of Lactococcus chungangensis CAU 28(T) against atopic dermatitis using murine macrophage RAW 264.7 cells, human keratinocyte HaCaT cells, human mast cell line HMC-1 cells, and a 2,4-dinitrochlorobenzene-induced atopic dermatitis model (NC/Nga mice). The results showed that L. chungangensis CAU 28(T) exhibited potent antiinflammatory activity by inhibiting the production of the proinflammatory mediators nitric oxide and prostaglandin E2 in lipopolysaccharide-stimulated RAW 264.7 cells. Treatment with L. chungangensis CAU 28(T) reduced the release of β-hexosaminidase and histamine in HMC-1 cells stimulated with mast cell activator compound 48/80. In addition, the back skin and ears of NC/Nga mice exhibited reduced histological manifestations of atopic skin lesions such as erosion, hyperplasia of the epidermis and dermis, and inflammatory cell infiltration. Oral administration of L. chungangensis CAU 28(T) suppressed the production of IL-4, IL-5, IL-12, IFN-γ, tumor necrosis factor-α, and thymus- and activation-regulated chemokine (TARC) in skin lesions, indicating that it strongly drives the local immune system with efficacy comparable to that of tacrolimus, a topical immunomodulatory drug used for the treatment of atopic dermatitis. The findings indicate that L. chungangensis CAU 28(T) could be a novel probiotic candidate for controlling the symptoms of atopic dermatitis. Copyright © 2016 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Zinc enhances the number of regulatory T cells in allergen-stimulated cells from atopic subjects.

PubMed

Rosenkranz, Eva; Hilgers, Ralf-Dieter; Uciechowski, Peter; Petersen, Arnd; Plümäkers, Birgit; Rink, Lothar

2017-03-01

The trace element zinc is essential for immune function and its regulation. Since zinc deficiency and allergic hyperresponsive reactions are often accompanied, the influence of zinc on allergen-induced cell growth, CD4+ regulatory T (Treg) cell numbers and cytokine expression during allergic immune reactions was investigated. Peripheral blood mononuclear cells (PBMCs) from non-atopic and atopic subjects were treated with timothy grass allergen pre-incubated with or without zinc. Proliferation was determined by analyzing the incorporation of 3 H-thymidine. Intracellular zinc and Foxp3 levels and cell surface antigens were measured by FACS, cytokine expression by ELISA and real-time PCR. Incubation with 50 μM zinc sulfate (Zn50) enhances cytosolic zinc concentrations in CD3+ T cells. The data also reveal that the combination of Zn50 plus allergen significantly reduces PBMC proliferation of atopic subjects. Additionally, Zn50 plus allergen enhances Th1 cytokine responses shown by increased interferon (IFN)-γ/interleukin (IL)-10 ratios as well as enhanced tumor necrosis factor-α release. In response to allergen, zinc increases Treg cells and upregulates the mRNA expression of cytotoxic T-lymphocyte antigen-4 in atopic subjects. Interestingly, Zn50 alone leads to an increase of CD4+CD25high(hi)+ cells in atopic and non-atopic subjects. Zinc may regulate unwanted hyperresponsive immune reactions by suppressing proliferation through a significant shift from IL-10 to the Th1 cytokine IFN-γ, and enhanced regulatory T cell numbers. Therefore, zinc supplementation may be a promising tool for the therapy of allergies, without negatively affecting the immune system.

Credit WCT. Photographic copy of photograph, view of Test Stand ...

Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

Credit WCT. Photographic copy of photograph, view of Test Stand "D" from the south with tower ejector system in operation during a 1972 engine test. Note steam evolving from Z-stage ejectors atop the interstage condenser in the tower. Note also the "Hyprox" steam generator straddling the Dd ejector train to the right. The new Dy horizontal train has not been erected as of this date. In the distance is Test Stand "E." (JPL negative no. 384-9766-AC, 28 November 1972) - Jet Propulsion Laboratory Edwards Facility, Test Stand D, Edwards Air Force Base, Boron, Kern County, CA

Orion EM-1 Crew Module Structural Test Article Prepped for Trans

NASA Image and Video Library

2017-04-24

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, the Orion Exploration Mission-1 (EM-1) structural test article is secured inside its transport container. Technicians monitor the progress as a crane is used to move the container toward a transport vehicle for the move to the Shuttle Landing Facility. The test article will be loaded in NASA's Super Guppy airplane and transported to Lockheed Martin's Denver facility for testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission.

Orion EM-1 Crew Module Structural Test Article Prepped for Trans

NASA Image and Video Library

2017-04-24

Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, the Orion Exploration Mission-1 (EM-1) structural test article is secured inside its transport container. A crane is used to move the container toward a transport vehicle for the move to the Shuttle Landing Facility. The test article will be loaded in NASA's Super Guppy airplane and transported to Lockheed Martin's Denver facility for testing. The Orion spacecraft will launch atop NASA’s Space Launch System rocket on EM-1, its first deep space mission.

Orion Hatch Window Testing

NASA Image and Video Library

2018-04-09

The first optical quality testing on a full window stack that is ready for installation in the docking hatch of NASA's Orion spacecraft is underway inside a laboratory in the Neil Armstrong Operations and Checkout Building at the agency's Kennedy Space Center in Florida. The test is being performed by a team from the center's Exploration Research and Technology Programs. The data from the tests will help improve the requirements for manufacturing tolerances on Orion's windows and verify how the window should perform in space. Orion is being prepared for its first integrated uncrewed flight atop NASA's Space Launch System rocket on Exploration Mission-1.

Feline atopic dermatitis. A model for Langerhans cell participation in disease pathogenesis.

PubMed

Roosje, P J; Whitaker-Menezes, D; Goldschmidt, M H; Moore, P F; Willemse, T; Murphy, G F

1997-10-01

Atopic dermatitis is a disorder characterized by cutaneous exanthemata as a consequence of exaggerated eczematous reactions to topical and systemic allergens. Langerhans cells, expressing CD1a and HLA-DR, and dermal dendritic cells, expressing HLA-DR, are known to be potent antigen-presenting cells and are thought to play an important role in the pathogenesis of atopic dermatitis. The immunophenotype of lesional skin in atopic dermatitis in humans involves increased numbers of CD1a+/MHC class II+ dendritic cells in addition to activated T cells, mast cells, and macrophages. To establish feline skin as a model for the study of human atopic dermatitis, and to elucidate the role of dendritic cells in feline atopic dermatitis, we investigated the presence of CD1a+ cells and MHC class II+ cells in the epidermis and dermis of lesional feline skin and in skin of healthy control animals. Immunohistochemistry revealed that MHC class II+ epidermal dendritic cells were CD1a+ in normal feline skin and significantly increased numbers of CD1a+ cells and MHC class II+ cells were present in the epidermis and dermis of lesional skin. These data provide the first correlative documentation of CD1a expression by feline dendritic cells containing Birbeck granules, and indicate the utility of feline skin in the study of human cutaneous atopy.

Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma.

PubMed

Demehri, Shadmehr; Morimoto, Mitsuru; Holtzman, Michael J; Kopan, Raphael

2009-05-19

Asthma is a common allergic lung disease frequently affecting individuals with a prior history of eczema/atopic dermatitis (AD); however, the mechanism underlying the progression from AD to asthma (the so-called "atopic march") is unclear. Here we show that, like humans with AD, mice with skin-barrier defects develop AD-like skin inflammation and are susceptible to allergic asthma. Furthermore, we show that thymic stromal lymphopoietin (TSLP), overexpressed by skin keratinocytes, is the systemic driver of this bronchial hyper-responsiveness. As an AD-like model, we used mice with keratinocyte-specific deletion of RBP-j that sustained high systemic levels of TSLP. Antigen-induced allergic challenge to the lung airways of RBP-j-deficient animals resulted in a severe asthmatic phenotype not seen in similarly treated wild-type littermates. Elimination of TSLP signaling in these animals blocked the atopic march, demonstrating that high serum TSLP levels were required to sensitize the lung to allergic inflammation. Furthermore, we analyzed outbred K14-TSLP(tg) mice that maintained high systemic levels of TSLP without developing any skin pathology. Importantly, epidermal-derived TSLP was sufficient to trigger the atopic march, sensitizing the lung airways to inhaled allergens in the absence of epicutaneous sensitization. Based on these findings, we propose that in addition to early treatment of the primary skin-barrier defects, selective inhibition of systemic TSLP may be the key to blocking the development of asthma in AD patients.

KSC-2013-3934

NASA Image and Video Library

2013-11-07

CAPE CANAVERAL, Fla. – At NASA’s Kennedy Space Center in Florida, technicians monitor the progress as the fourth ogive panel is lifted by crane so that they can be installed on the Orion ground test vehicle in Vehicle Assembly Building high bay 4. Three of the panels have already been installed on the test vehicle. The ogive panels enclose and protect the Orion spacecraft and attach to the Launch Abort System. The test vehicle is being used by the Ground Systems Development and Operations Program for path finding operations, including simulated manufacturing, assembly and stacking procedures. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion. Photo credit: Kim Shiflett

KSC-2013-3933

NASA Image and Video Library

2013-11-07

CAPE CANAVERAL, Fla. – At NASA’s Kennedy Space Center in Florida, three ogive panels have been installed on the Orion ground test vehicle in Vehicle Assembly Building high bay 4. The fourth ogive panel is being lifted by crane for installation. The ogive panels enclose and protect the Orion spacecraft and attach to the Launch Abort System. The test vehicle is being used by the Ground Systems Development and Operations Program for path finding operations, including simulated manufacturing, assembly and stacking procedures. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion. Photo credit: Kim Shiflett

KSC-2013-3930

NASA Image and Video Library

2013-10-30

CAPE CANAVERAL, Fla. – At NASA’s Kennedy Space Center in Florida, technicians assist as a crane is used to move one of four ogive panels closer for installation on the Orion ground test vehicle in Vehicle Assembly Building high bay 4. The ogive panels enclose and protect the Orion spacecraft and attach to the Launch Abort System. The test vehicle is being used by the Ground Systems Development and Operations Program for path finding operations, including simulated manufacturing, assembly and stacking procedures. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion. Photo credit: Kim Shiflett

KSC-2013-3929

NASA Image and Video Library

2013-10-30

CAPE CANAVERAL, Fla. – At NASA’s Kennedy Space Center in Florida, technicians monitor the progress as a crane is used to move one of four ogive panels closer for installation on the Orion ground test vehicle in Vehicle Assembly Building high bay 4. The ogive panels enclose and protect the Orion spacecraft and attach to the Launch Abort System. The test vehicle is being used by the Ground Systems Development and Operations Program for path finding operations, including simulated manufacturing, assembly and stacking procedures. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion. Photo credit: Kim Shiflett

KSC-2013-3927

NASA Image and Video Library

2013-10-30

CAPE CANAVERAL, Fla. – At NASA’s Kennedy Space Center in Florida, technicians prepare the four ogive panels for lifting by crane so that they can be installed on the Orion ground test vehicle in Vehicle Assembly Building high bay 4. The ogive panels enclose and protect the Orion spacecraft and attach to the Launch Abort System. The test vehicle is being used by the Ground Systems Development and Operations Program for path finding operations, including simulated manufacturing, assembly and stacking procedures. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion. Photo credit: Kim Shiflett

KSC-2013-3932

NASA Image and Video Library

2013-10-30

CAPE CANAVERAL, Fla. – At NASA’s Kennedy Space Center in Florida, technicians assist as a crane is used to move one of four ogive panels closer for installation on the Orion ground test vehicle in Vehicle Assembly Building high bay 4. The ogive panels enclose and protect the Orion spacecraft and attach to the Launch Abort System. The test vehicle is being used by the Ground Systems Development and Operations Program for path finding operations, including simulated manufacturing, assembly and stacking procedures. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion. Photo credit: Kim Shiflett

KSC-2013-3936

NASA Image and Video Library

2013-11-07

CAPE CANAVERAL, Fla. – At NASA’s Kennedy Space Center in Florida, technicians monitor the progress as the fourth ogive panel is lifted by crane so that they can be installed on the Orion ground test vehicle in Vehicle Assembly Building high bay 4. Three of the panels have already been installed on the test vehicle. The ogive panels enclose and protect the Orion spacecraft and attach to the Launch Abort System. The test vehicle is being used by the Ground Systems Development and Operations Program for path finding operations, including simulated manufacturing, assembly and stacking procedures. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion. Photo credit: Kim Shiflett

KSC-2013-3931

NASA Image and Video Library

2013-10-30

CAPE CANAVERAL, Fla. – At NASA’s Kennedy Space Center in Florida, technicians assist as a crane is used to move one of four ogive panels closer for installation on the Orion ground test vehicle in Vehicle Assembly Building high bay 4. The ogive panels enclose and protect the Orion spacecraft and attach to the Launch Abort System. The test vehicle is being used by the Ground Systems Development and Operations Program for path finding operations, including simulated manufacturing, assembly and stacking procedures. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion. Photo credit: Kim Shiflett

KSC-2013-3935

NASA Image and Video Library

2013-11-07

CAPE CANAVERAL, Fla. – At NASA’s Kennedy Space Center in Florida, technicians monitor the progress as the fourth ogive panel is lifted by crane so that they can be installed on the Orion ground test vehicle in Vehicle Assembly Building high bay 4. Three of the panels have already been installed on the test vehicle. The ogive panels enclose and protect the Orion spacecraft and attach to the Launch Abort System. The test vehicle is being used by the Ground Systems Development and Operations Program for path finding operations, including simulated manufacturing, assembly and stacking procedures. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion. Photo credit: Kim Shiflett

KSC-2013-3928

NASA Image and Video Library

2013-10-30

CAPE CANAVERAL, Fla. – At NASA’s Kennedy Space Center in Florida, technicians monitor the progress as a crane is used to move one of four ogive panels closer for installation on the Orion ground test vehicle in Vehicle Assembly Building high bay 4. The ogive panels enclose and protect the Orion spacecraft and attach to the Launch Abort System. The test vehicle is being used by the Ground Systems Development and Operations Program for path finding operations, including simulated manufacturing, assembly and stacking procedures. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion. Photo credit: Kim Shiflett

Orion Flight Test Preview Briefing

NASA Image and Video Library

2014-11-06

In the Kennedy Space Center’s Press Site auditorium, members of the news media are briefed on the upcoming Orion flight test. From left are: Rachel Kraft, NASA Public Affairs, Bill Hill, NASA deputy associate administrator for Exploration Systems Development, Mark Geyer, NASA Orion Program manager, Bryan Austin, Lockheed Martin mission manager, Jeremy Graeber, Operations Integration Branch of Ground Systems Development and Operations at Kennedy, and Ron Fortson, United Launch Alliance director of Mission Management. Mike Sarafin, NASA's lead flight director, participated by video from the Johnson Space Center. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted flight test of Orion is scheduled to launch Dec. 4, 2014 atop a United Launch Alliance Delta IV Heavy rocket, and in 2018 on NASA’s Space Launch System rocket.

Diet and Dermatitis: Food Triggers

PubMed Central

Schlichte, Megan

2014-01-01

Given increasing awareness of the link between diet and health, many patients are concerned that dietary factors may trigger dermatitis. Research has found that dietary factors can indeed exacerbate atopic dermatitis or cause dermatitis due to systemic contact dermatitis. In atopic dermatitis, dietary factors are more likely to cause an exacerbation among infants or children with moderate-to-severe atopic dermatitis relative to other populations. Foods may trigger rapid, immunoglobulin E-mediated hypersensitivity reactions or may lead to late eczematous reactions. While immediate reactions occur within minutes to hours of food exposure, late eczematous reactions may occur anywhere from hours to two days later. Screening methods, such as food allergen-specific serum immunoglobulin E tests or skin prick tests, can identify sensitization to specific foods, but a diagnosis of food allergy requires specific signs and symptoms that occur reproducibly upon food exposure. Many patients who are sensitized will not develop clinical findings upon food exposure; therefore, these tests may result in false-positive tests for food allergy. This is why the gold standard for diagnosis remains the double-blind, placebo-controlled food challenge. In another condition, systemic contact dermatitis, ingestion of a specific food can actually cause dermatitis. Systemic contact dermatitis is a distinct T-cell mediated immunological reaction in which dietary exposure to specific allergens results in dermatitis. Balsam of Peru and nickel are well-known causes of systemic contact dermatitis, and reports have implicated multiple other allergens. This review seeks to increase awareness of important food allergens, elucidate their relationship with atopic dermatitis and systemic contact dermatitis, and review available diagnostic and treatment strategies. PMID:24688624

Search for a scalar partner of the top quark in the jets plus missing transverse momentum final state at $$\\sqrt{s}=13 $$ TeV with the ATLAS detector

DOE PAGES

Aaboud, M.; Aad, G.; Abbott, B.; ...

2017-12-15

A search for pair production of a scalar partner of the top quark in events with four or more jets plus missing transverse momentum is presented. Here, an analysis of 36.1 fb -1 ofmore » $$ \\sqrt{s}=13 $$ TeV proton-proton collisions collected using the ATLAS detector at the LHC yields no significant excess over the expected Standard Model background. To interpret the results a simplified supersymmetric model is used where the top squark is assumed to decay via $$\\sim\\atop{t}$$ 1→t(*)$$\\sim\\atop{χ}$$ $$0\\atop{1}$$ and $$\\sim\\atop{t}$$ 1→b$$\\sim\\atop{χ}$$ $$±\\atop{1}$$→bW(*)$$\\sim\\atop{χ}$$ $$0\\atop{1}$$, where χ 1 0 (χ 1 ± ) denotes the lightest neutralino (chargino). Exclusion limits are placed in terms of the top-squark and neutralino masses. Assuming a branching ratio of 100% to t$$\\sim\\atop{χ}$$ $$0\\atop{1}$$, top-squark masses in the range 450–1000 GeV are excluded for $$\\sim\\atop{χ}$$ $$0\\atop{1}$$ masses below 160 GeV. In the case where m$$\\sim\\atop{t}$$ 1-m t+m $$\\sim\\atop{χ}$$ $$0\\atop{1}$$ , top-squark masses in the range 235–590 GeV are excluded.« less

Search for a scalar partner of the top quark in the jets plus missing transverse momentum final state at $$\\sqrt{s}=13 $$ TeV with the ATLAS detector

DOE Office of Scientific and Technical Information (OSTI.GOV)

Aaboud, M.; Aad, G.; Abbott, B.

A search for pair production of a scalar partner of the top quark in events with four or more jets plus missing transverse momentum is presented. Here, an analysis of 36.1 fb -1 ofmore » $$ \\sqrt{s}=13 $$ TeV proton-proton collisions collected using the ATLAS detector at the LHC yields no significant excess over the expected Standard Model background. To interpret the results a simplified supersymmetric model is used where the top squark is assumed to decay via $$\\sim\\atop{t}$$ 1→t(*)$$\\sim\\atop{χ}$$ $$0\\atop{1}$$ and $$\\sim\\atop{t}$$ 1→b$$\\sim\\atop{χ}$$ $$±\\atop{1}$$→bW(*)$$\\sim\\atop{χ}$$ $$0\\atop{1}$$, where χ 1 0 (χ 1 ± ) denotes the lightest neutralino (chargino). Exclusion limits are placed in terms of the top-squark and neutralino masses. Assuming a branching ratio of 100% to t$$\\sim\\atop{χ}$$ $$0\\atop{1}$$, top-squark masses in the range 450–1000 GeV are excluded for $$\\sim\\atop{χ}$$ $$0\\atop{1}$$ masses below 160 GeV. In the case where m$$\\sim\\atop{t}$$ 1-m t+m $$\\sim\\atop{χ}$$ $$0\\atop{1}$$ , top-squark masses in the range 235–590 GeV are excluded.« less

Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): the role of anti-IgE in severe paediatric eczema: study protocol for a randomised controlled trial.

PubMed

Chan, Susan; Cornelius, Victoria; Chen, Tao; Radulovic, Suzana; Wan, Mandy; Jahan, Rahi; Lack, Gideon

2017-03-22

The evidence for systemic treatments for severe childhood eczema is limited and largely based on extrapolation of data from adult studies. Current therapies are often immunosuppressant and may be associated with both short- and long-term side effects. There is increasing in vitro and murine-model evidence for the role of IgE in the immunopathogenesis of atopic eczema. The aim of the study is to assess whether anti-IgE treatment (omalizumab) improves eczema, compared to placebo. The Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT) is a randomised, double-blind, placebo-controlled study assessing the role of anti-IgE in the management of severe paediatric eczema. Children with severe atopic eczema, with an objective SCORing Atopic Dermatitis (SCORAD) score of over 40 will be recruited. These children are candidates for systemic therapy, have failed systemic therapy or have experienced side effects from systemic therapy. Sixty-two patients aged between 4 and 19 years will receive anti-IgE for 6 months. The primary outcome measure will be the validated eczema score, the objective SCORAD at 24 weeks. This study has 90% power to detect a 33% relative reduction in SCORAD between active and placebo groups, with 5% significance. IgE may have a role to play in eczema, particularly in childhood. This forms the basis for the hypothesis that anti-IgE may be an effective treatment in this patient population. This will be the largest study to evaluate the efficacy of anti-IgE (omalizumab) versus placebo in children with severe eczema. The findings will help to clarify the role of anti-IgE as a potential treatment option in patients with severe childhood eczema. European Clinical Trials Database (EudraCT) Number: 2010-020841-29 . Assigned on 14 May 2010. ISRCTN Registry, Identifier: ISRCTN15090567 . Retrospectively assigned on 3 December 2014. ClinicalTrials.gov, Identifier: NCT02300701 . First received 21 November 2014.

Atopic children and use of prescribed medication: A comprehensive study in general practice

PubMed Central

Nielen, Mark M. J.; Bohnen, Arthur M.; Korevaar, Joke C.; Bindels, Patrick J. E.

2017-01-01

Purpose A comprehensive and representative nationwide general practice database was explored to study associations between atopic disorders and prescribed medication in children. Method All children aged 0–18 years listed in the NIVEL Primary Care Database in 2014 were selected. Atopic children with atopic eczema, asthma and allergic rhinitis (AR) were matched with controls (not diagnosed with any of these disorders) within the same general practice on age and gender. Logistic regression analyses were performed to study the differences in prescribed medication between both groups by calculating odds ratios (OR); 93 different medication groups were studied. Results A total of 45,964 children with at least one atopic disorder were identified and matched with controls. Disorder-specific prescriptions seem to reflect evidence-based medicine guidelines for atopic eczema, asthma and AR. However, these disorder-specific prescriptions were also prescribed for children who were not registered as having that specific disorder. For eczema-related medication, about 3.7–8.4% of the children with non-eczematous atopic morbidity received these prescriptions, compared to 1.4–3.5% of the non-atopic children. The same pattern was observed for anti-asthmatics (having non-asthmatic atopic morbidity: 0.8–6.2% vs. controls: 0.3–2.1%) and AR-related medication (having non-AR atopic morbidity: 4.7–12.5% vs. controls: 2.8–3.1%). Also, non-atopic related medication, such as laxatives and antibiotics were more frequently prescribed for atopic children. Conclusions The present study shows that atopic children received more prescriptions, compared to non-atopic children. Non-atopic controls frequently received specific prescriptions for atopic disorders. This indicates that children with atopic disorders need better monitoring by their GP. PMID:28837578

Study of B$$0\\atop{s}$$ Mixing at the D-Zero Detector at Fermilab Using the Semi-leptonic Decay B$$0\\atop{s}$$ → D$$-\\atop{s}$$ μ +v X

DOE Office of Scientific and Technical Information (OSTI.GOV)

Anzelc, Meghan

2008-06-01

Bmore » $$0\\atop{s}$$ mixing studies provide a precision test of Charge-Parity violation in the Standard Model. A measurement of Δm s constrains elements of the CKM quark rotation matrix [1], providing a probe of Standard Model Charge-Parity violation. This thesis describes a study of $$0\\atop{s}$$ mixing in the semileptonic decay $$0\\atop{s}$$ → D s - μ +vX, where D s - → Φπ -, using data collected at the D-Zero detector at Fermi National Accelerator in atavia, Illinois. Approximately 2.8 fb -1 of data collected between April 2002 and August 2007 was used, covering the entirety of the Tevatron's RunIIa (April 2002 to March 2006) and part of RunIIb (March 2006-August 2007). Taggers using both opposite-side and same-side information were used to obtain the flavor information of the s 0 meson at production. The charge of the muon in the decay $$0\\atop{s}$$ → D s -μ +vX was used to determine the flavor of the $$0\\atop{s}$$ at decay. The $$d\\atop{0}$$ mixing frequency, Δm d, was measured to verify the analysis procedure. A log-likelihood calculation was performed, and a measurement of Δm s was obtained. The final result was Δm s = 18.86 ± 0.80(stat.) ± 0.37(sys.) with a significance of 2.6σ.« less

Measurement of the dijet transverse thrust distribution in proton - anti-proton collisions

DOE Office of Scientific and Technical Information (OSTI.GOV)

Sorin, Maria Veronica

2003-01-01

This dissertation presents the first measurement in a hadron collider of an event shape variable, the Dijet Transverse Thrust Tmore » $$t\\atop{2}$$ which is sensitive to the spatial jet distribution on the plane perpendicular to the colliding p$$\\bar{p}$$ beams. $$t\\atop{2}$$ is calculated with the two most energetic jets reconstructed with the k$$\\perp$$ algorithm, and it ranges from T$$t\\atop{2}$$ =1, for a pencil-like configuration, to T$$t\\atop{2}$$ =√2/2, for two equal energy jets at 90°. The measurement is based on 87.3 pb -1 of data collected with the D0 detector at the Fermilab Tevatron p$$\\bar{p}$$ Collider. The cross section is reported as a function of 1-T$$t\\atop{2}$$ and log (1-T$$t\\atop{2}$$), with enhances the high statistics T$$t\\atop{2}$$→1 region, and presented for four separate event energy ranges. The measurement is in good agreement with a fixed-order O(α$$3\\atop{s}$$) perturbative QCD prediction, except at high T$$t\\atop{2}$$, where resummation corrections are expected to be important, and below T$$t\\atop{2}$$≃√3/2, where the leading order diagrams contributing to T$$t\\atop{2}$$ are O(α$$4\\atop{s}$$). The data also show a very good level of agreement with a recent Next-to-Leading pQCD three jet generator which covers the full T$$t\\atop{2}$$ range, except for the T$$t\\atop{2}$$=1 point.« less

KSC-2013-3790

NASA Image and Video Library

2013-11-01

CAPE CANAVERAL, Fla. – The United Launch Alliance Centaur upper stage that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit arrives at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station for checkout in preparation for launch. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/ Jim Grossman

KSC-2013-3792

NASA Image and Video Library

2013-11-01

CAPE CANAVERAL, Fla. – The United Launch Alliance Centaur upper stage that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit arrives at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station for checkout in preparation for launch. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/ Jim Grossman

KSC-2013-2344

NASA Image and Video Library

2013-05-13

CAPE CANAVERAL, Fla. -- At NASA’s Kennedy Space Center in Florida, Lockheed Martin crews begin uncovering the Orion ground test vehicle in the Launch Equipment Test Facility, or LETF. The GTA was moved from the Operations and Checkout Facility to the LETF for a series of pyrotechnic bolt tests. The GTA is being used for path finding operations in the O&C, including simulated manufacturing and assembly procedures. Launching atop NASA's heavy-lift Space Launch System SLS, which also is under development, the Orion Multi-Purpose Crew Vehicle MPCV will serve as the exploration vehicle that will carry astronaut crews beyond low Earth orbit. It also will provide emergency abort capabilities, sustain the crew during space travel and provide safe re-entry from deep space return velocities. For more information, visit www.nasa.gov/orion. Photo credit: Jim Grossman

KSC-2013-2345

NASA Image and Video Library

2013-05-13

CAPE CANAVERAL, Fla. -- At NASA’s Kennedy Space Center in Florida, Lockheed Martin crews uncover the Orion ground test vehicle in the Launch Equipment Test Facility, or LETF. The GTA was moved from the Operations and Checkout Facility to the LETF for a series of pyrotechnic bolt tests. The GTA is being used for path finding operations in the O&C, including simulated manufacturing and assembly procedures. Launching atop NASA's heavy-lift Space Launch System SLS, which also is under development, the Orion Multi-Purpose Crew Vehicle MPCV will serve as the exploration vehicle that will carry astronaut crews beyond low Earth orbit. It also will provide emergency abort capabilities, sustain the crew during space travel and provide safe re-entry from deep space return velocities. For more information, visit www.nasa.gov/orion. Photo credit: Jim Grossman

KSC-2012-6105

NASA Image and Video Library

2012-11-01

CAPE CANAVERAL, Fla. – The Orion Exploration Flight Test 1 crew module is undergoing proof pressure testing at the Operations and Checkout Building at NASA's Kennedy Space Center in Florida. The test incrementally pressurizes the spacecraft with breathing air and is designed to demonstrate weld strength capability and structural performance at maximum flight operating pressures. Orion is the exploration spacecraft designed to carry crews to space beyond low Earth orbit. It will provide emergency abort capability, sustain the crew during the space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on a Space Launch System rocket. For more information, visit http://www.nasa.gov/orion Photo credit: NASA/Ben Smegelsky

KSC-2012-6103

NASA Image and Video Library

2012-11-01

CAPE CANAVERAL, Fla. – The Orion Exploration Flight Test 1 crew module is undergoing proof pressure testing at the Operations and Checkout Building at NASA's Kennedy Space Center in Florida. The test incrementally pressurizes the spacecraft with breathing air and is designed to demonstrate weld strength capability and structural performance at maximum flight operating pressures. Orion is the exploration spacecraft designed to carry crews to space beyond low Earth orbit. It will provide emergency abort capability, sustain the crew during the space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on a Space Launch System rocket. For more information, visit http://www.nasa.gov/orion Photo credit: NASA/Ben Smegelsky

KSC-2012-6104

NASA Image and Video Library

2012-11-01

CAPE CANAVERAL, Fla. – The Orion Exploration Flight Test 1 crew module is undergoing proof pressure testing at the Operations and Checkout Building at NASA's Kennedy Space Center in Florida. The test incrementally pressurizes the spacecraft with breathing air and is designed to demonstrate weld strength capability and structural performance at maximum flight operating pressures. Orion is the exploration spacecraft designed to carry crews to space beyond low Earth orbit. It will provide emergency abort capability, sustain the crew during the space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on a Space Launch System rocket. For more information, visit http://www.nasa.gov/orion Photo credit: NASA/Ben Smegelsky

Presence of Headache and Migraine in Asthma Patients

PubMed Central

Turan, Muzaffer Onur; Susuz, Çiğdem Çelik; Turan, Pakize Ayşe

2017-01-01

OBJECTIVES Migraine is a diseases characterized with severe headaches, with neurological and systemic findings. The purpose of this study is to investigate the prevalence of migraine and to examine whether there is a relationship between atopic disorders, parental history and migraine in asthma patients. MATERIAL AND METHODS A total of 288 asthma outpatients, who had the diagnosis by an early or late test of reversibility showing a reversible airway obstruction according to hospital database were included. The presence of headache, atopic symptoms and parental history about asthma, atopic disorders and migraine were asked. The patients with headache were consultated by neurology department and investigated about the presence of migraine. The diagnosis of migraine headache was made if patients fulfilled the International Headache Society (IHS) criteria. RESULTS 60.4% of patients described a headache. There were 94 patients (32.6%) with headaches meeting the IHS criteria for migraine. Only 12 patients had migraine with aura. There were atopic symptoms in 86.8% of patients. According to parental history, there were asthma in 47.9%, atopic symptoms in 39.6% and migraine in 22.2% of parents. Patients with atopic symptoms were found to have significantly high rate of headaches (65.3%) “p=0.007”. The prevalence of migraine was significantly high in patients with parental atopic symptoms (54%) “p=0.002”. Multiple logistic regression analysis identified that gender, parental history of asthma, allergia and migraine, and smoking were independent risk factors for presence of migraine in asthmatics. CONCLUSION There is a high prevalence of migraine headaches in patients with asthma. The coexistence of asthma and headaches may be related with a similar pathophysiological mechanism; parental history, common genetic compounds and smoking may play role in this mechanism. The headaches in asthma patients, atopic symptoms and family history should be questioned, and clinicians should be careful about the presence of migraine. PMID:29404159

Phenotypes of asthma revisited upon the presence of atopy.

PubMed

Nieves, Ana; Magnan, Antoine; Boniface, Stéphanie; Proudhon, Hervé; Lanteaume, André; Romanet, Stéphanie; Vervloet, Daniel; Godard, Philippe

2005-03-01

Immunological studies claimed that atopic and non-atopic asthma share more similarities than differences. However, these two phenotypes of asthma are considered to be distinguishable upon distinct clinical patterns, which were not systematically assessed before in a large population. We studied characteristics discriminating atopic from non-atopic asthma among 751 asthmatic patients and 80 factors were analysed in univariate and multivariate analysis. Age, age of onset of asthma, female/male ratio were higher in non-atopic (n=200) than in atopic (n=551) asthmatics. Familial asthma, seasonal symptoms, rhinitis, conjunctivitis, allergen-triggered symptoms, improvement in altitude, exercise-induced asthma were associated with atopy. Non-atopic asthmatics displayed lower FEV(1) and FVC. Smoking was more frequent and asthma was more severe in these patients. Younger age, early onset, male sex, rhinitis and smoking were independent factors discriminating atopic from non-atopic asthma. This study establishes in a large population of asthmatics that although similarities exist between atopic and non-atopic asthma, two clinical phenotypes can still distinguish both kinds of asthma.

Fermented rice bran prevents atopic dermatitis in DNCB-treated NC/Nga mice.

PubMed

Saba, Evelyn; Lee, Chun Hee; Jeong, Da Hye; Lee, Kija; Kim, Tae-Hwan; Roh, Seong-Soo; Kim, Seung-Hyung; Rhee, Man Hee

2016-07-01

The fermentation of natural plants has a favorable effect on the functional and biological activities of living systems. These include anti-oxidative, anti-inflammatory, and anti-platelet aggregation activities. This is attributed to the chemical conversion of the parent plants to functional constituents, which show more potent biological activity. In our study, rice bran along with oriental medicinal plants (Angelicae gigantis, Cnidium officinale, Artemisia princeps, and Camellia sinensis) was fermented by Lactobacillus rhamnosus and Pichia deserticola (FRBE). We evaluated the effects of oral administration of FRBE on atopic dermatitis in 1-chloro-2,4-dinitrobenzene (DNCB)-treated NC/Nga mice. FRBE significantly ameliorated the macroscopic and microscopic appearance of skin lesions in DNCB-induced atopic dermatitis and reduced levels of serum immunoglobulin E and the differential white blood cell count. In addition, it reduced skin thickness compared to that of atopic dermatitis-affected skin. FRBE treatment also reduced mast cell incorporation in skin lesions of atopic dermatitis. The total cell number in dorsal skin tissue and the axillary lymph node increased following DNCB application, and this was normalized by FRBE treatment. Moreover, it decreased the levels of CD8(+) helper T cells and Gr-1(+)/CD11b(+) B cells in peripheral blood mononuclear cells and skin lesions in DNCB-induced atopic dermatitis. Using real-time polymerase chain reaction analysis, we demonstrated that FRBE significantly inhibited mRNA expression of cytokines (e.g., interleukin-5 and interleukin-13) and cyclooxygenase-2 in AD skin lesions. These results suggest that FRBE could be a valuable herbal remedy for the treatment of atopic dermatitis. © 2016 the Journal of Biomedical Research. All rights reserved.

Flexural eczema versus atopic dermatitis.

PubMed

Jacob, Sharon E; Goldenberg, Alina; Nedorost, Susan; Thyssen, Jacob P; Fonacier, Luz; Spiewak, Radoslaw

2015-01-01

Flexural eczema and atopic dermatitis are frequently synonymized. As respiratory atopy is rarely tested for and found in these patients, systematically equating a flexural distribution of dermatitis with atopic dermatitis may too frequently result in misclassified diagnoses and potentially missed opportunity for intervention toward improving patients' symptoms and quality of life. We present a critical review of the available evidence for the atopic dermatitis diagnosis and discuss the similarities between atopic dermatitis and allergic contact dermatitis. Because neither flexural predilection nor atopy is specific for atopic dermatitis, we conclude that the term atopic dermatitis is a misnomer and propose an etymologic reclassification of atopic dermatitis to "atopy-related" dermatitis. Allergic contact dermatitis can induce an atopic dermatitis-like phenotype, and thus, flexural dermatitis cannot be assumed as atopic without further testing. Patch testing should at least be considered in cases of chronic or recurrent eczema regardless of the working diagnosis.

Atopic dermatitis phenotypes and the need for personalized medicine

PubMed Central

Cabanillas, Beatriz; Brehler, Ann-Christin; Novak, Natalija

2017-01-01

Purpose of review To describe recent developments in therapies which target the molecular mechanisms in atopic dermatitis. Recent findings Current advances in the understanding of the molecular basis of atopic dermatitis are leading to the stratification of different atopic dermatitis phenotypes. New therapies offer the option to target-specific molecules involved in the pathophysiology of atopic dermatitis. Current new therapies under investigation aim to modulate specific inflammatory pathways associated with distinctive atopic dermatitis phenotypes, which would potentially translate into the development of personalized, targeted-specific treatments of atopic dermatitis. Summary Despite the unmet need for well tolerated, effective, and personalized treatment of atopic dermatitis, the current standard treatments of atopic dermatitis do not focus on the individual pathogenesis of the disease. The development of targeted, phenotype-specific therapies has the potential to open a new promising era of individualized treatment of atopic dermatitis. PMID:28582322

TDRS-M Departure from Astrotech and Transport to VIF Pad 41

NASA Image and Video Library

2017-08-09

Enclosed in its payload fairing, NASA's Tracking and Data Relay Satellite (TDRS-M) is transported from Astrotech Space Operations Facilityin Titusville Florida to the Vertical Integration Facility at Space Launch Complex 41 at Cape Canaveral Air Force Station. TDRS-M will be stacked atop the United Launch Alliance Atlas V Centaur upper stage. It will be the latest spacecraft destined for the agency's constellation of communications satellites that allows nearly continuous contact with orbiting spacecraft ranging from the International Space Station and Hubble Space Telescope to the array of scientific observatories. Liftoff atop the ULA Atlas V rocket is scheduled to take place from Cape Canaveral's Space Launch Complex 41 on Aug. 18, 2017.

Dalitz plot analyses of J / ψ → π + π - π 0 , J / ψ → K + K - π 0 , and J / ψ → K s 0 K ± π ∓ produced via e + e - annihilation with initial-state radiation

DOE Office of Scientific and Technical Information (OSTI.GOV)

Lees, J. P.; Poireau, V.; Tisserand, V.

We study the processes e + e - → γ ISR J / ψ , where J / ψ → π + π - π 0 , J / ψ → K + K - π 0 , and J / ψ → Kmore » $$0\\atop{S}$$ K ± π ∓ using a data sample of 519 fb - 1 recorded with the BABAR detector operating at the SLAC PEP-II asymmetric-energy e + e - collider at center-of-mass energies at and near the Υ ( n S ) ( n = 2 , 3 , 4 ) resonances.« less

The effect of a Web-based education programme (WBEP) on disease severity, quality of life and mothers' self-efficacy in children with atopic dermatitis.

PubMed

Son, Hae Kyoung; Lim, Jiyoung

2014-10-01

To develop and evaluate the effects of a web-based education programme in early childhood for children with atopic dermatitis. The prevalence rate of atopic dermatitis is highest in early childhood. A holistic approach is urgently needed for young children with respect to disease severity, quality of life and management, particularly parental knowledge about atopic dermatitis and adherence to treatment. A quasi-experimental study design was used. A total of 40 mother-child dyads participated in the study from 1 July-30 November 2011 in Korea. All children were under 3 years of age. The programme was based on the Network-Based Instructional System Design model, which consists of five phases: analysis, design, development, implementation and evaluation. The experimental group participated in the programme for 2 weeks. Participants took part in a learning session during the first week and then conducted the practice session at home during the second week. Participant knowledge and compliance were evaluated through online quizzes and self-checklists. Statistical analyses (chi-square test and t-test) were performed using the Statistical Analysis System, Version 9.13. There was a significant improvement in disease severity, quality of life and mothers' self-efficacy in the experimental group; thus, the web-based education programme was effective. The web-based education programme as an advanced intervention may be useful in providing basic data for future atopic dermatitis-related studies. Moreover, the programme may serve as a nursing educational intervention tool for clinical nursing practices. © 2014 John Wiley & Sons Ltd.

Maternal mental health and social support: effect on childhood atopic and non-atopic asthma symptoms.

PubMed

Marques dos Santos, Letícia; Neves dos Santos, Darci; Rodrigues, Laura Cunha; Barreto, Maurício Lima

2012-11-01

Atopic and non-atopic asthma have distinct risk factors and immunological mechanisms, and few studies differentiate between the impacts of psychosocial factors on the prevalence of these disease phenotypes. The authors aimed to identify whether the effect of maternal mental health on prevalence of asthma symptoms differs between atopic and non-atopic children, taking into account family social support. This is a cross-sectional study of 1013 children participating in the Social Change Allergy and Asthma in Latin America project. Psychosocial data were collected through a household survey utilising Self-Reporting Questionnaire and Medical Outcome Study Social Support Scale. Socioeconomic and wheezing information was obtained through the questionnaire of the International Study of Allergy and Asthma in Childhood, and level of allergen-specific IgE was measured to identify atopy. Polytomous logistic regression was used to estimate the association between maternal mental health, social support and atopic and non-atopic wheezing. Effect modification was evaluated through stratified polytomous regression according to social support level. Maternal mental disorder had the same impact on atopic and non-atopic wheezing, even after adjusting for confounding variables. Affective, material and informational supports had protective effects on non-atopic asthma, and there is some evidence that social supports may act as a buffer for the impact of maternal mental disorder on non-atopic wheezing. Poor maternal mental health is positively associated with wheezing, independent of whether asthma is atopic or non-atopic, but perception of high levels of social support appears to buffer this relationship in non-atopic wheezers only.

Extensions to PIFCGT: Multirate output feedback and optimal disturbance suppression

NASA Technical Reports Server (NTRS)

Broussard, J. R.

1986-01-01

New control synthesis procedures for digital flight control systems were developed. The theoretical developments are the solution to the problem of optimal disturbance suppression in the presence of windshear. Control synthesis is accomplished using a linear quadratic cost function, the command generator tracker for trajectory following and the proportional-integral-filter control structure for practical implementation. Extensions are made to the optimal output feedback algorithm for computing feedback gains so that the multirate and optimal disturbance control designs are computed and compared for the advanced transport operating system (ATOPS). The performance of the designs is demonstrated by closed-loop poles, frequency domain multiinput sigma and eigenvalue plots and detailed nonlinear 6-DOF aircraft simulations in the terminal area in the presence of windshear.

Vehicle Support Posts Installation onto Mobile Launcher

NASA Image and Video Library

2017-05-25

Construction workers on the deck of the mobile launcher at NASA's Kennedy Space Center in Florida, prepare to install a vehicle support post. A total of eight support posts are being installed to support the load of the Space Launch System's (SLS) solid rocket boosters, with four posts for each of the boosters. The support posts are about five feet tall and each weigh about 10,000 pounds. The posts will structurally support the SLS rocket through T-0 and liftoff, and will drop down before vehicle liftoff to avoid contact with the flight hardware. The Ground Systems Development and Operations Program is overseeing installation of the support posts to prepare for the launch of the Orion spacecraft atop the SLS rocket.

Vehicle Support Posts Installation onto Mobile Launcher

NASA Image and Video Library

2017-05-25

At NASA's Kennedy Space Center in Florida, construction workers on the deck of the mobile launcher install the final four vehicle support posts. A total of eight support posts are being installed to support the load of the Space Launch System's (SLS) solid rocket boosters, with four posts for each of the boosters. The support posts are about five feet tall and each weigh about 10,000 pounds. The posts will structurally support the SLS rocket through T-0 and liftoff, and will drop down before vehicle liftoff to avoid contact with the flight hardware. The Ground Systems Development and Operations Program is overseeing installation of the support posts to prepare for the launch of the Orion spacecraft atop the SLS rocket.

Vehicle Support Posts Installation onto Mobile Launcher

NASA Image and Video Library

2017-05-25

At NASA's Kennedy Space Center in Florida, the final four vehicle support posts are being installed on the deck of the mobile launcher. A total of eight support posts are being installed to support the load of the Space Launch System's (SLS) solid rocket boosters, with four posts for each of the boosters. The support posts are about five feet tall and each weigh about 10,000 pounds. The posts will structurally support the SLS rocket through T-0 and liftoff, and will drop down before vehicle liftoff to avoid contact with the flight hardware. The Ground Systems Development and Operations Program is overseeing installation of the support posts to prepare for the launch of the Orion spacecraft atop the SLS rocket.

Vehicle Support Posts Installation onto Mobile Launcher

NASA Image and Video Library

2017-05-11

Construction workers on the deck of the mobile launcher at NASA's Kennedy Space Center in Florida, prepare a platform for installation of a vehicle support post. A total of eight support posts will be installed to support the load of the Space Launch System's (SLS) solid rocket boosters, with four posts for each of the boosters. The support posts are about five feet tall and each weigh about 10,000 pounds. The posts will structurally support the SLS rocket through T-0 and liftoff, and will drop down before vehicle liftoff to avoid contact with the flight hardware. The Ground Systems Development and Operations Program is overseeing installation of the support posts to prepare for the launch of the Orion spacecraft atop the SLS rocket.

Vehicle Support Posts Installation onto Mobile Launcher

NASA Image and Video Library

2017-05-11

A vehicle support post will lifted up by crane and lowered onto the deck of the mobile launcher at NASA's Kennedy Space Center in Florida. A total of eight support posts will be installed to support the load of the Space Launch System's (SLS) solid rocket boosters, with four posts for each of the boosters. The support posts are about five feet tall and each weigh about 10,000 pounds. The posts will structurally support the SLS rocket through T-0 and liftoff, and will drop down before vehicle liftoff to avoid contact with the flight hardware. The Ground Systems Development and Operations Program is overseeing installation of the support posts to prepare for the launch of the Orion spacecraft atop the SLS rocket.

Vehicle Support Posts Installation onto Mobile Launcher

NASA Image and Video Library

2017-05-11

In view are three vehicle support posts installed on the deck of the mobile launcher at NASA's Kennedy Space Center in Florida. A total of eight support posts will be installed to support the load of the Space Launch System's (SLS) solid rocket boosters, with four posts for each of the boosters. The support posts are about five feet tall and each weigh about 10,000 pounds. The posts will structurally support the SLS rocket through T-0 and liftoff, and will drop down before vehicle liftoff to avoid contact with the flight hardware. The Ground Systems Development and Operations Program is overseeing installation of the support posts to prepare for the launch of the Orion spacecraft atop the SLS rocket.

Final Flame Trench Brick Installation at Launch Pad 39B

NASA Image and Video Library

2017-05-09

A view of the north side of the flame trench at Launch Complex 39B at NASA's Kennedy Space Center in Florida. The final brick was installed in the flame trench, completing about a year's worth of work to upgrade the walls to withstand the intense heat and fire at launch of NASA's Space Launch System rocket with Orion atop. About 96,000 heat-resistant bricks, in three different sizes, were secured to the walls using bonding mortar in combination with adhesive anchors. The Ground Systems Development and Operations Program is overseeing upgrades and modifications to Pad 39B to support the launch of the SLS and Orion spacecraft for Exploration Mission-1 and NASA’s journey to Mars.

Crawler Transporter 2 (CT-2) Trek from Pad 39B to VAB

NASA Image and Video Library

2017-03-21

A full view of crawler-transporter 2 (CT-2) as it moves slowly along the crawlerway on its way back to the Vehicle Assembly Building at NASA's Kennedy Space Center in Florida. The crawler took a trip to the Pad A/B split to test upgrades recently completed that will allow the giant vehicle to handle the load of the agency's Space Launch System rocket and Orion spacecraft atop the mobile launcher. The Ground Systems Development and Operations Program oversaw upgrades to the 50-year-old CT-2. New generators, gear assemblies, jacking, equalizing and leveling (JEL) hydraulic cylinders, roller bearings and brakes were installed, and other components were upgraded to prepare for Exploration Mission 1.

KSC-2013-3689

NASA Image and Video Library

2013-08-30

CAPE CANAVERAL, Fla. – Inside the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, a tile technician works on a section of thermal protection system tiles that will be installed on the Orion crew module. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Dimitri Gerondidakis

KSC-2013-3690

NASA Image and Video Library

2013-08-30

CAPE CANAVERAL, Fla. – Inside the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, a tile technician places spacers between the thermal protection system tiles that will be installed on the Orion crew module. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Dimitri Gerondidakis

KSC-2013-3691

NASA Image and Video Library

2013-08-30

CAPE CANAVERAL, Fla. – Inside the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, two tile technicians wrap a section of the thermal protection system tiles that will be installed on the Orion crew module. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Dimitri Gerondidakis

Assessment of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Atopic Dermatitis Patients

PubMed Central

Jiang, Ying; Ma, Wencong

2017-01-01

Background To develop new strategies for identifying atopic dermatitis patients, a better understanding of the signs for chronic inflammatory status is needed. This study was designed to investigate whether neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are related to the severity of atopic dermatitis (AD) assessed by the Scoring Atopic Dermatitis (SCORAD) index. Material/Methods A retrospective study involving 80 AD patients and 45 healthy control subjects was performed. NLR, PLR, and the number of peripheral blood eosinophils were compared between AD patients and healthy controls, and correlations between these indexes and clinical characteristics were analyzed. Results NLR, PLR, and eosinophils in AD patients were all significantly higher than in healthy individuals. Among AD patients, NLR (p<0.001) and PLR (p<0.001), as contrasted with eosinophils (p=0.146), were correlated positively with SCORAD index. Additionally, an NLR level of 1.75 was determined as the predictive cut-off value of severe AD (SCORAD ≥51) (sensitivity 94.7%, specificity 58.6%, the area under the receiver-operating characteristic curve (AUROC) 0.778, p=0.001). For eosinophils, the sensitivity and specificity were 78.9% and 62.1%, respectively, and the AUROC was only 0.685 (p=0.032) in predicting high SCORAD. Conclusions NLR and PLR reflect inflammatory response and disease severity in AD patients. PMID:28306706

Orion Journey to Mars, L-2 Briefing

NASA Image and Video Library

2014-12-02

At NASA's Kennedy Space Center in Florida, NASA leaders spoke to members of the news media about how the first flight of the new Orion spacecraft is a first step in the agency's plans to send humans to Mars. At Kennedy's News Center auditorium from the left are: Mike Curie of NASA Public Affairs, Mike Bolger, program manager of Ground Systems Development and Operations Program, and Chris Crumbly, manager of Space Launch System Spacecraft/Payload Integration and Evolution. Participating via video from the agency's headquarters in Washington included Jason Crusan, director of Advanced Exploration Systems Division of Human Exploration and Operations Mission Directorate, seen on the monitor on the right. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted flight test of Orion is scheduled to launch Dec. 4, 2014 atop a United Launch Alliance Delta IV Heavy rocket, and in 2018 on NASA’s Space Launch System rocket.

GSDO PDR (Preliminary Design Review) Morning Meeting

NASA Image and Video Library

2014-03-20

CAPE CANAVERAL, Fla. – The Ground Systems Development and Operations, or GSDO, Program completed its preliminary design review which allows development of the ground systems to proceed to detailed design. Representatives from NASA, its contractor partners and experts from across the aerospace industry met in the Mission Briefing Room inside the Operations and Checkout Building at NASA’s Kennedy Space Center in Florida to conclude the initial design and technology development phase. Completion of this review has validated that the baseline architecture is sound and aligns with the agency's exploration objectives. NASA is developing the Space Launch System and Orion spacecraft to provide an entirely new capability for human exploration beyond low-Earth orbit, with the flexibility to launch spacecraft for crew and cargo missions, including to an asteroid and Mars. Orion’s first unpiloted test flight is scheduled to launch later this year atop a Delta IV rocket. A second uncrewed flight test is scheduled for fiscal year 2018 on the Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Cory Huston

Technician Shawn Warren carefully smoothes out the composite skin of an instrument fairing atop the

NASA Technical Reports Server (NTRS)

2002-01-01

Technician Shawn Warren carefully smoothes out the composite skin of an instrument fairing atop the upper fuselage of the Altair unmanned aerial vehicle (UAV) at General Atomics Aeronautical Systems, Inc., facility at Adelanto, Calif. General Atomics Aeronautical Systems, Inc., is developing the Altair version of its Predator B unmanned reconnaissance aircraft under NASA's Environmental Research Aircraft and Sensor Technology (ERAST) project. NASA plans to use the Altair as a technology demonstrator to validate a variety of command and control technologies for UAVs, as well as demonstrate the capability to perform a variety of Earth science missions. The Altair is designed to carry an 700-lb. payload of scientific instruments and imaging equipment for as long as 32 hours at up to 52,000 feet altitude. Eleven-foot extensions have been added to each wing, giving the Altair an overall wingspan of 86 feet with an aspect ratio of 23. It is powered by a 700-hp. rear-mounted TPE-331-10 turboprop engine, driving a three-blade propeller. Altair is scheduled to begin flight tests in the fourth quarter of 2002, and be acquired by NASA following successful completion of basic airworthiness tests in early 2003 for evaluation of over-the-horizon control, detect, see and avoid and other technologies required to allow UAVs to operate safely with other aircraft in the national airspace.

GSDO PDR (Preliminary Design Review) Morning Meeting

NASA Image and Video Library

2014-03-20

CAPE CANAVERAL, Fla. – Mike Bolger, program manager for the Ground Systems Development and Operations, or GSDO, Program speaks to participants during completion of the preliminary design review in the Mission Briefing Room inside the Operations and Checkout Building at NASA’s Kennedy Space Center in Florida. Representatives from NASA, its contractor partners and experts from across the aerospace industry met in the Mission Briefing Room inside the Operations and Checkout Building at NASA’s Kennedy Space Center in Florida to conclude the initial design and technology development phase. Completion of this review has validated that the baseline architecture is sound and aligns with the agency's exploration objectives. NASA is developing the Space Launch System and Orion spacecraft to provide an entirely new capability for human exploration beyond low-Earth orbit, with the flexibility to launch spacecraft for crew and cargo missions, including to an asteroid and Mars. Orion’s first unpiloted test flight is scheduled to launch later this year atop a Delta IV rocket. A second uncrewed flight test is scheduled for fiscal year 2018 on the Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Cory Huston

Atopic and Non-atopic Eczema.

PubMed

Rożalski, Michał; Rudnicka, Lidia; Samochocki, Zbigniew

2016-06-01

Atopic dermatitis is a common term used in the medical literature, but according to The Nomenclature Review Committee Of The World Allergy Organization the name which should be used is eczema. Eczema is divided into two subtypes: atopic and non-atopic. These subtypes differ in the level of total immunoglobulin E (IgE) in serum, response to allergens in skin prick tests, and detection of specific IgE antibodies. Non-atopic eczema is characterized by a low level of total IgE, negative skin prick tests, and undetectable specific IgE antibodies. It is estimated that 10-45% cases of eczema are non-atopic ones. In recent studies, other features differentiating these two subtypes have been identified, such as female predominance in non-atopic eczema. A more severe course, damage of the epidermal barrier, predominance of Th2 (T helper cells 2) response, and a lower positive reaction to metal patch tests are the characteristics of the atopic subtype. In our opinion, new diagnostic criteria taking into account the non-atopic subtype of eczema need to be established.

B s 0 lifetime measurement in the C P -odd decay channel B s 0 → J / ψ f 0 ( 980 )

DOE Office of Scientific and Technical Information (OSTI.GOV)

Abazov, V. M.; Abbott, B.; Acharya, B. S.

2016-07-01

Here, the lifetime of the Bmore » $$0\\atop{S}$$ meson is measured in the decay channel B$$0\\atop{S}$$→J/ψπ +π - with 880 ≤ M π+π- ≤ 1080 MeV/c 2, which is mainly a CP-odd state and dominated by the f 0(980) resonance. In 10.4 fb -1 of data collected with the D0 detector in Run II of the Tevatron, the lifetime of the B$$0\\atop{S}$$ meson is measured to be τ(B$$0\\atop{S}$$) = 1.70 ± 0.14(stat) ± 0.05(syst) ps. Neglecting CP violation in B$$0\\atop{S}/$$\\bar{B}$ 0 s mixing, the measurement can be translated into the width of the heavy mass eigenstate of the B$$0\\atop{S}$$, Γ H = 0.59 ± 0.05(stat) ± 0.02(syst) ps -1.« less

Atopic eczema is associated with delayed maturation of the antibody response to Pneumococcal vaccine

PubMed Central

Arkwright, P D; Patel, L; Moran, A; Haeney, M R; Ewing, C I; David, T J

2000-01-01

The aim of this study was to investigate a previously undocumented observation, that children with atopic eczema under 9 years of age tended to have a poor antibody response to Pneumococcal vaccination. Thirty-five children (mean age 8·8 years, range 3–16 years) with moderate to severe atopic eczema but no history of systemic infection were studied retrospectively. Pneumococcal antibody responses after immunization with Pneumovax II were compared with a hospital control group consisting of 36 children (mean age 6·0 years, range 3–16 years) with recurrent upper respiratory tract infections. Only 17% of children with atopic eczema aged 3–8 years responded to Pneumovax. This response was significantly poorer than that of the controls (57%) (odds ratio 0·20, 95% confidence interval (CI) 0·05–0·84, P = 0·03). There were no significant differences in the levels of total IgG2, the component of IgG associated with protective antibody responses to Pneumococcus between the two groups. Delay in maturation of the total IgG and IgG2 antibody response to Pneumococcus is a feature in this group of children with moderately severe atopic eczema. PMID:11012612

Identification of allergens by IgE-specific testing improves outcomes in atopic dermatitis.

PubMed

Will, Brett M; Severino, Richard; Johnson, Douglas W

2017-11-01

IgE quantitative assaying of allergens (IgEQAA) has long been implemented by allergists in determining patients' reactivities for allergic rhinitis and asthma, two of the three diagnoses in atopic syndrome. This test operates by measuring the patient's IgE response to different allergens and can identify potential triggers for a patient's symptoms. Despite this, IgEQAA has yet to see the same widespread use in the field of dermatology, specifically in the treatment of patients with atopic dermatitis (AD). The affected body surface area (BSA) at first presentation, IgEQAA classes, and total immunoglobulin E (IgE) concentration were taken retrospectively for 54 patients with AD. Of the 54 patients observed, 41 had an abnormally high total IgE concentration (76%). Additionally, it was observed that nine (17%) of our patients significantly improved after making lifestyle changes. Knowledge of the identified specific antigens can guide patients to make lifestyle modifications that may improve disease outcomes. IgEQAA and avoidance of allergens may help some patients with AD. © 2017 The International Society of Dermatology.

KSC-2013-3143

NASA Image and Video Library

2013-07-26

CAPE CANAVERAL, Fla. – The Orion crew module for Exploration Flight Test 1 sits inside a clean room processing cell in the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida. Orion is the exploration spacecraft designed to carry crews to space beyond low Earth orbit. It will provide emergency abort capability, sustain the crew during the space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on a Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Jim Grossmann

KSC-2013-3142

NASA Image and Video Library

2013-07-26

CAPE CANAVERAL, Fla. – The Orion crew module for Exploration Flight Test 1 sits inside a clean room processing cell in the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida. Orion is the exploration spacecraft designed to carry crews to space beyond low Earth orbit. It will provide emergency abort capability, sustain the crew during the space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on a Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Jim Grossmann

ML Crew Access Arm Move

NASA Image and Video Library

2017-10-16

The Orion crew access arm departs Precision Fabricating and Cleaning in Cocoa, Florida, atop a flatbed truck. The access arm is transported to a storage location at NASA's Kennedy Space Center in Florida. Later this month, the arm will be transported to the mobile launcher (ML) tower at the center. The crew access arm will be located at about the 274-foot level on the tower. It will rotate from its retracted position and interface with the Orion crew hatch location to provide entry to the Orion crew module. The Ground Systems Development and Operations Program is overseeing installation of umbilicals and launch accessories on the ML tower.

Cygnus Orbital ATK OA-6 Post Launch Press Conference

NASA Image and Video Library

2016-03-23

In the Press Site auditorium of NASA's Kennedy Space Center in Florida, NASA and industry leaders speak to members of the news media at a post-launch news conference following the liftoff of Orbital ATK CRS-6, a commercial resupply services mission to the International Space Station, or ISS. From left are: Kathryn Hambleton of NASA Communications; Kenneth Todd, NASA ISS Operations Integration manager; Frank Culbertson, president of Orbital ATK's Space System Group; Vern Thorp, United Space Alliance's program manager for NASA missions. The Cygnus spacecraft lifted off atop an Atlas V rocket from Space Launch Complex 41 at Cape Canaveral Air Force Station at 11:05 p.m. EDT.

Cygnus Orbital ATK OA-6 Post Launch Press Conference

NASA Image and Video Library

2016-03-23

In the Press Site auditorium of NASA's Kennedy Space Center in Florida, NASA and industry leaders speak to members of the news media at a post-launch news conference following the liftoff of Orbital ATK CRS-6, a commercial resupply services mission to the International Space Station, or ISS. From left are: Kenneth Todd, NASA ISS Operations Integration manager; Frank Culbertson, president of Orbital ATK's Space System Group; Vern Thorp, United Space Alliance's program manager for NASA missions. The Cygnus spacecraft lifted off atop an Atlas V rocket from Space Launch Complex 41 at Cape Canaveral Air Force Station at 11:05 p.m. EDT.

Interim Cryogenic Propulsion Stage (ICPS) for EM-1 Transport fro

NASA Image and Video Library

2017-04-11

The Interim Cryogenic Propulsion Stage (ICPS) for NASA's Space Launch System rocket arrives at the Delta Operations Center at Cape Canaveral Air Force Station in Florida. The ICPS was moved from the United Launch Alliance (ULA) Horizontal Integration Facility near Space Launch Complex 37 at the Cape. The ICPS is the first integrated piece of flight hardware to arrive for the SLS. It is the in-space stage that is located toward the top of the rocket, between the Launch Vehicle Stage Adapter and the Orion Spacecraft Adapter. It will provide some of the in-space propulsion during Orion's first flight test atop the SLS on Exploration Mission-1.

Does IFN-γ play a role on the pathogenesis of non-atopic asthma in Latin America children?

PubMed

Figueiredo, Camila Alexandrina; Rodrigues, Laura Cunha; Alcantara-Neves, Neuza Maria; Cooper, Philip J; Amorim, Leila Denise; Silva, Nivea Bispo; Cruz, Alvaro A; Barreto, Mauricio Lima

2012-12-19

In this work we explore differences in blood cells and cytokine profiles in children according to atopic status and asthma (atopic or non-atopic). The study involved measurement of Th1(IFN-γ) and Th2 (IL-5 and IL-13) cytokines in Dermatophagoides pteronyssinus stimulated peripheral blood leukocytes, blood cell count, skin prick test and specific IgE against common aeroallergens. Atopic status was associated with eosinophilia and production of Th2 type cytokines. Atopic asthma was associated with eosinophilia and non-atopic asthma was associated with IFN-γ and elevated monocytes in blood. IFN-γ and monocytes might play a role in immunopathology of non-atopic asthma in Latin American children.

Observation of Bs-Bsbar Oscillations Using Partially Reconstructed Hadronic Bs Decays

DOE Office of Scientific and Technical Information (OSTI.GOV)

Miles, Jeffrey Robert

2008-02-01

This thesis describes the contribution of partially reconstructed hadronic decays in the world's first observation of Bmore » $$0\\atop{s}$$-$$\\bar{B}$$$0\\atop{s}$$ oscillations. The analysis is a core member of a suite of closely related studies whose combined time-dependent measurement of the B$$0\\atop{s}$$-$$\\bar{B}$$$0\\atop{s}$$ oscillation frequency Δm s is of historic significance. Using a data sample of 1 fb -1 of p$$\\bar{p}$$ collisions at √s = 1.96 TeV collected with the CDF-II detector at the Fermilab Tevatron, they find signals of 3150 partially reconstructed hadronic B s decays from the combined decay channels B$$0\\atop{s}$$ → D*$$-\\atop{s}$$ π + and B$$0\\atop{s}$$ → D$$-\\atop{s}$$ ρ + with D$$-\\atop{s}$$ → Φπ -. These events are analyzed in parallel with 2000 fully reconstructed B$$0\\atop{s}$$ → D$$-\\atop{s}$$ π + (D$$-\\atop{s}$$ → Φπ -) decays. The treatment of the data is developed in stages of progressive complexity, using high-statistics samples of hadronic B 0and B + decays to study the attributes of partially reconstructed events. The analysis characterizes the data in mass and proper decay time, noting the potential of the partially reconstructed decays for precise measurement of B branching fractions and lifetimes, but consistently focusing on the effectiveness of the model for the oscillation measurement. They efficiently incorporate the measured quantities of each decay into a maximum likelihood fitting framework, from which they extract amplitude scans and a direct measurement of the oscillation frequency. The features of the amplitude scans are consistent with expected behavior, supporting the correctness of the calibrations for proper time uncertainty and flavor tagging dilution. The likelihood allows for the smooth combination of this analysis with results from other data samples, including 3500 fully reconstructed hadronic B s events and 61,500 partially reconstructed semileptonic B s events. The individual analyses show compelling evidence for B$$0\\atop{s}$$-$$\\bar{B}$$$0\\atop{s}$$ oscillations, and the combination yields a clear signal. The probability that random fluctuations could produce a comparable signature is 8 x 10 -8, which exceeds the 5 standard deviations threshold of significance for observation. The discovery threshold would not be achieved without inclusion of the partially reconstructed hadronic decays. They measure Δm s = 17.77 ± 0.10(stat) ± 0.07(syst) ps -1 and extract |V td/V ts| = 0.2060 ± 0.0007(exp)$$+0.0081\\atop{-0.0060}$$(theory), consistent with the Standard Model expectation.« less

Use of ustekinumab for severe refractory atopic dermatitis in a young teenager.

PubMed

Wlodek, C; Hewitt, H; Kennedy, C T

2016-08-01

When conventional systemic immunosuppressive treatments fail in the setting of severe eczema, unlike in psoriasis, there are limited treatment options and only anecdotal evidence to help guide clinicians. There is a growing body of evidence for the use of certain biologic agents for moderate to severe eczema. We report the youngest case to date successfully and safely treated with ustekinumab for severe refractory atopic dermatitis. © 2016 British Association of Dermatologists.

Measurement of the Exclusive and Inclusive Branching Fractions of $$B^{0}_{s} \\to D^{(*)+}_{s}D^{(*)-}_{s}$$ Decays at CDF and its Implications on the Decay Width Difference in the $$B^{0}_{s}-B^{-0}_{s}$$ Meson System

DOE Office of Scientific and Technical Information (OSTI.GOV)

Horn, Dominik

2011-01-01

The purpose of this thesis is threefold: Firstly, new measurements of both the exclusive and semi-inclusive partial decay widths ofmore » $$B^{0}_{s} \\to D^{(*)+}_{s}D^{(*)-}_{s}$$ meson decays are presented. Secondly, the feasibility of extracting the unknown polarization components in $$B^{0}_{s} \\to D^{(*)+}_{s}D^{(*)-}_{s}$$ by partial reconstruction of this pseudo-scalar to vector-vector decay in a Monte Carlo driven analysis scheme is studied. Finally, based on the suggestions contributed by the theory community this study discusses how a measurement of the branching fraction of semi-inclusive decays $$B^{0}_{s} \\to D^{(*)+}_{s}D^{(*)-}_{s}$$ can contribute to gain insight about the relative decay width di erence in the B$$0\\atop{s}$$--B$$0\\atop{s}$$ meson system.« less

Burden of atopic dermatitis in Japanese adults: Analysis of data from the 2013 National Health and Wellness Survey.

PubMed

Arima, Kazuhiko; Gupta, Shaloo; Gadkari, Abhijit; Hiragun, Takaaki; Kono, Takeshi; Katayama, Ichiro; Demiya, Sven; Eckert, Laurent

2018-04-01

Atopic dermatitis is a chronic inflammatory skin disease. The objective of this study was to characterize the burden of atopic dermatitis in Japanese adult patients relative to the general population. Japanese adults (≥18 years) with a self-reported diagnosis of atopic dermatitis and adult controls without atopic dermatitis/eczema/dermatitis were identified from the 2013 Japan National Health and Wellness Survey. Atopic dermatitis patients were propensity-score matched with non-atopic dermatitis controls (1:2 ratio) on demographic variables. Patient-reported outcome data on comorbidities, mood and sleep disorders, health-related quality of life, work productivity and activity impairment, and health-care resource utilization were analyzed in atopic dermatitis patients and matched controls. A total of 638 Japanese adult patients with atopic dermatitis were identified, of whom 290 (45.5%) rated their disease as "moderate/severe" and 348 (54.5%) as "mild". The analysis cohort comprised 634 atopic dermatitis patients and 1268 matched controls. Atopic dermatitis patients reported a significantly higher prevalence of arthritis, asthma, nasal allergies/hay fever, anxiety, depression and sleep disorders compared with controls (all P < 0.001). Atopic dermatitis patients also reported a significantly poorer health-related quality of life, higher overall work and activity impairment, and higher health-care resource utilization (all P < 0.001). Self-rated disease severity was not associated with disease burden, except for a significantly higher overall work and activity impairment. In conclusion, Japanese adult patients with atopic dermatitis reported a substantial disease burden relative to adults without atopic dermatitis, suggesting an unmet need for effective strategies targeting disease management. © 2018 The Authors. The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association.

Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma.

PubMed

Montuschi, Paolo; Mondino, Chiara; Koch, Pierluigi; Barnes, Peter J; Ciabattoni, Giovanni

2006-08-01

Leukotriene (LT) E(4) and 8-isoprostane concentrations are elevated in exhaled breath condensate in children with asthma. The effects of leukotriene receptor antagonists (LTRAs) on exhaled leukotriene and prostanoids in children with asthma are unknown. (1) To study the effect of montelukast, a LTRA, on exhaled LTE(4), 8-isoprostane, and prostaglandin E(2) in children with asthma and atopic children; (2) to measure exhaled nitric oxide. An open-label study with oral montelukast (5 mg once daily for 4 weeks) was undertaken in 17 atopic children with asthma and 16 atopic children without asthma. Pretreatment exhaled LTE(4) (P < .0001) and 8-isoprostane (P < .0001) values were higher in atopic children with asthma than in atopic children without asthma. In atopic children with asthma, montelukast reduced exhaled LTE(4) by 33% (P < .001), and this reduction was correlated with pretreatment LTE(4) values (r = -0.90; P = .0001). Posttreatment exhaled LTE(4) levels in children with asthma were higher than pretreatment LTE(4) values in atopic children without asthma (P < .004). Montelukast had no effect on exhaled LTE(4) in atopic children without asthma (P = .74), or on exhaled 8-isoprostane (atopic children with asthma, P = .94; atopic children without asthma, P = .55) and PGE(2) (atopic children with asthma, P = .56; atopic children without asthma, P = .93) in both groups. In atopic children with asthma, exhaled nitric oxide concentrations were reduced by 27% (P < .05) after montelukast. Leukotriene receptor antagonists decrease exhaled LTE(4) in atopic children with asthma. This reduction is dependent on baseline exhaled LTE(4) values. Measurement of exhaled LTE(4) might help identify children with asthma most likely to benefit from LTRAs.

KSC-2013-2884

NASA Image and Video Library

2013-06-20

CAPE CANAVERAL, Fla. – Representatives from the European Space Agency, or ESA, toured the Operations and Checkout Building high bay and viewed the Orion crew module at NASA’s Kennedy Space Center in Florida. Among the group were Nico Dettman, ESA Space Transportation Department director Bernardo Patti, ESA International Space Station Operations manager and Philippe Deloo, ESA European Service Module Study manager. Orion is the exploration spacecraft designed to carry crews to space beyond low Earth orbit. It will provide emergency abort capability, sustain the crew during the space travel and provide safe re-entry from deep space return velocities. Orion’s first unpiloted test flight is scheduled to launch in 2014 atop a Delta IV rocket. A second uncrewed flight test is scheduled for 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Jim Grossmann

KSC-2013-4418

NASA Image and Video Library

2013-12-13

CAPE CANAVERAL, Fla. – The United Launch Alliance Centaur second stage that will help boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit is being transported from the hangar at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station to Launch Complex 41. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Charisse Nahser

KSC-2013-3791

NASA Image and Video Library

2013-11-01

CAPE CANAVERAL, Fla. – The United Launch Alliance Atlas V launch vehicle that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit arrives at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station for checkout in preparation for launch. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/ Jim Grossman

KSC-2013-4389

NASA Image and Video Library

2013-12-12

CAPE CANAVERAL, Fla. – The United Launch Alliance Atlas V first stage booster that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit is being transported from the hangar at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station to Launch Complex 41. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Kim Shiflett

KSC-2013-3793

NASA Image and Video Library

2013-11-01

CAPE CANAVERAL, Fla. – The United Launch Alliance Atlas V launch vehicle that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit arrives at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station for checkout in preparation for launch. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/ Jim Grossman

KSC-2013-4417

NASA Image and Video Library

2013-12-13

CAPE CANAVERAL, Fla. – The United Launch Alliance Centaur second stage that will help boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit is being transported from the hangar at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station to Launch Complex 41. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Charisse Nahser

KSC-2013-3789

NASA Image and Video Library

2013-11-01

CAPE CANAVERAL, Fla. – The United Launch Alliance Centaur upper stage that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit is being transported to the hangar at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station for checkout in preparation for launch. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/ Jim Grossman

KSC-2013-3794

NASA Image and Video Library

2013-11-01

CAPE CANAVERAL, Fla. – The United Launch Alliance Atlas V launch vehicle that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit arrives at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station for checkout in preparation for launch. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/ Jim Grossman

KSC-2013-4393

NASA Image and Video Library

2013-12-12

CAPE CANAVERAL, Fla. – The United Launch Alliance Atlas V first stage booster that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit is being transported from the hangar at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station to Launch Complex 41. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Kim Shiflett

KSC-2013-3784

NASA Image and Video Library

2013-11-01

CAPE CANAVERAL, Fla. – The United Launch Alliance Atlas V launch vehicle that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit is being transported to the hangar at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station for checkout in preparation for launch. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/ Jim Grossman

KSC-2013-4392

NASA Image and Video Library

2013-12-12

CAPE CANAVERAL, Fla. – The United Launch Alliance Atlas V first stage booster that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit is being transported from the hangar at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station to Launch Complex 41. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Kim Shiflett

KSC-2013-3788

NASA Image and Video Library

2013-11-01

CAPE CANAVERAL, Fla. – The United Launch Alliance Atlas V launch vehicle that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit is being transported to the hangar at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station for checkout in preparation for launch. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/ Jim Grossman

KSC-2013-4419

NASA Image and Video Library

2013-12-13

CAPE CANAVERAL, Fla. – The United Launch Alliance Centaur second stage that will help boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit is being transported from the hangar at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station to Launch Complex 41. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Charisse Nahser

KSC-2013-3787

NASA Image and Video Library

2013-11-01

CAPE CANAVERAL, Fla. – The United Launch Alliance Atlas V launch vehicle that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit is being transported to the hangar at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station for checkout in preparation for launch. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/ Jim Grossman

KSC-2013-4390

NASA Image and Video Library

2013-12-12

CAPE CANAVERAL, Fla. – The United Launch Alliance Atlas V first stage booster that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit is being prepared for transport from the hangar at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station to Launch Complex 41. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Kim Shiflett

KSC-2013-3785

NASA Image and Video Library

2013-11-01

CAPE CANAVERAL, Fla. – The United Launch Alliance Atlas V launch vehicle that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit is being transported to the hangar at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station for checkout in preparation for launch. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/ Jim Grossman

KSC-2013-4391

NASA Image and Video Library

2013-12-12

CAPE CANAVERAL, Fla. – The United Launch Alliance Atlas V first stage booster that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit is being transported from the hangar at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station to Launch Complex 41. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Kim Shiflett

KSC-2013-2342

NASA Image and Video Library

2013-05-13

CAPE CANAVERAL, Fla. -- At NASA’s Kennedy Space Center in Florida, workers move the Orion ground test vehicle, or GTA, into the Launch Equipment Test Facility, or LETF, from the Operations and Checkout Building. At the LETF, Lockheed Martin will put the GTA through a series of pyrotechnic bolt tests. The ground test vehicle is being used for path finding operations in the O&C, including simulated manufacturing and assembly procedures. Launching atop NASA's heavy-lift Space Launch System SLS, which also is under development, the Orion Multi-Purpose Crew Vehicle MPCV will serve as the exploration vehicle that will carry astronaut crews beyond low Earth orbit. It also will provide emergency abort capabilities, sustain the crew during space travel and provide safe re-entry from deep space return velocities. For more information, visit www.nasa.gov/orion. Photo credit: Jim Grossman

KSC-2013-2340

NASA Image and Video Library

2013-05-13

CAPE CANAVERAL, Fla. -- At NASA’s Kennedy Space Center in Florida, workers prepare to move the Orion ground test vehicle, or GTA, from the Operations and Checkout Building to the Launch Equipment Test Facility, or LETF. At the LETF, Lockheed Martin will put the GTA through a series of pyrotechnic bolt tests. The ground test vehicle is being used for path finding operations in the O&C, including simulated manufacturing and assembly procedures. Launching atop NASA's heavy-lift Space Launch System SLS, which also is under development, the Orion Multi-Purpose Crew Vehicle MPCV will serve as the exploration vehicle that will carry astronaut crews beyond low Earth orbit. It also will provide emergency abort capabilities, sustain the crew during space travel and provide safe re-entry from deep space return velocities. For more information, visit www.nasa.gov/orion. Photo credit: Jim Grossman

KSC-2013-2341

NASA Image and Video Library

2013-05-13

CAPE CANAVERAL, Fla. -- At NASA’s Kennedy Space Center in Florida, workers move the Orion ground test vehicle, or GTA, from the Operations and Checkout Building to the Launch Equipment Test Facility, or LETF. At the LETF, Lockheed Martin will put the GTA through a series of pyrotechnic bolt tests. The ground test vehicle is being used for path finding operations in the O&C, including simulated manufacturing and assembly procedures. Launching atop NASA's heavy-lift Space Launch System SLS, which also is under development, the Orion Multi-Purpose Crew Vehicle MPCV will serve as the exploration vehicle that will carry astronaut crews beyond low Earth orbit. It also will provide emergency abort capabilities, sustain the crew during space travel and provide safe re-entry from deep space return velocities. For more information, visit www.nasa.gov/orion. Photo credit: Jim Grossman

KSC-2013-2343

NASA Image and Video Library

2013-05-13

CAPE CANAVERAL, Fla. -- At NASA’s Kennedy Space Center in Florida, workers move the Orion ground test vehicle, or GTA, into the Launch Equipment Test Facility, or LETF, from the Operations and Checkout Building. At the LETF, Lockheed Martin will put the GTA through a series of pyrotechnic bolt tests. The ground test vehicle is being used for path finding operations in the O&C, including simulated manufacturing and assembly procedures. Launching atop NASA's heavy-lift Space Launch System SLS, which also is under development, the Orion Multi-Purpose Crew Vehicle MPCV will serve as the exploration vehicle that will carry astronaut crews beyond low Earth orbit. It also will provide emergency abort capabilities, sustain the crew during space travel and provide safe re-entry from deep space return velocities. For more information, visit www.nasa.gov/orion. Photo credit: Jim Grossman

Any benefits of probiotics in allergic disorders?

PubMed

Ozdemir, Oner

2010-01-01

Development of the child's immune system tends to be directed toward a T-helper 2 (Th2) phenotype in infants. To prevent development of childhood allergic/atopic diseases, immature Th2-dominant neonatal responses must undergo environment-driven maturation via microbial contact in the early postnatal period. Lactic acid bacteria and bifidobacteria are found more commonly in the composition of the intestinal flora of nonallergic children. Epidemiological data also showed that atopic children have a different intestinal flora from healthy children. Probiotics are ingested live health-promoting microbes that can modify intestinal microbial populations in a way that benefits the host; and enhanced presence of probiotic bacteria in the intestinal microbiota is found to correlate with protection against atopy. There is insufficient but very promising evidence to recommend the addition of probiotics to foods for prevention and treatment of allergic diseases, especially atopic dermatitis. Clinical improvement especially in allergic rhinitis and IgE-sensitized (atopic) eczema has been reported too. Literature data for food allergy/hypersensitivity and asthma are not adequate for this guaranteed conclusion; however, clinical benefit of probiotic therapy depends on numerous factors, such as type of bacterium, dosing regimen, delivery method, and other underlying host factors, e.g., the age and diet of the host. The selection of the most beneficial probiotic strain, the dose, and the timing of supplementation still need to be determined. Accordingly, probiotics can not be recommended generally for primary prevention of atopic disease; and if probiotics are used in atopic infants/children for any reason, such as therapy or prevention, cautionary approach ought to be taken.

URT-3 At Sea Recovery Operation with Bolden

NASA Image and Video Library

2014-09-15

The Orion boilerplate test vehicle is in the water-filled well deck of the USS Anchorage during the first day of Underway Recovery Test 3 in the Pacific Ocean. NASA, Lockheed Martin and U.S. Navy personnel are conducting the recovery test to prepare for recovery of the Orion crew module on its return from a deep space mission. The test allows the teams to demonstrate and evaluate the recovery processes, procedures, hardware and personnel in open waters. The Ground Systems Development and Operations Program is conducting the underway recovery tests. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a United Launch Alliance Delta IV Heavy rocket and in 2018 on NASA’s Space Launch System rocket.

URT-3 At Sea Recovery Operation with Bolden

NASA Image and Video Library

2014-09-15

Underway Recovery Test team members help secure the Orion boilerplate test vehicle in the well deck of the USS Anchorage during the first day of Underway Recovery Test 3 in the Pacific Ocean. NASA, Lockheed Martin and U.S. Navy personnel are conducting the recovery test to prepare for recovery of the Orion crew module on its return from a deep space mission. The test allows the teams to demonstrate and evaluate the recovery processes, procedures, hardware and personnel in open waters. The Ground Systems Development and Operations Program is conducting the underway recovery tests. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a United Launch Alliance Delta IV Heavy rocket and in 2018 on NASA’s Space Launch System rocket.

URT-3 At Sea Recovery Operation with Bolden

NASA Image and Video Library

2014-09-15

The Orion boilerplate test vehicle is secured in the well deck of the USS Anchorage during the first day of Underway Recovery Test 3 in the Pacific Ocean. NASA, Lockheed Martin and U.S. Navy personnel are conducting the recovery test to prepare for recovery of the Orion crew module on its return from a deep space mission. The test allows the teams to demonstrate and evaluate the recovery processes, procedures, hardware and personnel in open waters. The Ground Systems Development and Operations Program is conducting the underway recovery tests. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a United Launch Alliance Delta IV Heavy rocket and in 2018 on NASA’s Space Launch System rocket.

KSC-2009-1563

NASA Image and Video Library

2009-02-12

CAPE CANAVERAL, Fla. – A lightning mast remains to be lifted atop the third and final lightning tower erected on Launch Pad 39B at NASA's Kennedy Space Center. Three towers surround the pad. The new lightning protection system is being built for the Constellation Program and Ares/Orion launches. Each of the towers is 500 feet tall with an additional 100-foot fiberglass mast atop supporting a wire catenary system. This improved lightning protection system allows for the taller height of the Ares I rocket compared to the space shuttle. Pad 39B will be the site of the first Ares vehicle launch, including the Ares I-X test flight that is targeted for July 2009. Photo credit: NASA/Jack Pfaller

Search for top squark pair production in compressed-mass-spectrum scenarios in proton–proton collisions at s = 8  TeV using the α T variable

DOE PAGES

Khachatryan, V.; Sirunyan, A. M.; Tumasyan, A.; ...

2017-02-10

An inclusive search is performed for supersymmetry in final states containing jets and an apparent imbalance in transverse momentum,more » $$→\\atop{p}$$ $$miss\\atop{T}$$, due to the production of unobserved weakly interacting particles in pp collisions at a centre-of-mass energy of 8 TeV. The data, recorded with the CMS detector at the CERN LHC, correspond to an integrated luminosity of 18.5 fb $-$1 . The dimensionless kinematic variable α T is used to discriminate between events with genuine $$→\\atop{p}$$ $$miss\\atop{T}$$ associated with unobserved particles and spurious values of $$→\\atop{p}$$ $$miss\\atop{T}$$ arising from jet energy mismeasurements. No excess of event yields above the expected standard model backgrounds is observed. The results are interpreted in terms of constraints on the parameter space of several simplified models of supersymmetry that assume the pair production of top squarks. The search provides sensitivity to a broad range of top squark ($$\\sim\\atop{t}$$) decay modes, including the two-body decay $$\\sim\\atop{t}$$→c$$\\sim\\atop{\\chi}$$$0\\atop{1}$$ , where c is a charm quark and$$\\sim\\atop{\\chi}$$$0\\atop{1}$$ is the lightest neutralino, as well as the four-body decay $$\\sim\\atop{t}$$→bf$$\\bar{f}$$'χ$$\\sim\\atop{\\chi}$$$0\\atop{1}$$ , where b is a bottom quark and f and$$\\bar{f}$$' are fermions produced in the decay of an intermediate off-shell W boson. Furthermore, these modes dominate in scenarios in which the top squark and lightest neutralino are nearly degenerate in mass. For these modes, top squarks with masses as large as 260 and 225 GeV are excluded, respectively, for the two- and four-body decays.« less

Search for top squark pair production in compressed-mass-spectrum scenarios in proton–proton collisions at s = 8  TeV using the α T variable

DOE Office of Scientific and Technical Information (OSTI.GOV)

Khachatryan, V.; Sirunyan, A. M.; Tumasyan, A.

An inclusive search is performed for supersymmetry in final states containing jets and an apparent imbalance in transverse momentum,more » $$→\\atop{p}$$ $$miss\\atop{T}$$, due to the production of unobserved weakly interacting particles in pp collisions at a centre-of-mass energy of 8 TeV. The data, recorded with the CMS detector at the CERN LHC, correspond to an integrated luminosity of 18.5 fb $-$1 . The dimensionless kinematic variable α T is used to discriminate between events with genuine $$→\\atop{p}$$ $$miss\\atop{T}$$ associated with unobserved particles and spurious values of $$→\\atop{p}$$ $$miss\\atop{T}$$ arising from jet energy mismeasurements. No excess of event yields above the expected standard model backgrounds is observed. The results are interpreted in terms of constraints on the parameter space of several simplified models of supersymmetry that assume the pair production of top squarks. The search provides sensitivity to a broad range of top squark ($$\\sim\\atop{t}$$) decay modes, including the two-body decay $$\\sim\\atop{t}$$→c$$\\sim\\atop{\\chi}$$$0\\atop{1}$$ , where c is a charm quark and$$\\sim\\atop{\\chi}$$$0\\atop{1}$$ is the lightest neutralino, as well as the four-body decay $$\\sim\\atop{t}$$→bf$$\\bar{f}$$'χ$$\\sim\\atop{\\chi}$$$0\\atop{1}$$ , where b is a bottom quark and f and$$\\bar{f}$$' are fermions produced in the decay of an intermediate off-shell W boson. Furthermore, these modes dominate in scenarios in which the top squark and lightest neutralino are nearly degenerate in mass. For these modes, top squarks with masses as large as 260 and 225 GeV are excluded, respectively, for the two- and four-body decays.« less

Total and Toxocara canis larval excretory/secretory antigen- and allergen-specific IgE in atopic and non-atopic dogs.

PubMed

Zwickl, Lena L M N; Joekel, Deborah E; Fischer, Nina M; Rostaher, Ana; Thamsborg, Kristian; Deplazes, Peter; Favrot, Claude

2018-06-01

Total IgE concentrations are higher in dogs than in humans. Persistent Toxocara canis larval infection is prevalent in dogs and is associated with substantial specific antibody reactions. A correlation, however, between total IgE and T. canis-specific antibody levels in dogs has not been evaluated. To determine the relationship between total IgE, T. canis-specific IgG and IgE, and allergen-specific IgE levels in atopic and non-atopic dogs, and to evaluate possible confounding factors. Sera of 30 atopic and 30 non-atopic client-owned dogs. Total IgE, T. canis-specific antibody and allergen-specific IgE levels were evaluated by ELISA. Total IgE, T. canis-specific antibody and allergen-specific IgE levels were significantly higher in non-atopic compared to atopic dogs. A positive correlation was demonstrated between T. canis-specific IgG and T. canis-specific IgE; T. canis-specific IgG and total IgE; T. canis-specific IgE and total IgE; and allergen-specific IgE and total IgE. No differences were detected on the basis of age, gender, vaccination status; deworming or season between atopic and non-atopic dogs. Previous immunomodulatory treatment and cause of atopy did not influence antibody levels of atopic dogs. Toxocara canis-specific IgE appears to be a major component of total IgE in dogs. Total and T. canis-specific IgE levels are higher in non-atopic compared to atopic dogs. It is speculated that T. canis infection may have a protective effect against the development of canine atopic dermatitis and/or that elevations in total serum IgE level are often not associated with atopic dermatitis. © 2018 ESVD and ACVD.

Orion Journey to Mars, L-2 Briefing

NASA Image and Video Library

2014-12-02

At NASA's Kennedy Space Center in Florida, Mike Bolger, program manager of Ground Systems Development and Operations Program, and Chris Crumbly, manager of Space Launch System Spacecraft/Payload Integration and Evolution, were among several agency leaders who spoke to members of the news media about how the first fight of the new Orion spacecraft is a first step in NASA's plans to send humans to Mars. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted flight test of Orion is scheduled to launch Dec. 4, 2014 atop a United Launch Alliance Delta IV Heavy rocket, and in 2018 on NASA’s Space Launch System rocket.

Comparing high altitude treatment with current best care in Dutch children with moderate to severe atopic dermatitis (and asthma): study protocol for a pragmatic randomized controlled trial (DAVOS trial).

PubMed

Fieten, Karin B; Zijlstra, Wieneke T; van Os-Medendorp, Harmieke; Meijer, Yolanda; Venema, Monica Uniken; Rijssenbeek-Nouwens, Lous; l'Hoir, Monique P; Bruijnzeel-Koomen, Carla A; Pasmans, Suzanne G M A

2014-03-26

About 10 to 20% of children in West European countries have atopic dermatitis (AD), often as part of the atopic syndrome. The full atopic syndrome also consists of allergic asthma, allergic rhinitis and food allergy. Treatment approaches for atopic dermatitis and asthma include intermittent anti-inflammatory therapy with corticosteroids, health education and self-management training. However, symptoms persist in a subgroup of patients. Several observational studies have shown significant improvement in clinical symptoms in children and adults with atopic dermatitis or asthma after treatment at high altitude, but evidence on the efficacy when compared to treatment at sea level is still lacking. This study is a pragmatic randomized controlled trial for children with moderate to severe AD within the atopic syndrome. Patients are eligible for enrolment in the study if they are: diagnosed with moderate to severe AD within the atopic syndrome, aged between 8 and 18 years, fluent in the Dutch language, have internet access at home, able to use the digital patient system Digital Eczema Center Utrecht (DECU), willing and able to stay in Davos for a six week treatment period. All data are collected at the Wilhelmina Children's Hospital and DECU. Patients are randomized over two groups. The first group receives multidisciplinary inpatient treatment during six weeks at the Dutch Asthma Center in Davos, Switzerland. The second group receives multidisciplinary treatment during six weeks at the outpatient clinic of the Wilhelmina Children's Hospital, Utrecht, the Netherlands. The trial is not conducted as a blind trial. The trial is designed with three components: psychosocial, clinical and translational. Primary outcomes are coping with itch, quality of life and disease activity. Secondary outcomes include asthma control, medication use, parental quality of life, social and emotional wellbeing of the child and translational parameters. The results of this trial will provide evidence for the efficacy of high altitude treatment compared to treatment at sea level for children with moderate to severe AD. Current Controlled Trials ISRCTN88136485.

Herpesviruses and the microbiome.

PubMed

Dreyfus, David H

2013-12-01

The focus of this article will be to examine the role of common herpesviruses as a component of the microbiome of atopic patients and to review clinical observations suggesting that atopic patients might be predisposed to more severe and atypical herpes-related illness because their immune response is biased toward a TH2 cytokine profile. Human populations are infected with 8 herpesviruses, including herpes simplex virus HSV1 and HSV2 (also termed HHV1 and HHV2), varicella zoster virus (VZV or HHV3), EBV (HHV4), cytomegalovirus (HHV5), HHV6, HHV7, and Kaposi sarcoma-associated herpesvirus (termed KSV or HHV8). Herpesviruses are highly adapted to lifelong infection of their human hosts and thus can be considered a component of the human "microbiome" in addition to their role in illness triggered by primary infection. HSV1 and HSV2 infection and reactivation can present with more severe cutaneous symptoms termed eczema herpeticum in the atopic population, similar to the more severe eczema vaccinatum, and drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) is associated with reactivation of HSV6 and possibly other herpesviruses in both atopic and nonatopic patients. In this review evidence is reviewed that primary infection with herpesviruses may have an atypical presentation in the atopic patient and conversely that childhood infection might alter the atopic phenotype. Reactivation of latent herpesviruses can directly alter host cytokine profiles through viral expression of cytokine-like proteins, such as IL-10 (EBV) or IL-6 (cytomegalovirus and HHV8), viral encoded and secreted siRNA and microRNAs, and modulation of expression of host transcription pathways, such as nuclear factor κB. Physicians caring for allergic and atopic populations should be aware of common and uncommon presentations of herpes-related disease in atopic patients to provide accurate diagnosis and avoid unnecessary laboratory testing or incorrect diagnosis of other conditions, such as drug allergy or autoimmune disease. Antiviral therapy and vaccines should be administered promptly when indicated clinically. Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Comparing high altitude treatment with current best care in Dutch children with moderate to severe atopic dermatitis (and asthma): study protocol for a pragmatic randomized controlled trial (DAVOS trial)

PubMed Central

2014-01-01

Background About 10 to 20% of children in West European countries have atopic dermatitis (AD), often as part of the atopic syndrome. The full atopic syndrome also consists of allergic asthma, allergic rhinitis and food allergy. Treatment approaches for atopic dermatitis and asthma include intermittent anti-inflammatory therapy with corticosteroids, health education and self-management training. However, symptoms persist in a subgroup of patients. Several observational studies have shown significant improvement in clinical symptoms in children and adults with atopic dermatitis or asthma after treatment at high altitude, but evidence on the efficacy when compared to treatment at sea level is still lacking. Methods/Design This study is a pragmatic randomized controlled trial for children with moderate to severe AD within the atopic syndrome. Patients are eligible for enrolment in the study if they are: diagnosed with moderate to severe AD within the atopic syndrome, aged between 8 and 18 years, fluent in the Dutch language, have internet access at home, able to use the digital patient system Digital Eczema Center Utrecht (DECU), willing and able to stay in Davos for a six week treatment period. All data are collected at the Wilhelmina Children’s Hospital and DECU. Patients are randomized over two groups. The first group receives multidisciplinary inpatient treatment during six weeks at the Dutch Asthma Center in Davos, Switzerland. The second group receives multidisciplinary treatment during six weeks at the outpatient clinic of the Wilhelmina Children’s Hospital, Utrecht, the Netherlands. The trial is not conducted as a blind trial. The trial is designed with three components: psychosocial, clinical and translational. Primary outcomes are coping with itch, quality of life and disease activity. Secondary outcomes include asthma control, medication use, parental quality of life, social and emotional wellbeing of the child and translational parameters. Discussion The results of this trial will provide evidence for the efficacy of high altitude treatment compared to treatment at sea level for children with moderate to severe AD. Trial Registration Current Controlled Trials ISRCTN88136485. PMID:24670079

Skewness and kurtosis of net baryon-number distributions at small values of the baryon chemical potential

DOE PAGES

Bazavov, A.; Ding, H. -T.; Hegde, P.; ...

2017-10-27

In this paper, we present results for the ratios of mean (M B), variance (σmore » $$2\\atop{B}$$), skewness (S B) and kurtosis (κ B) of net baryon-number fluctuations obtained in lattice QCD calculations with physical values of light and strange quark masses. Using next-to-leading order Taylor expansions in baryon chemical potential we find that qualitative features of these ratios closely resemble the corresponding experimentally measured cumulants ratios of net proton-number fluctuations for beam energies down to √sNN ≥ 19.6 GeV. We show that the difference in cumulant ratios for the mean net baryon-number, M B/σ$$2\\atop{B}$$ = χ$$B\\atop{1}$$ (T, µ B)/χ$$B\\atop{2}$$ (T, µ B) and the normalized skewness, S Bσ B = χ$$B\\atop{3}$$ (T, µB)/χ2 (T, µB ), nat-urally arises in QCD thermodynamics. Moreover, we establish a close relation between skewness and kurtosis ratios, S Bσ$$B\\atop{3}$$/M B = χ$$B\\atop{3}$$ (T, µ B)/χ$$B\\atop{1}$$ (T,µ B) and κ Bσ$$2\\atop{B}$$ = χ$$B\\atop{4}$$ (T,μ B)/χ$$B\\atop{2}$$ (T,μ B), valid at small values of the baryon chemical potential.« less

Skewness and kurtosis of net baryon-number distributions at small values of the baryon chemical potential

DOE Office of Scientific and Technical Information (OSTI.GOV)

Bazavov, A.; Ding, H. -T.; Hegde, P.

In this paper, we present results for the ratios of mean (M B), variance (σmore » $$2\\atop{B}$$), skewness (S B) and kurtosis (κ B) of net baryon-number fluctuations obtained in lattice QCD calculations with physical values of light and strange quark masses. Using next-to-leading order Taylor expansions in baryon chemical potential we find that qualitative features of these ratios closely resemble the corresponding experimentally measured cumulants ratios of net proton-number fluctuations for beam energies down to √sNN ≥ 19.6 GeV. We show that the difference in cumulant ratios for the mean net baryon-number, M B/σ$$2\\atop{B}$$ = χ$$B\\atop{1}$$ (T, µ B)/χ$$B\\atop{2}$$ (T, µ B) and the normalized skewness, S Bσ B = χ$$B\\atop{3}$$ (T, µB)/χ2 (T, µB ), nat-urally arises in QCD thermodynamics. Moreover, we establish a close relation between skewness and kurtosis ratios, S Bσ$$B\\atop{3}$$/M B = χ$$B\\atop{3}$$ (T, µ B)/χ$$B\\atop{1}$$ (T,µ B) and κ Bσ$$2\\atop{B}$$ = χ$$B\\atop{4}$$ (T,μ B)/χ$$B\\atop{2}$$ (T,μ B), valid at small values of the baryon chemical potential.« less

TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries.

PubMed

Gerbens, Louise A A; Boyce, Aaron E; Wall, Dmitri; Barbarot, Sebastien; de Booij, Richard J; Deleuran, Mette; Middelkamp-Hup, Maritza A; Roberts, Amanda; Vestergaard, Christian; Weidinger, Stephan; Apfelbacher, Christian J; Irvine, Alan D; Schmitt, Jochen; Williamson, Paula R; Spuls, Phyllis I; Flohr, Carsten

2017-02-27

Patients with moderate-to-severe atopic eczema (AE) often require photo- or systemic immunomodulatory therapies to induce disease remission and maintain long-term control. The current evidence to guide clinical management is small, despite the frequent and often off-label use of these treatments. Registries of patients on photo- and systemic immunomodulatory therapies could fill this gap, and the collection of a core set concerning these therapies in AE will allow direct comparisons across registries as well as data sharing and pooling. Using an eDelphi approach, the international TREatment of ATopic eczema (TREAT) Registry Taskforce aims to seek consensus between key stakeholders internationally on a core set of domains and domain items for AE patient registries with a research focus that collect data of children and adults on photo- and systemic immunomodulatory therapies. Participants from six stakeholder groups will be invited: doctors, nurses, non-clinical researchers, patients, as well as industry and regulatory body representatives. The eDelphi will comprise three sequential online rounds, requesting participants to rate the importance of each proposed domain and domain items. Participants will be able to add domains and domain items to the proposed list in round 1. A final consensus meeting will be held with representatives of each stakeholder group. Identifying a uniform core set of domains and domain items to be captured by AE patient registries will increase the utility of individual registries, and provide greater insight into the effectiveness, safety and cost-effectiveness of photo- and systemic immunomodulatory therapies to guide clinical management across dermatology centres and country borders. Not applicable. This eDelphi study was registered in the Core Outcome Measures for Effectiveness Trials (COMET) database.

Electro-optical interfacial effects on a graphene/π-conjugated organic semiconductor hybrid system

PubMed Central

Araujo, Karolline A S; Cury, Luiz A; Matos, Matheus J S; Fernandes, Thales F D; Cançado, Luiz G

2018-01-01

The influence of graphene and retinoic acid (RA) – a π-conjugated organic semiconductor – interface on their hybrid system is investigated. The physical properties of the interface are assessed via scanning probe microscopy, optical spectroscopy (photoluminescence and Raman) and ab initio calculations. The graphene/RA interaction induces the formation of a well-organized π-conjugated self-assembled monolayer (SAM) at the interface. Such structural organization leads to the high optical emission efficiency of the RA SAM, even at room temperature. Additionally, photo-assisted electrical force microscopy, photo-assisted scanning Kelvin probe microscopy and Raman spectroscopy indicate a RA-induced graphene doping and photo-charge generation. Finally, the optical excitation of the RA monolayer generates surface potential changes on the hybrid system. In summary, interface-induced organized structures atop 2D materials may have an important impact on both design and operation of π-conjugated nanomaterial-based hybrid systems. PMID:29600157

Temporal Regulation by Innate Type 2 Cytokines in Food Allergies.

PubMed

Graham, Michelle T; Andorf, Sandra; Spergel, Jonathan M; Chatila, Talal A; Nadeau, Kari C

2016-10-01

Food allergies (FAs) are a growing epidemic in western countries with poorly defined etiology. Defined as an adverse immune response to common food allergens, FAs present heterogeneously as a single- or multi-organ response that ranges in severity from localized hives and angioedema to systemic anaphylaxis. Current research focusing on epithelial-derived cytokines contends that temporal regulation by these factors impact initial sensitization and persistence of FA responses upon repeated food allergen exposure. Mechanistic understanding of FA draws insight from a myriad of atopic conditions studied in humans and modeled in mice. In this review, we will highlight how epithelial-derived cytokines initiate and then potentiate FAs. We will also review existing evidence of the contribution of other atopic diseases to FA pathogenesis and whether FA symptoms overlap with other atopic diseases.

[Peripheral blood cells luminol-dependent chemiluminescence at the different stages of atopic dermatitis].

PubMed

Elistratova, I V; Morozov, S G; Zakharova, I A; Tarasova, M V

2015-01-01

Aim of this work was to record the luminol-dependent spontaneous and induced chemiluminescence at the different stages of atopic dermatitis. Peripheral blood cells were obtained from adult patient with atopic dermatitis followed by the registration of luminol-dependent chemiluminescence on luminograph. Opsonized zymosan as well as yeasts Candida tropicalis have been used to induce the chemiluminescence. Spontaneous and induced chemiluminescence were slightly elevated at the mild atopic dermatitis but were decreased at the severe stage of disease. Statistically significant difference has been found between group with mild and severe atopic dermatitis, Skin contamination by yeasts Candida tropicalis causes the increased level of blood cells chemiluminescence at the first week of atopic relapse when the disease was mild. Severe stage of atopic dermatitis was coupled with statistically significant inhibition of both, spontaneous and induced chemiluminescence. Luminol-dependent chemiluminescence of peripheral blood cells from adult atopic dermatitis patients may be stimulated at the mild stage and suppressed at severe stage of atopic dermatitis.

GUIDELINES OF CARE FOR THE MANAGEMENT OF ATOPIC DERMATITIS

PubMed Central

Sidbury, Robert; Davis, Dawn M.; Cohen, David E.; Cordoro, Kelly M.; Berger, Timothy G.; Bergman, James N.; Chamlin, Sarah L.; Cooper, Kevin D.; Feldman, Steven R.; Hanifin, Jon M.; Krol, Alfons; Margolis, David J.; Paller, Amy S.; Schwarzenberger, Kathryn; Silverman, Robert A.; Simpson, Eric L.; Tom, Wynnis L.; Williams, Hywel C.; Elmets, Craig A.; Block, Julie; Harrod, Christopher G.; Begolka, Wendy Smith; Eichenfield, Lawrence F.

2014-01-01

Atopic dermatitis (AD) is a chronic, pruritic inflammatory dermatosis that affects up to 25% of children and 2-3% of adults. This guideline addresses important clinical questions that arise in AD management and care, providing recommendations based on the available evidence. In this third of four sections, treatment of AD with phototherapy and systemic immunomodulators, antimicrobials, and antihistamines is reviewed, including indications for use and the risk-benefit profile of each treatment option. PMID:24813298

Oral supplementation of Lithospermum erythrorhizon prevents the development of atopic dermatitis with reducing ceramide degradation in the epidermis of NC/Nga mice.

PubMed

Kim, JungMin; Kim, YoungRan; Seo, DaeBang; Kim, SungHan; Lee, SangJun; Cho, Yunhi

2009-09-01

Lithospermum erythrorhizon Sieb. et Zucc. (LE) is widely used in the treatment of abnormal skin conditions, but its systemic efficacy, especially in atopic dermatitis (AD), is not clear. To examine the systemic efficacy of LE on the clinical manifestation of AD-like skin lesions, NC/Nga mice, a murine model of AD, were fed a control diet (group CA: atopic control) or a diet with a 70% ethanol extract from 5% LE (group LE) for 10 weeks. In group LE, the clinical manifestation of AD-like skin lesions was prevented as the level of serum IgE, epidermal hyperproliferation, and the number and duration of scratching episodes, which were greater in group CA, were significantly reduced to a similar level of the normal control group of BALB/c mice (group C). In addition, the level of ceramides, the major lipid maintaining the epidermal barrier, in the epidermis of group LE was increased, and was inversely associated with a decreased protein level of ceramidase, an enzyme of ceramide degradation. However, the mRNA and the protein levels of serine palmitoyl transferase (enzyme for de novo ceramide synthesis) in groups C, CA and LE did not differ. It was demonstrated that oral supplementation with LE extract prevented the development of atopic dermatitis with reducing ceramide degradation coupled with a low expression of ceramidase protein.

KSC-2014-3788

NASA Image and Video Library

2014-09-10

CAPE CANAVERAL, Fla. – Inside the Neil Armstrong Operations and Checkout Building high bay at NASA's Kennedy Space Center in Florida, members of the Brevard Police and Fire Pipes and Drums lead NASA and Lockheed Martin workers out of the high bay after a ceremony to turn over the Orion spacecraft for Exploration Flight Test-1 to Lockheed Martin Ground Operations from Orion Assembly, Integration and Production. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch atop a United Launch Alliance Delta IV Heavy rocket from Cape Canaveral Air Force Station in Florida in December to an altitude of 3,600 miles above the Earth's surface. The two-orbit, four-hour flight test will help engineers evaluate the systems critical to crew safety including the heat shield, parachute system and launch abort system. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Daniel Casper

KSC-2014-4387

NASA Image and Video Library

2014-11-06

CAPE CANAVERAL, Fla. – In the Kennedy Space Center’s Press Site auditorium, members of the news media are briefed on the upcoming Orion flight test. From left are: Rachel Kraft, NASA Public Affairs, Bill Hill, NASA deputy associate administrator for Exploration Systems Development, Mark Geyer, NASA Orion Program manager, Bryan Austin, Lockheed Martin mission manager, Jeremy Graeber, Operations Integration Branch of Ground Systems Development and Operations at Kennedy, and Ron Fortson, United Launch Alliance director of Mission Management. Mike Sarafin, NASA's lead flight director, participated by video from the Johnson Space Center. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted flight test of Orion is scheduled to launch Dec. 4, 2014 atop a United Launch Alliance Delta IV Heavy rocket, and in 2018 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion Photo credit: NASA/Kim Shiflett

KSC-2014-4386

NASA Image and Video Library

2014-11-06

CAPE CANAVERAL, Fla. – In the Kennedy Space Center’s Press Site auditorium, members of the news media are briefed on the upcoming Orion flight test. From left are: Rachel Kraft, NASA Public Affairs, Bill Hill, NASA deputy associate administrator for Exploration Systems Development, Mark Geyer, NASA Orion Program manager, Bryan Austin, Lockheed Martin mission manager, Jeremy Graeber, Operations Integration Branch of Ground Systems Development and Operations at Kennedy, and Ron Fortson, United Launch Alliance director of Mission Management. Mike Sarafin, NASA's lead flight director, participated by video from the Johnson Space Center. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted flight test of Orion is scheduled to launch Dec. 4, 2014 atop a United Launch Alliance Delta IV Heavy rocket, and in 2018 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion Photo credit: NASA/Kim Shiflett

Alcohol Intake During Pregnancy and Offspring's Atopic Eczema Risk.

PubMed

Wada, Keiko; Konishi, Kie; Tamura, Takashi; Shiraki, Makoto; Iwasa, Shinichi; Nagata, Chisato

2016-05-01

Although alcohol consumption has been suggested to have an effect on the immune system, it is unknown whether alcohol consumption has a role in developing allergic diseases. We aimed to examine the associations of total alcohol intake during pregnancy with the risks of childhood asthma and atopic eczema in a birth cohort in Japan. Pregnant women were recruited at a maternal clinic from May 2000 to October 2001. The children who were born to these mothers were followed until November 2007. Total alcohol intake, including alcohol as a cooking ingredient, was assessed using 5-day dietary records. Mother reports of physician-diagnosed asthma and atopic eczema were annually obtained from the questionnaires. Asthma assessed by the American Thoracic Society Division of Lung Diseases questionnaire and atopic eczema assessed by International Study of Asthma and Allergies in Childhood questions were also obtained in 2007. A total of 350 children participated in the follow-up survey. Maternal total alcohol intake during pregnancy was associated with increased risks of atopic eczema before age 3. The positive association with atopic eczema was also observed when it was defined as before age 5. In the high versus the low tertile of maternal total alcohol intake, the estimated hazard ratios (HRs) of child's eczema were 1.90 (95% CI: 0.96 to 3.76) before age 3 and 1.74 (95% CI: 0.93 to 3.24) before age 5, respectively. The estimated HRs of child's asthma before age 3 was 1.61 (95% CI: 0.70 to 3.69) in the high versus the low of maternal total alcohol intake and 2.11 (95% CI: 0.93 to 4.81) among children having drinking mothers versus nondrinking mothers in pregnancy, although maternal alcohol intake during pregnancy was not significantly associated with the risk of asthma before age 5. Alcohol consumption during pregnancy might have an effect on developing atopic eczema in offspring. Copyright © 2016 by the Research Society on Alcoholism.

Physicians' perceptions of an eczema action plan for atopic dermatitis.

PubMed

Ntuen, Edidiong; Taylor, Sarah L; Kinney, Megan; O'Neill, Jenna L; Krowchuk, Daniel P; Feldman, Steven R

2010-01-01

Poor adherence to topical medications in atopic dermatitis may lead to exposure to more costly and potentially toxic systemic agents. Written action plans (WAPs) improve adherence and treatment outcomes in asthma patients and may be useful for children with atopic dermatitis. To assess physicians' perceptions of a WAP for atopic dermatitis and their openness to using it. An Eczema Action Plan (EAP) was modeled from those used in pediatric asthma. A brief survey to assess the perceived practicality and usefulness of the EAP was sent to 48 pediatricians in our local area and to 17 pediatric dermatologists nationally. Survey items included layout, graphics, readability, accuracy, and utility. Qualitative analyses were performed due to small sample sizes. Seventeen pediatricians from five community practices and eight pediatric dermatologists responded (response rates of 35% and 41%, respectively). Layout was rated as excellent by 59% of pediatricians and 43% of pediatric dermatologists, the graphics were rated good (60% and 70%), the readability as good to excellent (100% and 86%), the accuracy as excellent or good (83% and 86%), and usefulness as good to excellent (100% of both groups). Most (71%) of the pediatric dermatologists reported already having their own patient education materials for atopic dermatitis, but none of the pediatricians did. All pediatricians and 60% of pediatric dermatologists reported they were likely to use the EAP in their clinical practices. Limitations included the sample size being small, but it still provided for qualitative assessment of generalists and sub-specialists. We did not assess how the EAP would be perceived by patients or their families. The practice settings of the community and academic physicians are not identical, which may make for weakened comparisons. Pediatricians are open to using an EAP for atopic dermatitis. If an EAP were effective at improving adherence and outcomes in atopic dermatitis, widespread implementation should be feasible.

Increased IgE serum levels are unrelated to allergic and parasitic diseases in patients with juvenile systemic lupus erythematosus.

PubMed

Liphaus, Bernadete L; Jesus, Adriana A; Silva, Clovis A; Coutinho, Antonio; Carneiro-Sampaio, Magda

2012-11-01

The aim of this study was to assess the IgE serum levels in juvenile systemic lupus erythematosus patients and to evaluate possible associations with clinical and laboratory features, disease activity and tissue damage. The IgE serum concentrations in 69 consecutive juvenile systemic lupus erythematosus patients were determined by nephelometry. IgG, IgM and IgA concentrations were measured by immunoturbidimetry. All patients were negative for intestinal parasites. Statistical analysis methods included the Mann-Whitney, chi-square and Fisher's exact tests, as well as the Spearman rank correlation coefficient. Increased IgE concentrations above 100 IU/mL were observed in 31/69 (45%) juvenile systemic lupus erythematosus patients. The mean IgE concentration was 442.0 ± 163.4 IU/ml (range 3.5-9936.0 IU/ml). Fifteen of the 69 patients had atopic disease, nine patients had severe sepsis and 56 patients presented with nephritis. The mean IgE level in 54 juvenile systemic lupus erythematosus patients without atopic manifestations was 271.6 ± 699.5 IU/ml, and only nine of the 31 (29%) patients with high IgE levels had atopic disease. The IgE levels did not statistically differ with respect to the presence of atopic disease, severe sepsis, nephritis, disease activity, or tissue damage. Interestingly, IgE concentrations were inversely correlated with C4 levels (r = -0.25, p = 0.03) and with the SLICC/ACR-DI score (r = -0.34, p = 0.005). The IgE concentration was also found to be directly correlated with IgA levels (r = 0.52, p = 0.03). The present study demonstrated for the first time that juvenile systemic lupus erythematosus patients have increased IgE serum levels. This increase in IgE levels was not related to allergic or parasitic diseases. Our results are in line with the hypothesis that high IgE levels can be considered a marker of immune dysregulation.

ASCANS Class of 2013 Tour the O&C with Cabana

NASA Image and Video Library

2014-03-03

CAPE CANAVERAL, Fla. -- In the Operations and Checkout Building of NASA's Kennedy Space Center in Florida, astronaut candidate Tyler Nick Hague examines part of the thermal protection system for the agency's Orion spacecraft being prepared for Exploration Flight Test, or EFT-1. Plans call for the Lockheed Martin-built Orion to launch atop a United Launch Alliance Delta IV Heavy rocket from Cape Canaveral Air Force Station. The astronaut class of 2013 was selected by NASA after an extensive year-and-a-half search. The new group will help the agency push the boundaries of exploration and travel to new destinations in the solar system. To learn more about the astronaut class of 2013, visit: http://www.nasa.gov/astronauts/2013astroclass.html Photo credit: NASA/Kim Shiflett

Vehicle Support Posts Installation onto Mobile Launcher

NASA Image and Video Library

2017-05-11

A construction worker on the deck of the mobile launcher welds a portion of a platform for installation of a vehicle support post at NASA's Kennedy Space Center in Florida. A total of eight support posts will be installed to support the load of the Space Launch System's (SLS) solid rocket boosters, with four posts for each of the boosters. The support posts are about five feet tall and each weigh about 10,000 pounds. The posts will structurally support the SLS rocket through T-0 and liftoff, and will drop down before vehicle liftoff to avoid contact with the flight hardware. The Ground Systems Development and Operations Program is overseeing installation of the support posts to prepare for the launch of the Orion spacecraft atop the SLS rocket.

GFAST Software Demonstration

NASA Image and Video Library

2017-03-17

NASA engineers and test directors gather in Firing Room 3 in the Launch Control Center at NASA's Kennedy Space Center in Florida, to watch a demonstration of the automated command and control software for the agency's Space Launch System (SLS) and Orion spacecraft. In front, far right, is Charlie Blackwell-Thompson, launch director for Exploration Mission 1 (EM-1). The software is called the Ground Launch Sequencer. It will be responsible for nearly all of the launch commit criteria during the final phases of launch countdowns. The Ground and Flight Application Software Team (GFAST) demonstrated the software. It was developed by the Command, Control and Communications team in the Ground Systems Development and Operations (GSDO) Program. GSDO is helping to prepare the center for the first test flight of Orion atop the SLS on EM-1.

Vehicle Support Posts Installation onto Mobile Launcher

NASA Image and Video Library

2017-05-11

Construction workers on the deck of the mobile launcher prepare the platforms for installation of vehicle support posts at NASA's Kennedy Space Center in Florida. At left, four of the support posts are installed. A total of eight support posts will be installed to support the load of the Space Launch System's (SLS) solid rocket boosters, with four posts for each of the boosters. The support posts are about five feet tall and each weigh about 10,000 pounds. The posts will structurally support the SLS rocket through T-0 and liftoff, and will drop down before vehicle liftoff to avoid contact with the flight hardware. The Ground Systems Development and Operations Program is overseeing installation of the support posts to prepare for the launch of the Orion spacecraft atop the SLS rocket.

Vehicle Support Posts Installation onto Mobile Launcher

NASA Image and Video Library

2017-05-11

Several heavy lift cranes surround the mobile launcher at NASA's Kennedy Space Center in Florida. Preparations are underway to lift a vehicle support post up and onto the mobile launcher for installation on the deck. A total of eight support posts will be installed to support the load of the Space Launch System's (SLS) solid rocket boosters, with four posts for each of the boosters. The support posts are about five feet tall and each weigh about 10,000 pounds. The posts will structurally support the SLS rocket through T-0 and liftoff, and will drop down before vehicle liftoff to avoid contact with the flight hardware. The Ground Systems Development and Operations Program is overseeing installation of the support posts to prepare for the launch of the Orion spacecraft atop the SLS rocket.

Crawler Transporter 2 (CT-2) Trek from Pad 39B to VAB

NASA Image and Video Library

2017-03-21

Crawler-transporter 2 (CT-2) moves slowly along the crawlerway on its way back to the Vehicle Assembly Building (in view in the background) at NASA's Kennedy Space Center in Florida. Water sprayed by a truck in front to reduce dust creates a small rainbow. The crawler took a trip to the Pad A/B split to test upgrades recently completed that will allow the giant vehicle to handle the load of the agency's Space Launch System rocket and Orion spacecraft atop the mobile launcher. The Ground Systems Development and Operations Program oversaw upgrades to the 50-year-old CT-2. New generators, gear assemblies, jacking, equalizing and leveling (JEL) hydraulic cylinders, roller bearings and brakes were installed, and other components were upgraded to prepare for Exploration Mission 1.

Orion Flight Test Preview Briefing

NASA Image and Video Library

2014-11-06

In the Kennedy Space Center’s Press Site auditorium, members of the news media are briefed on the upcoming Orion flight test by Jeremy Graeber, Orion Recovery Director in Ground Systems Development and Operations at Kennedy. Also participating in the news conference are Bryan Austin, Lockheed Martin mission manager, left, and Ron Fortson, United Launch Alliance director of Mission Management. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted flight test of Orion is scheduled to launch Dec. 4, 2014 atop a United Launch Alliance Delta IV Heavy rocket, and in 2018 on NASA’s Space Launch System rocket.

Orion Flight Test Preview Briefing

NASA Image and Video Library

2014-11-06

In the Kennedy Space Center’s Press Site auditorium, members of the news media are briefed on the upcoming Orion flight test by Mark Geyer, NASA Orion Program manager. Also participating in the news conference are Bryan Austin, Lockheed Martin mission manager, center, and Jeremy Graeber, Orion Recovery Director in Ground Systems Development and Operations at Kennedy. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted flight test of Orion is scheduled to launch Dec. 4, 2014 atop a United Launch Alliance Delta IV Heavy rocket, and in 2018 on NASA’s Space Launch System rocket.

Risk of developing major depression and bipolar disorder among adolescents with atopic diseases: A nationwide longitudinal study in Taiwan.

PubMed

Wei, Han-Ting; Lan, Wen-Hsuan; Hsu, Ju-Wei; Huang, Kai-Lin; Su, Tung-Ping; Li, Cheng-Ta; Lin, Wei-Chen; Chen, Tzeng-Ji; Bai, Ya-Mei; Chen, Mu-Hong

2016-10-01

Previous studies have found an increased prevalence of atopic diseases among patients with major depression and bipolar disorder. But the temporal association between atopic diseases in adolescence and the subsequent risk of developing mood disorders has been rarely investigated. Using the Taiwan National Health Insurance Research Databases, 5075 adolescents with atopic diseases (atopic cohort) and 44,729 without (non-atopic cohort) aged between 10 and 17 in 2000 were enrolled into our study and followed to the end of 2010. Subjects who developed major depression or bipolar disorder during the follow-up were identified. The atopic cohort had an increased risk of developing major depression (HR: 2.45, 95% CI: 1.93~3.11) and bipolar disorder (HR: 2.51, 95% CI: 1.71~3.67) compared to the non-atopic cohort, with a dose-dependent relationship between having a greater number of atopic comorbidities and a greater likelihood of major depression (1 atopic disease: HR: 1.80, 95% CI: 1.29~2.50; 2 atopic comorbidities: HR: 2.42, 95% CI: 1.93~3.04;≥3 atopic comorbidities: HR: 3.79, 95% CI: 3.05~4.72) and bipolar disorder (HR: 1.40, 95% CI: 0.57~3.44; HR: 2.81, 95% CI: 1.68~4.68; HR: 3.02, 95% CI: 1.69~5.38). Having atopic diseases in adolescence increased the risk of developing major depression and bipolar disorder in later life. Further studies may be required to clarify the underlying mechanism between atopy and mood disorders, and to investigate whether prompt intervention may decrease the risk of subsequent mood disorders. Copyright © 2016 Elsevier B.V. All rights reserved.

54. DETAIL OF GENERAL ELECTRIC AIRBORNE BEACON EQUIPMENT TEST SET ...

Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

54. DETAIL OF GENERAL ELECTRIC AIRBORNE BEACON EQUIPMENT TEST SET (LEFT) AND ASSOCIATED GOULD BRUSH CHART RECORDERS (RIGHT). ELAPSED TIME COUNTER SITS ATOP AIRBORNE BEACON EQUIPMENT TEST SET. - Vandenberg Air Force Base, Space Launch Complex 3, Launch Operations Building, Napa & Alden Roads, Lompoc, Santa Barbara County, CA

Immune responses in children infected with the pinworm Enterobius vermicularis in central Greece.

PubMed

Patsantara, G G; Piperaki, E-T; Tzoumaka-Bakoula, C; Kanariou, M G

2016-05-01

Previous studies have suggested an immunomodulatory and even protective role for Enterobius vermicularis, the least pathogenic human intestinal helminth. Here, in a study using haematological and serological parameters, we tested a total of 215 children from central Greece, with a mean age of 8.39, of whom 105 (48.84%) were infected with E. vermicularis and 110 (51.16%) were matched healthy controls. In particular, we analysed eosinophil counts (EO), serum eosinophil cationic protein (ECP), total and specific serum immunoglobulin E (IgE) and the ECP/EO ratio. The atopic status and the potential occurrence of clinically expressed allergic diseases were both taken into account. Eosinophils, ECP and IgE were found to be higher in infected than in uninfected children, indicating a type-2 immune response activation during infection. Atopic infected children exhibited higher IgE levels compared to non-atopic ones. EO and ECP were found to be lower in atopic children who had a history of allergic disease than in those with no such history. The type-2 oriented immune response elicited against E. vermicularis could contribute to a balanced activation of the immune system in the examined children. Interestingly, although the atopic children showed a stronger activation, they did not exhibit any symptoms and, moreover, there seemed to be some indication of immunosuppression in those children with a positive history of allergic disease.

Efficacy of a novel phosphodiesterase inhibitor, E6005, in patients with atopic dermatitis: An investigator-blinded, vehicle-controlled study.

PubMed

Ohba, Fuminori; Matsuki, Shunji; Imayama, Shuhei; Matsuguma, Kyoko; Hojo, Seiichiro; Nomoto, Maiko; Akama, Hideto

2016-10-01

Phosphodiesterase type 4 (PDE4) inhibition is a well-known anti-inflammatory mechanism. However, the clinical use of PDE4 inhibitors has been compromised by the occurrence of mechanism-associated adverse reactions, which often limit the maximum tolerated dose. To minimize systemic exposure, a topically active PDE4 inhibitor with low transdermal bioavailability could be clinically useful. The purpose of this study was to evaluate the efficacy of a novel topical PDE4 inhibitor, E6005, in patients with atopic dermatitis. This randomized, investigator-blinded, vehicle-controlled, multiple ascending dose study included 40 adult male patients with atopic dermatitis, who were randomly assigned to 10 days of treatment with either E6005 ointment (0.01, 0.03, 0.1 or 0.2%) or vehicle ointment. Of 81 patients screened, 40 who had typical lesions on their posterior trunk were randomized into the study. One patient receiving 0.03% E6005 treatment discontinued because of acute gout and one receiving vehicle treatment discontinued because of progression of atopic dermatitis. The targeted lesion severity scores decreased in a concentration-dependent manner in patients treated with E6005. This drop was significant in the 0.2% E6005 ointment treatment group (mean percent change: -54.30%, p = 0.007). E6005 ointment showed anti-inflammatory efficacy in adult patients with atopic dermatitis.

Serum, cheek cell and breast milk fatty acid compositions in infants with atopic and non-atopic eczema.

PubMed

Laitinen, K; Sallinen, J; Linderborg, K; Isolauri, E

2006-02-01

The major theory implicating diet with allergic diseases is associated with altered food consumption and subsequent changes in fatty acid composition. To investigate fatty acid compositions among infants with atopic and non-atopic eczema and healthy infants and to evaluate the expediency of non-invasive cheek cell phospholipid fatty acid composition as a marker in patients with eczema. Diagnosis of eczema in infants was confirmed clinically and by positive (atopic eczema, n=6) or negative (non-atopic eczema, n=6) skin prick testing in comparison with controls (n=19). The fatty acid compositions of infant cheek cell and serum phospholipids and breast milk total lipids were analysed by gas chromatography. The distinction between atopic and non-atopic eczema was manifested in cheek cell phospholipids as linoleic acid (14.69 (13.67-15.53)% of total fatty acids; the median (interquartile range)), the sum of n-6 fatty acids (19.94 (19.06-20.53)%) and the sum of polyunsaturated fatty acids (22.70 (21.31-23.28)%) were higher in infants with atopic eczema compared with non-atopic eczema (12.69 (10.87-13.93); 17.72 (15.63-18.91) and 19.90 (17.64-21.06), respectively; P<0.05) and controls (12.50 (12.16-13.42); 18.19 (17.43-18.70) and 20.32 (19.32-21.03), respectively; P<0.05). Serum phospholipid gamma-linolenic acid was lower in both atopic and non-atopic eczema compared with controls (P<0.05) and additionally eicosapentaenoic acid was higher in atopic eczema compared with controls (P<0.05). These preliminary results suggest differences in fatty acid compositions between the two types of eczema, calling for further evaluation in a larger setting. The two types of eczema may be regulated by different immunological processes, and fatty acids may have a more profound role in the atopic type.

Poverty, dirt, infections and non-atopic wheezing in children from a Brazilian urban center

PubMed Central

2010-01-01

Background The causation of asthma is poorly understood. Risk factors for atopic and non-atopic asthma may be different. This study aimed to analyze the associations between markers of poverty, dirt and infections and wheezing in atopic and non-atopic children. Methods 1445 children were recruited from a population-based cohort in Salvador, Brazil. Wheezing was assessed using the ISAAC questionnaire and atopy defined as allergen-specific IgE ≥0.70 kU/L. Relevant social factors, environmental exposures and serological markers for childhood infections were investigated as risk factors using multivariate multinomial logistic regression. Results Common risk factors for wheezing in atopic and non-atopic children, respectively, were parental asthma and respiratory infection in early childhood. No other factor was associated with wheezing in atopic children. Factors associated with wheezing in non-atopics were low maternal educational level (OR 1.49, 95% CI 0.98-2.38), low frequency of room cleaning (OR 2.49, 95% CI 1.27-4.90), presence of rodents in the house (OR 1.48, 95% CI 1.06-2.09), and day care attendance (OR 1.52, 95% CI 1.01-2.29). Conclusions Non-atopic wheezing was associated with risk factors indicative of poverty, dirt and infections. Further research is required to more precisely define the mediating exposures and the mechanisms by which they may cause non-atopic wheeze. PMID:21122116

Poverty, dirt, infections and non-atopic wheezing in children from a Brazilian urban center.

PubMed

Barreto, Mauricio L; Cunha, Sergio S; Fiaccone, Rosemeire; Esquivel, Renata; Amorim, Leila D; Alvim, Sheila; Prado, Matildes; Cruz, Alvaro A; Cooper, Philip J; Santos, Darci N; Strina, Agostino; Alcantara-Neves, Neuza; Rodrigues, Laura C

2010-12-01

The causation of asthma is poorly understood. Risk factors for atopic and non-atopic asthma may be different. This study aimed to analyze the associations between markers of poverty, dirt and infections and wheezing in atopic and non-atopic children. 1445 children were recruited from a population-based cohort in Salvador, Brazil. Wheezing was assessed using the ISAAC questionnaire and atopy defined as allergen-specific IgE ≥ 0.70 kU/L. Relevant social factors, environmental exposures and serological markers for childhood infections were investigated as risk factors using multivariate multinomial logistic regression. Common risk factors for wheezing in atopic and non-atopic children, respectively, were parental asthma and respiratory infection in early childhood. No other factor was associated with wheezing in atopic children. Factors associated with wheezing in non-atopics were low maternal educational level (OR 1.49, 95% CI 0.98-2.38), low frequency of room cleaning (OR 2.49, 95% CI 1.27-4.90), presence of rodents in the house (OR 1.48, 95% CI 1.06-2.09), and day care attendance (OR 1.52, 95% CI 1.01-2.29). Non-atopic wheezing was associated with risk factors indicative of poverty, dirt and infections. Further research is required to more precisely define the mediating exposures and the mechanisms by which they may cause non-atopic wheeze.

The association of intrafamilial violence against children with symptoms of atopic and non-atopic asthma: A cross-sectional study in Salvador, Brazil.

PubMed

Bonfim, Camila Barreto; dos Santos, Darci Neves; Barreto, Maurício Lima

2015-12-01

This study aims to describe the types of intrafamilial violence perpetrated against children according to living conditions, family factors, and child characteristics, and to identify the association between types of intrafamilial violence and asthma symptoms in atopic and non-atopic children. A cross-sectional study was carried out with 1,370 caregivers as part of the Social Changes, Asthma and Allergy in Latin America (SCAALA) study, conducted in 2006 in Brazil. The study population was selected by random sampling. The main outcome measures were atopic and non-atopic asthma. We investigate the association between intrafamilial violence and asthma symptoms in atopic and non-atopic children. A backward multivariate logistic polytomous regression was performed to verify the main association. Nonviolent discipline (NVD) and maltreatment nonviolent discipline (MNVD) were positively associated with non-atopic asthma symptoms (NVD: odds ratio (OR)=1.95/95% confidence interval (CI)=1.17-3.25; MNVD: OR=1.95/95% CI=1.19-3.20). However, for the most severe intrafamilial violence, this association was not found after control of potential confounders. This study demonstrates the effect of types of intrafamilial violence on non-atopic asthma. Intrafamilial violence against children represents one more component in the determination of non-atopic asthma in Latin America. Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Spectroscopic research of Lambda hypernuclei up to medium-heavy mass region with the (e,e'K +) reaction

DOE Office of Scientific and Technical Information (OSTI.GOV)

Gogami, Toshiyuki

In 2009 (August-November), the E05-115 experiment was carried out at JLab to investigate L hypernuclei in the wide mass region up to A = 52 (more » $$7\\atop{Λ}$$He, $$10\\atop{Λ}$$Be, $$12\\atop{Λ}$$B and $$52\\atop{Λ}$$V) with the (e,e'K +) reaction. This is the first attempt to investigate a medium heavy L hypernucleus with the (e,e'K +) reaction. Experimentally, it is difficult to measure heavier L hypernuclei as background rates of particles which originate from electromagnetic processes are roughly in proportion to Z2 (Z: target proton number) in the (e,e'K +) experiment. To perform the experiment, many experimental techniques have been developed and introduced such as optimization of the electron spectrometer configuration (tilt method), clean kaon identification, particle tracking under high multiplicity environment, precise energy scale calibration and so on. In the present thesis, experimental results of the elementary process of p(e,e'K +)L, L hypernuclei of $$7\\atop{Λ}$$He, $$10\\atop{Λ}$$Be, $$12\\atop{Λ}$$B and $$52\\atop{Λ}$$V are shown. Elementary processes of the electroproduction of L and Σ 0, p(e,e'K +)L, Σ 0 were used for the absolute energy scale calibration of our spectrometer systems. A careful Monte Carlo simulation shows that the binding energy can be obtained with a systematic error of 0.11 MeV with our energy scale calibration method. A study of the elementary process of L is important to understand L hypernuclei as it is essential for theoretical calculations of L hypernuclei. The differential cross section of the p(e,e'K +)L reaction at the small K + scattering angle (theta-CM/gamma-K approx. 15.5°), the small Q 2 (approx 0.01 [GeV/c] 2) and the total energy of W = 1.92 GeV, where no experimental data exists was obtained to be 235 ± 13$$+28\\atop{-24}$$ nb/sr. The ground state (1/2 +) binding energy of $$7\\atop{Λ}$$He was already measured in JLab E01-011 (2005). In the present work, the binding energy of 1/2 + state was determined to be B Λ = 5.55 ± 0.10 ±0.11 MeV with five times more statistic and smaller systematic errors than those of the previous experiment. The ground state binding energy is important to test the phe- nomenologically introduced CSB (Charge Symmetry Breaking) LN interaction for A = 7, T = 1 hypernuclear systems. In addition, a peak which is interpreted as 3/2 + and 5/2 + states was measured to be B Λ = 3.65 ± 0.20 ±0.11 MeV with sufficient statistic for the first time. Only three events of the ground state of $$10\\atop{Λ}$$ Be had been observed in the emulsion experiments. The present experiment is the first spectroscopic measurement of 10/L-Be, and the detailed structures have been successfully measured for the first time. About three times better energy resolution was achieved in the present experiment (0.78 MeV in FWHM) than that of the mirror L hy- pernucleus, $$10\\atop{Λ}$$B (2.2 MeV in FWHM) which was measured in the (π +,K +) experiment at KEK. The result of the ground state binding energy was obtained to be B Λ = 8.55 ± 0.07 ± 0.11 MeV which serves also to discuss about the CSB effect in the LN interaction. $$12\\atop{Λ}$$B has been measured with the world best energy resolution of 0:5 MeV (FWHM) among the reaction spectroscopy of L hypernuclei. The results of $$12\\atop{Λ}$$B are compared with the experimental results in the previous experiments to confirm the consistency. Furthermore, the obtained ground state binding energies of $$12\\atop{Λ}$$B (B Λ= 11.38 ± 0.02 ± 0.11 MeV) and $$52\\atop{Λ}$$V (B Λ = 21.88 ± 0.59 ± 0.11 MeV) indicate that the reported value of 12/L-C which has been used as a reference of binding energy measurements for the (π +,K +) experiments would be shallower by ~ 0.5 MeV. A pilot study for investigation in the medium-heavy mass region with the (e,e'K +) experiment was performed by measuring $$52\\atop{Λ}$$V. The ground state binding energy of $$52\\atop{Λ}$$V has been measured, overcoming high multiplicity environment. The results are discussed with the ex- perimental results of 51/L-V measured at KEK. The present result is the first measurement of L's binding energy of the ground state without the emulsion reference in the medium-heavy mass region, which could be a substantial improvement in the information needed for understanding the single particle potential of L. In the present experiment, L hypernuclear measurement with a small systematic error of ~ 0.1 MeV by the (e,e'K +) reaction has been established. Moreover, the present work opened a door to the heavier L hypernuclear measurement with the (e,e'K +) reaction in the future.« less

Differential Effects of Peptidoglycan Recognition Proteins on Experimental Atopic and Contact Dermatitis Mediated by Treg and Th17 Cells

PubMed Central

Park, Shin Yong; Gupta, Dipika; Kim, Chang H.; Dziarski, Roman

2011-01-01

Skin protects the body from the environment and is an important component of the innate and adaptive immune systems. Atopic dermatitis and contact dermatitis are among the most frequent inflammatory skin diseases and are both determined by multigenic predisposition, environmental factors, and aberrant immune response. Peptidoglycan Recognition Proteins (Pglyrps) are expressed in the skin and we report here that they modulate sensitivity to experimentally-induced atopic dermatitis and contact dermatitis. Pglyrp3 −/− and Pglyrp4 −/− mice (but not Pglyrp2 −/− mice) develop more severe oxazolone-induced atopic dermatitis than wild type (WT) mice. The common mechanism underlying this increased sensitivity of Pglyrp3 −/− and Pglyrp4 −/− mice to atopic dermatitis is reduced recruitment of Treg cells to the skin and enhanced production and activation Th17 cells in Pglyrp3 −/− and Pglyrp4 −/− mice, which results in more severe inflammation and keratinocyte proliferation. This mechanism is supported by decreased inflammation in Pglyrp3 −/− mice following in vivo induction of Treg cells by vitamin D or after neutralization of IL-17. By contrast, Pglyrp1 −/− mice develop less severe oxazolone-induced atopic dermatitis and also oxazolone-induced contact dermatitis than WT mice. Thus, Pglyrp3 and Pglyrp4 limit over-activation of Th17 cells by promoting accumulation of Treg cells at the site of chronic inflammation, which protects the skin from exaggerated inflammatory response to cell activators and allergens, whereas Pglyrp1 has an opposite pro-inflammatory effect in the skin. PMID:21949809

High circulating folate and vitamin B-12 concentrations in women during pregnancy are associated with increased prevalence of atopic dermatitis in their offspring.

PubMed

Kiefte-de Jong, Jessica C; Timmermans, Sarah; Jaddoe, Vincent W V; Hofman, Albert; Tiemeier, Henning; Steegers, Eric A; de Jongste, Johan C; Moll, Henriette A

2012-04-01

Recent studies suggest that in utero exposure of methyl donors influences programming of the fetal immune system in favor of development of allergic disease. The aim of this study was to assess whether the MTHFR C677T polymorphism, folic acid supplementation, and circulating folate and vitamin B-12 concentrations during pregnancy were associated with wheezing, shortness of breath, and atopic dermatitis in offspring. The study was a population-based birth cohort from fetal life until 48 mo (n = 8742). The use of folic acid supplementation during pregnancy was assessed by questionnaire. Plasma folate and serum vitamin B-12 concentrations and the MTHFR C677T polymorphism were available from blood collected in early pregnancy. Atopic dermatitis, wheezing, and shortness of breath in the offspring were assessed by parental-derived questionnaires at 12, 24, 36, and 48 mo. Maternal folate >16.2 nmol/L and vitamin B-12 >178 pmol/L were positively associated with the development of atopic dermatitis [adjusted OR: 1.18 (95% CI: 1.05-1.33) and adjusted OR: 1.30 (95% CI: 1.06-1.60) for the highest quartiles of folate and vitamin B-12 concentrations, respectively] but not with wheezing and shortness of breath. Maternal MTHFR C677T polymorphism and folic acid supplementation were not associated with wheezing, shortness of breath, and atopic dermatitis. No interactions were found by age, family history of atopy, folic acid supplementation, MTHFR C677T polymorphism, or maternal smoking (P-interaction > 0.10). High folate and vitamin B-12 levels during pregnancy are associated with increased prevalence of atopic dermatitis in the offspring. Potential risks of high folate and vitamin B-12 concentrations on allergic outcomes should be evaluated when discussing mandatory fortification programs.

Difficult to control atopic dermatitis

PubMed Central

2013-01-01

Difficult to control atopic dermatitis (AD) presents a therapeutic challenge and often requires combinations of topical and systemic treatment. Anti-inflammatory treatment of severe AD most commonly includes topical glucocorticosteroids and topical calcineurin antagonists used for exacerbation management and more recently for proactive therapy in selected cases. Topical corticosteroids remain the mainstay of therapy, the topical calcineurin inhibitors tacrolimus and pimecrolimus are preferred in certain locations. Systemic anti-inflammatory treatment is an option for severe refractory cases. Microbial colonization and superinfection contribute to disease exacerbation and thus justify additional antimicrobial / antiseptic treatment. Systemic antihistamines (H1) may relieve pruritus but do not have sufficient effect on eczema. Adjuvant therapy includes UV irradiation preferably of UVA1 wavelength. “Eczema school” educational programs have been proven to be helpful. PMID:23663504

KSC-2009-1008

NASA Image and Video Library

2009-01-02

CAPE CANAVERAL, Fla. – On Launch Pad 39B at NASA's Kennedy Space Center in Florida, a crane places the 100-foot fiberglass mast atop the new lightning tower constructed on the pad. The towers are part of the new lightning protection system for the Constellation Program and Ares/Orion launches. Each of the three new lightning towers will be 500 feet tall with the additional 100-foot fiberglass mast atop supporting a wire catenary system. This improved lightning protection system allows for the taller height of the Ares I rocket compared to the space shuttle. Pad 39B will be the site of the first Ares vehicle launch, including the Ares I-X test flight that is targeted for July 2009. Photo credit: NASA/Kim Shiflett

KSC-2009-1006

NASA Image and Video Library

2009-01-02

CAPE CANAVERAL, Fla. – On Launch Pad 39B at NASA's Kennedy Space Center in Florida, a crane places the 100-foot fiberglass mast atop the new lightning tower constructed on the pad. The towers are part of the new lightning protection system for the Constellation Program and Ares/Orion launches. Each of the three new lightning towers will be 500 feet tall with the additional 100-foot fiberglass mast atop supporting a wire catenary system. This improved lightning protection system allows for the taller height of the Ares I rocket compared to the space shuttle. Pad 39B will be the site of the first Ares vehicle launch, including the Ares I-X test flight that is targeted for July 2009. Photo credit: NASA/Kim Shiflett

Search for the Exotic Meson X ( 5568 ) with the Collider Detector at Fermilab

DOE Office of Scientific and Technical Information (OSTI.GOV)

Aaltonen, T.; Amerio, S.; Amidei, D.

Here, a search for the exotic meson X(5568) decaying into the Bmore » $$0\\atop{s}$$ π ± final state is performed using data corresponding to 9.6 fb -1 from $$p\\bar{p}$$ collisions at $$\\sqrt{s}$$ = 1960 GeV recorded by the Collider Detector at Fermilab. No evidence for this state is found and an upper limit of 6.7% at the 95% confidence level is set on the fraction of B$$0\\atop{s}$$ produced through the X(5568)→B$$0\\atop{s}$$ π ± process.« less

Search for the Exotic Meson X ( 5568 ) with the Collider Detector at Fermilab

DOE PAGES

Aaltonen, T.; Amerio, S.; Amidei, D.; ...

2018-05-18

Here, a search for the exotic meson X(5568) decaying into the Bmore » $$0\\atop{s}$$ π ± final state is performed using data corresponding to 9.6 fb -1 from $$p\\bar{p}$$ collisions at $$\\sqrt{s}$$ = 1960 GeV recorded by the Collider Detector at Fermilab. No evidence for this state is found and an upper limit of 6.7% at the 95% confidence level is set on the fraction of B$$0\\atop{s}$$ produced through the X(5568)→B$$0\\atop{s}$$ π ± process.« less

Search for direct top squark pair production in events with a $Z$ boson, $b$-jets and missing transverse momentum in $$\\sqrt{s}$$= 8 TeV $pp$ collisions with the ATLAS detector

DOE PAGES

Aad, G.; Abbott, B.; Abdallah, J.; ...

2014-06-01

Here, a search is presented for direct top squark pair production using events with at least two leptons including a same-flavour opposite-sign pair with invariant mass consistent with the Z boson mass, jets tagged as originating from b-quarks and missing transverse momentum. The analysis is performed with proton–proton collision data at √s = 8 TeV collected with the ATLAS detector at the LHC in 2012 corresponding to an integrated luminosity of 20.3 fb -1. No excess beyond the Standard Model expectation is observed. Interpretations of the results are provided in models based on the direct pair production of the heavier top squark state (more » $$\\sim\\atop{t}_2$$) followed by the decay to the lighter top squark state ($$\\sim\\atop{t}_1$$) via $$\\sim\\atop{t}_2$$ → Z$$\\sim\\atop{t}_1$$, and for $$\\sim\\atop{t}_1$$ pair production in natural gauge-mediated supersymmetry breaking scenarios where the neutralino ($$\\sim\\atop{χ}$$$0\\atop{1}$$) is the next-to-lightest supersymmetric particle and decays producing a Z boson and a gravitino ($$\\sim\\atop{G}$$) via the $$\\sim\\atop{χ}$$$0\\atop{1}$$ → Z G process.« less

Atopic asthmatic subjects but not atopic subjects without ...

EPA Pesticide Factsheets

BACKGROUND: Asthma is a known risk factor for acute ozone-associated respiratory disease. Ozone causes an immediate decrease in lung function and increased airway inflammation. The role of atopy and asthma in modulation of ozone-induced inflammation has not been determined. OBJECTIVE: We sought to determine whether atopic status modulates ozone response phenotypes in human subjects. METHODS: Fifty volunteers (25 healthy volunteers, 14 atopic nonasthmatic subjects, and 11 atopic asthmatic subjects not requiring maintenance therapy) underwent a 0.4-ppm ozone exposure protocol. Ozone response was determined based on changes in lung function and induced sputum composition, including airway inflammatory cell concentration, cell-surface markers, and cytokine and hyaluronic acid concentrations. RESULTS: All cohorts experienced similar decreases in lung function after ozone. Atopic and atopic asthmatic subjects had increased sputum neutrophil numbers and IL-8 levels after ozone exposure; values did not significantly change in healthy volunteers. After ozone exposure, atopic asthmatic subjects had significantly increased sputum IL-6 and IL-1beta levels and airway macrophage Toll-like receptor 4, Fc(epsilon)RI, and CD23 expression; values in healthy volunteers and atopic nonasthmatic subjects showed no significant change. Atopic asthmatic subjects had significantly decreased IL-10 levels at baseline compared with healthy volunteers; IL-10 levels did not significa

One remarkable molecule: Filaggrin

PubMed Central

Brown, Sara J.; McLean, W. H. Irwin

2011-01-01

The discovery, in 2006, that loss-of-function mutations in the filaggrin gene (FLG) are the cause of ichthyosis vulgaris – the most common disorder of keratinization – and also a strong genetic risk factor for atopic eczema, marked a significant breakthrough in the understanding of eczema pathogenesis. Subsequent investigations of the role of FLG null mutations have identified a series of significant associations with atopic disease phenotypes, including atopic asthma, allergic rhinitis and peanut allergy. However, many questions remain to be answered in relation to the precise mechanisms by which deficiency of an intracellular protein expressed primarily in the differentiating epidermis may contribute to the development of cutaneous and systemic pathology. This review aims to highlight the key milestones in filaggrin research over the past 25 years, to discuss the mechanistic, clinical and therapeutic implications and to consider possible future directions for ongoing investigation. PMID:22158554

The role of vitamin D in atopic dermatitis.

PubMed

Dębińska, Anna; Sikorska-Szaflik, Hanna; Urbanik, Magdalena; Boznański, Andrzej

2015-01-01

Vitamin D has been suggested to have an important impact on a much wider aspects on human health than calcium homeostasis and mineral metabolism, specifically in the field of human immunology. It has been reported that vitamin D influences the regulation of both innate and adaptive immune systems, which makes the association between vitamin D and allergic diseases a field of interest. Although many studies have sought to determine whether vitamin D has an influence on progression of allergic disease, the impact of vitamin D on atopic dermatitis development and severity remains unclear. In this review, we summarize recent studies relating vitamin D to atopic dermatitis and discuss its possible role in the pathogenesis of allergic skin diseases, emphasizing the need for well-designed, prospective trials on vitamin D supplementation in the context of prevention and treatment for allergic conditions.

Atopic dermatitis and concomitant disease patterns in children up to two years of age.

PubMed

Böhme, Maria; Lannerö, Eva; Wickman, Magnus; Nordvall, S Lennart; Wahlgren, Carl-Fredrik

2002-01-01

There are few prospective studies of atopic dermatitis and co-existing diseases such as respiratory infections in children up to 2 years of age. Using annual questionnaires, we studied the cumulative incidence of atopic dermatitis and concomitant symptoms indicating other atopic diseases and respiratory infections in 0-2-year-old children in a prospective birth cohort of 4089 children. We found associations between atopic dermatitis and asthma (ratio of proportion 1.45, 95% CI 1.16-1.80), allergic rhinoconjunctivitis (RP 2.25, CI 1.77-2.85), adverse reactions to foods (RP 3.20, CI 2.83-3.62), urticaria (RP 2.04, CI 1.80-2.31), acute otitis media (RP 1.13, CI 1.05-1.21), more than one pneumonia during the first and/or second year of life (RP 2.17, CI 1.14-4.15), and use of antibiotics at least twice yearly (RP 1.29, CI 1.07-1.56). The association between atopic dermatitis and respiratory infections persisted after stratification for asthma. There was a higher proportion of atopic disease manifestations, but not respiratory infections, in children with onset of atopic dermatitis during the first year of life than during the second. The study shows that during the first 2 years of life there is a significant association not only between atopic dermatitis and other atopic disease manifestations, but also between atopic dermatitis and respiratory infections manifested in an increased rate of acute otitis media, pneumonia and use of antibiotics.

Empirical moments of inertia of axially asymmetric nuclei

DOE PAGES

Allmond, J. M.; Wood, J. L.

2017-02-06

We extracted empirical moments of inertia, J1, J2, J3, of atomic nuclei with E(4more » $$+\\atop{1}$$)/E(2$$+\\atop{1}$$ ) > 2.7 from experimental 2$$+\\atop{g,y}$$, energies and electric quadrupole matrix elements, determined from multi- step Coulomb excitation data, and the results are compared to expectations based on rigid and irro- tational inertial flow. Only by having the signs of the E2 matrix elements, i.e., <2$$+\\atop{g}$$ ||M (E2)||2$$+\\atop{g}$$> and <0$$+\\atop{g}$$ ||M (E2)||2$$+\\atop{g}$$> < 2$$+\\atop{g}$$ ||M (E2)||2$$+\\atop{γ}$$> <2$$+\\atop{γ}$$ ||M (E2)||0$$+\\atop{g}$$> , can a unique solution to all three components of the inertia tensor of an asymmetric top be obtained. And while the absolute moments of inertia fall between the rigid and irrotational values as expected, the relative moments of inertia appear to be qualitatively consistent with the β 2 sin 2(γ ) dependence of the Bohr Hamiltonian which originates from a SO(5) in- variance. A better understanding of inertial flow is central to improving collective models, particularly hydrodynamic-based collective models. The results suggest that a better description of collective dynamics and inertial flow for atomic nuclei is needed. The inclusion of vorticity degrees of freedom may provide a path forward. This is our first report of empirical moments of inertia for all three axes and the results should challenge both collective and microscopic descriptions of inertial flow.« less

DOE Office of Scientific and Technical Information (OSTI.GOV)

Allmond, J. M.; Wood, J. L.

We extracted empirical moments of inertia, J1, J2, J3, of atomic nuclei with E(4more » $$+\\atop{1}$$)/E(2$$+\\atop{1}$$ ) > 2.7 from experimental 2$$+\\atop{g,y}$$, energies and electric quadrupole matrix elements, determined from multi- step Coulomb excitation data, and the results are compared to expectations based on rigid and irro- tational inertial flow. Only by having the signs of the E2 matrix elements, i.e., <2$$+\\atop{g}$$ ||M (E2)||2$$+\\atop{g}$$> and <0$$+\\atop{g}$$ ||M (E2)||2$$+\\atop{g}$$> < 2$$+\\atop{g}$$ ||M (E2)||2$$+\\atop{γ}$$> <2$$+\\atop{γ}$$ ||M (E2)||0$$+\\atop{g}$$> , can a unique solution to all three components of the inertia tensor of an asymmetric top be obtained. And while the absolute moments of inertia fall between the rigid and irrotational values as expected, the relative moments of inertia appear to be qualitatively consistent with the β 2 sin 2(γ ) dependence of the Bohr Hamiltonian which originates from a SO(5) in- variance. A better understanding of inertial flow is central to improving collective models, particularly hydrodynamic-based collective models. The results suggest that a better description of collective dynamics and inertial flow for atomic nuclei is needed. The inclusion of vorticity degrees of freedom may provide a path forward. This is our first report of empirical moments of inertia for all three axes and the results should challenge both collective and microscopic descriptions of inertial flow.« less

KSC-2013-3810

NASA Image and Video Library

2013-09-20

CAPE CANAVERAL, Fla. – Inside the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, technicians work on the service module bulkhead wiring for the Orion spacecraft. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Jim Grossmann

KSC-2013-3801

NASA Image and Video Library

2013-09-27

CAPE CANAVERAL, Fla. – Inside the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, a technician prepares the forward bay cover for the Orion crew module. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Dimitri Gerondidakis

KSC-2013-3811

NASA Image and Video Library

2013-09-20

CAPE CANAVERAL, Fla. – Inside the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, a technician works on the service module bulkhead wiring for the Orion spacecraft. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Jim Grossmann

KSC-2013-3800

NASA Image and Video Library

2013-09-27

CAPE CANAVERAL, Fla. – Inside the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, a technician prepares the forward bay cover for the Orion crew module. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Dimitri Gerondidakis

Mobile Launcher Crew Access Arm Transport from Cocoa FL to KSC

NASA Image and Video Library

2017-10-17

A flatbed truck with the Orion crew access arm secured atop travels along a road in Cocoa, Florida, after departing Precision Fabricating and Cleaning. The access arm will be transported to a storage location at NASA's Kennedy Space Center in Florida. Later this month, the arm will be transported to the mobile launcher (ML) tower at the center. The crew access arm will be located at about the 274-foot level on the tower. It will rotate from its retracted position and interface with the Orion crew hatch location to provide entry to the Orion crew module. The Ground Systems Development and Operations Program is overseeing installation of umbilicals and launch accessories on the ML tower.

Mobile Launcher Crew Access Arm Transport from Cocoa FL to KSC

NASA Image and Video Library

2017-10-17

The Orion crew access arm departs Precision Fabricating and Cleaning in Cocoa, Florida, atop a flatbed truck. The access arm will be transported to a storage location at NASA's Kennedy Space Center in Florida. Later this month, the arm will be transported to the mobile launcher (ML) tower at the center. The crew access arm will be located at about the 274-foot level on the tower. It will rotate from its retracted position and interface with the Orion crew hatch location to provide entry to the Orion crew module. The Ground Systems Development and Operations Program is overseeing installation of umbilicals and launch accessories on the ML tower.

Mobile Launcher Crew Access Arm Transport from Cocoa FL to KSC

NASA Image and Video Library

2017-10-17

A flatbed truck with the Orion crew access arm secured atop arrives in a storage location at NASA's Kennedy Space Center in Florida. The access arm was transported from Precision Fabricating and Cleaning in Cocoa, Florida. Later this month, the arm will be transported to the mobile launcher (ML) tower at the center. The crew access arm will be located at about the 274-foot level on the tower. It will rotate from its retracted position and interface with the Orion crew hatch location to provide entry to the Orion crew module. The Ground Systems Development and Operations Program is overseeing installation of umbilicals and launch accessories on the ML tower.

Eurelios - The 1-MW(el) helioelectric power plant of the European Community Program

NASA Astrophysics Data System (ADS)

Borgese, D.; Dinelli, G.; Faure, J. J.; Gretz, J.; Schober, G.

1984-02-01

The Eurelios solar thermal electricity-generating plant is based on the central receiver principle. Mirror surfaces totaling 6200 sq m are mounted on 182 heliostats which reflect solar flux into a central receiver atop a 55-m high tower. Water is circulated through the receiver, which converts it to steam that in turn drives a turbine generator. A bypass is used for start-up and shut-down procedures, and a thermal buffer system has been incorporated so that the plant can continue operating without solar energy input over a period of 30 min. Attention is given to heliostat and central receiver design details and optical performance values.

Interim Cryogenic Propulsion Stage (ICPS) Transport from DOC to

NASA Image and Video Library

2017-07-26

The Interim Cryogenic Propulsion Stage (ICPS) for NASA's Space Launch System (SLS) rocket, packed inside a canister, exits the United Launch Alliance (ULA) Delta Operations Center near Space Launch Complex 37 at Cape Canaveral Air Force Station for its move to the Space Station Processing Facility at NASA's Kennedy Space Center in Florida. The ICPS is the first integrated piece of flight hardware to arrive for the SLS. It is the in-space stage that is located toward the top of the rocket, between the Launch Vehicle Stage Adapter and the Orion Spacecraft Adapter. It will provide some of the in-space propulsion during Orion's first flight test atop the SLS on Exploration Mission-1.

Interim Cryogenic Propulsion Stage (ICPS) for EM-1 Transport fro

NASA Image and Video Library

2017-04-11

The Interim Cryogenic Propulsion Stage (ICPS) for NASA's Space Launch System rocket is moved inside the Delta Operations Center at Cape Canaveral Air Force Station in Florida. The ICPS was moved from the United Launch Alliance (ULA) Horizontal Integration Facility near Space Launch Complex 37 at the Cape. The ICPS is the first integrated piece of flight hardware to arrive for the SLS. It is the in-space stage that is located toward the top of the rocket, between the Launch Vehicle Stage Adapter and the Orion Spacecraft Adapter. It will provide some of the in-space propulsion during Orion's first flight test atop the SLS on Exploration Mission-1.

Interim Cryogenic Propulsion Stage (ICPS) Prep for Transport fro

NASA Image and Video Library

2017-07-25

The Interim Cryogenic Propulsion Stage (ICPS) for NASA's Space Launch System (SLS) rocket is packed inside a canister and ready to be moved from the United Launch Alliance (ULA) Delta Operations Center near Space Launch Complex 37 at Cape Canaveral Air Force Station to the Space Station Processing Facility at NASA's Kennedy Space Center in Florida. The ICPS is the first integrated piece of flight hardware to arrive for the SLS. It is the in-space stage that is located toward the top of the rocket, between the Launch Vehicle Stage Adapter and the Orion Spacecraft Adapter. It will provide some of the in-space propulsion during Orion's first flight test atop the SLS on Exploration Mission-1.

Interim Cryogenic Propulsion Stage (ICPS) for EM-1 Transport fro

NASA Image and Video Library

2017-04-11

The Interim Cryogenic Propulsion Stage (ICPS) for NASA's Space Launch System (SLS) rocket has been moved on its transport stand by truck out of the United Launch Alliance (ULA) Horizontal Integration Facility near Space Launch Complex 37 at Cape Canaveral Air Force Station in Florida. The ICPS will be transported to the Delta Operations Center. The ICPS is the first integrated piece of flight hardware to arrive for the SLS. It is the in-space stage that is located toward the top of the rocket, between the Launch Vehicle Stage Adapter and the Orion Spacecraft Adapter. It will provide some of the in-space propulsion during Orion's first flight test atop the SLS on Exploration Mission-1.

Interim Cryogenic Propulsion Stage (ICPS) for EM-1 Transport fro

NASA Image and Video Library

2017-04-11

The Interim Cryogenic Propulsion Stage (ICPS) for NASA's Space Launch System (SLS) rocket is moved on its transport stand by truck out of the United Launch Alliance (ULA) Horizontal Integration Facility near Space Launch Complex 37 at Cape Canaveral Air Force Station in Florida. The ICPS will be transported to the Delta Operations Center. The ICPS is the first integrated piece of flight hardware to arrive for the SLS. It is the in-space stage that is located toward the top of the rocket, between the Launch Vehicle Stage Adapter and the Orion Spacecraft Adapter. It will provide some of the in-space propulsion during Orion's first flight test atop the SLS on Exploration Mission-1.

Interim Cryogenic Propulsion Stage (ICPS) for EM-1 Transport fro

NASA Image and Video Library

2017-04-11

The Interim Cryogenic Propulsion Stage (ICPS) for NASA's Space Launch System (SLS) rocket has been moved on its transport stand by truck out of the United Launch Alliance (ULA) Horizontal Integration Facility near Space Launch Complex 37 at Cape Canaveral Air Force Station in Florida, on its way to the Delta Operations Center. The ICPS is the first integrated piece of flight hardware to arrive for the SLS. It is the in-space stage that is located toward the top of the rocket, between the Launch Vehicle Stage Adapter and the Orion Spacecraft Adapter. It will provide some of the in-space propulsion during Orion's first flight test atop the SLS on Exploration Mission-1.

Interim Cryogenic Propulsion Stage (ICPS) Transport from DOC to

NASA Image and Video Library

2017-07-26

The Interim Cryogenic Propulsion Stage (ICPS) for NASA's Space Launch System (SLS) rocket, packed inside a canister, is transported from the United Launch Alliance (ULA) Delta Operations Center near Space Launch Complex 37 at Cape Canaveral Air Force Station along the route to the Space Station Processing Facility at NASA's Kennedy Space Center in Florida. The ICPS is the first integrated piece of flight hardware to arrive for the SLS. It is the in-space stage that is located toward the top of the rocket, between the Launch Vehicle Stage Adapter and the Orion Spacecraft Adapter. It will provide some of the in-space propulsion during Orion's first flight test atop the SLS on Exploration Mission-1.

Interim Cryogenic Propulsion Stage (ICPS) for EM-1 Transport fro

NASA Image and Video Library

2017-04-11

The Interim Cryogenic Propulsion Stage (ICPS) for NASA's Space Launch System (SLS) rocket has been moved on its transport stand by truck out of the United Launch Alliance (ULA) Horizontal Integration Facility near Space Launch Complex 37 at Cape Canaveral Air Force Station in Florida, and is on its way to the Delta Operations Center. The ICPS is the first integrated piece of flight hardware to arrive for the SLS. It is the in-space stage that is located toward the top of the rocket, between the Launch Vehicle Stage Adapter and the Orion Spacecraft Adapter. It will provide some of the in-space propulsion during Orion's first flight test atop the SLS on Exploration Mission 1.

Lack of association between atopic eczema and the genetic variants of interleukin-4 and the interleukin-4 receptor alpha chain gene: heterogeneity of genetic backgrounds on immunoglobulin E production in atopic eczema patients.

PubMed

Tanaka, K; Sugiura, H; Uehara, M; Hashimoto, Y; Donnelly, C; Montgomery, D S

2001-10-01

The genetic background of atopic eczema might be heterogeneous and there is a possibility that immunoglobulin (Ig)E responsiveness in patients with atopic eczema is controlled separately from the development of atopic eczema. Although both interleukin (IL)-4 and the IL-4 receptor alpha chain have an important role for IgE production and are therefore possible candidate genes for atopy, it has not been clarified whether these genes play any roles in atopic eczema patients who have normal IgE productivity. We aimed to assess whether the polymorphisms of the IL-4 gene and the IL-4 receptor alpha chain gene play any roles in atopic eczema patients, particularly in patients who have normal IgE productivity. We determined the genotype with regard to polymorphisms in the genes for IL-4 and the IL-4 receptor alpha chain (- 589C/T of IL-4; Ile50Val, Ala375Glu and Arg551Gln of IL-4 receptor alpha chain) in patients with atopic eczema using the fluorogenic 5' nuclease assay. IL-4 and the IL-4 receptor alpha chain genotypes were not significantly associated with either total patients with atopic eczema or atopic eczema patients who had normal IgE productivity. The distribution of genotypes of IL-4-589C/T differed by the serum IgE levels in patients with atopic eczema. These results suggest that the polymorphisms in the IL-4 gene and the IL-4 receptor alpha chain gene play no role in the development of atopic eczema in patients who have normal IgE productivity.

Pro-inflammatory interleukins in middle ear effusions from atopic and non-atopic children with chronic otitis media with effusion.

PubMed

Zielnik-Jurkiewicz, Beata; Stankiewicz-Szymczak, Wanda

2016-06-01

Chronic otitis media with effusion (OME) is associated with irreversible changes in the middle ear, sometimes leading to hearing loss and abnormal language development in children. While the pathogenesis of OME is not fully understood, inflammatory and allergic factors are thought to be involved. The study aimed to investigate the role of cytokines in the local development of chronic OME, and assess differences in the cytokine profiles between atopic and non-atopic children. 84 atopic and non-atopic children with chronic OME (mean age of 6 years 7 months) were studied. Age-matched children with hypertrophy of the adenoids and Eustachian tube dysfunction served as the control group. The number of past acute otitis media (AOM) episodes, their age, and the type of effusion were recorded for all children. Pro-inflammatory cytokine concentrations (TNF-α, IL-1β, IL-6 and IL-8) were determined and the presence of pathogenic bacteria in the patients' effusions was examined. High concentrations of TNF-α, IL-1β, IL-6 and IL-8 were found in the effusions in all children with chronic OME, with the highest levels observed in the non-atopic group. The atopic group showed persistently high IL-1β levels, while in the non-atopic children, IL-1β and TNF-α levels positively correlated with the patient's age and the number of past AOM episodes. Pathogenic bacteria were more frequently isolated from effusions in non-atopic children. In both atopic and non-atopic children, pro-inflammatory cytokines are found at high concentrations. This argues in favor of instituting anti-inflammatory management for treating OME, regardless of atopy.

KSC-2013-3786

NASA Image and Video Library

2013-11-01

CAPE CANAVERAL, Fla. – The United Launch Alliance Atlas V launch vehicle, left, and Centaur upper stage that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit is being transported to the hangar at the Atlas Spaceflight Operations Center on Cape Canaveral Air Force Station for checkout in preparation for launch. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/ Jim Grossman

KSC-2013-4402

NASA Image and Video Library

2013-12-13

CAPE CANAVERAL, Fla. – At Cape Canaveral Air Force Station, engineers and technicians support lifting the first stage of the United Launch Alliance Atlas V rocket during stacking operations in the Vertical Integration Facility at Launch Complex 41. The vehicle will be used to boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft to orbit. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Charisse Nahser

KSC-2013-4413

NASA Image and Video Library

2013-12-13

CAPE CANAVERAL, Fla. – At Cape Canaveral Air Force Station, a technician support lifting the first stage of the United Launch Alliance Atlas V rocket during stacking operations in the Vertical Integration Facility at Launch Complex 41. The vehicle will be used to boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft to orbit. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Charisse Nahser

KSC-2013-4412

NASA Image and Video Library

2013-12-13

CAPE CANAVERAL, Fla. – At Cape Canaveral Air Force Station, engineers and technicians support lifting the first stage of the United Launch Alliance Atlas V rocket during stacking operations in the Vertical Integration Facility at Launch Complex 41. The vehicle will be used to boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft to orbit. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Charisse Nahser

KSC-2013-3782

NASA Image and Video Library

2013-11-01

PORT CANAVERAL, Fla. – Following arrival at Port Canaveral, Fla., the United Launch Alliance Atlas V first stage and Centaur upper stage that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit is being transported to Cape Canaveral Air Force Station's Atlas Spaceflight Operations Center for checkout in preparation for launch. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/ Kim Shiflett

KSC-2013-4404

NASA Image and Video Library

2013-12-13

CAPE CANAVERAL, Fla. – At Cape Canaveral Air Force Station, engineers and technicians support lifting the first stage of the United Launch Alliance Atlas V rocket during stacking operations in the Vertical Integration Facility at Launch Complex 41. The vehicle will be used to boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft to orbit. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/Charisse Nahser

KSC-2013-3781

NASA Image and Video Library

2013-11-01

PORT CANAVERAL, Fla. – Following arrival at Port Canaveral, Fla., the United Launch Alliance Atlas V first stage and Centaur upper stage that will boost the Tracking and Data Relay Satellite, or TDRS-L, spacecraft into orbit is being transported to Cape Canaveral Air Force Station's Atlas Spaceflight Operations Center for checkout in preparation for launch. TDRS-L is the second of three next-generation satellites designed to ensure vital operational continuity for the NASA Space Network. It is scheduled to launch from Cape Canaveral's Space Launch Complex 41 atop an Atlas V rocket in January 2014. The current Tracking and Data Relay Satellite system consists of eight in-orbit satellites distributed to provide near continuous information relay service to missions such as the Hubble Space Telescope and International Space Station. For more information, visit: http://www.nasa.gov/content/tracking-and-data-relay-satellite-tdrs/ Photo credit: NASA/ Kim Shiflett

KSC-2014-4627

NASA Image and Video Library

2014-12-02

CAPE CANAVERAL, Fla. – At NASA's Kennedy Space Center in Florida, NASA leaders spoke to members of the news media about how the first flight of the new Orion spacecraft is a first step in the agency's plans to send humans to Mars. At Kennedy's News Center auditorium from the left are: Mike Curie of NASA Public Affairs, Mike Bolger, program manager of Ground Systems Development and Operations Program, and Chris Crumbly, manager of Space Launch System Spacecraft/Payload Integration and Evolution. Participating via video from the agency's headquarters in Washington included Jason Crusan, director of Advanced Exploration Systems Division of Human Exploration and Operations Mission Directorate, seen on the monitor on the right. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted flight test of Orion is scheduled to launch Dec. 4, 2014 atop a United Launch Alliance Delta IV Heavy rocket, and in 2018 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion Photo credit: NASA/Kim Shiflett

Differences in itch characteristics between psoriasis and atopic dermatitis patients: results of a web-based questionnaire.

PubMed

O'Neill, Jenna L; Chan, Yiong Huak; Rapp, Stephen R; Yosipovitch, Gil

2011-09-01

Differences in itch characteristics between different inflammatory dermatoses are not well described. The aim of this study was to assess differences in itch characteristics between patients with psoriasis and atopic dermatitis using a previously validated web-based questionnaire that was made available through the National Psoriasis Foundation and National Eczema Association for Science and Education websites. Participants rated frequency and intensity of itch, associated symptoms, itch descriptors, and effect of scratching. A total of 524 subjects with atopic dermatitis and 195 subjects with psoriasis completed the survey. Atopic dermatitis responders experienced more frequent and more intense itch. Associated sweating and heat sensation were also more common in atopic dermatitis. Scratching was considered pleasurable in both atopic dermatitis and psoriasis; pleasurability correlated weakly with itch intensity in atopic dermatitis. Psoriasis respondents reported higher embarrassment associated with itch. Itch sensation is experienced differently among patients with atopic dermatitis and psoriasis. Future therapeutic interventions may be developed to target these differences.

Influences of Environmental Chemicals on Atopic Dermatitis.

PubMed

Kim, Kwangmi

2015-06-01

Atopic dermatitis is a chronic inflammatory skin condition including severe pruritus, xerosis, visible eczematous skin lesions that mainly begin early in life. Atopic dermatitis exerts a profound impact on the quality of life of patients and their families. The estimated lifetime prevalence of atopic dermatitis has increased 2~3 fold during over the past 30 years, especially in urban areas in industrialized countries, emphasizing the importance of life-style and environment in the pathogenesis of atopic diseases. While the interplay of individual genetic predisposition and environmental factors contribute to the development of atopic dermatitis, the recent increase in the prevalence of atopic dermatitis might be attributed to increased exposure to various environmental factors rather than alterations in human genome. In recent decades, there has been an increasing exposure to chemicals from a variety of sources. In this study, the effects of various environmental chemicals we face in everyday life - air pollutants, contact allergens and skin irritants, ingredients in cosmetics and personal care products, and food additives - on the prevalence and severity of atopic dermatitis are reviewed.

Electron impact excitation of molecular hydrogen

DOE PAGES

Zammit, Mark Christian; Savage, Jeremy S.; Fursa, Dmitry V.; ...

2017-02-06

Here, we report the electron impact integrated and differential cross sections for excitation to the b 3Σmore » $$+\\atop{u}$$, a 3Σ$$+\\atop{g}$$, c 3Π u, B 1Σ$$+\\atop{u}$$, E, F 1Σ$$+\\atop{g}$$, C 1Π u, e 3Σ$$+\\atop{u}$$, h 3Σ $$+\\atop{g}$$, d 3Π u, B'' 1Σ$$+\\atop{u}$$ , D 1Π u, B'' 1Σ$$+\\atop{u}$$, and D' 1Π u states of molecular hydrogen in the energy range from 10 to 300 eV. Total scattering and total ionization cross sections are also presented. The calculations have been performed by using the convergent close-coupling method within the fixed-nuclei approximation. Detailed convergence studies have been performed with respect to the size of the close-coupling expansion and a set of recommended cross sections has been produced. Significant differences with previous calculations are found. Agreement with experiment is mixed, ranging from excellent to poor depending on the transition and incident energies.« less

KSC-2014-3929

NASA Image and Video Library

2014-09-11

SAN DIEGO, Calif. – The USS Anchorage is docked at Naval Base San Diego during loading operations in its well deck for Orion Underway Recovery Test 3. The ship will head out to sea, off the coast of San Diego, in search of conditions to support test needs for a full dress rehearsal of recovery operations. NASA, Lockheed Martin and U.S. Navy personnel will conduct tests in the Pacific Ocean to prepare for recovery of the Orion crew module on its return from a deep space mission. The test will allow the teams to demonstrate and evaluate the recovery processes, procedures, new hardware and personnel in open waters. The Ground Systems Development and Operations Program is conducting the underway recovery tests. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a United Launch Alliance Delta IV Heavy rocket and in 2018 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Cory Huston

KSC-2014-3932

NASA Image and Video Library

2014-09-11

SAN DIEGO, Calif. – The USS Anchorage is docked at Naval Base San Diego during loading operations in its well deck for Orion Underway Recovery Test 3. The ship will head out to sea, off the coast of San Diego, in search of conditions to support test needs for a full dress rehearsal of recovery operations. NASA, Lockheed Martin and U.S. Navy personnel will conduct tests in the Pacific Ocean to prepare for recovery of the Orion crew module on its return from a deep space mission. The test will allow the teams to demonstrate and evaluate the recovery processes, procedures, new hardware and personnel in open waters. The Ground Systems Development and Operations Program is conducting the underway recovery tests. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a United Launch Alliance Delta IV Heavy rocket and in 2018 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Cory Huston

KSC-2014-3930

NASA Image and Video Library

2014-09-11

SAN DIEGO, Calif. – The USS Anchorage is docked at Naval Base San Diego during loading operations in its well deck for Orion Underway Recovery Test 3. The ship will head out to sea, off the coast of San Diego, in search of conditions to support test needs for a full dress rehearsal of recovery operations. NASA, Lockheed Martin and U.S. Navy personnel will conduct tests in the Pacific Ocean to prepare for recovery of the Orion crew module on its return from a deep space mission. The test will allow the teams to demonstrate and evaluate the recovery processes, procedures, new hardware and personnel in open waters. The Ground Systems Development and Operations Program is conducting the underway recovery tests. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a United Launch Alliance Delta IV Heavy rocket and in 2018 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Cory Huston

Children with atopic dermatitis may have unacknowledged contact allergies contributing to their skin symptoms.

PubMed

Simonsen, A B; Johansen, J D; Deleuran, M; Mortz, C G; Skov, L; Sommerlund, M

2018-03-01

Whether children with atopic dermatitis have an altered risk of contact allergy than children without atopic dermatitis is frequently debated and studies have been conflicting. Theoretically, the impaired skin barrier in atopic dermatitis (AD) facilitates the penetration of potential allergens and several authors have highlighted the risk of underestimating and overlooking contact allergy in children with atopic dermatitis. To determine the prevalence of contact allergy in Danish children with atopic dermatitis and explore the problem of unacknowledged allergies maintaining or aggravating the skin symptoms. In a cross-sectional study, 100 children and adolescents aged 5-17 years with a diagnosis of atopic dermatitis were patch tested with a paediatric series of 31 allergens. Thirty per cent of the children had at least one positive patch test reaction, and 17% had at least one contact allergy that was relevant to the current skin symptoms. The risk of contact allergy was significantly correlated to the severity of atopic dermatitis. Metals and components of topical skincare products were the most frequent sensitizers. Patch testing is relevant as a screening tool in the management of children with atopic dermatitis as they may have unacknowledged contact allergies contributing to or maintaining their skin symptoms. Children with atopic dermatitis seem to be at greater risk of sensitization to certain allergens including metals and components of skincare products. © 2017 European Academy of Dermatology and Venereology.

Economic Impact of Atopic Dermatitis in Korean Patients

PubMed Central

Kim, Chulmin; Park, Kui Young; Ahn, Seohee; Kim, Dong Ha; Li, Kapsok; Kim, Do Won; Kim, Moon-Beom; Jo, Sun-Jin; Yim, Hyeon Woo

2015-01-01

Background Atopic dermatitis is a global public health concern owing to its increasing prevalence and socioeconomic burden. However, few studies have assessed the economic impact of atopic dermatitis in Korea. Objective We conducted a cost analysis of atopic dermatitis and evaluated its economic impacts on individual annual disease burden, quality of life, and changes in medical expenses with respect to changes in health related-quality of life. Methods The cost analysis of atopic dermatitis was performed by reviewing the home accounting records of 32 patients. The economic impact of the disease was evaluated by analyzing questionnaires. To handle uncertainties, we compared the results with the data released by the Health Insurance Review & Assessment Board on medical costs claimed by healthcare facilities. Results The direct cost of atopic dermatitis per patient during the 3-month study period was 541,280 Korean won (KRW), and expenditures on other atopic dermatitis-related products were 120,313 KRW. The extrapolated annual direct cost (including expenditures on other atopic dermatitis-related products) per patient was 2,646,372 KRW. The estimated annual indirect cost was 1,507,068 KRW. Thus, the annual cost of illness of atopic dermatitis (i.e., direct+indirect costs) was estimated to be 4,153,440 KRW. Conclusion The annual total social cost of atopic dermatitis on a national level is estimated to be 5.8 trillion KRW. PMID:26082587

Translation and validation of Portuguese of a questionnaire for evaluation of psychosomatic symptoms in adults with atopic dermatitis*

PubMed Central

Boleira, Manuela; Lupi, Omar; Pires, Gisele Vianna; Dias, Gabriela; Seba, Amanda Jaccobson; Guimarães, Daniel Boleira Sieiro

2014-01-01

BACKGROUND atopic dermatitis is directly related to psychological stress, reduced quality of life and psychosomatic symptoms. The Psychosomatic Scale for Atopic Dermatitis is the only questionnaire developed specifically for assessment of psychosomatization in atopic dermatitis. OBJECTIVES the objective of this study was to cross-culturally adapt and validate a Brazilian-Portuguese version of the Psychosomatic Scale for Atopic Dermatitis. METHODS adaptation consisted of independent translation and backtranslation by three bilingual translators, followed by a pre-test. The Psychosomatic Scale for Atopic Dermatitis and the Dermatology Life Quality Index were self-administered to 47 patients with atopic dermatitis. Disease severity was evaluated using the Eczema Area and Severity Index. Factor analysis was used to identify the dimensions of the Brazilian Portuguese version of the Psychosomatic Scale for Atopic Dermatitis. Internal consistency and convergence validity were also analyzed. Reproducibility was assessed using the Kappa coefficient. RESULTS factor analysis revealed a two-dimensional structure: stress/laziness/insecurity (I) and maladjustment/social relationships (II), explaining 54.4% of total variance. All dimensions revealed excellent internal consistency. External construct validity was confirmed by positive correlations between the Psychosomatic Scale for Atopic Dermatitis and the Dermatology Life Quality Index. Test-retest reliability was excellent, with k>0.7 for all questions. CONCLUSIONS the Brazilian Portuguese version of the Psychosomatic Scale for Atopic Dermatitis demonstrated acceptable psychometric properties and can be used for the evaluation of psychosomatic symptoms in patients with atopic dermatitis and as a tool in clinical and epidemiological research. PMID:25184916

Relationship between dietary fat and fish intake and the prevalence of atopic eczema in pregnant Japanese females: baseline data from the Osaka Maternal and Child Health Study.

PubMed

Miyake, Yoshihiro; Sasaki, Satoshi; Tanaka, Keiko; Ohya, Yukihiro; Matsunaga, Ichiro; Yoshida, Toshiaki; Hirota, Yoshio; Oda, Hajime

2008-01-01

Dietary factors may be important in the development of atopic eczema. It remains controversial whether n-3 polyunsaturated fatty acid intake is preventive against allergic disorders and whether n-6 polyunsaturated fatty acid intake increases the risk of allergic disorders. The current cross-sectional study examined the association between intake of fatty acids and foods high in fatty acids and the prevalence of atopic eczema. Study subjects were 1002 pregnant Japanese females. Current atopic eczema and atopic eczema after age 18 were defined as present if subjects had been treated with medications at some time in the previous 12 months and after reaching the age of 18, respectively. Information on dietary factors was collected using a validated self-administered diet history questionnaire. Docosahexaenoic acid intake was statistically significantly related to a decreased prevalence of atopic eczema after age 18 and current atopic eczema. Inverse dose-response relationships with regard to consumption of n-3 polyunsaturated fatty acids, eicosapentaenoic acid, and fish and the ratio of n-3 to n-6 polyunsaturated fatty acids with atopic eczema were not observed although these dietary variables in the second tertile were inversely significantly associated with atopic eczema after age 18. Intake of total fat, saturated fatty acids, monounsaturated fatty acids, n-6 polyunsaturated fatty acids, cholesterol, meat, eggs, or dairy products was not related to either of the outcomes for atopic eczema. Docosahexaenoic acid intake may be associated with a reduced prevalence of atopic eczema in pregnant Japanese females.

Quantum oscillations in a bilayer with broken mirror symmetry: A minimal model for YBa 2 Cu 3 O 6 + δ

DOE PAGES

Maharaj, Akash V.; Zhang, Yi; Ramshaw, B. J.; ...

2016-03-01

Using an exact numerical solution and semiclassical analysis, we investigate quantum oscillations (QOs) in a model of a bilayer system with an anisotropic (elliptical) electron pocket in each plane. Key features of QO experiments in the high temperature superconducting cuprate YBCO can be reproduced by such a model, in particular the pattern of oscillation frequencies (which reflect “magnetic breakdown” between the two pockets) and the polar and azimuthal angular dependence of the oscillation amplitudes. However, the requisite magnetic breakdown is possible only under the assumption that the horizontal mirror plane symmetry is spontaneously broken and that the bilayer tunneling t ⊥ is substantially renormalized from its ‘bare’ value. Lastly, under the assumption that t ⊥ =more » $$\\sim\\atop{Z}_t$$ $$(0)\\atop{⊥}$$, where $$\\sim\\atop{Z}$$ is a measure of the quasiparticle weight, this suggests that $$\\sim\\atop{Z}$$ ≲ 1/20. Detailed comparisons with new YBa 2Cu 3O 6.58 QO data, taken over a very broad range of magnetic field, confirm specific predictions made by the breakdown scenario.« less

Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industry.

PubMed

Siegfried, Elaine C; Jaworski, Jennifer C; Eichenfield, Lawrence F; Paller, Amy; Hebert, Adelaide A; Simpson, Eric L; Altman, Emily; Arena, Charles; Blauvelt, Andrew; Block, Julie; Boguniewicz, Mark; Chen, Suephy; Cordoro, Kelly; Hanna, Diane; Horii, Kimberly; Hultsch, Thomas; Lee, James; Leung, Donald Y; Lio, Peter; Milner, Joshua; Omachi, Theodore; Schneider, Christine; Schneider, Lynda; Sidbury, Robert; Smith, Timothy; Sugarman, Jeffrey; Taha, Sharif; Tofte, Susan; Tollefson, Megha; Tom, Wynnis L; West, Dennis P; Whitney, Lucinda; Zane, Lee

2018-05-01

Atopic dermatitis is the most common chronic skin disease, and it primarily affects children. Although atopic dermatitis (AD) has the highest effect on burden of skin disease, no high-level studies have defined optimal therapy for severe disease. Corticosteroids have been used to treat AD since the 1950s and remain the only systemic medication with Food and Drug Administration approval for this indication in children, despite published guidelines of care that recommend against this option. Several clinical trials with level 1 evidence have supported the use of topical treatments for mild to moderate atopic dermatitis in adults and children, but these trials have had little consistency in protocol design. Consensus recommendations will help standardize clinical development and trial design for children. The Food and Drug Administration issues guidance documents for industry as a source for "the Agency's current thinking on a particular subject." Although they are nonbinding, industry considers these documents to be the standard for clinical development and trial design. Our consensus group is the first to specifically address clinical trial design in this population. We developed a draft guidance document for industry, Developing Drugs for Treatment of Atopic Dermatitis in Children (≥3 months to <18 years of age). This draft guidance has been submitted to the Food and Drug Administration based on a provision in the Federal Register (Good Guidance Practices). © 2018 Wiley Periodicals, Inc.

Diet Quality throughout Early Life in Relation to Allergic Sensitization and Atopic Diseases in Childhood.

PubMed

Nguyen, Anh N; Elbert, Niels J; Pasmans, Suzanne G M A; Kiefte-de Jong, Jessica C; de Jong, Nicolette W; Moll, Henriëtte A; Jaddoe, Vincent W V; de Jongste, Johan C; Franco, Oscar H; Duijts, Liesbeth; Voortman, Trudy

2017-08-05

Early-life nutrition is an important modifiable determinant in the development of a child's immune system, and may thereby influence the risk of allergic sensitization and atopic diseases. However, associations between overall dietary patterns and atopic diseases in childhood remain unclear. We examined associations of diet quality in early life with allergic sensitization, self-reported physician-diagnosed inhalant and food allergies, eczema, and asthma among 5225 children participating in a population-based cohort in the Netherlands. Diet was assessed during pregnancy, infancy, and childhood using validated food-frequency questionnaires. We calculated food-based diet quality scores (0-10 or 0-15), reflecting adherence to dietary guidelines. At age 10 years, allergic sensitization was assessed with skin prick tests. Information on physician-diagnosed inhalant and food allergies, eczema, and asthma was obtained with questionnaires. We observed no associations between diet quality during pregnancy and allergic sensitization (odds ratio (OR) = 1.05 per point in the diet score, 95% confidence interval (CI): 0.99, 1.13), allergies (0.96, 95% CI: 0.88, 1.04), eczema (0.99, 95% CI: 0.93, 1.06), or asthma (0.93, 95% CI: 0.85, 1.03) in childhood. Also, diet quality in infancy or childhood were not associated with atopic outcomes in childhood. Our findings do not support our hypothesis that a healthy dietary pattern in early life is associated with a lower risk of allergic sensitization or atopic diseases in childhood.

The Role of Interleukins 4 and/or 13 in the Pathophysiology and Treatment of Atopic Dermatitis.

PubMed

Silverberg, Jonathan I; Kantor, Robert

2017-07-01

Moderate to severe atopic dermatitis (AD) can be debilitating and often requires use of systemic immunosuppressant therapy to achieve adequate disease control. There are currently no US Food and Drug Administration-approved systemic agents for the long-term treatment of AD. Recent insight has identified the T helper 2 cytokines, interleukins 4 and 13, as playing a major role in the pathogenesis of AD. There are multiple novel biologic agents in development that target interleukins 4 and/or 13 for the treatment of moderate to severe AD. The age of targeted biologics for AD has arrived. Copyright © 2017 Elsevier Inc. All rights reserved.

Childhood exposure to ambient polycyclic aromatic hydrocarbons is linked to epigenetic modifications and impaired systemic immunity in T cells

PubMed Central

Hew, K. M.; Walker, A. I.; Kohli, A.; Garcia, M.; Syed, A.; McDonald-Hyman, C.; Noth, E. M.; Mann, J. K.; Pratt, B.; Balmes, J.; Hammond, S. Katharine; Eisen, E. A.; Nadeau, K. C.

2015-01-01

Summary Background Evidence suggests that exposure to polycyclic aromatic hydrocarbons (PAHs) increases atopy; it is unclear how PAH exposure is linked to increased severity of atopic diseases. Objective We hypothesized that ambient PAH exposure is linked to impairment of immunity in atopic children (defined as children with asthma and/or allergic rhinitis) from Fresno, California, an area with elevated ambient PAHs. Methods We recruited 256 subjects from Fresno, CA. Ambient PAH concentrations (ng/m3) were measured using a spatial-temporal regression model over multiple time periods. Asthma diagnosis was determined by current NHLBI criteria. Phenotyping and functional immune measurements were performed from isolated cells. For epigenetic measurements, DNA was isolated and pyrosequenced. Results We show that higher average PAH exposure was significantly associated with impaired Treg function and increased methylation in the forkhead box protein 3 (FOXP3) locus (P < 0.05), conditional on atopic status. These epigenetic modifications were significantly linked to differential protein expression of FOXP3 (P < 0.001). Methylation was associated with cellular functional changes, specifically Treg dysfunction, and an increase in total plasma IgE levels. Protein expression of IL-10 decreased and IFN-γ increased as the extent of PAH exposure increased. The strength of the associations generally increased as the time window for average PAH exposure increased from 24 hr to 1 year, suggesting more of a chronic response. Significant associations with chronic PAH exposure and immune outcomes were also observed in subjects with allergic rhinitis. Conclusions and Clinical Relevance Collectively, these results demonstrate that increased ambient PAH exposure is associated with impaired systemic immunity and epigenetic modifications in a key locus involved in atopy: FOXP3, with a higher impact on atopic children. The results suggest that increased atopic clinical symptoms in children could be linked to increased PAH exposure in air pollution. PMID:25048800

KSC-2009-1007

NASA Image and Video Library

2009-01-02

CAPE CANAVERAL, Fla. – On Launch Pad 39B at NASA's Kennedy Space Center in Florida, a crane places the 100-foot fiberglass mast atop the new lightning tower constructed on the pad. The towers are part of the new lightning protection system for the Constellation Program and Ares/Orion launches. At left of the service structures is another tower under construction. Each of the three new lightning towers will be 500 feet tall with the additional 100-foot fiberglass mast atop supporting a wire catenary system. This improved lightning protection system allows for the taller height of the Ares I rocket compared to the space shuttle. Pad 39B will be the site of the first Ares vehicle launch, including the Ares I-X test flight that is targeted for July 2009. Photo credit: NASA/Kim Shiflett

KSC00pp0086

NASA Image and Video Library

2000-01-17

One of two new payload transporters for Kennedy Space Center sits on the dock at Port Canaveral. In the background is a cruise ship docked at the Port. The transporters were shipped by barge from their manufacturer, the KAMAG Company of Ulm, Germany. They are used to carry spacecraft and International Space Station elements from payload facilities to and from the launch pads and orbiter hangars. Each transporter is 65 feet long and 22 feet wide and has 24 tires divided between its two axles. The transporter travels 10 miles per hour unloaded, 5 miles per hour when loaded; it weighs up to 172,000 pounds when the canister with payloads rides atop. The transporters will be outfitted with four subsystems for monitoring the environment inside the canister during the payload moves: the Electrical Power System, Environmental Control System, Instrumentation and Communications System, and the Fluids and Gases System. Engineers and technicians are being trained on the transporter's operation and maintenance. The new transporters are replacing the 20-year-old existing Payload Canister Transporter system

KSC-00pp0085

NASA Image and Video Library

2000-01-17

One of two new payload transporters for Kennedy Space Center sits on the dock at Port Canaveral. In the background is a cruise ship docked at the Port. The transporters were shipped by barge from their manufacturer, the KAMAG Company of Ulm, Germany. They are used to carry spacecraft and International Space Station elements from payload facilities to and from the launch pads and orbiter hangars. Each transporter is 65 feet long and 22 feet wide and has 24 tires divided between its two axles. The transporter travels 10 miles per hour unloaded, 5 miles per hour when loaded; it weighs up to 172,000 pounds when the canister with payloads rides atop. The transporters will be outfitted with four subsystems for monitoring the environment inside the canister during the payload moves: the Electrical Power System, Environmental Control System, Instrumentation and Communications System, and the Fluids and Gases System. Engineers and technicians are being trained on the transporter's operation and maintenance. The new transporters are replacing the 20-year-old existing Payload Canister Transporter system

KSC-00pp0086

NASA Image and Video Library

2000-01-17

One of two new payload transporters for Kennedy Space Center sits on the dock at Port Canaveral. In the background is a cruise ship docked at the Port. The transporters were shipped by barge from their manufacturer, the KAMAG Company of Ulm, Germany. They are used to carry spacecraft and International Space Station elements from payload facilities to and from the launch pads and orbiter hangars. Each transporter is 65 feet long and 22 feet wide and has 24 tires divided between its two axles. The transporter travels 10 miles per hour unloaded, 5 miles per hour when loaded; it weighs up to 172,000 pounds when the canister with payloads rides atop. The transporters will be outfitted with four subsystems for monitoring the environment inside the canister during the payload moves: the Electrical Power System, Environmental Control System, Instrumentation and Communications System, and the Fluids and Gases System. Engineers and technicians are being trained on the transporter's operation and maintenance. The new transporters are replacing the 20-year-old existing Payload Canister Transporter system

KSC-00pp0084

NASA Image and Video Library

2000-01-17

One of two new payload transporters for Kennedy Space Center arrives at Port Canaveral. In the background is a cruise ship docked at the Port. The transporters were shipped by barge from their manufacturer, the KAMAG Company of Ulm, Germany. They are used to carry spacecraft and International Space Station elements from payload facilities to and from the launch pads and orbiter hangars. Each transporter is 65 feet long and 22 feet wide and has 24 tires divided between its two axles. The transporter travels 10 miles per hour unloaded, 5 miles per hour when loaded; it weighs up to 172,000 pounds when the canister with payloads rides atop. The transporters will be outfitted with four subsystems for monitoring the environment inside the canister during the payload moves: the Electrical Power System, Environmental Control System, Instrumentation and Communications System, and the Fluids and Gases System. Engineers and technicians are being trained on the transporter's operation and maintenance. The new transporters are replacing the 20-year-old existing Payload Canister Transporter system

KSC00pp0084

NASA Image and Video Library

2000-01-17

One of two new payload transporters for Kennedy Space Center arrives at Port Canaveral. In the background is a cruise ship docked at the Port. The transporters were shipped by barge from their manufacturer, the KAMAG Company of Ulm, Germany. They are used to carry spacecraft and International Space Station elements from payload facilities to and from the launch pads and orbiter hangars. Each transporter is 65 feet long and 22 feet wide and has 24 tires divided between its two axles. The transporter travels 10 miles per hour unloaded, 5 miles per hour when loaded; it weighs up to 172,000 pounds when the canister with payloads rides atop. The transporters will be outfitted with four subsystems for monitoring the environment inside the canister during the payload moves: the Electrical Power System, Environmental Control System, Instrumentation and Communications System, and the Fluids and Gases System. Engineers and technicians are being trained on the transporter's operation and maintenance. The new transporters are replacing the 20-year-old existing Payload Canister Transporter system

KSC00pp0085

NASA Image and Video Library

2000-01-17

One of two new payload transporters for Kennedy Space Center sits on the dock at Port Canaveral. In the background is a cruise ship docked at the Port. The transporters were shipped by barge from their manufacturer, the KAMAG Company of Ulm, Germany. They are used to carry spacecraft and International Space Station elements from payload facilities to and from the launch pads and orbiter hangars. Each transporter is 65 feet long and 22 feet wide and has 24 tires divided between its two axles. The transporter travels 10 miles per hour unloaded, 5 miles per hour when loaded; it weighs up to 172,000 pounds when the canister with payloads rides atop. The transporters will be outfitted with four subsystems for monitoring the environment inside the canister during the payload moves: the Electrical Power System, Environmental Control System, Instrumentation and Communications System, and the Fluids and Gases System. Engineers and technicians are being trained on the transporter's operation and maintenance. The new transporters are replacing the 20-year-old existing Payload Canister Transporter system

What Does Tympanostomy Tube Placement in Children Teach Us About the Association Between Atopic Conditions and Otitis Media?

PubMed Central

Juhn, Young J.; Wi, Chung-Il

2014-01-01

Otitis media is the most common infection second only to viral upper respiratory infection in the outpatient setting. Tympanostomy tube insertion (TTI) is the most common ambulatory surgical procedure in the United States. While many risk factors for otitis media have been identified, atopic conditions have been under-recognized as risk factors for recurrent and persistent otitis media. Given that asthma and other atopic conditions are the most common chronic conditions during childhood, it is worth examining the association between atopic conditions and risk of otitis media, which can provide insight into how atopic conditions influence the risk of microbial infections. This paper focuses its discussion on otitis media, however it is important that the association between atopic conditions and risk of otitis media be interpreted in the context of the association of atopic conditions with increased risks of various microbial infections. PMID:24816652

Evidence for a $$B_s^0 \\pi^\\pm$$ state

DOE Office of Scientific and Technical Information (OSTI.GOV)

Abazov, V. M.

Here, we report evidence for a narrow structure, X(5568), in the decay sequence X(5568)→more » $$B_s^0 \\pi^\\pm$$, B$$_s^0$$ →J/ψΦ, J/ψ→μ+μ-, Φ→K+K-. This is evidence for the first instance of a hadronic state with valence quarks of four different flavors. The mass and natural width of this state are measured to be m=5567.8±2.9(stat) $$+0.9\\atop{-1.9}$$ (syst) MeV/c 2 and Γ=21.9±6.4(stat)$$+5.0\\atop{-2.5}$$ (syst) MeV/c 2. If the decay is X(5568)→B$$*\\atop{s}$$ π ±→B$$0\\atop{s}$$ γπ ± with an unseen γ, m(X(5568)) will be shifted up by m(B$$*\\atop{s}$$ )-m(B$$0\\atop{s}$$)~49 MeV/c 2. This measurement is based on 10.4 fb -1 of $$p\\bar{p}$$ collision data at $$\\sqrt{s}$$ =1.96 TeV collected by the D0 experiment at the Fermilab Tevatron collider.« less

Association between mast cell chymase genotype and atopic eczema: comparison between patients with atopic eczema alone and those with atopic eczema and atopic respiratory disease.

PubMed

Tanaka, K; Sugiura, H; Uehara, M; Sato, H; Hashimoto-Tamaoki, T; Furuyama, J

1999-06-01

It has remained unclear whether genetic background of patients with atopic eczema (AE) alone is identical to that of patients with both AE and atopic respiratory disease. We aimed to assess whether there is a genetic difference between these two groups of AE patients. We determined the genotype with regard to an allelic polymorphism in the gene for mast cell chymase (MCC; a serine protease secreted from mast cells) in 169 AE patients. MCC genotype was significantly associated with pure AE patients who did not have a predisposition to atopic respiratory disease and whose serum IgE concentration was < 500 IU/mL. The distribution of MCC genotypes also differed significantly between the latter patients and those AE patients with bronchial asthma and a serum IgE concentration of > 2000 IU/mL. These results suggest that pure AE is associated with genetic variants of MCC, and that the genetic basis of pure AE differs from that of AE associated with atopic asthma.

Evidence for a $$B_s^0 \\pi^\\pm$$ state

DOE PAGES

Abazov, V. M.

2016-07-07

Here, we report evidence for a narrow structure, X(5568), in the decay sequence X(5568)→more » $$B_s^0 \\pi^\\pm$$, B$$_s^0$$ →J/ψΦ, J/ψ→μ+μ-, Φ→K+K-. This is evidence for the first instance of a hadronic state with valence quarks of four different flavors. The mass and natural width of this state are measured to be m=5567.8±2.9(stat) $$+0.9\\atop{-1.9}$$ (syst) MeV/c 2 and Γ=21.9±6.4(stat)$$+5.0\\atop{-2.5}$$ (syst) MeV/c 2. If the decay is X(5568)→B$$*\\atop{s}$$ π ±→B$$0\\atop{s}$$ γπ ± with an unseen γ, m(X(5568)) will be shifted up by m(B$$*\\atop{s}$$ )-m(B$$0\\atop{s}$$)~49 MeV/c 2. This measurement is based on 10.4 fb -1 of $$p\\bar{p}$$ collision data at $$\\sqrt{s}$$ =1.96 TeV collected by the D0 experiment at the Fermilab Tevatron collider.« less

Influences of Environmental Chemicals on Atopic Dermatitis

PubMed Central

2015-01-01

Atopic dermatitis is a chronic inflammatory skin condition including severe pruritus, xerosis, visible eczematous skin lesions that mainly begin early in life. Atopic dermatitis exerts a profound impact on the quality of life of patients and their families. The estimated lifetime prevalence of atopic dermatitis has increased 2~3 fold during over the past 30 years, especially in urban areas in industrialized countries, emphasizing the importance of life-style and environment in the pathogenesis of atopic diseases. While the interplay of individual genetic predisposition and environmental factors contribute to the development of atopic dermatitis, the recent increase in the prevalence of atopic dermatitis might be attributed to increased exposure to various environmental factors rather than alterations in human genome. In recent decades, there has been an increasing exposure to chemicals from a variety of sources. In this study, the effects of various environmental chemicals we face in everyday life - air pollutants, contact allergens and skin irritants, ingredients in cosmetics and personal care products, and food additives - on the prevalence and severity of atopic dermatitis are reviewed. PMID:26191377

[Psychosomatic aspects of parent-child relations in atopic eczema in childhood. II. Child-rearing style, the family situation in a drawing test and structured interview].

PubMed

Ring, J; Palos, E

1986-11-01

To evaluate the style of education in this group of children, "scale versions" according to Stapf were used. Mothers of atopic children were found to be significantly more "strict" in their educational approach compared with control mothers (P less than 0.01). There was no significant difference between the two groups of fathers. In particular, mothers of atopic children significantly more often favored "grown-up" behavior in their children and the capacity to enjoy the joy of children was significantly less pronounced compared with controls. In the children's drawings, children with atopic eczema lacked the "friendly atmosphere" expressed in drawings of control children. Fathers of atopic children were drawn significantly smaller than the respective mothers. In animal drawings, children with atopic eczema mostly selected unpleasant or dangerous animals to describe their parents, brothers, or sisters. From the structured interviews, the following points were remarkable: atopic children more often display aggressive thoughts or behavior against their parents than do controls. Mothers of atopic children react less spontaneously and less emotionally to children's emotions. Maternal affection often takes place as a hygienic ritual or in a body and achievement-oriented fashion. Mothers of atopic children like them to behave in a "grown-up" manner.

Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting.

PubMed

Schmitt, Jochen; Spuls, Phyllis; Boers, Maarten; Thomas, Kim; Chalmers, Joanne; Roekevisch, Evelien; Schram, Mandy; Allsopp, Richard; Aoki, Valeria; Apfelbacher, Christian; Bruijnzeel-Koomen, Carla; Bruin-Weller, Marjolein; Charman, Carolyn; Cohen, Arnon; Dohil, Magdalene; Flohr, Carsten; Furue, Masutaka; Gieler, Uwe; Hooft, Lotty; Humphreys, Rosemary; Ishii, Henrique Akira; Katayama, Ichiro; Kouwenhoven, Willem; Langan, Sinéad; Lewis-Jones, Sue; Merhand, Stephanie; Murota, Hiroyuki; Murrell, Dedee F; Nankervis, Helen; Ohya, Yukihiro; Oranje, Arnold; Otsuka, Hiromi; Paul, Carle; Rosenbluth, Yael; Saeki, Hidehisa; Schuttelaar, Marie-Louise; Stalder, Jean-Francois; Svensson, Ake; Takaoka, Roberto; Wahlgren, Carl-Fredrik; Weidinger, Stephan; Wollenberg, Andreas; Williams, Hywel

2012-09-01

The use of nonstandardized and inadequately validated outcome measures in atopic eczema trials is a major obstacle to practising evidence-based dermatology. The Harmonising Outcome Measures for Eczema (HOME) initiative is an international multiprofessional group dedicated to atopic eczema outcomes research. In June 2011, the HOME initiative conducted a consensus study involving 43 individuals from 10 countries, representing different stakeholders (patients, clinicians, methodologists, pharmaceutical industry) to determine core outcome domains for atopic eczema trials, to define quality criteria for atopic eczema outcome measures and to prioritize topics for atopic eczema outcomes research. Delegates were given evidence-based information, followed by structured group discussion and anonymous consensus voting. Consensus was achieved to include clinical signs, symptoms, long-term control of flares and quality of life into the core set of outcome domains for atopic eczema trials. The HOME initiative strongly recommends including and reporting these core outcome domains as primary or secondary endpoints in all future atopic eczema trials. Measures of these core outcome domains need to be valid, sensitive to change and feasible. Prioritized topics of the HOME initiative are the identification/development of the most appropriate instruments for the four core outcome domains. HOME is open to anyone with an interest in atopic eczema outcomes research. © 2012 John Wiley & Sons A/S.

Atopic Dermatitis and Comorbidities: Added Value of Comprehensive Dermatoepidemiology.

PubMed

Nijsten, Tamar

2017-05-01

Atopic dermatitis is common and in its severe form is devastating. This chronic inflammatory dermatosis is part of the atopic syndrome, which includes asthma, food allergies, and hay fever and is known to be associated with mental health disorders. In line with psoriasis, several recent observational studies using national survey and linkage data have suggested a link between atopic dermatitis and cardiovascular disease. The atopic dermatitis field can benefit from the past experiences in psoriasis research and should not follow the same path, but, rather, aim for a more comprehensive approach from the beginning. A recent German consortium studying links between atopic dermatitis and cardiovascular disease first screened a large claims database, followed by analyses of more deeply phenotyped (birth) cohorts with longitudinal data. In addition, genetic and metabolic analyses assessing the predisposition of patients with atopic dermatitis for cardiovascular disease were performed. Overall, the association between atopic dermatitis and cardiovascular disease was at most modest, but in more refined cohorts the cardiovascular risk profile and genetic architecture was comparable. A more integrated approach could create clarity about the clinical relevance of cardiovascular disease in individuals with atopic dermatitis sooner, avoid speculation that affects patient care, and save scientific resources. Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Phenotypic analysis of perennial airborne allergen-specific CD4+ T cells in atopic and non-atopic individuals.

PubMed

Crack, L R; Chan, H W; McPherson, T; Ogg, G S

2011-11-01

Accumulating evidence suggests that T cells play an important role in the pathogenesis of atopic dermatitis (AD); yet, little is known of the differentiation status of CD4+ T cells specific for common environmental allergens, such as the major cat allergen, Fel d 1. To determine the frequency, differentiation phenotype and function of circulating Fel d 1-specific CD4+ T cells in adult individuals with severe persistent AD in comparison with healthy controls. Using HLA class II tetrameric complexes based on a HLA-DPB1*0401-restricted Fel d 1 epitope, ex vivo and cultured T cell frequency and phenotype were analysed in individuals with AD and healthy controls. Cytokine secretion was measured by ex vivo and cultured IL-4 and IFN-γ ELISpots. Ex vivo Fel d 1-specific DPB1*0401-restricted CD4+ T cells in both atopics and non-atopics express high levels of CCR7, CD62L, CD27 and CD28, placing the cells largely within the central memory subgroup. However, the functional phenotype was distinct, with greater IL-4 production from the cells derived from atopics, which correlated with disease severity. Circulating Fel d 1-specific DPB1*0401-restricted CD4+ T cells in both atopic and non-atopic donors maintain a central memory phenotype; however in atopics, the cells had greater Th2 effector function, compatible with a disease model of altered antigen delivery in atopic individuals. © 2011 Blackwell Publishing Ltd.

Clinical efficacy of Avène hydrotherapy measured in a large cohort of more than 10,000 atopic or psoriatic patients.

PubMed

Merial-Kieny, C; Mengual, X; Guerrero, D; Sibaud, V

2011-02-01

Atopic dermatitis (AD) and psoriasis are chronic skin conditions. Local or systemic treatments are effective, but their effects are transient. Hydrotherapy, used alone or in combination with other treatments, could be considered as one form of care in providing effective management of these dermatoses. The objective of this observational study was to evaluate the benefit of a 3-week treatment at Avène Hydrotherapy Centre in a very large cohort of patients suffering from atopic dermatitis and psoriasis and to assess the treatment benefits on patients undergoing hydrotherapy for two consecutive years. This 8-year observational study analysed 14,328 records of patients having a dermatological disease and who came to Avène Hydrotherapy Centre for a 3-week treatment between 2001 and 2009. Among them, patients were suffering from atopic dermatitis (n = 5916) and psoriasis (n = 4887). On admission on D0 (day 0) and at the end of cure on D18 (day 18), the severity of AD and psoriasis were evaluated by SCORing Atopic Dermatitis (SCORAD) and Psoriasis Area and Severity Index (PASI), respectively. In order to assess the cumulative effect of the hydrotherapy treatment, the evolution of SCORAD or PASI of patients who came 2 years in a row was also calculated. A significant improvement in SCORAD was observed between D0 and D18 (-41.6%) (P < 0.0001) and similarly, a significant reduction in PASI was noted between D0 and D18 (-54.4%) (P < 0.0001) after 3-weeks of hydrotherapy. PASI 50 and PASI 75 were 64.3% and 19.5%, respectively. For atopic patients (n = 1102) or patients suffering from psoriasis (n = 833) who came for two consecutive years, a significant SCORAD and PASI improvement was observed on D0 of the second year when compared with D0 of the previous year (P < 0.0001). This study is the first observational study in such a large cohort demonstrating the benefit of a 3-week treatment at the Avène Hydrotherapy Centre for atopic and psoriatic patients. © 2010 The Authors. JEADV © 2010 European Academy of Dermatology and Venereology.

Home environment and suspected atopic eczema in Japanese infants: the Osaka Maternal and Child Health Study.

PubMed

Miyake, Yoshihiro; Ohya, Yukihiro; Tanaka, Keiko; Yokoyama, Tetsuji; Sasaki, Satoshi; Fukushima, Wakaba; Ohfuji, Satoko; Saito, Kyoko; Kiyohara, Chikako; Hirota, Yoshio

2007-08-01

Atopic eczema is most commonly diagnosed in children under the age of 5 yr. Environmental factors during pregnancy or in early life may confer risk for childhood atopic eczema. The present prospective study examined the relationship of the perinatal home environment and the risk of suspected atopic eczema among Japanese infants under the age of 1. Study subjects were 865 parent-child pairs. The term 'suspected atopic eczema' was used to define an outcome based on our questionnaire at 2-9 months postpartum. Adjustment was made for maternal age, gestation, family income, maternal and paternal education, maternal and paternal history of asthma, atopic eczema, and allergic rhinitis, time of delivery before the second survey, baby's older siblings, baby's sex, and baby's birth weight. A high mite allergen level from maternal bedclothes and mold in the kitchen during pregnancy were significantly associated with an increased risk of suspected atopic eczema. Frequent vacuuming practices during pregnancy and giving the infant a bath or shower at least once a day were significantly inversely related to the risk of suspected atopic eczema. Maternal smoking, maternal use of a synthetic duvet and pillow, carpet use in the living room and maternal bedroom, indoor domestic pets, no ducted heating appliance, and gas use for cooking during pregnancy and household smoking in the same room as the infant, infant's synthetic duvet, carpet use in the infant's room, or vacuuming the infant's room were not related to the risk of suspected atopic eczema. High house dust mite allergen levels and mold in the kitchen during pregnancy may increase the risk of infantile atopic eczema, whereas frequent vacuuming practices during pregnancy and giving the infant a bath or shower at least once a day may protect against infantile atopic eczema.

Atopic conditions and brain tumor risk in children and adolescents--an international case-control study (CEFALO).

PubMed

Shu, X; Prochazka, M; Lannering, B; Schüz, J; Röösli, M; Tynes, T; Kuehni, C E; Andersen, T V; Infanger, D; Schmidt, L S; Poulsen, A H; Klaeboe, L; Eggen, T; Feychting, M

2014-04-01

A number of epidemiological studies indicate an inverse association between atopy and brain tumors in adults, particularly gliomas. We investigated the association between atopic disorders and intracranial brain tumors in children and adolescents, using international collaborative CEFALO data. CEFALO is a population-based case-control study conducted in Denmark, Norway, Sweden, and Switzerland, including all children and adolescents in the age range 7-19 years diagnosed with a primary brain tumor between 2004 and 2008. Two controls per case were randomly selected from population registers matched on age, sex, and geographic region. Information about atopic conditions and potential confounders was collected through personal interviews. In total, 352 cases (83%) and 646 controls (71%) participated in the study. For all brain tumors combined, there was no association between ever having had an atopic disorder and brain tumor risk [odds ratio 1.03; 95% confidence interval (CI) 0.70-1.34]. The OR was 0.76 (95% CI 0.53-1.11) for a current atopic condition (in the year before diagnosis) and 1.22 (95% CI 0.86-1.74) for an atopic condition in the past. Similar results were observed for glioma. There was no association between atopic conditions and risk of all brain tumors combined or of glioma in particular. Stratification on current or past atopic conditions suggested the possibility of reverse causality, but may also the result of random variation because of small numbers in subgroups. In addition, an ongoing tumor treatment may affect the manifestation of atopic conditions, which could possibly affect recall when reporting about a history of atopic diseases. Only a few studies on atopic conditions and pediatric brain tumors are currently available, and the evidence is conflicting.

New measurements from fully reconstructed hadronic final states of the $$B^0_2$$ meson at CDF II experiment

DOE Office of Scientific and Technical Information (OSTI.GOV)

Da Ronco, Saverio

2006-01-01

This thesis reports the reconstruction and lifetime measurement of B +, Bmore » $$0/atop{d}$$ and B$$0/atop{s}$$ mesons, performed using fully reconstructed hadronic decays collected by a dedicated trigger at CDF II experiment. This dedicated trigger selects significantly displaced tracks from primary vertex of p$$\\bar{p}$$ collisions generated at Tevatron collider, obtaining, in this way, huge data samples enriched of long-lived particles, and is therefore suitable for reconstruction of B meson in hadronic decay modes. Due to the trigger track impact parameter selections, the proper decay time distributions of the B mesons no longer follow a simply exponential decay law. This complicates the lifetime measurement and requires a correct understanding and treatment of all the involved effects to keep systematic uncertainties under control. This thesis presents a method to extract the lifetime of B mesons in “ct- biased” samples, based on a Monte Carlo approach, to correct for the effects of the trigger and analysis selections. We present the results of this method when applied on fully re- constructed decays of B collected by CDF II in the data taking runs up to August 2004, corresponding to an integrated luminosity of about 360 pb -1. The lifetimes are extracted using the decay modes B + → $$\\bar{D}$$ 0π +,B$$0\\atop{d}$$ → D -π +, B$$0\\atop{d}$$ → D -π +π -π +, B$$0\\atop{s}$$ → D$$-\\atop{s}$$π + and B$$0\\atop{s}$$ → D$$-\\atop{s}$$ π +π -π +(and c.c.) and performing combined mass-lifetime unbinned maximum likelihood fits.« less

View of White Room atop Pad A during Apollo 9 Countdown Demonstration Test

NASA Image and Video Library

1969-02-23

S69-25884 (23 Feb. 1969) --- Interior view of the white room atop Pad A, Launch Complex 39, Kennedy Space Center, during Apollo 9 Countdown Demonstration Test activity. Standing next to spacecraft hatch is astronaut James A. McDivitt, commander. Also, taking part in the training exercise were astronauts David R. Scott, command module pilot; and Russell L. Schweickart, lunar module pilot. The Apollo 9 mission will evaluate spacecraft lunar module systems performance during manned Earth-orbital flight. Apollo 9 will be the second manned Saturn V mission.

The mediating effect of sleep satisfaction on the relationship between stress and perceived health of adolescents suffering atopic disease: Secondary analysis of data from the 2013 9th Korea Youth Risk Behavior Web-based Survey.

PubMed

Oh, Won Oak; Im, YeoJin; Suk, Min Hyun

2016-11-01

Difficulty in sleep is one disturbing symptom in adolescents with atopic diseases including asthma, allergic rhinitis, and atopic dermatitis. Assuming psychological stress can affect adolescents' health status, impaired sleep quality can be one mediator that negatively impacts the health status of adolescents with atopic disease. This study aimed to identify the mediating effect of sleep satisfaction on the relationship between stress and perceived health status in Korean adolescents with atopic disease and to examine the differences among three types of atopic disease. A cross-sectional descriptive study was completed based on secondary analysis of raw data from the 2013 9th Korea Youth Risk Behavior Web-based Survey. The 21,154 adolescents (29.2%) ever diagnosed and treated for at least one atopic disease regardless of the symptom presence in a recent year were extracted out of 72,435 survey participants. Then, the 13,216 individuals with exclusively single atopic diseases were included in analyzing the mediation model. Variables including demographics, stress, perceived health status, and sleep satisfaction were included. Pearson correlation, one-way ANOVA, path analysis to define direct/indirect effects with bootstrapping analysis, and multi-group variance analysis were conducted. High levels of stress in adolescents with atopic diseases had a significant and direct effect on their negative health status perception for all atopic disease groups. A significant negative mediating effect of sleep satisfaction was identified on the relationship between stress and perceived health status, irrespective of the type of atopic disease. Total effect and remaining direct effect on the path from stress and perceived health status via sleep satisfaction was high in adolescents with atopic dermatitis and allergic rhinitis compared to those with asthma. To improve sleep satisfaction for adolescents with atopic diseases, interventions are needed to enhance the adolescents' perceived health status through stress reduction and sleep quality improvement. Copyright © 2016 Elsevier Ltd. All rights reserved.

Lack of Association Between Toll-like Receptor 2 Polymorphisms (R753Q and A-16934T) and Atopic Dermatitis in Children from Thrace Region of Turkey

PubMed Central

Can, Ceren; Yazıcıoğlu, Mehtap; Gürkan, Hakan; Tozkır, Hilmi; Görgülü, Adnan; Süt, Necdet Hilmi

2017-01-01

Background: Atopic dermatitis is the most common chronic inflammatory skin disease. A complex interaction of both genetic and environmental factors is thought to contribute to the disease. Aims: To evaluate whether single nucleotide polymorphisms in the TLR2 gene c.2258C>T (R753Q) (rs5743708) and TLR2 c.-148+1614T>A (A-16934T) (rs4696480) (NM_0032643) are associated with atopic dermatitis in Turkish children. Study Design: Case-control study. Methods: The study was conducted on 70 Turkish children with atopic dermatitis aged 0.5-18 years. The clinical severity of atopic dermatitis was evaluated by the severity scoring of atopic dermatitis index. Serum total IgE levels, specific IgE antibodies to inhalant and food allergens were measured in both atopic dermatitis patients and controls, skin prick tests were done on 70 children with atopic dermatitis. Genotyping for TLR2 (R753Q and A-16934T) single nucleotide polymorphisms was performed in both atopic dermatitis patients and controls. Results: Cytosine-cytosine and cytosin-thymine genotype frequencies of the TLR2 R753Q single nucleotide polymorphism in the atopic dermatitis group were determined as being 98.6% and 1.4%, cytosine allele frequency for TLR2 R753Q single nucleotide polymorphism was determined as 99.29% and the thymine allele frequency was 0.71%, thymine-thymine, thymine-adenine, and adenine-adenine genotype frequencies of the TLR2 A-16934T single nucleotide polymorphism were 24.3%, 44.3%, and 31.4%. The thymine allele frequency for the TLR2 A-16934T single nucleotide polymorphism in the atopic dermatitis group was 46.43%, and the adenine allele frequency was 53.57%, respectively. There was not statistically significant difference between the groups for all investigated polymorphisms (p>0.05). For all single nucleotide polymorphisms studied, allelic distribution was analogous among atopic dermatitis patients and controls, and no significant statistical difference was observed. No homozygous carriers of the TLR2 R753Q single nucleotide polymorphism were found in the atopic dermatitis and control groups. Conclusion: The TLR2 (R753Q and A-16934T) single nucleotide polymorphisms are not associated with atopic dermatitis in a group of Turkish patients. PMID:28443596

Lack of Association Between Toll-like Receptor 2 Polymorphisms (R753Q and A-16934T) and Atopic Dermatitis in Children from Thrace Region of Turkey.

PubMed

Can, Ceren; Yazıcıoğlu, Mehtap; Gürkan, Hakan; Tozkır, Hilmi; Görgülü, Adnan; Süt, Necdet Hilmi

2017-05-05

Atopic dermatitis is the most common chronic inflammatory skin disease. A complex interaction of both genetic and environmental factors is thought to contribute to the disease. To evaluate whether single nucleotide polymorphisms in the TLR2 gene c.2258C>T (R753Q) (rs5743708) and TLR2 c.-148+1614T>A (A-16934T) (rs4696480) (NM_0032643) are associated with atopic dermatitis in Turkish children. Case-control study. The study was conducted on 70 Turkish children with atopic dermatitis aged 0.5-18 years. The clinical severity of atopic dermatitis was evaluated by the severity scoring of atopic dermatitis index. Serum total IgE levels, specific IgE antibodies to inhalant and food allergens were measured in both atopic dermatitis patients and controls, skin prick tests were done on 70 children with atopic dermatitis. Genotyping for TLR2 (R753Q and A-16934T) single nucleotide polymorphisms was performed in both atopic dermatitis patients and controls. Cytosine-cytosine and cytosin-thymine genotype frequencies of the TLR2 R753Q single nucleotide polymorphism in the atopic dermatitis group were determined as being 98.6% and 1.4%, cytosine allele frequency for TLR2 R753Q single nucleotide polymorphism was determined as 99.29% and the thymine allele frequency was 0.71%, thymine-thymine, thymine-adenine, and adenine-adenine genotype frequencies of the TLR2 A-16934T single nucleotide polymorphism were 24.3%, 44.3%, and 31.4%. The thymine allele frequency for the TLR2 A-16934T single nucleotide polymorphism in the atopic dermatitis group was 46.43%, and the adenine allele frequency was 53.57%, respectively. There was not statistically significant difference between the groups for all investigated polymorphisms (p>0.05). For all single nucleotide polymorphisms studied, allelic distribution was analogous among atopic dermatitis patients and controls, and no significant statistical difference was observed. No homozygous carriers of the TLR2 R753Q single nucleotide polymorphism were found in the atopic dermatitis and control groups. The TLR2 (R753Q and A-16934T) single nucleotide polymorphisms are not associated with atopic dermatitis in a group of Turkish patients.

KSC-2014-3449

NASA Image and Video Library

2014-08-10

LOS ANGELES, Calif. – Andy Quiett, Detachment 3 deputy operations lead for the Orion program and DoD liaison for NASA, answers questions about the Orion boilerplate test vehicle from visitors touring the well deck of the USS Anchorage during the Science, Technology, Engineering and Mathematics, or STEM, Expo for L.A. Navy Days at the Port of Los Angeles in California. A combined team from NASA’s Ground Systems Development and Operations Program and the U.S. Navy were in San Diego to practice recovering Orion from the ocean, as they will do in December following the spacecraft's first trip to space during Exploration Flight Test-1. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep-space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Kim Shiflett

KSC-2014-3448

NASA Image and Video Library

2014-08-10

LOS ANGELES, Calif. – Andy Quiett, Detachment 3 deputy operations lead for the Orion program and DoD liaison for NASA, answers questions about the Orion boilerplate test vehicle from visitors touring the well deck of the USS Anchorage during the Science, Technology, Engineering and Mathematics, or STEM, Expo for L.A. Navy Days at the Port of Los Angeles in California. A combined team from NASA’s Ground Systems Development and Operations Program and the U.S. Navy were in San Diego to practice recovering Orion from the ocean, as they will do in December following the spacecraft's first trip to space during Exploration Flight Test-1. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep-space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Kim Shiflett

KSC-2014-3447

NASA Image and Video Library

2014-08-10

LOS ANGELES, Calif. – Andy Quiett, Detachment 3 deputy operations lead for the Orion program and DoD liaison for NASA, answers questions about the Orion boilerplate test vehicle from visitors touring the well deck of the USS Anchorage during the Science, Technology, Engineering and Mathematics, or STEM, Expo for L.A. Navy Days at the Port of Los Angeles in California. A combined team from NASA’s Ground Systems Development and Operations Program and the U.S. Navy were in San Diego to practice recovering Orion from the ocean, as they will do in December following the spacecraft's first trip to space during Exploration Flight Test-1. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep-space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Kim Shiflett

URT-3 At Sea Recovery Operation with Bolden

NASA Image and Video Library

2014-09-15

The Orion boilerplate test vehicle floats in the Pacific Ocean near the USS Anchorage during Underway Recovery Test 3. U.S. Navy divers and other recovery team members in two Zodiac boats attach tether lines to Orion. Other recovery team members are nearby in two rigid hull inflatable boats. NASA, Lockheed Martin and U.S. Navy personnel are conducting the recovery test to prepare for recovery of the Orion crew module on its return from a deep space mission. The test allows the teams to demonstrate and evaluate the recovery processes, procedures, hardware and personnel in open waters. The Ground Systems Development and Operations Program is conducting the underway recovery tests. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a United Launch Alliance Delta IV Heavy rocket and in 2018 on NASA’s Space Launch System rocket.

Early-life risk factors for occurrence of atopic dermatitis during the first year.

PubMed

Sugiyama, Mikio; Arakawa, Hirokazu; Ozawa, Kiyoshi; Mizuno, Takahisa; Mochizuki, Hiroyuki; Tokuyama, Kenichi; Morikawa, Akihiro

2007-03-01

In a prospective birth cohort study, we sought to identify perinatal predictors of the occurrence of atopic dermatitis in the first year of life. Associations of family history, infection during pregnancy, cord blood cytokine concentrations, and skin function parameters with atopic dermatitis were analyzed. Stratum corneum hydration was measured with an impedance meter until 5 days after delivery and again at 1 month. Complete data were obtained for 213 infants, including 27 diagnosed by a physician as having atopic dermatitis during their first year and 26 diagnosed as having infantile eczema during their first month. The risk of atopic dermatitis during the first year of life was related to maternal atopic dermatitis, lower concentrations of macrophage inflammatory protein-1beta in cord blood, and greater skin moisture in the surface and stratum corneum of the forehead and cheek at 1 month of age but not to viral or bacterial infection during pregnancy or breastfeeding. Paternal hay fever was associated negatively with the development of atopic dermatitis. High concentrations of interleukin-5, interleukin-17, and macrophage chemotactic protein-1 and only surface moisture in the cheek were associated with greater risk of infantile eczema in the first month. The association of atopic dermatitis in infancy with reduced neonatal macrophage inflammatory protein-1beta levels suggests a link with immature immune responses at birth. Stratum corneum barrier disruption in atopic dermatitis may involve impairment of cutaneous adaptation to extrauterine life. The majority of risk factors had different effects on infant eczema and atopic dermatitis, indicating different causes.

Prebiotics and probiotics: the prevention and reduction in severity of atopic dermatitis in children.

PubMed

Foolad, N; Armstrong, A W

2014-06-01

The purpose of this review was to identify whether supplementation with prebiotics and/or probiotics help prevent the development or reduce the severity of atopic dermatitis in children less than three years of age. Since 1997, immunostimulatory supplements, such as prebiotics and probiotics, have been investigated. Various supplementations include probiotics (single strain or mix), probiotics with formula, probiotics mix with prebiotics, and prebiotics. In this narrative review, we examined 13 key articles on prebiotics and/or probiotics, and their effects on infant atopic dermatitis. Among the selected studies, a total of 3,023 participants received supplements or placebo. Eight out of the 13 (61.5%) studies reported a significant effect on the prevention of atopic dermatitis after supplementation with probiotics and/or prebiotics. Five out of the 13 (38.5%) studies indicated significant reduction in the severity of atopic dermatitis after supplementation. Based on the available studies, supplementation with certain probiotics (Lactobacillus rhamnosus GG) appears to be an effective approach for the prevention and reduction in severity of atopic dermatitis. A mix of specific probiotic strains prevented atopic dermatitis among infants. Based on studies with prebiotics, there was a long-term reduction in the incidence of atopic dermatitis. Supplementation with prebiotics and probiotics appears useful for the reduction in the severity of atopic dermatitis. Additional interventional studies exploring prebiotics and probiotics are imperative before recommendations can be made.

Lung function, atopy, specific hypersensitivity, and smoking of workers in the enzyme detergent industry over 11 years.

PubMed

Flood, D F; Blofeld, R E; Bruce, C F; Hewitt, J I; Juniper, C P; Roberts, D M

1985-01-01

A study of 2800 workers employed in three factories of the two major manufacturers of enzymatic products in the United Kingdom covering 11 years of operation from 1969 to 1980 showed that 2344 workers had sufficient lung function data to meet the operational criteria and these were analysed in three separate groups by factory locations. Spirometry and prick tests for specific skin reactions to standardised enzyme were performed at six monthly intervals for the first six years of the study and then annually. Factory enzyme dust and total dust measurements were made to determine the degree of dust exposure of the subjects. The lung function of the factory groups was analysed for the effects of working in the detergent industry, the degree of exposure to enzymes, skin prick test positivity to enzymes, atopicity, and smoking. The 4.5% of workers who had experienced respiratory effects from enzymes were analysed separately. Exposure to the enzyme allergen has had no significant long term effect on the lung function of the detergent workers. A higher proportion of atopics than non-atopics became skin test positive to the allergen and more smokers than non-smokers were sensitised. The overall lung function of detergent workers showed 39 ml/year loss in FEV1 on the 11 year longitudinal study and 51 ml/year loss on the lateral (cross sectional) analysis with better lung function in the south east than the north west of England. In the development of the methodology for the study several potential problems were discovered that could remain unrecognised in a cross sectional analysis performed in isolation.

Kaon BSM B -parameters using improved staggered fermions from N f = 2 + 1 unquenched QCD

DOE Office of Scientific and Technical Information (OSTI.GOV)

Choi, Benjamin J.

2016-01-28

In this paper, we present results for the matrix elements of the additional ΔS = 2 operators that appear in models of physics beyond the Standard Model (BSM), expressed in terms of four BSM B -parameters. Combined with experimental results for ΔM K and ε K, these constrain the parameters of BSM models. We use improved staggered fermions, with valence hypercubic blocking transfromation (HYP)-smeared quarks and N f = 2 + 1 flavors of “asqtad” sea quarks. The configurations have been generated by the MILC Collaboration. The matching between lattice and continuum four-fermion operators and bilinears is done perturbatively at one-loop order. We use three lattice spacings for the continuum extrapolation: a ≈ 0.09 , 0.06 and 0.045 fm. Valence light-quark masses range down to ≈ mmore » $$phys\\atop{s}$$ /13 while the light sea-quark masses range down to ≈ m$$phys\\atop{s}$$ / 20 . Compared to our previous published work, we have added four additional lattice ensembles, leading to better controlled extrapolations in the lattice spacing and sea-quark masses. We report final results for two renormalization scales, μ = 2 and 3 GeV, and compare them to those obtained by other collaborations. Agreement is found for two of the four BSM B-parameters (B 2 and B$$SUSY\\atop{3}$$ ). The other two (B 4 and B 5) differ significantly from those obtained using regularization independent momentum subtraction (RI-MOM) renormalization as an intermediate scheme, but are in agreement with recent preliminary results obtained by the RBC-UKQCD Collaboration using regularization independent symmetric momentum subtraction (RI-SMOM) intermediate schemes.« less

Stressors in Atopic Dermatitis.

PubMed

Barilla, Steven; Felix, Kayla; Jorizzo, Joseph L

2017-01-01

As with other inflammatory skin disorders, atopic dermatitis has a tendency to cause stress and also be exacerbated by it. Patients with atopic dermatitis have several disease-associated stressors, some of which include physical discomfort due to itching and altered appearance due to flare-ups. These stressors have been shown to effect patients psychosocially by altering sleep patterns, decreasing self-esteem and interfering with interpersonal relationships. In combination with its direct effect on patients, atopic dermatitis also causes stress for parents and caregivers. Studies suggest that atopic dermatitis is strongly correlated with co-sleeping habits, which can negatively impact the health and mood of parents or caregivers. It has also been reported to interfere with the formation of a strong mother-child relationship. In order to optimize treatment for patients with atopic dermatitis, it is important to note the impact that it has on quality of life. By implementing patient counseling, sleep-targeted therapies, and the use of quality of life (QoL) indices, atopic dermatitis patients and caregivers have the potential to experience greater satisfaction with treatment.

The Association Between Bathing Habits and Severity of Atopic Dermatitis in Children.

PubMed

Koutroulis, Ioannis; Pyle, Tia; Kopylov, David; Little, Anthony; Gaughan, John; Kratimenos, Panagiotis

2016-02-01

Atopic dermatitis is an inflammatory skin disease that frequently affects children. The current recommendations on management using lifestyle modification are highly variable, leading to confusion and uncertainty among patients. To determine current bathing behaviors and the subsequent impact on disease severity. This was an observational cross-sectional study conducted at an urban pediatric emergency department. Parents were asked to fill out a questionnaire concerning the patient's bathing habits. The results were correlated with the atopic dermatitis severity determined by the SCORAD (SCORing Atopic Dermatitis) tool. No difference between variables was found to be significant for bathing frequency, time spent bathing, or use of moisturizers. Multivariate analysis showed that atopic dermatitis severity increased with age greater than 2 years (P = .0004) and with greater bathing duration (P = .001). Atopic dermatitis severity may be associated with a longer duration of bathing. The frequency of bathing does not appear to affect atopic dermatitis severity. © The Author(s) 2015.

ASCANS Class of 2013 Tour the O&C with Cabana

NASA Image and Video Library

2014-03-03

CAPE CANAVERAL, Fla. -- In the Operations and Checkout Building of NASA's Kennedy Space Center in Florida, astronaut candidate Christina Hammock listens to a briefing on preparations for the launch the Orion spacecraft on Exploration Flight Test EFT-1. Plans call for the Lockheed Martin-built Orion to launch atop a United Launch Alliance Delta IV Heavy rocket from Cape Canaveral Air Force Station. The astronaut class of 2013 was selected by NASA after an extensive year-and-a-half search. The new group will help the agency push the boundaries of exploration and travel to new destinations in the solar system. To learn more about the astronaut class of 2013, visit: http://www.nasa.gov/astronauts/2013astroclass.html Photo credit: NASA/Kim Shiflett

ASCANS Class of 2013 Tour the O&C with Cabana

NASA Image and Video Library

2014-03-03

CAPE CANAVERAL, Fla. -- In the Operations and Checkout Building of NASA's Kennedy Space Center in Florida, agency astronaut candidates are briefed on preparations for the launch the Orion spacecraft on Exploration Flight Test EFT-1. Plans call for the Lockheed Martin-built Orion to launch atop a United Launch Alliance Delta IV Heavy rocket from Cape Canaveral Air Force Station. The astronaut class of 2013 was selected by NASA after an extensive year-and-a-half search. The new group will help the agency push the boundaries of exploration and travel to new destinations in the solar system. To learn more about the astronaut class of 2013, visit: http://www.nasa.gov/astronauts/2013astroclass.html Photo credit: NASA/Kim Shiflett

KSC-2013-4110

NASA Image and Video Library

2013-11-07

CAPE CANAVERAL, Fla. -- Inside the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, the spacecraft adapter cone for the Orion spacecraft is positioned on special protective blocks for processing work. It will be mated to the service module for testing. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Daniel Casper

KSC-2013-4109

NASA Image and Video Library

2013-11-07

CAPE CANAVERAL, Fla. -- Inside the Operations and Checkout Building high bay at NASA’s Kennedy Space Center in Florida, the spacecraft adapter cone for the Orion spacecraft is positioned on special protective blocks for processing work. It will be mated to the service module for testing. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Daniel Casper

Orion Hatch Window Testing

NASA Image and Video Library

2018-04-09

Inside a laboratory in the Neil Armstrong Operations and Checkout Building at NASA's Kennedy Space Center in Florida, Mark Nurge, Ph.D., at left, a physicist in the Applied Physics Lab with the center's Exploration Research and Technology Programs, and Bence Bartha, Ph.D., a specialist in non-destructive testing with URS Federal Services, are performing the first optical quality testing on a full window stack that is ready for installation in the docking hatch of NASA's Orion spacecraft. The data from the tests will help improve the requirements for manufacturing tolerances on Orion's windows and verify how the window should perform in space. Orion is being prepared for its first integrated uncrewed flight atop NASA's Space Launch System rocket on Exploration Mission-1.

Interim Cryogenic Propulsion Stage (ICPS) Transport from DOC to

NASA Image and Video Library

2017-07-26

The Interim Cryogenic Propulsion Stage (ICPS) for NASA's Space Launch System (SLS) rocket is packed inside a canister and ready to exit the United Launch Alliance (ULA) Delta Operations Center near Space Launch Complex 37 at Cape Canaveral Air Force Station for its move to the Space Station Processing Facility at NASA's Kennedy Space Center in Florida. The ICPS is the first integrated piece of flight hardware to arrive for the SLS. It is the in-space stage that is located toward the top of the rocket, between the Launch Vehicle Stage Adapter and the Orion Spacecraft Adapter. It will provide some of the in-space propulsion during Orion's first flight test atop the SLS on Exploration Mission-1.

KSC-2013-3718

NASA Image and Video Library

2013-10-22

CAPE CANAVERAL, Fla. – At NASA’s Kennedy Space Center in Florida, the Orion test vehicle, or GTA, is lifted by crane in the transfer aisle of the Vehicle Assembly Building. The ground test vehicle is being used for path finding operations, including simulated manufacturing, assembly and stacking procedures. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion. Photo credit: Dimitri Gerondidakis

KSC-2013-3716

NASA Image and Video Library

2013-10-22

CAPE CANAVERAL, Fla. – At NASA’s Kennedy Space Center in Florida, the Orion ground test vehicle, or GTA, is being prepared for lifting in the transfer aisle of the Vehicle Assembly Building. The GTA is being used for path finding operations, including simulated manufacturing, assembly and stacking procedures. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit www.nasa.gov/orion. Photo credit: Dimitri Gerondidakis

KSC-2013-4444

NASA Image and Video Library

2013-11-12

CAPE CANAVERAL, Fla. – Inside the Operations and Checkout Building at NASA’s Kennedy Space Center in Florida, workers are preparing to move the spacecraft adapter cone for the Orion vehicle closer to the service module which is suspended above the floor by a movable crane. Orion is the exploration spacecraft designed to carry astronauts to destinations not yet explored by humans, including an asteroid and Mars. It will have emergency abort capability, sustain the crew during space travel and provide safe re-entry from deep space return velocities. The first unpiloted test flight of the Orion is scheduled to launch in 2014 atop a Delta IV rocket and in 2017 on NASA’s Space Launch System rocket. For more information, visit http://www.nasa.gov/orion. Photo credit: NASA/Kim Shiflett

Exposure to pets and atopic dermatitis during the first two years of life. A cohort study.

PubMed

Zirngibl, Angelika; Franke, Kaethe; Gehring, Ulrike; von Berg, Andrea; Berdel, Dietrich; Bauer, Carl Peter; Reinhardt, Dietrich; Wichmann, H-Erich; Heinrich, Joachim

2002-12-01

The aim of this study was to assess the association between keeping pets in early childhood and the occurrence of atopic dermatitis in an ongoing birth cohort followed up to the age of 2 years. We analyzed data of 4578 children in the intervention and observation part of an ongoing cohort study. The children were recruited at birth in the two study regions Wesel and Munich between January 1996 and June 1998. Information on atopic diseases and pet ownership was obtained by questionnaire at the child's first and second birthday. The logistic regression model showed a negative association between 'keeping any pet' and in particular 'keeping dogs' in the 1st year of life and the development of atopic dermatitis in the 1st and the 2nd years of life. The protective effects remained statistically significant after adjusting for several possible confounding variables (1st year(any) pet OR 0.71, 95% CI [0.55;0.92], 1st year(dog) OR 0.62, 95% CI [0.39;0.98], 2nd year(any) pet OR 0.74, 95% CI [0.57;0.97], 2nd year(dog) OR 0.63, 95% CI [0.40;0.98]). Ownership of small furred pets (hamster, rabbit and guinea pig) also showed a borderline protective effect for the 1st year. We assume an association between keeping pets and undefined environmental factor(s) that contribute protectively to the development of atopic dermatitis in early life, presumably by effects on the maturation of the immune system.

Spectroscopic study of the Lambda hypernuclei by the (e,e'K +) reaction

DOE Office of Scientific and Technical Information (OSTI.GOV)

Miyoshi, Toshinobu

Hypernuclear spectroscopy study via the (e,e'K +) reaction has been carried out for the first time, establishing a new technique to study Lambda hypernuclei. The high quality electron beam at Jefferson Lab made it possible to measure Lambda hypernuclear spectra with an energy resolution better than 1 MeV (FWHM). The present experiment was designed to make full use of the virtual photon flux, which peaks at very forward angles, by detecting scattered electrons at 0 degrees. Scattered positive kaons were also detected near 0 degrees, where the cross section of the kaon photo-production is maximized. This unique kinematical configuration was realized with the HyperNuclear Spectrometer System (HNSS), which consisted of the Short-Orbit Spectrometer, the Enge Split-Pole Spectrometer, and the splitter magnet. Themore » $$12\\atop{Λ}$$B mass spectrum was measured in the 12C(e,e'K +)$$12\\atop{Λ}$$ reaction with 0.9 MeV (FWHM) energy resolution. The averaged binding energy of the $$12\\atop{Λ}$$B ground state doublet was obtained to be 11.7 ± 0.1 (statistical) ± 0.3 (systematic) MeV, which is consistent with emulsion data. The general spectral structure of the 12C(e,e'K +) $$12\\atop{Λ}$$B reaction was found to be similar to that of the 12C(Λ +,K +)$$12\\atop{Λ}$$C reaction, showing characteristic peaks corresponding to sLambda and pLambda orbits, as well as a few core-excited states. The cross section of the $$12\\atop{Λ}$$B ground state doublet was derived to be 117 ± 13 (statistical) ± 14 (systematic) nb/sr. The theoretical prediction of the cross section was consistent with the present result, validating DWIA calculation for hypernuclear yields. The present study proved the effectiveness of the (e,e'K +) reaction for future Lambda hypernuclear spectroscopy studies.« less

Therapeutic strategies for allergic diseases

NASA Astrophysics Data System (ADS)

Barnes, Peter J.

1999-11-01

Many drugs are now in development for the treatment of atopic diseases, including asthma, allergic rhinitis and atopic dermatitis. These treatments are based on improvements in existing therapies or on a better understanding of the cellular and molecular mechanisms involved in atopic diseases. Although most attention has been focused on asthma, treatments that inhibit the atopic disease process would have application to all atopic diseases, as they often coincide. Most of the many new therapies in development are aimed at inhibiting components of the allergic inflammatory response, but in the future there are real possibilities for the development of preventative and even curative treatments.

Levels of soluble CD30 in cord blood and peripheral blood during childhood are not correlated with the development of atopic disease or a family history of atopy.

PubMed

Holmlund, U; Bengtsson, A; Nilsson, C; Kusoffsky, E; Lilja, G; Scheynius, A; Sverremark-Ekström, E

2003-11-01

The CD30 molecule has been linked to Th2 responses. Furthermore, elevated levels of the soluble form of CD30 (sCD30) in blood as well as of the expression of CD30 on the plasma membrane of T cells are associated with atopic disease. To assess the potential usefulness of sCD30 levels as a prognostic indicator of and/or diagnostic marker for the development of atopic disease in children. sCD30 levels in cord blood and peripheral blood from 36 2-year-old (10 atopic and 26 non-atopic) and 74 7-year-old (35 atopic and 39 non-atopic) children were determined employing an ELISA procedure. Atopy was diagnosed on the basis of clinical evaluation in combination with a positive skin prick test. No significant correlation between sCD30 levels in cord blood and the development of atopic disease at 2 or 7 years of age was observed. At 7 years of age, the circulating sCD30 levels in children with atopic disease (median 41 U/mL, range 6-503 U/mL) did not differ from the corresponding values for non-atopic subjects (median 41 U/mL, range 8-402 U/mL). The same was true for children at 2 years of age. Furthermore, the sCD30 levels of children who had developed atopic eczema/dermatitis syndrome by the age of 7 years (median 49 U/mL, range 14-503 U/mL) were not significantly elevated in comparison with those of the non-atopic children. Finally, neither sCD30 levels in cord blood nor peripheral blood at 2 or 7 years of age could be linked to a family history of atopy. These findings indicate that the sCD30 concentration in cord blood is not a reliable prognostic indicator of, nor a useful diagnostic marker for, atopic disease in children up to 7 years of age. If such correlations do exist, they might be masked by age-dependent variations in the circulating levels of sCD30, which may reflect individual differences in the maturation of children's immunological responses.

Does Stress Increase the Risk of Atopic Dermatitis in Adolescents? Results of the Korea Youth Risk Behavior Web-Based Survey (KYRBWS-VI)

PubMed Central

Kwon, Jeoung A.; Park, Eun-Cheol; Lee, Minjee; Yoo, Ki-Bong; Park, Sohee

2013-01-01

This study investigated the relationship between level of stress in middle and high school students aged 12–18 and risk of atopic dermatitis. Data from the Sixth Korea Youth Risk Behavior Web-based Survey (KYRBWS-VI), a cross-sectional study among 74,980 students in 800 middle schools and high schools with a response rate of 97.7%, were analyzed. Ordinal logistic regression analyses were conducted to determine the relationship between stress and atopic dermatitis with severity. A total of 5,550 boys and 6,964 girls reported having been diagnosed with atopic dermatitis. Younger students were more likely to have atopic dermatitis. Interestingly, the educational level of parents was found to be associated with having atopic dermatitis and having more severe condition. In particular, girls with mothers with at least college education had a 41% higher risk of having atopic dermatitis and severe atopic condition (odds ratio (OR)) = 1.41, 95% CI, 1.22–1.63; P<0.0001) compared with those with mothers who had attended middle school at most. Similar trend was shown among both boys and girls for their father's education level. The stress level was found to be significantly associated with the risk of atopic dermatitis. Compared to boys with who reported “no stress”, boys with “very high” stress had 46% higher the risk of having more severe atopic dermatitis (OR = 1.46, 95% CI, 1.20–1.78; P<0.0001), 44% higher (OR = 1.44, 95% CI, 1.19–1.73; P<0.0001) with “high” stress, and 21% higher (OR = 1.21, 95% CI, 1.00–1.45; P = 0.05) with “moderate” stress. In contrast, we found no statistically significant relationship between stress and atopic dermatitis in girls. This study suggests that stress and parents' education level were associated with atopic dermatitis. Specifically, degree of stress is positively correlated with likelihood of being diagnosed with this condition and increasing the severity. PMID:23940513

Increased risk of asthma in overweight children born large for gestational age.

PubMed

Pinto, L A; Guerra, S; Anto, J M; Postma, D; Koppelman, G H; de Jongste, J C; Gehring, U; Smit, H A; Wijga, A H

2017-08-01

Being born large for gestational age (LGA) is a marker of increased growth velocity in fetal life and a risk factor for childhood overweight. Both being born LGA and childhood overweight may influence the development of asthma, although the role of overweight in the association between LGA and childhood asthma is unclear. Importantly, recent studies have suggested that the association between overweight and asthma may be related to non-allergic pathways. If this also applies to the association between LGA and asthma, the association between being born LGA and asthma may be different for atopic and non-atopic children. We investigated the association of being LGA with the prevalence of asthma at age 8 in atopic and non-atopic children and the role of overweight in this association. Complete data on asthma, anthropometry and atopy at age of 8 years, and potential confounders were available for 1608 participants of the PIAMA birth cohort. Odds ratios for the association between LGA and asthma in atopic and non-atopic children were estimated by logistic regression analysis adjusting for potential confounders. Overweight was assessed as a potential modifier of the association between LGA and asthma. Being born LGA was not significantly associated with asthma at age of 8 in atopic and non-atopic children. However, overweight at age of 8 years modified the association between asthma at age of 8 and LGA. In non-atopic children, children who were born LGA and were overweight at age of 8 years had a significantly increased odds of asthma compared to non-LGA, non-overweight children (adj OR 7.04; 95% CI 2.2-24). We observed that non-atopic children born LGA, who were overweight by 8 years have an increased risk of asthma. If confirmed, these findings suggest that non-atopic children born LGA may be identified early in life as a high-risk group for asthma. © 2017 John Wiley & Sons Ltd.

Breastfeeding and atopic eczema in Japanese infants: The Osaka Maternal and Child Health Study.

PubMed

Miyake, Yoshihiro; Tanaka, Keiko; Sasaki, Satoshi; Kiyohara, Chikako; Ohya, Yukihiro; Fukushima, Wakaba; Yokoyama, Tetsuji; Hirota, Yoshio

2009-05-01

Epidemiological studies associated with breastfeeding have provided conflicting results about whether it is preventive or a risk factor for atopic eczema in children. The current prospective study investigated the relationship between breastfeeding and the risk of atopic eczema in Japan. A birth cohort of 763 infants was followed. The first survey during pregnancy and the second survey between 2 and 9 months postpartum collected information on potential confounding factors and atopic eczema status. Data on breastfeeding and symptoms of atopic eczema were obtained from questionnaires in the third survey from 16 to 24 months postpartum. The following variables were a priori selected as potential confounders: maternal age, maternal and paternal history of asthma, atopic eczema, and allergic rhinitis, indoor domestic pets (cats, dogs, birds, or hamsters), family income, maternal and paternal education, maternal smoking during pregnancy, baby's sex, baby's birth weight, baby's older siblings, household smoking in the same room as the infant, and time of delivery before the third survey. In the third survey, 142 infants (18.6%) were revealed to have developed atopic eczema based on criteria of the International Study of Asthma and Allergies in Childhood. In an overall analysis, neither exclusive nor partial breastfeeding was significantly related to the risk of atopic eczema. After excluding 64 infants identified with suspected atopic eczema in the second survey, both exclusive breastfeeding for 4 months or more and partial breastfeeding for 6 months or more were independently associated with an increased risk of atopic eczema only among infants with no parental history of allergic disorders [multivariate odds ratios were 2.41 (95% confidence interval, 1.10-5.55) and 3.39 (95% confidence interval, 1.20-12.36), respectively]. The authors found that, overall, neither exclusive nor partial breastfeeding had a strong impact on the risk of atopic eczema. However, a parental allergic history may affect the risk.

Basophil activation test compared to skin prick test and fluorescence enzyme immunoassay for aeroallergen-specific Immunoglobulin-E

PubMed Central

2012-01-01

Background Skin prick test (SPT) and fluorescence enzyme immunoassay (FEIA) are widely used for the diagnosis of Immunoglobulin-E (IgE)-mediated allergic disease. Basophil activation test (BAT) could obviate disadvantages of SPT and FEIA. However, it is not known whether BAT gives similar results as SPT or FEIA for aeroallergens. Objectives In this study, we compared the results of SPT, BAT and FEIA for different aeroallergens. Methods We performed BAT, SPT and FEIA in 41 atopic subjects (symptomatic and with positive SPT for at least 1 of 9 common aeroallergens) and 31 non-atopic subjects (asymptomatic and with negative SPT). Results Correlations between SPT and BAT, SPT and FEIA, and BAT and FEIA results were statistically significant but imperfect. Using SPT as the "gold standard", BAT and FEIA were similar in sensitivity. However, BAT had lower specificity than FEIA. False positive (BATposSPTneg) results were frequent in those atopic subjects who were allergic by SPT to a different allergen and rare in non-atopic subjects. The false positivity in atopic subjects was due in part to high levels of serum Total-IgE (T-IgE) levels in atopic individuals that lead to basophil activation upon staining with fluorochrome-labeled anti-IgE. Conclusion As an alternative to SPT in persons allergic to aeroallergens, BAT in its present form is useful for distinguishing atopic from non-atopic persons. However, BAT in its present form is less specific than FEIA when determining the allergen which a patient is allergic to. This is due to IgE staining-induced activation of atopic person's basophils and/or nonspecific hyperreactivity of atopic person's basophils. PMID:22264407

Maternal stress and psychological distress preconception: association with offspring atopic eczema at age 12 months

PubMed Central

El-Heis, S; Crozier, SR; Healy, E; Robinson, SM; Harvey, NC; Cooper, C; Inskip, HM; Baird, J; Godfrey, KM

2017-01-01

Background Perinatal maternal stress and low mood have been linked to offspring atopic eczema. Objectives To examine the relation of maternal stress/mood with atopic eczema in the offspring, focusing particularly on stress/psychological distress preconception. Methods At recruitment in the UK Southampton Women’s Survey, preconception maternal reports of perceived stress in daily living and the effect of stress on health were recorded; in a sub-sample psychological distress was assessed (12-item General Health Questionnaire). Infants were followed up at ages 6 (n=2956) and 12 (n=2872) months and atopic eczema ascertained (based on UK Working Party Criteria for the Definition of Atopic Dermatitis). At 6 months postpartum, mothers were asked if they had experienced symptoms of low mood since childbirth and completed the Edinburgh Post-natal Depression Scale. Results Preconception perceived stress affecting health (OR 1.21 (95%CI 1.08-1.35), p=0.001) and stress in daily living (OR 1.16 (1.03-1.30), p=0.014) were associated with an increased risk of offspring atopic eczema at age 12 months but not at 6 months, robust to adjustment for potentially confounding variables. Findings were similar for maternal psychological distress preconception. Low maternal mood between delivery and 6 months postpartum was associated with an increased risk of infantile atopic eczema at age 12 months, but no significant association between postnatal mood and atopic eczema was seen after taking account of preconception stress. Conclusion & Clinical Relevance Our data provide novel evidence linking maternal stress at preconception to atopic eczema risk, supporting a developmental contribution to the aetiology of atopic eczema and pointing to potentially modifiable influences. PMID:28218994

Genetic polymorphism of the beta-2 adrenergic receptor in atopic and non-atopic subjects.

PubMed

Potter, P C; Van Wyk, L; Martin, M; Lentes, K U; Dowdle, E B

1993-10-01

To investigate a possible genetic basis for reported differences in beta-2 receptor expression in atopic subjects, DNA from 42 atopic children (22 asthmatics and 22 with allergic rhinitis) and 30 non-atopic subjects was Southern blotted and Ban-1 restriction fragment polymorphisms (RFLPS) were studied using a 2.6 kb probe of the human beta-2 receptor gene. Two alleles 3.1 kb and 2.9 kb were identified. Homozygotes and heterozygotes for the two alleles were found with equal frequency in the atopic patients who had asthma and in those who had allergic rhinitis only. The gene frequencies for the upper and lower alleles were 0.45 and 0.55 respectively. Our studies do not provide evidence for an association between a particular polymorphic form of the human beta-2 receptor gene and atopy.

Longitudinal Evaluation of the Skin Microbiome and Association with Microenvironment and Treatment in Canine Atopic Dermatitis.

PubMed

Bradley, Charles W; Morris, Daniel O; Rankin, Shelley C; Cain, Christine L; Misic, Ana M; Houser, Timothy; Mauldin, Elizabeth A; Grice, Elizabeth A

2016-06-01

Host-microbe interactions may play a fundamental role in the pathogenesis of atopic dermatitis, a chronic relapsing inflammatory skin disorder characterized by universal colonization with Staphylococcus species. To examine the relationship between epidermal barrier function and the cutaneous microbiota in atopic dermatitis, this study used a spontaneous model of canine atopic dermatitis. In a cohort of 14 dogs with canine atopic dermatitis, the skin microbiota were longitudinally evaluated with parallel assessment of skin barrier function at disease flare, during antimicrobial therapy, and post-therapy. Sequencing of the bacterial 16S ribosomal RNA gene showed decreased bacterial diversity and increased proportions of Staphylococcus (S. pseudintermedius in particular) and Corynebacterium species compared with a cohort of healthy control dogs (n = 16). Treatment restored bacterial diversity with decreased proportions of Staphylococcus species, concurrent with decreased canine atopic dermatitis severity. Skin barrier function, as measured by corneometry, pH, and transepidermal water loss also normalized with treatment. Bacterial diversity correlated with transepidermal water loss and pH level but not with corneometry results. These findings provide insights into the relationship between the cutaneous microbiome and skin barrier function in atopic dermatitis, show the impact of antimicrobial therapy on the skin microbiome, and highlight the utility of canine atopic dermatitis as a spontaneous nonrodent model of atopic dermatitis. Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Analysis of Food Allergy in Atopic Dermatitis Patients – Association with Concomitant Allergic Diseases

PubMed Central

Čelakovská, Jarmila; Bukač, Josef

2014-01-01

Background: A few reports demonstrate the comorbidity of food allergy and allergic march in adult patients. Aims and Objectives: To evaluate, if there is some relation in atopic dermatitis patients at the age 14 years and older who suffer from food allergy to common food allergens to other allergic diseases and parameters as bronchial asthma, allergic rhinitis, duration of atopic dermatitis, family history and onset of atopic dermatitis. Materials and Methods: Complete dermatological and allergological examination was performed; these parameters were examined: food allergy (to wheat flour, cow milk, egg, peanuts and soy), the occurrence of bronchial asthma, allergic rhinitis, duration of atopic dermatitis, family history and onset of atopic dermatitis. The statistical evaluation of the relations among individual parameters monitored was performed. Results: Food allergy was altogether confirmed in 65 patients (29%) and these patients suffer significantly more often from bronchial asthma and allergic rhinitis. Persistent atopic dermatitis lesions and positive data in family history about atopy are recorded significantly more often in patients with confirmed food allergy to examined foods as well. On the other hand, the onset of atopic dermatitis under 5 year of age is not recorded significantly more often in patients suffering from allergy to examined foods. Conclusion: Atopic dermatitis patients suffering from food allergy suffer significantly more often from allergic rhinitis, bronchial asthma, persistent eczematous lesions and have positive data about atopy in their family history. PMID:25284847

Risk factors for atopic and non-atopic asthma in a rural area of Ecuador.

PubMed

Moncayo, Ana Lucia; Vaca, Maritza; Oviedo, Gisela; Erazo, Silvia; Quinzo, Isabel; Fiaccone, Rosemeire L; Chico, Martha E; Barreto, Mauricio L; Cooper, Philip J

2010-05-01

BACKGROUND Asthma has emerged as an important public health problem of urban populations in Latin America. Epidemiological data suggest that a minority of asthma cases in Latin America may be associated with allergic sensitisation and that other mechanisms causing asthma have been overlooked. The aim of the present study was to investigate risk factors for atopic and non-atopic asthma in school-age children. METHODS A cross-sectional study was conducted among 3960 children aged 6-16 years living in Afro-Ecuadorian rural communities in Esmeraldas province in Ecuador. Allergic diseases and risk factors were assessed by questionnaire and allergic sensitisation by allergen skin prick reactivity. RESULTS A total of 390 (10.5%) children had wheeze within the previous 12 months, of whom 14.4% had at least one positive skin test. The population-attributable fraction for recent wheeze associated with atopy was 2.4%. Heavy Trichuris trichiura infections were strongly inversely associated with atopic wheeze. Non-atopic wheeze was positively associated with maternal allergic symptoms and sedentarism (watching television (>3 h/day)) but inversely associated with age and birth order. CONCLUSIONS The present study showed a predominance of non-atopic compared with atopic wheeze among schoolchildren living in a poor rural region of tropical Latin America. Distinct risk factors were associated with the two wheeze phenotypes and may indicate different causal mechanisms. Future preventive strategies in such populations may need to be targeted at the causes of non-atopic wheeze.

Pigmentary changes and atopic dermatitis in a patient with Seckel syndrome.

PubMed

Brackeen, Amy; Babb-Tarbox, Michelle; Smith, Jennifer

2007-01-01

Seckel syndrome is a very rare form of primordial dwarfism characterized by antenatal and postnatal growth delay, proportionate extreme short stature, a prominent beak-like nose, hypoplasia of the malar area, small chin, microcephaly, deformed ears lacking lobules, skeletal malformations, mental retardation, and developmental delay. This syndrome has been described with associated disorders of orthopedic, neurologic, hematologic, cardiac, and ocular systems; however, only a few reports mention dermatologic involvement. We describe a 5-year-old girl with classic Seckel syndrome who presented with moderately severe atopic dermatitis and diffuse hypopigmented macules and papules.